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Shoes with a rocker sole are marketed as reducing low back pain. There is minimal 
evidence to support these claims. This investigation compared rocker sole shoes to flat sole 
shoes in people with chronic low back pain (CLBP). 
The thesis reports findings of a randomised clinical trial and a series of biomechanical 
experiments. Following preparatory pilot and reliability studies, 115 people with CLBP were 
randomised to wear rocker sole shoes or flat sole shoes; all participants attended an 
exercise and education programme. Participants were assessed without knowledge of 
group allocation pre-randomisation, at six weeks, six months, and one year (main outcome 
point). Primary outcome was the Roland Morris Disability Questionnaire (RMDQ).  Analysis 
was by intention-to-treat.  
Biomechanical experiments recruited 20 participants from the main study and investigated 
effects of wearing rocker sole and flat sole shoes on standing balance and gait, immediately 
and after 6 months of shoe wear, using centre of pressure and motion-analysis derived 
kinetic, kinematic and spatio-temporal measures.  Balance and gait in people with and age- 
and gender-matched controls without CLBP were compared. 
Rocker sole shoes were no more beneficial than flat sole shoes for CLBP patients; flat sole 
shoes were more beneficial in a sub-group of CLBP aggravated by standing or walking. 
Biomechanical studies found rocker sole shoes introduced immediately greater postural 
instability than flat sole shoes but neither shoe had long-term training effects on postural 
control. Furthermore, although both shoes resulted in small immediate changes in kinetic, 
kinematic and spatio-temporal parameters of shod gait, neither shoe had long-term 
training effects on these parameters in barefoot gait. Finally, in contrast to some previous 
research, postural control during standing, and kinetics, kinematic, and spatio-temporal 
parameters during gait were similar between people with and without CLBP.  The 
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1 Introduction: Chronic Low Back Pain 
1.1 Aim of chapter  
This chapter defines chronic low back pain (CLBP), reports its incidence, prevalence and 
cost to society. The effectiveness of exercise therapy, a recommended conservative 
treatment in the management of chronic low back pain is discussed, and potential 
mechanisms underpinning CLBP are presented. 
1.2 Definition of chronic low back pain 
Defining CLBP is complex, with little agreement between studies regarding area of 
symptoms, expression of pain, and duration of symptoms (Stanton et al., 2010). Without an 
agreed definition, it is difficult to interpret and compare results of randomised, controlled 
trials (RCTs) that investigate CLBP.  
The National Institute for Health and Clinical Excellence (NICE) define non-specific LBP as 
“tension, soreness and/or stiffness in the lower back region for which it isn’t possible to 
identify a specific cause of the pain” (NICE, 2009). ‘Specific causes’ for the pain include: 
fracture, malignancy, infection, ankylosing spondylitis and other inflammatory disorders 
(NICE, 2009). The guideline defines the lower back as the area bound by the bottom of the 
12th rib and the buttock creases; when pain is also felt in the upper legs the back pain is 
usually the more dominant (NICE, 2009). The NICE guideline definition of non-specific LBP 
will be used for the purpose of participant recruitment in this thesis (NICE, 2009). ‘Chronic’ 
will mean a duration of pain for three months or longer (International Association for the 
Study of Pain, 1986). Patients presenting with radicular pain supposed by the clinician to 




1.3 Epidemiology and financial impact of chronic low back 
pain  
Low back pain (LBP) is reported by 49% to 80% of the general population at some stage 
during their lives (Airaksinen et al., 2006; Koes et al., 2006). In 2008, the incidence of 
chronic back problems was 31 per 1000 in males and 28 per 1000 in females (Office for 
National Statistics, 2008). Annually, 7% of the adult population will present to their general 
practitioner with LBP (McCormick et al., 1995) accounting for 14% of all musculoskeletal 
consultations (Jordan et al., 2010). Five to twenty percent will develop CLBP (Johanssen et 
al., 1995; Klaber Moffett et al., 1986; Quittan, 2002; Tortensen et al., 1998). If low back pain 
progresses to a chronic status it is likely to run a recurrent course in the majority of patients 
(Carey et al., 1999; Korff, 1994). The financial implications of LBP are substantial; in 1998 
the direct healthcare costs of LBP in the UK were estimated at £1623 million (Maniadakis 
and Gray, 2000). 
1.4 Possible biomechanical mechanisms underpinning 
chronic low back pain  
Although a wealth of research on CLBP exists, the causative mechanisms underpinning CLBP 
remain equivocal.  To understand CLBP and propose appropriate treatment it is important 
to recognise the many different mechanisms thought to underpin the condition. Further 
understanding of potential mechanisms may assist researchers in developing improved 
treatment approaches, more specifically directed at influencing such mechanisms. When 
considering the musculoskeletal system, it has been suggested that postural control deficits 
(Byl and Sinnott, 1991; Della Volpe et al., 2006; Henry et al., 2006; Luoto et al., 1996; 
Mientjes and Frank, 1999; Takala et al., 1997a) and biomechanical adaptations during gait 
(Keefe and Hill, 1985; Khodadadeh and Eisenstein, 1993; Vogt et al., 2001) are contributing 




1.4.1 Postural stability and control strategies in chronic low back pain 
Postural control strategies provide postural stability to the human body during movement 
and the maintenance of static postures (Horak and Nashner, 1986). Small perturbations 
during standing result in sway at the ankle joint in order to maintain the body’s centre of 
mass within its base of support; this is called the ankle strategy (Horak and Nashner, 1986). 
Although an ankle strategy is adequate to maintain upright stance on a flat surface, it is not 
adequate when on a short base or during more challenged standing conditions (Horak and 
Nashner, 1986). During large perturbations greater movements at the hip assist in the 
maintenance of the body’s centre of mass within its base of support; this is  known as the 
hip strategy (Horak and Nashner, 1986). A third strategy called the stepping strategy is 
implemented when a perturbation displaces the centre of mass outside an individual’s base 
of support. Individuals with CLBP have demonstrated altered postural control strategies 
when compared to asymptomatic individuals (Byl and Sinnott, 1991; Della Volpe et al., 
2006; Henry et al., 2006; Luoto et al., 1996; Mientjes and Frank, 1999; Takala et al., 1997a). 
Della Volpe et al. (2006) investigated whether CLBP patients with mild disability exhibited 
altered postural control during quiet standing when compared with asymptomatic, age-
matched controls. Six standing conditions, varying visual and proprioceptive input, were 
assessed. Measures of postural stability (centre of pressure (CoP) velocity and 
displacement) were recorded from a force plate. The CLBP patients oscillated with a greater 
velocity than asymptomatic patients during the more challenging balance conditions, 
indicating reduced postural stability in the CLBP group (Ruhe et al., 2011a). However, the 
sample size was small, and anthropometric data capable of influencing CoP excursions, such 
as age (Choy et al., 2003; Era and Heikkinen, 1985; Hasselkus and Shambes, 1975; Hue et 
al., 2007), height (Chiari et al., 2002; Hue et al., 2007), and weight (Chiari et al., 2002; Hue 
et al., 2007) were omitted for the control group, hence these findings must be regarded 
with caution.  
Brumagne et al. (2008) investigated the influence of support surface on postural stability 
and control strategies in those with and without CLBP. Twenty one participants with CLBP 
(fourteen women, seven men) and twenty four asymptomatic individuals were assessed. 
There were no differences in postural stability between groups during normal standing on a 
firm support surface with eyes open, however, when standing during more challenging 
standing conditions (visual occlusion or the addition of ballistic arm movements) the CLBP 
group demonstrated significantly larger CoP displacements compared to the pain-free 
18 
 
controls. Due to the larger CoP displacements in the CLBP group it was concluded that 
people with CLBP favour an ankle strategy during unstable standing conditions when a hip 
strategy is thought to be more biomechanically effective (Horak and Nashner, 1986). This 
abnormal postural strategy in people with CLBP may result from a reduced ability to initiate 
a hip strategy secondary to co-contraction of superficial muscles around the hip (Mok et al., 
2004). 
Mok et al. (2004) observed standing balance in twenty four participants with CLBP and 
twenty four age- and gender- matched controls. Participants stood on either a flat surface 
or a short base (a block 9cm in length), on one or both legs, whilst visual inputs were varied. 
Horizontal shear force, CoP excursion, and the number of successful balance trials were 
assessed. CLBP participants were found to have poorer balance when compared to the 
asymptomatic group. A reduced ‘hip strategy’ (inferred from a reduction in antero-
posterior horizontal shear force) was demonstrated in participants with CLBP during 
standing trials on firm ground. These findings suggest that people with CLBP have poorer 
balance and altered postural control strategies in standing when compared to 
asymptomatic individuals. 
It is likely that a number of different mechanisms contribute to the presence of these 
altered postural control strategies. Firstly, during quiet standing the mean CoP position is 
more posterior in people with back pain (Byl and Sinnott, 1991; Mientjes and Frank, 1999). 
Such posterior deviations of the CoP may influence the activation of ankle and hip 
strategies during standing due to a biomechanical ease or advantage for the recruitment of 
certain muscle groups to maintain the centre of mass within the base of support. Although 
the resting position of the CoP may help to explain why a different postural strategy may be 
used, it remains unclear as the why, in people with CLBP, the CoP should rest more 
posterior than it would in asymptomatic people.  
Reduced activity of the deep abdominal (Hodges and Richardson, 1996; Hodges and 
Richardson, 1998; Hodges and Richardson, 1999) and paraspinal muscles (Ahern et al., 
1988; Hides et al., 1996; Ng et al., 2002) have been identified in those with LBP, 
accompanied by co-contraction of the superficial muscles in the lumbo-pelvic region 
(Hodges and Moseley, 2003). It has been hypothesised that this superficial muscle co-
contraction restricts both range and pace of trunk and hip motion in response to large 
postural perturbations (Mok et al., 2004). This may result in a stiffened postural 
appearance, and a possible restriction in the initiation or efficiency of the hip strategy in 
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people with CLBP. This theory may also account for the increased, and supposed 
compensatory, ankle strategy observed during more challenging standing conditions 
(Brumagne et al., 2008; Mok et al., 2004).  
Proprioception is the ability to determine exactly where a body part is in space 
(Sherrington, 1907). Reduced lumbar spine proprioception (Brumagne et al., 2000; Gill and 
Callaghan, 1998; Parkhurst and Burnett, 1994; Taimela et al., 1999) has been reported in 
patients with LBP when compared to asymptomatic individuals. These deficits,  
hypothesized to cause delayed muscle responses to sudden trunk loading (Hodges and 
Richardson, 1996; Hodges and Richardson, 1998; Radebold et al., 2000; Wilder et al., 1996), 
may reduce  preparatory spinal movement (Mok et al., 2007), adversely affecting spinal 
control, and increasing spinal displacement (Mok et al., 2007). Hence, reduced 
proprioception has been proposed as a causative factor underpinning the presence of CLBP 
(Brumagne et al., 2000). However, uncertainties exist around the mechanisms underpinning 
the origin of such proprioceptive deficit. A poorer ability to accurately reposition the 
lumbar spine in people with low back pain compared to people without has been observed 
(Brumagne et al., 2000; Gill and Callaghan, 1998; Taimela et al., 1999), suggesting that the 
presence of pain may contribute to the proprioceptive deficit. The presence of pain stimuli 
may cause a reduction of position sense (Rossi et al., 1998) by altering neuronal excitability 
through increased presynaptic inhibition of muscle afferents at a spinal level (Rossi et al., 
1999) or the down regulation of cortical systems involved in proprioceptive processing 
(Porro et al., 2002; Rossi et al., 2003). Alternatively, injury to the lumbar spine, resulting in 
the presence of dysfunctional mechanoreceptors in surrounding muscles and ligaments 
(the main stabilizers of the lumbar spine) (Hodges and Richardson, 1998; Parkhurst and 
Burnett, 1994; Radebold et al., 2000; Taimela et al., 1999) offers a further mechanism 
which may explain the altered postural control observed in those with CLBP.  
The exact mechanisms underpinning altered postural stability and control strategies in 
people with CLBP are unclear (Cholewicki et al., 2003). Furthermore, it is not known 
whether differences in postural control mechanisms in people with CLBP are protective or 
maladaptive responses, or are epiphenomena (secondary symptoms occurring alongside a 
disease or condition but not directly related to its cause (Stedman, 2005)) of a different 
mechanism underpinning CLBP. If altered postural strategies are detrimental to recovery, 
treatment directed at influencing these strategies may result in more beneficial outcomes 
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for people with CLBP. This is discussed in 2.4 (p25). However, it is unclear whether 
approaches to ‘normalise’ these postural control alterations may be possible or effective. 
1.4.2 Gait, heel strike transients and shock attenuation alterations in 
chronic low back pain 
Alterations in gait have been observed in people with CLBP when compared to 
asymptomatic individuals. Whilst walking, people with LBP increase activity in lumbar 
extensors muscles (Arendt-Nielsen et al., 1996), reduce walking speed and step length, and 
increase their cadence (steps per minute) when compared to age-matched asymptomatic 
individuals (Keefe and Hill, 1985; Khodadadeh and Eisenstein, 1993; Vogt et al., 2001). 
These gait differences in people with LBP may be an attempt to modify external and 
internal forces imposed on the body by limiting hip and spine ranges of motion (Lee et al., 
2007). Reduced pain and improved functional ability have been reported in people with 
CLBP when the loading force on heel strike was reduced from walking with viscoelastic shoe 
insoles (Folman et al., 2004; Wosk and Voloshin, 1985). The reduced gait speed in people 
with CLBP may, therefore, be an attempt to attenuate vertical ground reaction forces (GRF) 
– the positive linear correlation between gait velocity and vertical GRF in pain free 
individuals (Keller et al., 1996) reinforces this theory. Alternatively, people with LBP may 
inadvertently adopt a ‘protective guarding’ gait pattern, modifying their pattern of 
muscular activity and restricting movements of the spine (Ahern et al., 1988) in an attempt 
to reduce the sensation of pain. Similarly, the ‘fear avoidance’ model (Leeuw et al., 2007) 
has been implicated as a possible cause of the altered gait. Psychological factors associated 
with low back pain, such as anxiety, hypervigilance and catastrophising, may lead to the 
avoidance or adaptation of physical activities, such as fast walking, due to the fear of an 
increase in pain (Al-Obaidi et al., 2003). 
However, consequences of such gait alterations may contribute to the development and 
chronicity of symptoms. A reduction in step length and walking speed decreases counter-
rotation between the lumbar, thoracic and pelvic regions during gait. This produces longer 
periods of loading on the lumbar spine during gait (Callaghan et al., 1999), which may be 
detrimental to spinal structures in the long term; whereas more cyclic, shorter periods of 
loading, thought to be less detrimental, occur during faster walking (Callaghan et al., 1999). 
Although gait alterations may initially be protective, such alterations may have detrimental 
long term consequences to those already in pain. 
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Heel strike force transients during gait have been implicated as a potential cause and 
aggravator of LBP (Light et al., 1980; Voloshin and Wosk, 1982). Heel-strike, the first 
component of the stance phase of the gait cycle, introduces a shock wave that is 
propagated upwards through the skeleton as a transient force (Light et al., 1980). The 
calcaneal heel pad, cartilage of the joints and their subchondral cancellous bone are 
thought to attenuate these transients. Although transient forces have been proposed as 
harmful to the musculoskeletal system, much of the evidence for this theory comes 
indirectly from animal studies (Radin et al., 1978; Radin et al., 1982; Radin et al., 1973; 
Simon et al., 1972). Although greater heel strike magnitudes have been observed in people 
with early signs of knee osteoarthritis when compared with age-matched asymptomatic 
individuals (Radin et al., 1991), little direct evidence indicating these transient forces are 
harmful under physiological conditions in humans exists; degenerative changes occur over 
long periods of time, making it difficult to perform adequate prospective studies. Voloshin 
and Wosk (1982) investigated the ability of the musculoskeletal system to attenuate shock 
during gait in asymptomatic participants, participants with LBP, and participants with other 
degenerative joint diseases. Accelerometers were attached to each participant’s forehead 
and femoral condyle. Levels of shock attenuation in non-LBP subjects were higher than in 
the LBP group. It was concluded from these findings that the presence of LBP correlated 
with a reduced shock absorbing capacity of the human musculoskeletal system from the 
femoral condyle to the forehead. More valid results may have been obtained by attaching 
accelerometers to points closer to the lumbar spine; alternatively, more accurate 
measurements may have been derived by using bone mounted accelerometers. Although 
research with bone mounted accelerometers has been conducted (Mendelson et al., 1998) 
this invasive approach has medical and ethical considerations. Due to the paucity of 
longitudinal data it is not known whether observations of reduced shock attenuation 
(Voloshin and Wosk, 1982) and increased heel strike transients  (Radin et al., 1991) existed 
pre- or post-onset of a participant’s pain, but provide a further potential mechanism to 
explain its presence. 
The manner in which a person stands or mobilises may contribute to the presence of CLBP. 
Closer analysis of the neuro-musculoskeletal systems involvement in the control of each of 




1.5 Conservative management of chronic low back pain 
As a result of the non-specific nature of the majority of CLBP, numerous conservative 
treatments have been proposed (Hayden et al., 2005a). National (NICE, 2009) and 
international guidelines (Koes et al., 2001) recommend exercise as a key component in the 
management of CLBP and will be discussed further within this thesis. Invasive procedures 
(such as acupuncture and surgery) and other approaches (such as manual therapy and 
psychology) recommended in the management of CLBP (NICE, 2009) fall outside the scope 
of this research, hence, will not be discussed further within this thesis. 
1.5.1 Exercise and chronic low back pain 
The NICE guideline for CLBP summarised findings into the effectiveness of general exercise 
programmes compared to ‘usual care’ on pain, and functional disability (NICE, 2009). The 
guideline (NICE, 2009) recommends that people with CLBP be advised to keep physically 
active. In agreement with other systematic reviews (Hayden et al., 2012; Koes et al., 2006; 
Koes et al., 2001), attendance to a structured, supervised, exercise programme, including 
aerobic activity, muscle strengthening, stretching, or tasks to challenge postural control is 
recommended for people with CLBP (NICE, 2009). The NICE guideline recommendations 
regarding exercise therapy are drawn from only 12 studies, all relating to participants with a 
CLBP history of between six weeks and one year. It is unclear whether response to 
treatment for people with CLBP of a duration greater than one year may differ to that of 
individuals with less chronic presentations, hence caution must be taken when relating 
these findings to a more chronic population. 
 
Although, previous research demonstrates strong evidence for exercise therapy (Hayden et 
al., 2012; Koes et al., 2006; Koes et al., 2001; NICE, 2009) no one form of exercise appears 
to be substantially superior to another (Bogduk, 2004; Unsgaard-Tondel et al., 2010; van 
Tulder et al., 2006). A systematic review investigating motor control exercises (including 
motor control, specific spinal stabilisation or core stability exercises) for CLBP (Macedo et 
al., 2009) concluded, from fourteen randomised, controlled trials (RCTs), that motor control 
exercises offer no more benefit than manual therapy, surgery or other forms of exercise. 
Furthermore, although a recommended ‘best practice’ (NICE, 2009), exercise intervention 
effects are small with minimal improvements in disability and pain at long term follow-up in 
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people with CLBP (Keller et al., 2007).Therefore, it is important to continue investigating, 
with high quality RCTs, novel and evidence based treatment approaches for those with 
CLBP. 
1.5.2 Footwear as a treatment for chronic low back pain 
Interventions yet to be investigated in robust RCTs may offer additional benefits, for people 
with CLBP, to the minimal improvements reported following ‘best practice’ interventions. 
Altered biomechanics during standing and gait in people with CLBP have been suggested as 
underpinning mechanisms contributing to the presence and recurrence of symptoms 
(Brumagne et al., 2008; Mok et al., 2004). Footwear has demonstrated an ability to 
influence human biomechanics, such as balance (Nigg et al., 2006b), spatio-temporal 
parameters of gait (Demura et al., 2012; Keenan et al., 2011; Lythgo et al., 2009), and joint 
kinematics (Taniguchi et al., 2012), hence, footwear may offer benefit to people with CLBP. 
Over the past 15 years shoe companies have designed, footwear marketed with strong 
advertising claims of the shoes ability to influence low back pain (Masai Barefoot 
Technology GB Ltd, 2011). Companies include Masai Barefoot Technology (MBT) GB 
LimitedTM, Chung Shi TM, Fitflops TM, Reebok’s ‘Easy Tone’ TM, and  Skechers ‘Shape up’ TM. 
Currently there is minimal evidence supporting or rejecting these claims. Hence, there is a 
need for large high quality RCTs, investigating potential effects of footwear on LBP, to 
determine whether footwear type can complement the current best practice approaches 
for CLBP. This is discussed in detail in Chapter 2 (p22). 
1.6 Conclusions 
The mechanisms underpinning CLBP remain unclear. In order to establish effective 
treatment approaches for those with CLBP a sound knowledge of the mechanisms 
underpinning the presence of pain is necessary. This lack of knowledge may contribute to 
the minimal clinical benefits observed in those with CLBP even when receiving current best 
practice treatment approaches. It is feasible that a novel approach to CLBP management, a 
rocker sole shoe, marketed with a shock absorbing heel and an unstable sole, promoting 
instability during standing and walking, may positively influence biomechanical mechanisms 




2 The potential for footwear to influence chronic low 
back pain 
2.1 Aim of chapter 
This chapter summarises previous research investigating the effect of footwear on the 
musculoskeletal system, and suggests how rocker sole shoes may positively influence 
chronic low back pain (CLBP) by affecting the underpinning mechanisms presented in 
Chapter 1 (p15). 
2.2 Evolution of footwear 
In 1938, an American anthropologist discovered what is thought to be the oldest surviving 
footwear in a cave in North America (Kuttruff et al., 1998). The sandals are thought to be 
9,300 to 10,500 years old. However, the first suggestion of the existance of footwear 
appeared in Spanish cave paintings, from the late Paleolithic period (15,000 years ago), 
showing humans wearing animal skins around their feet.  
The observation of anatomical changes in the structure of human foot bones, between 
10,000 and 100,000 years ago (Trinkaus and Shang, 2008), has lead researchers to propose 
that the use of shoes began at a much earlier time point. A reduction in  thickness, size and 
strength of the proximal phalanges was observed in toe bones disovered in a cave in China 
dating from 26,000 to 40,000 years ago. It was hypothesised that wearing shoes reduced 
the forces on these toes during walking, resulting in shorter and thinner toes (Trinkaus and 
Shang, 2008). These findings suggest that footwear may have the potential to change 
human biomechanics. 
2.3 Footwear and the modern human musculoskeletal 
system  
Footwear continues to evolve. Shoes are specifically designed to benefit participation in 
daily and sporting activities. Different designs of footwear have demonstrated differing 
influences on human biomechanics (Demura et al., 2012; Elbaz et al., 2009; New and Pearce, 
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2007; Nigg et al., 2006b; Romkes et al., 2006; Taniguchi et al., 2012). Over the past decade 
footwear manufacturers have made claims that, through altering human biomechanics, 
their footwear may benefit a variety of musculoskeletal conditions, for example, knee pain 
and low back pain (Masai Barefoot Technology GB Ltd, 2011). A recent example are shoes 
manufactured with convex soles, commonly known as rocker sole shoes. If the claims made 
by shoe manufacturers are substantiated, selection of appropriate footwear may add 
benefit to the management of certain musculoskeletal conditions. For symptomatic 
individuals, such as those with CLBP, there is a paucity of evidence in peer-reviewed 
literature to supporting these claims. Therefore, this thesis will investigate whether a rocker 
sole shoe may positively influence the musculoskeletal dysfunctions or adaptations 
observed in people suffering from CLBP. 
2.4 Rehabilitation of postural control in chronic low back 
pain 
Poorer postural stability and altered postural strategies have been identified in people with 
CLBP compared to asymptomatic individuals, as described in 1.4.1 (p17). Alterations to 
postural stability and postural strategy in the acute stages of LBP may be an attempt to 
reduce musculoskeletal discomfort (Lafond et al., 2009). However, if maintained following 
the acute stage of injury, these changes may mean the dynamic stability of the lumbar 
spine is compromised, potentially increasing a person’s vulnerability to further injury, or 
exacerbating an existing back problem (Radebold et al., 2001). Rehabilitation exercises 
aimed at training postural control to address this altered system therefore seems a 
plausible treatment approach.  
Rehabilitation with proprioceptive or balance training has been shown to be a successful 
treatment in other regions of the body (Fitzgerald et al., 2000; Tropp and Askling, 1988). In 
people with functional ankle instability, ten minutes of proprioceptive exercise on a wobble 
board, five times a week for 10 weeks, resulted in increased ankle evertor muscle strength, 
improved postural stability, and a reduced sensation of the ankle giving way when 
compared to people not undergoing wobble board training (Tropp and Askling, 1988). 
Similarly, in anterior cruciate ligament (ACL) deficient knees, specific perturbation 
rehabilitation programmes (using a roller board and wobble board for two to three sessions 
a week for approximately five weeks) resulted in a reduced incidence of giving way of the 
26 
 
knee during athletic activity at six months compared to those receiving standard ACL 
rehabilitation (Fitzgerald et al., 2000).  
The potential impact of rehabilitation techniques aimed at improving postural control in 
people with CLBP is unclear. Comparison of the effectiveness of co-ordination training 
(emphasising stability and balance exercises) with muscle endurance training (focusing on 
low back, abdominal, shoulder, hip and knee muscles) in people with CLBP has been 
conducted (Johanssen et al., 1995). Participants in both groups attended a one hour 
exercise class, twice a week, over a three month period. Results suggested that 
proprioceptive and endurance exercises produce similar pain reduction and functional 
improvement at three and six months. However, researchers were not blind to participant 
group allocation, and it is unclear whether the pain and disability measures assessed were 
valid or reliable.  
A manufacturer of rocker sole shoes (Masai Barefoot Technology GB Limited, London, UK) 
have suggested that the unstable sole in their footwear can help to increase muscle activity 
and improve balance, hence, can be used as a ‘sensorimotor training device’, easily 
incorporated into everyday life that will benefit functional daily activities (Masai Barefoot 
Technology GB Ltd, 2011). Nigg et al. (2006b) demonstrated the unstable nature of the 
rocker sole during standing. In a small asymptomatic sample (n=8) greater centre of 
pressure (CoP) excursions (indicating poorer postural stability) in both antero-posterior (AP) 
and medio-lateral (ML) directions were recorded in rocker sole compared to flat sole shoes. 
The unstable surface of the rocker sole shoes appears to challenge postural stability in a 
similar way to a wobble board. 
Wearing rocker sole shoes and hence ‘training’ for hours each day may enhance the 
effectiveness of training balance when compared to other interventions, such as the 
wobble board, offered at decreased frequencies and durations (Fitzgerald et al., 2000; 
Tropp and Askling, 1988). If rocker sole shoes serve as an effective training device for joint 
stability and proprioception training they may provide clinical benefit to those with CLBP 
who present with impaired postural control. 
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2.5 Influencing spatio-temporal parameters of gait with 
footwear in chronic low back pain 
Individuals with LBP walk slower, and take shorter steps with a greater cadence when 
compared with age-matched asymptomatic individuals (Keefe and Hill, 1985; Khodadadeh 
and Eisenstein, 1993; Vogt et al., 2001). These gait alterations may contribute to the 
chronicity of LBP symptoms. However, fast walking is thought to offer more benefits to the 
spine than slow walking (Nutter, 1988). A greater arm swing usually occurs whilst walking 
faster and this has been found to result in lower lumbar spine moments, muscle activity, 
and hence a reduction in joint loading (Callaghan et al., 1999; McGill, 2007). Furthermore, 
Kubo and colleagues (2006) reported higher torso stiffness, a positive co-factor in 
prevention of and more successful recovery from low back troubles (Nutter, 1988), with 
faster walking, and Holm and Nachemnson (1983) demonstrated that lumbar motion during 
faster walking increased nutrition to the intervertebral disc suggesting faster walking to be 
a more advantageous to the spine than slow walking. These findings complement the 
suggestion by Elbaz et al. (2009) that the increased walking speed observed following the 
use of specialised footwear may positively influence the symptoms of LBP. 
Elbaz et al. (2009) investigated the effects of a ‘novel biomedical device’ - the APOS (All 
Phases of Step cycle) system - on gait in nineteen CLBP patients. The footwear device 
comprises of two semi-circular discs which attach to the base of a shoe. At baseline, 
participants’ spatio-temporal parameters were assessed during barefoot gait at self-
selected speed. After twelve weeks of wearing the APOS system, velocity, cadence, and 
step length increased. No pain or functional outcome measures were recorded, hence, it is 
unknown whether biomechanical changes correlated with clinical improvement; nor was 
participant familiarity with the testing procedure considered as a possible contributing 
factor to the differences observed at follow-up. Furthermore, participant compliance with 
wearing the footwear device is unclear. However, their study suggests that footwear has 
the potential to influence barefoot gait in CLBP. 
If other types of footwear such as the rocker sole MBT shoe can influence gait parameters 
such as walking speed, in a similar manner to that demonstrated from use of the APOS 
system, a positive influence on low back pain may occur. Recommendations by a rocker 
sole shoe manufacture suggest walking at a quicker pace than normal, with a slightly 
shorter step length, whilst gently swinging the arms (5.3.6, p68). All three of these 
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suggested gait instructions have been associated with decreased load on the lumbar spine 
by either increasing lumbar movement during gait (Callaghan et al., 1999) or reducing the 
transient forces initiated at heel-strike (Folman et al., 2004; Wosk and Voloshin, 1985)  
from reaching the spine. 
In contrast to these walking recommendations and the findings of Elbaz et al. (2009), 
walking in rocker sole shoes (MBT shoes) compared to normal footwear has demonstrated 
decreases in cadence, stride length, step length and walking speed (Romkes et al., 2006). 
However, methodological differences between the studies may explain the contrasting 
findings; in the APOS study participants were assessed in barefoot pre- and post- a 12 week 
intervention period. In the rocker sole shoe study, participants were assessed shod in their 
normal shoes and in rocker sole shoes. Although a faster gait velocity has been suggested 
by some to have benefits for those with LBP (Callaghan et al., 1999; McGill, 2007; Nutter, 
1988), a slower gait velocity,  with concomitant reductions in ground reaction forces  (Keller 
et al., 1996) (2.6, p28) may also be beneficial to people with CLBP. 
2.6 Influencing shock attenuation and ground reaction forces 
with footwear in chronic low back pain 
As discussed in 1.4.2 (p20), mechanical stress such as the ground reaction forces during 
heel strike have been acknowledged as aggravating factors in the aetiology of CLBP. Whittle 
et al. (1999) stated that the body has two natural defences against potential damage from 
the heel strike transient (the sharp increase in ground reaction force detected immediately 
after heel strike): appropriate joint alignment (such as knee flexion) at heel strike and the 
presence of viscoelastic materials in the heel  pad and joints. People with LBP have 
reported reduced pain and improved functional ability when repetitive axial loading forces 
during walking were reduced by walking with viscoelastic shoe insoles (Wosk and Voloshin, 
1985). Spinal loading can be influenced by footwear type – it has been demonstrated that 
running in sports trainers compared to barefoot decreases the rate of shock transmission to 
the spine (Ogon et al., 2001); whereas, increasing footwear heel height increases the 
loading on the erector spinae muscles  when walking (Lee et al., 2001, Mika et al., 2012). A 
cushioning effect from footwear may assist in reducing external forces reaching the spine, 
or may influence lower quadrant joint angles during the stance phase of the gait cycle, 
increasing shock attenuation.  
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MBT GB Ltd suggest that musculoskeletal disorders such as back pain may be associated 
with walking on hard flat surfaces, and that walking in MBT shoes will provide a more 
comfortable heel strike compared to normal shoes due to the ‘Masai sensor’- a 
polyurethane cushion incorporated into the heel portion of the sole (Masai Barefoot 
Technology GB Ltd, 2011). MBT GB Ltd claim that mobilising in MBT shoes, whereby the 
curved sole provides a more gentle rolling movement through each step than a flat sole 
shoe, simulates walking on soft natural terrain such as on sand, hence may reduce 
supposedly detrimental impact to the musculoskeletal system during gait (Masai Barefoot 
Technology GB Ltd, 2011).  
An unpublished study investigating the effect of shoe type on ground reaction forces in 
twenty two asymptomatic individuals (Vernon et al., 2004) demonstrated a reduced 
incidence of transient force peaks when walking in rocker sole shoes compared with normal 
flat sole shoes. If these findings are replicated in a CLBP population, and if transient heel 
strike forces are a contributing factor to the presence of LBP, footwear may offer symptom 
relief to this population.  
New and Pearce (2007) reported a small increase in knee flexion angle at heel strike for 
participants walking in rocker sole shoes compared to their normal footwear. Similarly, 
during gait, Romkes et al. (2006) reported a  greater knee flexion on initial heel strike when 
in MBT shoes. If this increase in knee flexion improves shock absorption (Whittle, 1999) in 
the distal musculoskeletal system, potentially reducing the passage of transient forces to 
the lumbar region, and if recurrent force transients during gait are a contributing factor to 
the presence of LBP, such biomechanical alterations may influence the symptoms of LBP. 
However, it is not known whether forces reaching the spine are reduced when wearing a 
rocker sole shoe compared to when mobilising in a flat sole shoe or whether forces 




2.7  Conclusions 
Biomechanical mechanisms have been proposed to underpin CLBP. Wearing footwear 
influences the biomechanics of the musculoskeletal system. Footwear manufacturers claim 
that biomechanical effects from wearing their footwear may positively influence 
musculoskeletal conditions, such as CLBP. Currently there is minimal evidence to support or 
reject these claims. Hence, there is a need for large high quality RCTs, investigating 
potential effects of footwear on LBP, to determine whether footwear type can complement 




3 Evolution of the thesis 
Dr Jeremy Lewis (JL) conceived the pilot study protocol and approached Masai GB Limited 
(the manufacturer the rocker sole shoes investigated in this study) with a proposed 
research protocol to determine whether rocker sole shoes influenced chronic low back pain 
– a claim made by the footwear company. Masai GB Limited agreed to fund the proposed 
trial. At this point JL approached Siân MacRae (SM) with regards to SM developing and 
conducting the trial as a PhD research project. Conducting a pilot study was a requirement 
of the funding agreement for this research. Furthermore, the pilot study was conducted to 
inform the design of the main clinical study in terms of: sample size calculation; integrity of 
the study protocol; acceptability and practicality of data collection methods; the 
randomisation process; recruitment and consent; and selection of the most appropriate 
primary and secondary outcome measure. The recruitment of participants into the pilot 
study occurred between January 2008 and November 2008. A reliability study to determine 
the reliability of the chief investigator (C.I.) to measure spinal impairment measures 
(secondary outcome measures in the main study) recruited patients in June 2009. 
 
The recruitment of participants into the main clinical study occurred from April 2009 to 
December 2010. Following commencement of the main clinical study, SM felt it important 
to determine, if changes in outcome measures were obtained in the rocker sole group 
compared to the flat sole group, whether biomechanical mechanisms may be a contributing 
factor to such changes. Hence, SM conceived a series of biomechanical studies to help 
explain any clinically significant changes that may have occurred as a result of the 
intervention. Subsequent to attaining ethical approval, these studies ran concurrently with 
the main study, commencing during the latter part of the main study recruitment period.  
The recruitment period for the biomechanical studies occurred from June 2010 to 
December 2010. The Gantt chart in Figure 3.1 demonstrates the thesis time-line. 







































































































































































































































































































































































































































































































































































   Figure 3.1 Gantt chart demonstrating time-line of studies conducted within the thesis 
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4 Development of Methodologies for main clinical 
study 
4.1 Aim of chapter 
This chapter describes the development of the methods employed in the main clinical 
study. Two preparatory studies were conducted to inform methodologies: i) a pilot study; 
and ii) a reliability study for the assessment of spinal posture and impairment (secondary 
outcome measures in the main clinical study). Adaptations of pilot study methods to 
improve the main clinical study are presented following reflection on study successes and 
challenges. Reasons underpinning i.) the choice of primary and secondary outcome 
measures and ii.) the choice of statistical tests in the main study are discussed. 
4.2 Pilot study 
4.2.1 Introduction 
The pilot study was conducted to inform the design of the main clinical study in terms of: 
sample size calculation; integrity of the study protocol; acceptability and practicality of data 
collection methods; the randomisation process; recruitment and consent; and selection of 
the most appropriate primary and secondary outcome measures. Conducting a pilot study 
was a requirement of the funding agreement for this research. 
4.2.2 Methods 
4.2.2.1 Design 
This randomised controlled study design was prospective with repeated measures at 
baseline and six weeks. The co-researcher (Dr Jeremy Lewis (JL)) remained blind to 




Ethical approval for the study was granted from the Riverside Research Ethics Committee 
(REC reference number: 07/H0706/74). Twenty participants were recruited from general 
practitioner and consultant referrals to the Neuro-musculoskeletal Physiotherapy 
Department at the Chelsea and Westminster Hospital, London. Participants were suitable 
for inclusion if they fulfilled the inclusion and exclusion criteria (Table 4.1). 
Table 4.1 Inclusion and exclusion criteria 
Inclusion criteria Exclusion criteria 
 Aged 18 to 65 years 
 A  three month or greater history of low 
back pain 
 Lumbosacral pain with or without 
referral (of a supposed non-radicular 
nature) 
 Pain of a mechanical nature (pain 
aggravated or eased by activity) 
 Willing to comply with the 
randomisation process. 
 Able to fully communicate in English 
 Able to participate in an exercise group 
and perform exercises at home 
 
 Constant pain 
 Non-mechanical pain (pain not aggravated 
or eased  by activity or posture) 
 Nerve root entrapment accompanied by 
neurological deficit 
 Neoplasms 
 Severe structural deformity or 
osteoporosis 
 Known spondylolysthesis or spinal stenosis 
 Fracture of the spine within the past year 
 Inflammatory disease of the spine 
 Spinal infection 
 Severe cardiovascular or metabolic disease 
 Pregnancy 
 Previous spinal surgery 
 Known Morton’s Neuroma 
 Skin ulceration over the foot 
 Peripheral neuropathy with loss of 
sensation 
 History of falls 
 Surgery to the lower limb in the past 8 
weeks 
 History of deep vein thrombosis (DVT) yet 
to be stabilised/yet to be advised to return 
to exercise by their medical practitioner 
 Unresolved legal issues regarding their 
back pain 
 Participants who have previously used 
rocker sole shoes 
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4.2.2.3 Outcome Measures 
The primary outcome measure in the pilot study was the Oswestry Disability Questionnaire 
(ODQ) version 2.0 (a questionnaire to assess self-reported low back disability) (11.2, p224). 
The secondary outcome measures used are shown in Table 4.2. 
Table 4.2 Secondary outcome measures 
Secondary outcome measures 
 Roland Morris Disability questionnaire (RMDQ) (a questionnaire to assess self-
reported low back disability) (11.3, p225) 
 SF36 health questionnaire (a measure of health related quality of life) (11.4, p227) 
 Numerical rating score for pain 
 Tampa Kinesiophobia Scale (a questionnaire measuring fear of movement and fear of 
(re)injury during movements) (11.5, p231) 
 Hospital Anxiety and Depression Score (a questionnaire measuring anxiety and 
depression) (11.6, p232) 
 Range of spine movement (flexion, extension, left and right side flexion) 
 Straight leg raise 
 Hours study shoes worn per day 
4.2.2.4 Consent and Randomisation. 
Patients who fulfilled the inclusion and did not fulfil the exclusion criteria were asked to 
read the Patient Information Sheet (11.7, p234) before consenting to take part in the study. 
They were advised to discuss their participation in the study with family, friends, other 
healthcare workers, and their physiotherapist before deciding whether or not to 
participate. 
Patients happy to participate were consented into the study by the Chief Investigator (C.I. 
Siân MacRae). Those signing consent forms (11.8, p241) were then assigned by block 
randomisation (blocks of four), into one of two groups: 
 Group 1: Participants received a pair of rocker sole shoes and attended eight back 
exercise group sessions over four weeks 
 Group 2: Participants received a pair of flat sole shoes and attended eight back 
exercise group sessions over four weeks 
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The block randomisation protocol was chosen in order to ensure the numbers of 
participants in each group were similar. Possible combinations for a block size of four with 
two rocker sole shoe and two flat sole shoe allocations per block was calculated as six. 
These blocks were written on pieces of paper by Dr Matt Morrissey (original PhD supervisor 
before he left King’s College London), then randomly selected in order to determine the 
group allocation of all 20 participants taking part in the study. The C.I. was informed of the 
participant’s group allocation by Dr Matt Morrissey once a baseline assessment 
appointment had been booked. 
4.2.2.5 Assessment procedure 
The C.I. supervised each participant whilst outcome measure questionnaires were 
completed. The C.I. then fitted each participant with their allocated study shoes, instructed 
them in the correct walking and standing technique whilst wearing the shoes 
(approximately twenty minutes duration), and explained how to complete the diary sheet 
(11.9, p243) regarding number of hours of study shoe wear per day. The co-researcher, 
blind to group allocation, recorded the spinal impairment measurements (range of motion 
into flexion, extension, left and right side flexion, and left and right straight leg raise (SLR)). 
The methods used for assessing lumbar movement have been demonstrated to be reliable 
by the C.I. (van Blommestein et al., 2012) and by other research (Lewis et al., 2005). 
Participants, standing barefoot, with their feet hip width apart, were asked to lean 
forwards, then backwards, then to each side, until they either reached the limit of their 
available movement, or until their low back pain started to present or worsen. Using a non-
stretch tape measure the distance between the patients’ left middle finger fingertip and the 
floor directly below the left medial malleolus was recorded for the flexion and extension 
movements; for the side flexion movements the ipsilateral middle fingertip and the floor 
just behind the lateral malleoli were used as marker points for measurement recording. 
Three readings for each movement were taken and the average used in the data analysis. In 
order to assess SLR, an Isomed inclinometer (Figure 4.1) was placed on the tibial tuberosity 
and the patients’ leg passively raised by the co-researcher. Participants were asked to 
report when they would like the co-researcher to stop raising their leg. This could be due to 
a strong stretching sensation in the posterior aspect of their leg, or if their symptoms of low 
back pain presented, or worsened.  At this point, the SLR movement was stopped, a 
Numerical Rating Score (NRS) for pain was ascertained from the patient (from 0 to 10, 
where 0 = no pain, and 10 = worst imaginable pain, and their leg lowered back to the plinth 
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by the assessor. Three readings were recorded for the SLR angle for each leg, and the 
average documented. The study conducted to investigate reliability of these measurement 
techniques is described in 4.4 (p53). 
Figure 4.1 Isomed inclinometer 
 
4.2.2.6 Interventions 
Baseline assessment occurred one week before participants started the back exercise group 
in order to allow the participants to gradually wear in their new shoes. During this 
adaptation week participants were given instruction to gradually increase the time the 
study shoes were worn each day, initially wearing for only 15 - 30 minutes, progressing to a 
minimum wear of two hours per day (whilst standing and walking) before attendance at  
their first exercise group. The back exercise group was an established programme that had 
been running for approximately three years at the Chelsea and Westminster Hospital, 
London, UK. The programme involved education, advice and a ten station exercise circuit. 
Each class was approximately one hour in duration. Participants were asked to attend the 
group twice a week for a period of four weeks (a total of eight sessions). Study participants 
were requested to wear their study shoes during the exercise group, and for a minimum of 
two hours per day during the six week duration of the pilot study. 
At the end of their last exercise group participants were re-assessed. The assessment 
involved the same questionnaires (conducted by the C.I.) and physical tests (conducted by 
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the co-researcher) as performed at baseline. To ensure the co-researcher remained blind to 
participant group allocation, study shoes were kept out of sight of the co-researcher whilst 
the spinal measurements were assessed. This point marked the end of each participant’s 
involvement in the pilot study. 
4.2.2.7 Adverse events  
Adverse events were defined as an increase in pain or symptoms within one week of 
commencing an intervention (the ‘adaptation week’ for initial shoe wear, and a participants 
first week of attendance at the low back exercise group) that required general practitioner 
or casualty consultation as reported to the investigator (Hay et al., 2005). 
4.2.2.8 Data analysis 
Distributions were checked to see if normal distributions had been met, if this was not the 
case, non-parametric test were performed. The primary analysis was by intention to treat, 
including all eligible randomised participants who provided follow-up data. Independent t-
tests for parametric data, were applied to determine differences between groups at 
baseline. Mixed ANOVAs were conducted with one within-subject factor (assessment time 
points) and one between group factor (footwear type) to compare the effectiveness of shoe 
type over time (rocker sole shoes versus flat sole shoes).  
Data were analysed using IBM SPSS (Statistical Package for the Social Sciences) 20.0.0 (IBM, 
New York). Results are presented as means (standard deviations [SD]) unless otherwise 
stated. 
4.2.3 Results 
Participant entry into the study, randomisation, and participant retention including 
participants lost to follow-up at each stage of the investigation are presented in Figure 4.2. 
Twenty participants (nine males, eleven females) with a mean age of 42 years (SD 10.5, 
range 24 to 60 years) and a mean duration of 5.0 years (SD 6.1, range 0.3 to 20.0 years) of 
low back pain symptoms were recruited. Table 4.3 presents demographic data and primary 
outcome at baseline for the two groups. The flat sole shoe group presented with greater 
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disability than the rocker sole shoe group at baseline. Table 4.4 presents the pain and 
disability outcome measures at baseline and follow-up.  
 




















(P: participant; n: number of participants) 
  
Patients fulfilling inclusion and exclusion criteria, and 
agreeing to participate in study 
(approximately 1 week prior to entry into study) 
Consent form signed (n=20) 
(week 1) 
Randomised to Group 1 or Group 2 
Group 1: Rocker sole sports shoe and 
exercise group (n=10) 
 
Group 2: Flat sole sports shoe and 
exercise group (n=10) 
 
Pre-intervention assessment (n=10) 
(week 1) 
Pre-intervention assessment (n=10) 
(week 1) 
Post-intervention assessment (n=8) 
(week 6) 
 
(P3) no contact possible after treatment 
(P12) did not commence treatment, left 
the country 
 
(P5, P18, P19) documentation of hours 
study shoes worn per day lost by 
participant 
 
Post-intervention assessment (n=10) 
(week 6) 
 
(P17) documentation of hours study 
shoes worn per day lost by participant 
 
Participation in exercise group (n=10) 
(week 2-6) 




Table 4.3 Participant demographics and primary outcome at baseline 
 Rocker sole shoe 
(n=10) 
Flat sole  shoe     
(n=10) 
P - value 
Age [years] 37.5 (8.6) 46.6 (10.7) 0.05 
Height [cm] 174.1 (13.4) 169.5 (9.1) 0.38 
Body Mass [kg] 80.0 (16.1) 77.1 (21.9) 0.72 
Duration of symptoms 
[years] 
5.5 (6.9) 4.5 (5.7) 0.71 
Gender : male 








23.4 (11.9) 37.4 (12.3) 0.04 
Summary measures represent means (SD) or *numbers (percentages) 
Table 4.4 Pain and disability measures at baseline and follow-up 
Outcome measure Rocker sole shoe 
(n=8) 
Flat sole shoe      
(n=10) 
P - value 
 
Baseline 6 weeks Baseline 6 weeks  
Oswestry Disability 
questionnaire (ODI) 











Roland Morris Disability 
questionnaire (RMDQ) 











Numerical rating score for 
pain (NRS) 











Summary measure  represent means (SD). Between group analysis with mixed 
ANOVA 
No between group differences were detected for change in disability or pain at six weeks 
compared to baseline (ODQ: F(1, 16) = 3.07, p = 0.10, Ƞ2 = 0.16; RMDQ: F(1,16) = 1.52, p = 
0.24, Ƞ2 = 0.09; NRS: F(1,16) = 1.30, p = 0.27, Ƞ2 = 0.08). 
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4.2.3.1 Duration of recruitment period 
Recruitment of participants into the pilot study occurred over an eleven month period. This 
recruitment period continued longer than had been anticipated due to the rate of 
recruitment. 
4.2.3.2 Acceptability of participant assessment 
When completing the Oswestry disability questionnaire participants generally took longer 
and asked more questions to the C.I. than when completing the Roland Morris Disability 
Questionnaire. At times explanations by the C.I. were lengthy, hence increasing the time 
participants were in a seated position - an aggravating factor for many. The Roland Morris 
Disability Questionnaire presented little time or difficulty to complete. 
The SF36 Health-related quality of life questionnaire was time consuming for participants to 
complete. This again increased the duration of time participants were in a seated position. 
All other outcome measures were assessed or completed with no reported problems or 
concerns from participants or assessors. 
4.2.3.3 Participant attrition 
An acceptable number of participants who entered the study also attended the six week 
assessment. Ten per cent of participants (two participants) did not attend their final review 
– one participant left the country between consent into the study and commencement of 
the exercise class, and the second participant was lost to follow-up due to an inability to 
contact them by phone or letter. In addition to the participants lost to follow-up, three 
participants reported losing their study diary sheets, documenting hours of shoe wear per 
day.  Twenty-five percent of participants’ ‘adherence to shoe use’ data was missing; the CI 
did not have confidence in the data, hence it was not presented. 
4.2.3.4 Acceptability of the interventions 
Feedback from referring physiotherapists indicated that one reason that potential 
participants declined to take part in the study was their inability to attend the back exercise 
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classes due to the classes running mid-morning. Patients suggested that an early morning 
class would be more convenient to attend. 
Further feedback from patients unable to commit to the exercise classes identified that 
attending a class twice a week was not possible due to other commitments, for example, 
gaining time off work. They reported that a required class attendance of once a week would 
have enabled them to participate. 
4.2.3.5 Success of participant randomisation 
Equal numbers of participants were randomised into each footwear group. However, at 
baseline, demographic data demonstrated a failure in the randomisation process to 
produce two matched groups for many of the parameters of interest. Differences in age, 
gender and disability are evident. This was most likely due to the small sample size of the 
pilot study. 
4.2.4 Discussion 
This pilot study suggests that change in pain and disability at six weeks follow-up, following 
attendance at a back exercise group, was similar for people wearing rocker sole and flat 
sole shoes. However, the pilot study had a small sample size and demonstrated less than 
optimal group randomisation, hence findings should not be generalised to the general 
population.  
The pilot study proved valuable in demonstrating study feasibility, limitations in the study 
design and the degree of acceptability of the intervention to participants. This enabled 
alterations of the planned methodology to be put in place, ensuring the main study to be a 
more robust and higher quality RCT. The planned alterations form the body of this 
discussion. 
4.2.4.1 Alterations in outcome measures for the main clinical study 
The use of the Oswestry Disability Questionnaire has been recommended for back pain 
patients who are likely to have severe persistent disability, whereas the Roland Morris 
Disability Questionnaire has been recommended for back pain patients who are likely to 
have relatively less disability (the population expected to be recruited into the main study) 
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(Roland and Fairbank, 2000). The Roland Morris Disability Questionnaire has been shown to 
be reliable and valid (Roland and Morris, 1983) and responsive to change over time (Boulter 
et al., 1998). It was therefore decided to replace the Oswestry Disability Questionnaire with 
the Roland Morris Disability Questionnaire as the primary outcome measure in the main 
clinical study (4.3.4.1, p46). 
The SF36 health-related quality of life questionnaire was lengthy and time consuming for 
participants to complete. Furthermore, the SF36 subscales have been demonstrated to 
show a floor effect for those patients who deteriorate, hence for those reporting worsening 
health, SF36 subscales may not adequately reflect changes in their health status (Suarez-
Almazor et al., 2000).  It was therefore decided to replace the SF36 health-related quality of 
life questionnaire with the EuroQol 5D (EQ-5D) health-related quality of life questionnaire 
(11.10, p245) for the main clinical study (4.3.4.3, p47). 
4.2.4.2 Duration of participant recruitment  
Due to the extended length of the recruitment period, alterations to recruitment protocol 
with a view to improving the rate of recruitment into the main study would be necessary. A 
multi-site study may allow for a greater number of appropriate participants to be recruited 
over a shorter period of time compared to recruitment from the originally planned single 
site. 
4.2.4.3 Alteration to exercise group accessibility 
In an aim to improve participant accessibility to the low back exercise group, class timings 
were altered. It was anticipated that this would offer patients a wider variety of potential 
attendance times which may increase recruitment into the main research study. 
Furthermore, potential participants had reported that it would not be possible to attend 
two exercise classes each week. Reducing the number of exercise sessions each participant 
would be required to attend whilst adhering to the NICE guideline recommendations (NICE, 
2009) (which states that a CLBP exercise programme “should consist of a maximum of eight 
sessions over a period of up to twelve weeks”) may increase the recruitment rate. 
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4.2.4.4 Participant acceptability of interventions and study documentation 
Eighty per cent of participants completed the study and no informal negative feedback was 
gained from these eighteen participants regarding footwear use or exercise class 
participation. This suggests that the interventions of exercise class attendance and 
footwear use, and the reassessment at six weeks were acceptable. Three participants, 
however, reported losing their study diary sheets. Clarification of diary sheet wording and 
clearer explanation to participants when describing how these sheets should be completed 
may assist in an increased percentage return of these documents at follow-up assessments 
in the main study. 
4.2.4.5 Appropriate sample size calculation 
One purpose for conducting the pilot study was to inform the main study of an appropriate 
sample size. Standard deviation data for the Roland Morris Disability Questionnaire 
obtained in the pilot study in addition to the minimal clinically important difference for the 
Roland Morris Disability Questionnaire in the CLBP population (reported in previous 
research (Maughan and Lewis, 2010)) were used to inform the sample size for the main 
clinical study. 
4.2.5 Conclusions 
Conducting the pilot study highlighted certain aspects of the planned main study 
methodology that may benefit from change, in order to improve study design, namely: 
 Reducing the frequency of exercise class attendance from twice to once a week to 
improve recruitment rate. 
 Providing a greater range of exercise class times may improve recruitment rate 
 Conducting the research at more than one site may improve recruitment rate 
 Reviewing the clarity and ease of completion of the study diary sheet may increase 
the number of diary sheets returned 
 Alteration of outcome measure choice to improve i.) ease of completion by 
participants and ii.) suitability to sample population 
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4.3 Methodological considerations for main clinical study 
Conducting the pilot study (4.2, p33) identified several methodological concerns requiring 
amendment in order to improve the main clinical study design. This section describes 
alterations made to the main study methodology, and the justification for choice of 
outcome measure and statistical tests in the main clinical study. 
4.3.1 Alterations to the participant recruitment protocol 
Due to the extended length of the recruitment period in the pilot study, several 
methodological alterations were implemented with a view to improving the rate of 
recruitment into the main study. It was decided that a multi-site study incorporating five 
sites, may allow for a greater number of appropriate participants to be recruited over a 
shorter period of time compared to recruitment from the originally planned single site. 
Four additional sites in south west London were identified and meetings were held with 
departmental leads at each of the proposed sites to explain the study and determine 
whether each site would be happy to host the trial.  All sites approached were happy for 
their physiotherapy departments to be involved. The additional four sites were: 
 Balance Performance Physiotherapy, Clapham, London SW4 
 Kingston Hospital, Kingston, Surrey KT2 
 St. George’s Hospital, Tooting, London SW18 
 Queen Mary’s Hospital, Roehampton, London SW14 
4.3.2 Method of randomisation chosen for the main trial 
Equal numbers of participants were randomised into each footwear group utilising the 
block randomisation method chosen in the pilot study. Therefore, this block randomisation 
protocol (blocks of four) was chosen for the main clinical study in order to ensure the 




4.3.3 Justification for selection of assessment time points in the main 
clinical study 
Baseline, six weeks, six months and one year were selected as assessment time points for 
participants in the main clinical study. The six week assessment aimed to detect combined 
change in outcome measures corresponding to completion of the back exercise class and 
early use of study footwear. The six month assessment aimed to detect outcome measure 
changes occurring following the prolonged use of study shoes. Primary outcome point 
occurred at one year from baseline to provide adequate follow-up time for such a chronic, 
recurrent and fluctuating condition. 
4.3.4 Justification for selection of outcome measures assessed in the 
main clinical study 
No single outcome measure accurately reflects the effects a treatment programme may 
have on all areas of a patient’s life (McIlveen and Robertson, 1998). The World Health 
Organisation (2000) states that the health of an individual is based on three categories; 
impairment, activity and participation. Appropriate outcome measures should be assessed 
for each of these categories. In CLBP, the assessment of psychosocial and physical aspects 
are of particular importance (Hope, 2002; Staal et al., 2002). There is currently no ‘gold 
standard’ group of outcome measures for the assessment of CLBP. However, it is 
considered satisfactory to include outcomes assessing three or more of the following five 
categories in CLBP research trials; back specific function, generic health status, pain, work 
disability and satisfaction with care/intervention (Bombardier, 2000; Deyo et al., 1998; 
Dworkin et al., 2005). Outcome measures assessed in the main clinical study are presented 
below. 
4.3.4.1 Self-reported disability 
The Roland Morris Disability Questionnaire (RMDQ) (10.3, p225) consists of twenty four 
statements selected from the Sickness Impact Profile (Bergner et al., 1981) and adapted to 
determine how a person’s back pain may affect activities of daily living. Participants 
completing the RMDQ are asked to tick a statement if it applies to them ‘today’. Outcome 
scores range from 0 (no disability) to 24 (severe disability). During the pilot study the 
Roland Morris Disability Questionnaire (RDQ) presented little difficulty for participants to 
47 
 
complete. The questionnaire has a high sensitivity in CLBP participants with lower disability 
scores (the population expected to be recruited into the main study) (Roland and Fairbank, 
2000). The RMDQ has been shown to be reliable, valid (Roland and Morris, 1983) and 
responsive to change over time (Boulter et al., 1998) in a CLBP population. 
4.3.4.2 Self-reported pain 
The Numerical rating score for pain asks patients to verbally rate their pain intensity on an 
eleven point scale where zero represents ‘no pain’ and ten indicates ‘worst imaginable 
pain’. It has been demonstrated to be responsive to change in chronic low back pain 
populations (Pengel et al., 2004). 
4.3.4.3 Health related quality of life 
The EQ-5D-3L (or EuroQol) is a generic preference-based tool for the measurement of self-
reported health-related quality of life (11.10, p245) (Brooks, 1996). The EQ-5D-3L has two 
components. The first component evaluates five domains: mobility, self-care, activity, pain 
and depression and anxiety (the latter two domains are evaluated together). Each domain 
has three possible levels: no impairment, mild to moderate impairment, and severe 
impairment. The second component is the EQ-VAS (visual analogue scale) ranging from 0 to 
100 where zero represents ‘worst imaginable health’ and 100 ‘best imaginable health’. The 
EQ-5D-3L demonstrates high reliability when re-tested over time (Centre for Health 
Economics, 1994). The generic EQ-5D-3L visual  analogue scale component has been found 
to perform better than most SF36 subscales (the health-related quality of life questionnaire 
assessed in the pilot study) in discriminating among those who improved and those who 
became worse in a LBP population (Suarez-Almazor et al., 2000). A further advantage of the 
EQ-5D-3L is its ease of completion by participants. 
4.3.4.4 Fear of movement 
Fear avoidance, the avoidance of movement or activities based on fear, has been proposed 
as a central mechanism in the development of chronic back problems (Vlaeyen and Linton, 
2000). Hence, when assessing changes in disability and pain experience, fear-avoidance 
beliefs are an important measure to monitor. Previous studies in patients with chronic and 
acute LBP have demonstrated that fear-avoidance beliefs are predictive of disability and 
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work status (Fritz et al., 2001; Vlaeyen and Linton, 2000; Waddell et al., 1993).The Tampa 
scale of Kinesiophobia (11.5, p231) (a questionnaire assessing fear of movement and 
(re)injury) requires patients to rate seventeen items on a four point scale ranging from 
‘strongly agree’ to ‘strongly disagree’. Total scores range from 17 to 68, with higher scores 
reflecting a greater fear of movement or (re)injury. The scale possesses good psychometric 
properties, is a reliable measure (Woby et al., 2005) and offers well-established construct 
and predictive validity (Vlaeyen and Linton, 2000) in the back pain population. 
4.3.4.5 Anxiety and depression 
Back symptoms are frequently accompanied by depression or anxiety and psychological 
distress (Kinney et al., 1993; Rush et al., 2000). Anxiety may increase pain perception 
leading to less than optimal coping behaviours (Adams et al., 1994; Simmonds et al., 1996). 
Hence, outcome measures to assess such bio-psychosocial influences on a patient’s 
recovery should be included in CLBP research. The Hospital Anxiety and Depression Scale 
(HADS) (11.6, p232) is a reliable and valid measure for assessing anxiety and depression in 
medical patients (Herrmann, 1997); the depression subscale has established validity and 
reliability (Greenough and Fraser, 1991) for an inpatient CLBP population - the reliability of 
the HADS has yet to be demonstrated in an out-patient setting for CLBP patients. The 
anxiety and depression sub-scales consists of seven questions each (a total of fourteen 
questions). Each question is scored on a four point scale from 0 to 3. Scores can range from 
0-21 with higher scores reflecting greater anxiety and depression. 
4.3.4.6 Restoration of functional activity 
The Patient Specific Functional Score (PSFS) is a questionnaire used to quantify a 
participant’s activity limitations (11.11, p247). A participant may improve functionally but 
show little or no change in their level of impairment (Beattie and Maher, 1997; Waddell et 
al., 1992), hence, it is considered important to investigate restoration of activity and 
participation despite levels of pain and disability (Liddle et al., 2004). Although the RMDQ, 
the primary outcome measure in the main study, measures self-reported function, it is not 
patient specific; hence the PSFS may be more sensitive to detect an individual’s change 
than the RMDQ (Pengel et al., 2004). In CLBP patients the patient specific functional scale 
has demonstrated moderate to excellent reliability, validity and sensitivity to change 
(Maughan and Lewis, 2010; Stratford, 1995). 
49 
 
4.3.4.7 Patient satisfaction 
A simple global measure of patient satisfaction towards the study shoe they received was 
assessed (Hudak and Wright, 2000). The C.I. asked participants at six months and at one 
year “How satisfied are you with the study shoes you have received?’ Participants were 
asked to rate their satisfaction on a scale from 1 (extremely dissatisfied) to 7 (extremely 
satisfied) (11.12, p248). 
4.3.4.8 Impairment measures 
In studies investigating rocker sole shoes in asymptomatic participants a reduction in the 
degree of trunk flexion, both in standing (New and Pearce, 2007) and during locomotion 
(Vernon et al., 2004), has been reported. This is suggestive of a more upright posture. The 
main study will investigate whether a change in thoracic kyphosis angle in barefoot 
standing occurs following the use of either shoe type and, if changes do occur, whether 
these potential changes correlate with changes in other outcome measures such as 
reduction in pain or disability. The assessment method for measuring thoracic kyphosis 
angle demonstrated excellent clinical reliability for intra-rater re-assessment by the C.I. 
(4.4, p53). 
The assessment of spinal impairment measurements by the C.I. demonstrated excellent 
reliability (4.4, p53). These measurements (spinal flexion, extension, left and right side 
flexions and left and right straight leg raise angles) will be recorded in the main clinical 
study. It is acknowledged that although such physical impairment measures are routinely 
measured in clinical practice and clinical research, their low responsiveness (Pengel et al., 
2004) (the ability of an outcome measure to detect clinically important change in a 
patient’s health status over time) indicates that this approach is not optimal for assessing 
change over time  in those with CLBP. However, these measures were included in the main 
clinical study to determine, if changes do occur between shoe groups, whether a sub-group 
demonstrating baseline movement restriction or pain provoked by a particular movement 




4.3.4.9 Primary outcome measure 
The Roland Morris disability questionnaire was chosen as the primary outcome for the main 
clinical study. 
4.3.5 Justification for the methods and statistical analysis chosen to 
analyse data in the main clinical study 
4.3.5.1 Removal of outliers 
Box plots enable visual comparisons of interquartile ranges, medians, and group ranges of 
data between groups to be made. In addition, box plots highlight the presence of ‘outliers’ 
– an observation very different from most other observations with the potential to bias 
statistics (Field, 2009). The presence of outliers may represent incorrect data entry or the 
inclusion of a variable that represents an extreme case within the population studies (Field, 
2009; Sim and Wright, 2000). When analysing the primary outcome, recalculation of study 
data occurred following removal of any outliers to determine whether extreme cases 
influenced the results. 
4.3.5.2 Analysis of variance 
Analysis of variance (ANOVA) is an appropriate method to statistically analyse the 
difference in mean values for one or more data sets when assessed under two or more 
experimental conditions (Field, 2009). Distributions within groups must be normally 
distributed to meet the requirements of an ANOVA test: variances in each experimental 
condition must be similar; observations must be independent; and the dependent variable 
must be measured on at least an interval scale (Field, 2009). A repeated measures factorial 
design ANOVA and mixed design ANOVA was selected as an appropriate method to 
statistically analyse within group and between group differences, respectively, for each 
shoe group across four assessment time points (Field, 2009). Macuhly test of sphericity 
assumption and Levene’s test of equality of variances assumption were considered for 
within-subject and between-subject effects, respectively (Field, 2009). In the presence of 
significant effects, multiple comparisons were made using the Bonferroni method (Field, 
2009). This method is conservative, reducing the probability of a type one error, although 
the probability of a type two error may be raised. Analysis of covariance (ANCOVA) is the 
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recommended analysis to perform when taking into account a variable thought to influence 
a dependent variable (Field, 2009). In the treatment of CLBP, baseline disability has been 
shown to influence the level of change observed in disability following an intervention 
(Stratford et al., 1998). Therefore, in the main clinical study, an ANCOVA was selected as an 
appropriate method to statistically analyse between group differences for each shoe group 
across the three reassessments points whilst taking into account differences in baseline 
disability between the groups (Field, 2009). 
4.3.5.3 Independent t-test 
To determine whether randomisation of participants between groups had been effective, 
baseline demographic and outcome measure data were compared between groups. An 
independent t-test is an appropriate method to statistically analyse the difference in mean 
values between two groups, when participants in each group are different, and where the 
assumption of normality is met (the variances of populations are similar and scores are 
independent) (Field, 2009). 
4.3.5.4 Pearson’s Chi-square test 
A Chi-square (χ2) test is an appropriate method to statistically analyse the presence of a 
relationship between two categorical variables (Field, 2009). Data must be independent, 
and expected frequencies must be greater than five in order to meet the assumptions of 
the Chi-square test (Field, 2009). Chi-square was used to assess the differences between 
the shoe groups regarding the number of participants reporting minimal clinically important 
differences in the primary outcome, and the number of participants very or extremely 
satisfied with the study shoes they received. 
4.3.5.5 Replacing missing values 
The presence of missing data may be a problem when conducting repeated measure 
ANOVAs due to the exclusion of any data sets with a missing value from the analysis. In a 
small sample these exclusions may result in remaining data sets being too few to have 
sufficient power to detect effects. SPSS has a specific package for evaluating missing data 
(IBM, 2011). Replacing missing values with predicted values allows the analysis of a 
complete data set which may be more powerful to detect change than analysing 
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incomplete data sets. In the main study, missing values were replaced only for the primary 
outcome measure – the Roland Morris Disability Questionnaire. To demonstrate that data 
in the main clincial study were missing at random Little’s ‘Missing Completely at Random’ 
test was conducted. Little’s test examines the hypothesis that data are missing completely 
at random - an assumption that must be satisfied prior to replacing missing values with 
imputation techniques. Missing numbers were then replaced using the Expectation-
Maximisation technique (Dempster et al., 1977) within the Missing Number Analysis 
function in SPSS (IBM, 2011). 
4.3.6 Calibration of measuring devices 
To ensure that the length of the ‘non-stretch’ tape measure did not change with repeated 
use the C.I. checked the accuracy of the tape measure once a month by comparing the 
centimetre scale on the tape with a metal metre ruler. To ensure accuracy of the 
inclinometer the C.I. calibrated the inclinometer scale (displayed in 2 degree divisions) 
against an electrical inclinometer (Saunders Digital Inclinometer; the Saunders Group, 





4.4 Intra-rater reliability study for the assessment of thoracic 
kyphosis angle, lumbar impairment measures, and 
straight leg raise 
4.4.1 Introduction 
This study was conducted to investigate the intra-rater reliability of the chief investigator 
(Siân MacRae) in the assessment of thoracic kyphosis angle, straight leg raise (SLR) angle, 
and the lumbar impairment measures of flexion, extension, and left and right side flexion. 
These are secondary outcome measures in the main clinical study (Chapter 5, p61). This 
study has been accepted for publication (van Blommestein et al.,2012) (11.13, p249). 
4.4.2 Methods 
4.4.2.1 Design 
This study employed a single-examiner, same-subject, repeated measures design. 
Participants were assessed on two occasions. 
4.4.2.2 Participants 
This study was approved by the Research Ethics Subcommittee at King's College London 
(BDM/08/09-85) (11.14, p255). Participants were recruited via email (11.15, p257) using the 
Kings College London website and by verbal invitation at Guy's Campus. Inclusion criteria 
involved male and female volunteers aged 18-65 years, and a straight leg raise (SLR) of 40 
degrees or more prior to first perceived onset of stretch. Exclusion criteria were: any 
indication of lower limb neurological compromise; a history of thoracic pain, low back pain, 
or lower limb problems over the past six months that required medical attention; limitation 
of movement of the hip or knee; scoliosis; chest conditions such as asthma, chronic 






The measures assessed in this study were thoracic kyphosis angle, left and right SLR angle, 
and the spinal impairment measures of flexion, extension, and left and right side flexion. 
Each measure was assessed using an Isomed gravitational inclinometer (Isomed, 975 Sandy 
Blvd., Portland, OR 97214) (Figure 4.1, p37).The thoracic kyphosis angles and lumbar 
impairment measures were assessed with the participant in standing and the SLR angle 
measured with the participant lying supine on a plinth. 
4.4.2.4 Assessment of participants 
All testing was performed in a private room at Guy's Campus, King's College London. On the 
testing days, the room temperature and lighting were kept constant and noise levels were 
kept to a minimum to prevent distraction.  
Individuals who agreed to participate, met the inclusion criteria, and did not fulfil the 
exclusion criteria attended two assessments, approximately one hour apart. At initial 
assessment participants were given a full explanation of the testing procedure by the co-
researcher (Andrew van Blommestein). All participants received a copy of the participant 
information sheet (11.16, p258). Those willing to participate in the study were asked to sign 
and date the consent form (11.17, p261). Participants were required to remove their shoes 
and socks for the test procedure. All participants were asked to wear short trousers; male 
participants were asked to remove their shirts; and female participants were requested to 
wear vest tops. Demographic data of height, body mass, and age were recorded. 
Assessment of thoracic kyphosis angles 
The angle of thoracic kyphosis was determined by the linear and triangular addition of 
angles rule (Figure 4.3). This equation simplifies to the kyphosis being equal to the 
difference between the tangent on the upper level (spinous process of the first and second 
thoracic vertebra (T1 and T2 respectively) and the tangent on the lower level (spinous 








Participants were asked to adopt a comfortable standing position that felt natural to them. 
The following standardised instructions were given to each participant: 
“Please stand in a position that feels comfortable and normal to you. Slowly bend your head 
forwards and backwards three times. Stop in a position that feels normal to you. Now gently 
swing your arms forwards and backwards three times. Let them rest comfortably by your 
side in a position that feels normal to you. Take three deep breaths and stand in a posture 
that feels comfortable and normal to you.” 
Following these instructions, the C.I. identified the relevant spinous processes. To locate the 
T1 and T2 thoracic spinous processes, the C.I. identified the spinous process of the 
commonly most prominent seventh cervical vertebra and then palpated distally to find the 
spinous processes of T1 and T2. To locate the T12 and L1 spinous processes the C.I. first 
located the iliac crests, and then palpated postero-medially to locate the spinous process of 
L4. From this level, the C.I. palpated proximally to locate the spinous processes of L1 and 
T12. Six millimetre diameter adhesive stickers were used to mark the located spinous 
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processes. The pegs of the inclinometer were placed on the pairs of upper and lower 
thoracic stickers. Three inclinometer measurements were recorded at the upper and lower 
thoracic spinal levels. Adhesive stickers were then removed.  
Assessment of spinal movement 
In standing, participants were asked to slide their hands down the front of their legs until 
they experienced the first point of painful stretch. Using a ‘non-stretch’ tape measure the 
distance between the participant’s left middle fingertip and the floor directly below the left 
medial malleolus was recorded for the flexion movement.  Lumbar extension 
measurements involved the participants sliding their hands down the posterior aspect of 
their legs, keeping knees straight. The distance between the patients’ left middle fingertip 
and the floor directly below the left medial malleolus was recorded for the extension 
movement. For the left and right side flexion movements participants were requested to 
slide their hands down the lateral aspects of their left and right legs respectively, without 
rotating their trunk. The distance between the ipsilateral middle fingertip and the floor just 
behind the lateral malleoli was recorded. Three readings for each movement were taken 
and the average used for data analysis. 
Assessment of straight leg raise 
On completion of the standing measurements, participants were asked to lie supine on a 
plinth, with arms by their sides, no lateral flexion or rotation at their trunk, and hips in 
neutral adduction/abduction. A single pillow supported the head and neck to ensure a 
standardised degree of neck flexion. The participant’s spines of scapulae rested on the 
bottom edge of the pillow. The following standardised instructions were then given: 
“Please remain in a relaxed lying position. I am going to slowly lift your leg. If at any time 
you feel discomfort or would like me to stop please inform me straight away. I will then 
record the angle of movement and return your leg to the starting position. It is normal to 




The inclinometer was placed on the most prominent aspect of the tibial tuberosity of the 
leg to be raised. The C.I. then raised the participant’s leg whilst maintaining the position of 
the inclinometer. When a participant reported the first perceived onset of a strong 
stretching sensation in the posterior aspect of the raised leg the C.I. recorded the 
inclinometer angle, and lowered the leg to the plinth. Three readings of SLR angle were 
recorded for each leg, and the average documented.  
Assessment 2 
Thoracic kyphosis angle, spinal impairment, and SLR were reassessed as described above. 
The procedure for assessment 2 replicated assessment 1. The interval between 
assessments was approximately one hour. This aimed to reduce memory bias by reducing 
the likelihood of the C.I. recalling participant measurements from assessment 1. To further 
reduce memory bias, the data collection for one participant was staggered by the 
assessment of two other participants during the time between the two assessments of the 
first participant (i.e. three participants were assessed twice over a two hour period). The 
hour interval between assessments allowed any residual marks left by the stickers on a 
participant’s skin, following the first assessment, to disappear. 
4.4.2.5 Data entry 
All measurements were relayed verbally by the C.I. to the co-researcher who recorded the 
results onto an Excel spread sheet. The C.I. was blind to all data between assessment 1 and 
assessment 2.  
4.4.2.6 Sample size calculation 
For a power of 0.8 and an alpha of 0.05, for two time points (or two assessments), or two 
raters, the number of participants required was suggested to be 19 (Portney and Watkins, 
2009; Walter et al., 1998). The number of participants recruited into the current study was 
increased to 30 in order to increase statistical power, and to allow for a loss of participant 




4.4.2.7 Data analysis 
Intraclass correlation coefficients (ICC), 95% confidence intervals (95% CI) and standard 
error of measurement (SEM) were calculated to determine intra-rater reliability (Hicks C., 
2004).  
Reliability was calculated by analysing the mean value of each measurement at each 
assessment. ICC model 2 was selected as it was suggested by Portney and Watkins (Portney 
and Watkins, 2009) to be best suited for generalising the findings of the method of 
measurement used in this study to clinicians with similar characteristics. ICC models (2,3) 
for average measures were evaluated using SPSS version 17.0 software (SPSS Inc., Chicago, 
Il, USA). Options of two-way random and absolute agreement were selected when 
analysing the single and mean measurements with the SPSS software. 
4.4.3 Results 
Thirty asymptomatic participants (15 males, 15 females) with a mean age of 33.0 years (SD 
11.2, range 23 to 65 years) were recruited. Table 4.5 presents participant demographic 
data. 
Table 4.5 Participant demographics 
 
Participants                                   
(n=30) 
Age [years] 33.0 (11.2) 
Height [cm] 172.0 (11.0) 
Body mass [kg] 72.0 (12.6) 
Gender 
Male: 15 (50%)* 
Female: 15 (50%)* 
Dominant leg 
Right: 27 (90%)* 
Left: 3 (10%)* 




Results demonstrate that using the average of three measures for thoracic kyphosis angle, 
SLR and spinal impairment measures, used as outcome indicators in the main 
investigation, provide excellent clinical reliability (Table 4.6 and 4.7) (Portney and Watkins, 
2009). The values for the SEM of each measure suggested that measurements less than or 
equal to the values obtained should be considered as measurement error and values 
above these figures should be considered as real change. Using the 1 SEM, a clinician may 
assume with 68% certainty that the individual’s true score will lie between +/-1 SEM; 
utilising the 2 SEM scores, increases the certainty to 95% (Portney and Watkins, 2009). For 
example, if a participant’s thoracic kyphosis angle changes by greater than 4.4 degrees 
from baseline to reassessment, there is only a 5% chance that this change has occurred by 
chance. 




Right straight leg 
raise angle 





Assessment 1 33.1 (8.4) 81.4 (12.2) 80.4 (11.3) 
Assessment 2 32.4 (8.2) 81.2 (12.6) 81.1 (11.9) 
Range 
[degrees] 
Assessment 1 14.6-49.3 61.3-105.3 64.0-102.7 
Assessment 2 15.3-46.7 57.3-105.3 64.7-108.0 
ICC (2,3) Average of three 
measures 
0.89 0.97 0.97 
 95% Confidence 
Interval 
0.77-0.95 0.93-0.99 0.94-0.99 
 SEM/degrees 2.2 2.1 2.0 
 2x SEM/degrees 4.4 4.3 3.9 
















Assessment 1 9.3 (9.2) 59.5 (5.7) 44.6 (5.4) 44.8 (5.9) 
Assessment 2 8.8 (9.2) 59.5 (5.6) 44.3 (5.2) 44.7 (5.2) 
Range 
[cm] 
Assessment 1 0.0-31.0 45.1-67.7 36.7-58.0 36.4-58.5 
Assessment 2 0.0-32.1 45.2-67.4 37.2-55.7 36.9-56.1 
ICC (2,3) Average of three 
measures 
0.99 0.99 0.99 0.98 
95% Confidence 
Intervals 
0.98-0.99 0.98-0.99 0.98-0.99 0.96-0.99 
SEM [cm] 0.9 0.6 0.5 0.8 
2x SEM [cm] 1.8 1.2 1.1 1.6 
(ICC: intraclass correlation coefficient; SEM: Standard error of measurement; cm: 
centremetres) 
4.4.4 Discussion 
This reliability study evaluated the intra-tester reliability of clinical methods for measuring 
thoracic kyphosis, lumbar impairment measures and SLR angles in pain free participants. 
The measurement techniques employed by the C.I. demonstrated excellent clinical 
reliability in pain free participants from using an Isomed inclinometer to assess thoracic 
kyphosis, spinal impairment measures and SLR in asymptomatic participants. Advantages 
associated with this reliable method of measurement are that it is simple to use, time 
efficient and inexpensive.  
Potential inaccuracies on palpation of anatomical landmarks may have affected the validity 
of the measurement. Additionally, study participants were 30 asymptomatic adults, with an 
average age of 33 (SD 11.2) years; therefore, generalisation of these results to individuals 




5 Effectiveness of rocker sole shoes in chronic low 
back pain 
5.1 Chapter summary 
This chapter investigates the effects of rocker sole shoes in the management of people with 
chronic low back pain (CLBP). One hundred and fifteen participants from five research sites 
were randomly allocated to receive either a flat sole shoe or a rocker sole shoe. Participants 
were requested to wear their study shoes for a minimum of two hours per day for the 
duration of the study, and attend a low back exercise group. Participants were assessed at 
baseline, six weeks, six months and one year. The primary outcome measure, the Roland 
Morris Disability Questionnaire, assessing self-reported disability, demonstrated no 
difference in improvement at one year between those allocated to either shoe group. 
5.2 Introduction 
Low back pain (LBP) is common with a life-time incidence of up to 80% (Airaksinen et al., 
2006; Koes et al., 2006); five to twenty percent develop more persistent chronic low back 
pain (CLBP) (Johanssen et al., 1995; Klaber Moffett et al., 1986; Quittan, 2002; Tortensen et 
al., 1998). Healthcare costs are consequently substantial (Maniadakis and Gray, 2000). 
Although national (NICE, 2009) and international guidelines (Koes et al., 2001) recommend 
exercise therapy in the management of CLBP, the long-term effectiveness of such an 
approach appears minimal (Hayden et al., 2005a; UK BEAM Trial Team, 2004). 
Consequently, novel approaches yet to be investigated in robust randomised controlled 
trials have been proposed as alternative and effective adjuncts to the management of LBP. 
During the past decade, rocker sole footwear have been marketed with persuasive 
advertising suggesting a positive correlation between wearing this type of footwear and a 
reduction in low back pain (Masai Barefoot Technology GB Ltd, 2012). Manufacturers claim 
that the unstable curved sole can positively influence mechanisms associated with CLBP, 
such as poor balance, poor posture, and reduced capacity to attenuate shock whilst walking 
(Masai Barefoot Technology GB Ltd, 2011). However, there is a paucity of evidence to 
suggest these claims are justified. This randomised, controlled trial aimed at determining 
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whether wearing a rocker sole shoe would result in a reduction in disability and pain when 
compared to wearing a flat sole shoe following a typical exercise treatment for LBP, and in 
particular, in those who report LBP when standing or walking. 
The hypotheses under investigation in this clinical trial are: 
Primary null hypothesis (H0): 
H0 1:  The addition of a rocker sole shoe to the treatment of chronic low back pain (CLBP) 
will not result in a significant improvement in disability (Roland Morris Disability 
Questionnaire) in patients when compared to the addition of a flat sole shoe when 
assessed at six weeks, six months and one year. 
Secondary null hypotheses (H0): 
H0 2: The addition of a rocker sole shoe to the treatment of chronic low back pain (CLBP) 
will not result in a significant reduction in pain (Numerical Rating Score) in patients 
when compared to the addition of a flat sole shoe when assessed at six weeks, six 
months and one year. 
H03: For people reporting pain on standing or walking, there will be no difference in 
change in disability in people wearing rocker sole shoes when compared to people 
wearing flat sole shoes at six weeks, six months and one year.  
 
Primary alternative hypothesis (H1): 
H1 1:  The addition of a rocker sole shoe to the treatment of CLBP will result in a 
significant reduction in disability (Roland Morris Disability Questionnaire) in 
patients with CLBP when compared to the addition of a flat sole shoe when 
assessed at six weeks, six months and one year. 
Secondary alternative hypotheses (H1): 
H1 2: The addition of a rocker sole shoe to the treatment of CLBP will result in a 
significant reduction in pain (Numerical Rating Score) in patients with CLBP when 
compared to the addition of a flat sole shoe when assessed at six weeks, six months 
and one year. 
H1 3:  For people reporting pain on standing or walking, there will be a better outcome 
for disability in people wearing rocker sole shoes when compared to people 






A multi-centre randomised, controlled trial was conducted with assessment of participants 
at baseline, six weeks, six months and twelve months. The chief investigator (C.I.) remained 
blind to participant group allocation for the duration of the data collection period. 
5.3.2 Participant recruitment 
Ethical Approval for the study was obtained from the Riverside Research Ethics Committee 
(REC reference number: 09/H0706/4) (11.18, p262). A total of 115 participants were 
recruited from the neuro-musculoskeletal physiotherapy department at the following 
locations: 
 
 Balance Performance Physiotherapy, Clapham, London SW4 
 Chelsea and Westminster Hospital, Chelsea, London SW10 
 Kingston Hospital, Kingston, Surrey KT2 
 St. George’s Hospital, Tooting, London SW18 
 Queen Mary’s Hospital, Roehampton, London SW14 
 
All patients referred from general practitioners and consultants for CLBP at the five 
participating physiotherapy sites were screened for appropriateness to participate (using 
the study screening sheet, (11.19, p266). The physiotherapist at each site responsible for 
triaging new referrals placed a purple sticker on those referrals that appeared appropriate 
for inclusion into the study. This aimed to increase the rate of recruitment by highlighting 
potential participants to the physiotherapists assessing them. Patients were deemed 
suitable for inclusion in the study if they met all of the inclusion criteria, and did not fulfil 
any of the exclusion criteria (Table 5.1). Patients fulfilling the inclusion criteria and 
interested in taking part in the research study were asked by their physiotherapist to read 
the Patient Information Sheet (11.20, p267) and informed that the C.I. would be in 
telephone contact in the following week to discuss the study in greater depth. During the 
telephone conversation with the C.I. the study screening questions were reassessed, and 
the study protocol described to the potential participant. If the potential participant 
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provided verbal consent to take part in the research an appointment was arranged within 
the physiotherapy department at the referring site to gain written consent and to conduct 
the baseline assessment. 
Table 5.1 Inclusion and exclusion criteria 
Inclusion criteria Exclusion criteria 
 
 Aged 18 to 65 years 
 More than 3 months of persistent or 
recurrent episodes of LBP 
 Lumbosacral pain with or without 
referral (of a non-radicular nature) 
 Pain of a mechanical nature (pain 
aggravated or eased by activity) 
 Willing to comply with the 
randomisation process 
 Able to fully communicate in English 
 Able to participate in an exercise group 
and perform exercises at home 
 
 
 Constant pain 
 Non mechanical pain (pain that is not 
eased or aggravated by activity or posture) 
 Nerve root entrapment accompanied by 
neurological deficit 
 Neoplasms 
 Severe structural deformity/osteoporosis 
 Known spondylolysthesis/ spinal stenosis 
 Fracture of the spine within the past year 
 Inflammatory disease of the spine 
 Spinal infection 
 Severe cardiovascular/ metabolic disease 
 Pregnancy 
 Previous spinal surgery 
 Known Morton’s Neuroma 
 Skin ulceration over the foot 
 Peripheral neuropathy with loss of 
sensation 
 History of falls 
 Surgery to the lower limb in the past 8 
weeks 
 History of deep vein thrombosis (DVT) yet 
to be stabilised /yet to be advised to 
return to exercise by their medical 
practitioner 
 Unresolved legal issues regarding their 
back pain 
 Participants who have previously used 





5.3.3 Outcome measures 
The primary outcome measure was the Roland Morris Disability Questionnaire (assessing 
self-reported disability).The secondary outcome measures assessed in the main study are 
presented in Table 5.2. Justification for choice of main study outcome measures is 
presented in Chapter 4 (4.3.4, p46). 
Table 5.2 Secondary outcome measures 
Secondary outcome measures 
 
 Numerical Rating Score for pain (self-reported pain) 
 EuroQol (EQ-5D-3L) health questionnaire (a measure of health related quality of life) 
 Patient Specific Functional Score (PSFS)(a questionnaire used to quantify activity 
limitation/measure functional outcome in patients) 
 Tampa Scale of Kinesiophobia (a questionnaire measuring fear of movement and fear   
of   (re)injury during movements) 
 Hospital anxiety and depression score (a questionnaire measuring anxiety and 
depression) 
 Range of lumbar spine movement (flexion, extension, left and right side flexion)  
 Straight leg raise 
 Thoracic spine kyphosis angle 
 Hours study shoes worn per day  
 
5.3.4 Consent and randomisation 
Study participants were consented into the study by the C.I. (11.8, p241) and were assigned 
by block randomisation (blocks of four), into one of two groups: 
 Group 1: Participants received a pair of rocker sole sports shoes and attended four 
back exercise group sessions over four weeks 
 Group 2: Participants received a pair of flat sole sports shoes and attended four 
back exercise group sessions over four weeks 
The block randomisation protocol was chosen in order to ensure i). the numbers of 
participants in each group remained similar at all times, as demonstrated in the pilot study, 
and  ii). that groups were not influenced by selection bias (by the participant or the 
investigator) which could lead to an overestimate or underestimate of differences between 
treatments (Altman and Bland, 1999). The number of possible combinations for a block size 
of four with two rocker sole shoe and two flat sole shoe allocations per block was 
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calculated as six. Choosing to randomise with blocks of four ensured that the numbers in 
the two groups at any time would not differ by more than half the block length i.e. two 
participants at each site. It was deemed important to keep the block size small because if 
group size at each site did differ by two, it is possible that group differences may be as large 
as 10 participants across the study. A larger choice of block size increases the possibility of 
larger differences between groups. These blocks were written on pieces of paper by Dr 
Matt Morrissey (original PhD supervisor before he left King’s College London), folded over, 
and then randomly selected to determine the order of group allocation for participants 
entering the study.  Five separate randomisation sheets were produced in this manner, one 
for each site, with a total of 60 potential participant group allocations (15 separate blocks) 
per randomisation sheet. The block randomisation sheets were forwarded to the Primary 
Investigators (P.I.) at each referring site, and were kept on a password protected computer 
at each site. This prevented accidental release of allocation information to the C.I. A list of 
all P.I.s and co-researchers at each site can be found in 11.21 (p274). 
5.3.5 Outcome points 
Participants were assessed at baseline, six weeks, six months and one year from the first 
assessment. The six week assessment aimed to detect combined change in outcome 
measures corresponding to completion of the back exercise class and early use of study 
footwear. The six month assessment aimed to detect outcome measure changes occurring 
following the prolonged use of study shoes. Primary outcome point occurred at one year 
from baseline to provide adequate follow-up time for such a chronic, recurrent and 
fluctuating condition. The one year assessment marked the end of each participant’s 
involvement in the study. A flow chart of participant involvement in the study is presented 





















































Rocker sole sport shoe group  
(day 1) 
 
Instruction on how to wear shoes 
and enter data in exercise diary 
 
Flat sole sports shoe group 
(day 1) 
 
Instruction on how to wear shoes 
and enter data in exercise diary  
 
Identification of participants (approximately 2-3 weeks 
prior to consenting into study) 
Participant information sheets distributed 
(approximately 2-3 weeks prior to consenting into study) 
Willingness to participate from participant and fulfils inclusion and exclusion criteria 
(approximately 1-2 weeks prior to consenting into study) 
Informed consent obtained (day one of study) 
Participant randomisation with allocation 
concealment (day one of study) 
 Baseline assessment (day one of study) 
Roland Morris Disability Questionnaire, Numerical Rating Scale for pain, Tampa Scale of 
Kinesiophobia, Hospital Anxiety and Depression Scale, spinal impairment measurements, 
EuroQol, Patient Specific Functional Score 
 
 
Six week assessment: re-assessed as at baseline assessment  
 
Six months assessment: re-assessed as at baseline assessment, plus 
satisfaction with study shoes, days off work  
 
Twelve month assessment: re-assessed as at baseline assessment plus 
satisfaction with study shoes, days off work  
 
 







5.3.6 Format and standardisation of baseline assessment 
 
The initial evaluation consisted of assessment of patient questionnaires, impairment 
measurements, instruction on completion of a diary sheet (11.9, p243) and the fitting of the 
allocated footwear accompanied by an education session on correct standing and walking 
technique for both footwear types (11.22, p275). In order to standardise this assessment 
between participants and between sites, a specific assessment order was adhered to: 
1.  Verbal review of study involvement with potential participant 
2. Gaining of consent 
3. Participant completed outcome measures in the following order: Roland Morris 
Disability questionnaire, Numerical rating score for pain, Hospital Anxiety and 
Depression score, EuroQol health questionnaire, Tampa Scale of Kinesiophobia, 
Patient Specific Functional Score 
4. Impairment measures in the following order: thoracic spine kyphosis angle, range 
of lumbar spine flexion, extension, right and left side flexion, right and left straight 
leg raises 
5. Instruction on completion of diary sheet  
6. Fitting of study shoes, instruction on standing and walking in study shoes (co-
researcher in absence of C.I.) 
 
The roles of the P.I.s and co-researchers at each site included checking group 
randomisation allocation for each participant, fitting each participant with the appropriate 
study shoes and instructing them in the correct walking and standing technique whilst 
wearing the footwear. The C.I., blind to participant group allocation, was responsible for 
supervising each participant whilst outcome measure questionnaires were completed, 
recording the thoracic kyphosis angle and spinal impairment measurements (motion into 
flexion, extension, left and right side flexion, and left and right straight leg raise (SLR)), and 
instructing each participant on correct completion of the diary sheet. The methods used for 
assessing lumbar and thoracic movement have been demonstrated to be reliable by Lewis 
at al. (Lewis et al., 2005) and by the C.I. (van Blomestein et al., 2012) in a reliability study for 
this research project (4.4, p53 and 11.13, p249). To summarise the methodology, patients 
stood barefoot in their normal posture, feet hip width apart and arms relaxed at their sides, 
whilst the C.I. took readings from the T1-2 spinous processes and the T12-L1 spinous 
processes using an inclinometer (Isomed, 975 Sandy Blvd., Portland, OR 97214) (Figure 5.2). 
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With their feet in the same position participants were then asked to lean forwards, then 
backwards, then to each side, until their pain started to present or worsen for each 
movement. Using a ‘non-stretch’ tape measure the distance between the participant’s left 
middle fingertip and the floor directly below the left medial malleolus was recorded for the 
flexion and extension movements; for the side flexion movements the ipsilateral middle 
fingertip and the floor just behind the lateral malleoli were used as marker points for 
measurement recording. In order to assess SLR the inclinometer was placed on the tibial 
tuberosity, and the C.I. raised the participant’s leg. Three readings for each movement were 
taken and the average used in the data analysis. Participants were asked to report when 
their symptoms of pain presented, or worsened, at which point movement was stopped 
and the inclinometer reading recorded. A Numerical Rating Score (NRS) for pain (from 0 to 
10, where 0 = no pain, and 10 = worst imaginable pain) was requested from the participants 
at the point when each range of movement was recorded. Measurements were 
documented on the Participant Assessment Sheet (11.23, p281). 
 





5.3.6.1 Observation of the assessment of participants. 
Dr Matt Morrissey (original PhD supervisor before he left Kings College London) observed 
the C.I. during an initial participant assessment to ensure the procedure for gaining a 
participants consent was appropriate, and to verify that assessment of the participant was 
of a high standard.  
5.3.7 Interventions 
5.3.7.1 Footwear 
Choice of study shoes 
Masai Barefoot Technology Limited manufactures a large variety of rocker sole shoes. It 
was deemed important to select a single footwear model for the participants allocated to 
the rocker sole shoe group, that: 
 appeared practical to wear throughout the year i.e. not a sandal model 
 appeared to be of a colour practical to wear both in leisure and work time, to 
increase the likelihood that participants would wear the shoes for a minimum of 
two hours  per day. 
 was a unisex model, to ensure standardised footwear design between genders. 
 displayed minimal branding logos on the shoe outer, sole and insole. 
With these points in mind the ‘Chapa’ style shoe in ‘caviar black’ was selected. These shoes 
had a retail value of £179 per pair (Figure 5.3). 
Selection criteria for the flat sole shoe were identical to the rocker sole shoe selection 
criteria, with the addition of: 
 a sports trainer in design – the chosen rocker sole shoe was from the 
manufacturers ‘sports trainer’ range 
 a model likely to be manufactured for the duration of the recruitment period of the 
trial, ensuring all participants in the flat sole shoe group would be allocated the 
same model of trainers. 
 a shoe marketed to provide good shock absorption qualities (in an attempt to 
concur with the shock absorption reportedly offered by the rocker sole shoe). 
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 a neutral/ minimal support footwear type that would be suitable for the majority of 
participants.  
The flat sole shoe chosen, fulfilling all these criteria was an ASICS TM sports trainer, model 
‘Gel-1140’ (Figure 5.3). This shoe had a ‘GEL cushioning system’ in the sole (suggested to 
improve shock absorption by dissipating vertical impact forces (ASICS, 2012)), and offered 
slight additional support to the midfoot when compared to a neutral trainer. From 
discussions with a specialist sports physiotherapist (Mr Graham Anderson, Balance 
Performance Physiotherapy, London, SW4) this shoe was deemed to be a high quality 
sports trainer suitable for a variety of foot types. These shoes had a retail value of £70. 
Figure 5.3 Study footwear  
 
 
(top: flat sole shoe; bottom: rocker sole shoe) 
Unbranding of study shoes 
Before a participant received their study shoes the shoes were unbranded with the aim that 
participants remain as blind as possible to their allocated shoe brand. This involved the C.I. 
removing or concealing company logos on the shoes by use of a scalpel, a black marker pen, 
or a piece of sand-paper as appropriate. The unbranded rocker sole and flat sole shoes are 























Unbranded shoe tongue (left) 
  
Figure 5.5 Unbranded flat sole shoes 
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Training of co-researchers to fit study shoes, and instruct the participants in the 
correct study shoe walking technique 
Co-researchers at each site were trained for approximately 30 minutes by the same 
representative from Masai Barefoot Technology (MBT) GB Ltd on the correct fitting and 
walking techniques for the rocker sole shoes. The C.I. was present at all five sites during 
these training sessions. Co-researchers were given a document for both the flat sole and 
rocker sole shoes describing the exact wording to be used when instructing participants on 
the correct walking style for each shoe type (11.22, p275). This was to ensure that co-
researchers at each site relayed similar information to every study participant. 
Allocation of shoes to study participants and education on correct standing and 
walking technique 
Following completion of all outcome measures at the initial assessment the C.I. left the 
assessment area. A co-researcher then fitted the participant with their allocated shoe type 
in accordance with the randomisation sheet specific to each hospital and instructed them 
on correct standing and walking technique for their allocated shoes. The fitting session 
lasted approximately 30 minutes. 
 
Participants were able to try on a variety of sizes in their allocated footwear to ensure the 
pair they received offered them the best fit. The C.I. ensured that prior to the assessment 
the appropriate sizes of shoe were available in each shoe type. This required there to be in 
stock the shoe size of the participant, a size above and a size below. If none of the available 
allocated shoes fitted the participant, the C.I. delivered the appropriate size in both shoe 
types (in order that the C.I. remained blind to shoe group allocation) to the P.I. at the 
earliest convenience and the participant returned to the department to be refitted. In order 
that the C.I. did not guess, through knowledge of the remaining shoes in stock, which shoe 
had been allocated, the P.I. or co-researcher would place a variety of footwear pairs in the 
C.I.’s shoe travel case (used for delivering footwear to each site). This case would then be 
taken back to the main footwear store (Chelsea and Westminster Hospital), whereby the 
P.I. at this site would again replace pairs in their store with those in the C.I.’s suitcase. This 
aimed to reduce the ability of the C.I. to determine, from remaining stock, which 




‘Adaptation week’ for footwear use 
Baseline assessment and shoe fitting occurred approximately one week before participants 
started the low back pain exercise group. During this ‘adaptation week’ participants were 
given instruction to gradually increase the time study shoes were worn each day, initially 
wearing for only 15-30 minutes, progressing to a minimum wear of two hours per day 
(whilst standing and walking) by the start of their first exercise group. This ‘pacing’ 
procedure aimed to reduce the potential for the occurrence of other aches or pains 
secondary to the wearing-in process of a new pair of shoes. 
5.3.7.2 Low back exercise group 
Participants were asked to attend the back exercise group once a week for a period of four 
weeks (four back exercise classes in total). The back exercise group involved education, 
advice and a ten station exercise circuit. Each class was approximately one hour in duration. 
Study participants were informed to wear their study shoes during the low back exercise 
group. 
Quality assurance and standardisation of exercise group between sites 
In order to standardise this intervention the C.I. designed a back exercise class to be run at 
all sites. Exercises were chosen according to the latest research recommendations for 
management of CLBP (McGill, 2007; NICE, 2009), whilst considering the available space, 
equipment, and class duration time at each site. In developing the programme, the C.I. 
liaised closely with the back exercise group co-ordinators at each of the five sites, observing 
all current back exercise groups, in order to gain more knowledge on which group formats 
and which group diary scheduling times had higher patient recruitment and retention rates. 
Format of low back exercise group 
The finalised study exercise programme was composed of a five minute warm-up, ten 
exercises, of 90 seconds duration, each designed with three levels of progression, to 
accommodate each participant’s ability (11.24, p282), a five minute warm-down and a ten 
minute education/advice session. The exercises aimed to improve strength of large muscle 
groups and cardio-vascular fitness, in addition to specific trunk muscle exercises. The topics 
covered during the four education sessions were entitled ‘Managing a flare up’, ‘Pain’, 
‘Exercise’ and ‘Relaxation’ (11.25, p286). Classes were run with a maximum of ten 
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participants and, site-dependent, one or two physiotherapists. This format, incorporating 
general exercise with education and advice and conducted under supervision, is a 
recommended best practice treatment approach for CLBP patients (Liddle et al., 2007; 
NICE, 2009). 
Observation of exercise classes to ensure consistency and correct performance at 
study sites 
The C.I. observed the back exercise group at all sites prior to the recruitment of participants 
into the study, and again once the last participant to enter the study had completed 
exercise group attendance. This assessed whether the standardisation of the exercise group 
protocol at all sites had been maintained over the duration of the study. The C.I. was 
unable to observe the exercise groups during the study recruitment period due to the 
likelihood of the presence of research participants wearing their study shoes, hence, 
removing the blinding of the C.I. to participant group allocation.  
5.3.8 Six week assessment 
The C.I. reassessed participants following the completion of the four week exercise 
programme. This assessment took place at approximately six weeks from baseline 
assessment. The assessment involved the same questionnaires and physical tests as 
performed at baseline. Participants were asked to hand in their completed diary sheets but 
asked to continue wearing their study shoes for a minimum of two hours each day. 
5.3.9  Six month assessment 
Participants were reassessed at six months (the same questionnaires and physical tests as 
performed in assessment one). All outcome measures assessed at baseline were 
completed. In addition participants were asked the following questions: 
 On a scale of 0-7 where 0 represents totally unsatisfied and 7 represents extremely 
satisfied, how satisfied are you with the shoes you received? 
 Over the last week, how many days did you wear your study shoes? 
 Over the last week, on average, how many hours per day did you wear your shoes? 




Participants were asked to continue wearing their study shoes for a minimum of two hours 
a day until their final one year follow-up assessment.  
5.3.10  One year assessment 
The final assessment occurred at one year from baseline. This assessment replicated the six 
month assessment. At the end of the one year follow-up assessment participation in the 
research study ended. Participants were able to keep their study shoes if they so wished.  
5.3.11  Sample size calculation 
The minimal clinically important difference and the standard deviation from the mean of 
the primary outcome measure, the Roland Morris disability questionnaire, informed the 
study sample size. The smallest change likely to be clinically significant in the Roland Morris 
Disability Questionnaire (where scores can range from 0-24) may vary depending on the 
level of disability of the patients (Stratford et al., 1998). Stratford et al. (1998) suggested 
that the minimal clinically important difference in scores is one to two points in patients 
with little disability, seven to eight points for patients reporting high levels of disability, and 
five points in patients with unspecified disability levels. Patrick et al. ( 1995) suggest two to 
three points as the minimum clinically important difference for a 23 item version of the 
RMDQ (Jaeschke et al., 1989). Participants in the pilot study (4.2, p33) reported a mean 
baseline Roland Morris Disability score of 7.1, indicating mild to moderate disability in the 
study population. Therefore, a  reduction in score of greater than or equal to four points on 
the Roland Morris Disability Questionnaire was determined to represent an improvement 
in this study (Maughan and Lewis, 2010). One purpose for conducting the pilot study was to 
inform the main study of an appropriate sample size. The standard deviation of mean 
Roland Morris Disability Questionnaire data from the pilot study (5 points on the RMDQ) 





n ≥  2 ( Za + Zb ) ²σ²   
   δ² 
 “where: 
n  is an adequate size for a random sample for each population 
σ  is the standard deviation for individual values in the population (5 points on the 
RMDQ) 
δ  reflects the difference in population means deemed important to detect (4 points 
on the RMDQ) 
Za+Zb  are standardised scores associated with the required significance level and power, 




Za Power Zb Za+Zb (Za+Zb)² 
0.01 2.576 0.9 1.282 3.858 14.884 
 
For a power of 0.9 and an alpha of 0.01 based on a standard deviation of five (standard 
deviation data collected from participants in the pilot study) and an ability to detect a four 
point change in the mean Roland Morris Disability Questionnaire scores between baseline 
and reassessment, the number of participants needed for each of the groups equalled 47. 
This was increased to 60 to allow for an anticipated 20% participant loss-to-follow up and 
missing data (Schulz and Grimes, 2002). Therefore, it was anticipated that approximately 
120 participants would need to be recruited.  
5.3.12 Adverse events 
Adverse events were defined as an increase in pain or symptoms within one week of 
commencing an intervention (the ‘adaptation week’ for initial shoe wear, and a participants 
first week of attendance at the low back exercise group) that required general practitioner 




5.3.13 Data analysis 
Baseline data are presented in order that results may be compared with other trials and to 
judge the effectiveness of participant randomisation. Distributions were checked to see if 
normal distributions had been met, if this was not the case, non-parametric tests were 
performed. Independent t-tests for parametric data, were applied to determine differences 
between groups. When assumptions of normality were not met, and data were non-
parametric, the Mann-Whitney test was performed. 
The primary analysis was by intention-to-treat, including all eligible randomised participants 
who provided follow-up data. Mixed analysis of variance (ANOVA) tests were conducted 
with one within-subject factor (assessment time point) and one between group factor (shoe 
type) to compare the effectiveness of shoe type over the duration of the study (rocker sole 
shoes versus flat sole shoes). ANOVA utilised data from participants with complete data 
sets for all four time points (rocker sole shoe group n = 40, flat sole shoe group n = 43) 
unless otherwise stated. If differences were demonstrated between groups, post hoc tests 
were conducted with Bonferroni adjustment. 
Although not significantly different, baseline mean disability was lower in the rocker sole 
shoe group than the flat sole shoe group. An ANCOVA takes into account differences 
between groups in specific variables which may influence outcomes (Field, 2009), such as 
baseline disability. Therefore, data was further analysed using an ANCOVA with baseline 
Roland Morris Disability Questionnaire score as a covariate. A further sensitivity analysis 
used ‘expectation maximisation’ to impute missing values.  
A difference of greater than or equal to a four points change in RMDQ was taken to 
represent a clinical improvement in this study (Maughan and Lewis, 2010). Changes in 
RMDQ score between baseline and each reassessment were calculated. Participants were 
labelled as ‘improved’ if their RMDQ score reduced by 4 or more points, ‘did not improve’ if 
their score reduced by less than 4 points and did not increase by 4 points of more, and 
‘became worse’ if their score increased by greater than 4 points. Differences between 
groups for numbers reporting minimal clinically important differences were assessed with 
Chi-squared (χ2) test. 
One pre-planned sub-group analysis was conducted. Rocker sole shoes influence body 
kinetics and kinematics, during standing and walking (New and Pearce, 2007; Nigg et al., 
2006b; Romkes et al., 2006). Hence, it was supposed that the rocker sole shoe may be more 
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likely to influence low back symptoms in those who reported difficulties in these activities. 
Data from participants reporting LBP aggravated by standing or walking activities on the 
Patient Specific Functional Scale at baseline were analysed with: mixed ANOVA utilising 
data from participants with complete data sets and; mixed ANOVA with missing number 
imputation, to determine whether shoe allocation influenced disability in this sub-group. 
An ANCOVA was not conducted on this sub-group due to the similarity of baseline disability 
between groups. 
Data were analysed using IBM SPSS 20.0.0 (IBM, New York). Results are presented as means 





5.4.1 Participant recruitment 
During the recruitment period (April 2009-November 2010) 152 patients were identified, by 
physiotherapists at the five referring sites for inclusion into the study. Following either a 
telephone conversation or a face-to-face meeting with the C.I., 37 of these potential 
participants were deemed ineligible to be recruited into the trial. Reasons for the exclusion 
of these potential participants are presented in Figure 5.6.  One hundred and fifteen 
patients were consented into the study. 
 
Figure 5.6 Reasons for exclusion of potential participants 
 
  
0 2 4 6 8 10 12
Objected to wearing a 'sports shoe'
Unable to wear shoes made from synthetic material
Developed other medical issues
Leaving the country within the year
Did not meet inclusion criteria due to medical history
Additional treatment for LBP within past year
Unable to wear study shoes for 2 hours per day
Unable to contact
Unable to attend back exercise group
Number of potential participants 
(shoe specific exclusion reasons indicated in green) 
82 
 
5.4.2 Participant demographic characteristics 
 
One hundred and fifteen participants were consented into the study between April 2009 
and November 2010. Baseline study demographics and baseline outcome measures for 
the 115 participants are presented in Table 5.3 and Table 5.4 respectively. There were no 
differences between groups for demographic data or outcome measures, however, 
Roland Morris Disability Questionnaire and Quality of Life EQ-5D-3L scores tended to be 
greater (indicating greater disability and a better quality of life respectively) in the flat sole 
shoe group than the rocker sole shoe group. 
 
Table 5.3 Participant demographic data 
 Flat sole shoe 
group 
(n=58) 
Rocker sole shoe 
group 
(n=57) 
P - value 
Gender: Male 






Age [yrs] 43.0 (12.1) 43.1 (12.1) 0.98 
Weight [kg] 75.7 (14.0) 74.3 (14.7) 0.38 
Height [cm] 170.0 (7.4) 169.1 (9.8) 0.61 
Body Mass Index [kgm-2] 26.2 (4.59) 25.7 (4.73) 0.53 
Time since first episode of 
LBP [years] 
7.9 (9.0) 7.0 (7.9) 0.57 
Summary measures represent means (SD) or *numbers (percentages). †Chi-square test 






















6.6 (2.0) 6.6 (1.7) 0.91 
Quality of life (EQ-5D VAS) 
[0-100; 100=best] 
 
67.8 (16.8) 62.7 (19.0) 0.13 
Quality of life (EQ-5D) 
[-0.5 to 1.0; 1 = best] 
 
0.68 (0.16) 0.62 (0.24) 0.10 
Tampa Scale of Kinesiophobia 
[17-68; 17 = best] 
 
38.4 (6.5) 38.4 (6.1) 0.64 
   
Hospital Anxiety and Depression 
Scale: Anxiety component 
[0-21; 0=best]  
 
7.7 (3.6) 7.5 (4.2) 0.33 
Hospital Anxiety and Depression 
Scale: Depression component 
[0-21; 0=best] 
 
5.2 (3.1) 4.8 (3.7) 0.22 
Patient Specific Functional Scale 
[0-10; 10 = best] 
 
4.5 (1.7) 4.3 (1.8) 0.46 
Pain on standing or walking† 30 (51.7)* 29 (50.9)* 0.93** 
Summary measures represent means (SD) or *numbers (percentages) **Chi square test, 
otherwise independent t-test. †as reported on the Patient Specific Functional Scale. 
5.4.3 Participant retention and attrition 
At six weeks 100 (87%) participants were reassessed; at six months 92 (80%) participants 
were reassessed; and at 12 months 93 (81%) participants were reassessed. Retention at 12 
months tended to be lower in the rocker sole shoe group [44/58 (77.2%)] than the flat sole 
shoe group [49/57 (84.5%)] but not significantly (p = 0.32). Participant attrition and 



























Participant identification codes are reported as initials of the referring site followed by a 
number identifying the ‘nth’ participant entering the trial at that site
Assessed for eligibility by C.I. (n =152) 
Excluded (n= 37)                
29 did not meet inclusion criteria    
8 unable to contact 
 
Consented and randomised into the trial (n=115) 
Flat sole shoe group 
Total randomised (n=58) 
58 (100%) started allocated intervention  
 
Rocker sole shoe group 
Total randomised (n=57) 
57 (100%) started allocated intervention 
6 week follow up  
Total completing data collection (n=50) 
 Completed intervention (n=50) 
 Did not complete intervention (n=0) 
Total lost to follow-up (n=8) 
 unable to attend assessment: CW18, SG10 
 unable to contact: CW29, CW36, KH3, SG6, 
SG19 
 withdrew due to time commitments:CW48 
 
6 month follow up 
Total completing data collection (n= 47) 
 Completed intervention (n=41) 
 Did not complete intervention (n=6) 
Total lost to follow-up (n=11) 
 unable to attend assessment: CW10, CW39, 
QM3, QM7 
 unable to contact: CW29, CW36, CW52, 
KH3, SG6, SG19 
 withdrew due to time commitments:CW48 
 
12 month follow up 
Total completing data collection (n= 49) 
 Completed intervention (n=42) 
 Did not complete intervention (n=7) 
Total lost to follow-up (n=9) 
 Unable to contact: CW16, CW29, CW30, 
CW36, CW52, KH3, SG6, SG19 




6 week follow up  
Total completing data collection (n=50) 
 Completed intervention (n=49) 
 Did not complete intervention (n=1) 
Total lost to follow-up: (n=7) 
 unable to attend assessment: CW53 
 unable to contact: CW4, CW35, BP8, SG9 
 withdrew due to blister from shoe wear: CW47 
 withdrew due to fear of blisters (diabetic): 
QM11 
6 month follow up 
Total completing data collection (n=45) 
 Completed intervention (n=38) 
 Did not complete intervention (n=7) 
Total lost to follow-up (n=12) 
 unable to attend assessment: CW31, CW34, 
BP6 
 unable to contact: CW4, CW15, CW19, CW35, 
BP8, SG1, SG9 
 withdrew due to blister from shoe wear: CW47 
 withdrew due to fear of blisters (diabetic): 
QM11  
12 month follow up 
Total completing data collection (n=44) 
 Completed intervention (n=32) 
 Did not complete intervention (n=12) 
Total lost to follow-up (n=13) 
 unable to contact: CW4, CW15, CW19, CW25, 
CW26, CW35, BP8, SG1, SG3, SG8, SG9 
 withdrew due to blister from shoe wear: CW47 








Total included in final analysis 
(n= 49) 
% dropout = 15.5% 
 
Total included in final analysis 
(n= 44) 





5.4.4 Baseline characteristics of participants completing and 
participants not completing the trial 
Twenty two (19%) participants did not provide primary outcome data (Roland Morris 
Disability Questionnaire) at the final assessment (twelve months from baseline). Baseline 
characteristics of participants completing and not-completing are presented in Table 5.5. 
There were no differences in baseline characteristics between participants that completed 
the trial and participants that did not. However, participants completing the trial tended to 
be older than those not completing the trial (44.0 (12.0) years and 39.2 (11.8) years 
respectively) and tended to report a longer duration of LBP than those not completing the 
trial (7.9 (9.0) years and 5.5 (5.0) years respectively). A greater proportion of those who did 
not complete the trial had been allocated to the rocker sole shoe group. Baseline fear of 
movement, anxiety and depression scores tended to be higher in participants that did not 
complete the trial compared to those who did.  
5.4.5 Primary outcome: Roland Morris Disability Questionnaire 
5.4.5.1 Comparison of change in disability between groups 
Primary analysis 
For the primary outcome, both groups demonstrated reductions in disability at each time 
point when compared to baseline (F(2.21,92.62) = 21.63, p < 0.01, Ƞ2 = 0.34 for the flat sole 
shoe group and F(2.46, 96.11) = 11.49, p < 0.01, Ƞ2 = 0.23) for the rocker sole shoe group) 
(Table 5.6, Figure 5.8). There were no differences between groups for change in disability at 
the four reassessment points (F(2.39,193.21) = 1.56, p = 0.21, Ƞ2 = 0.21) indicating that 
change in disability was unaffected by the type of shoe worn in this study. 
Following removal of two outliers highlighted from box plots of RMDQ baseline scores (one 
participant from the flat sole shoe group with RMDQ of 22 and one participant from the 
rocker sole shoe group with a RMDQ score of 23) a similar non-significant outcome was 
observed (F(3,2.39) = 1.56, p = 0.21, Ƞ2 = 0.02). The removed outliers were replaced, and 













P - value 
Rocker sole group allocation 44/93 (47.3%) 13/22 (59.1%) 0.32 
Female 61/93 (65.6%) 15/22 (68.2%) 0.82 
Age 44.0 (12.0) 39.2 (11.8) 0.10 
Time since first episode of LBP [years] 7.9 (9.0) 5.5 (5.0) 0.09 
Roland Morris Disability Questionnaire 
[0-24; 0=best] 
 
8.5 (4.9) 8.5 (5.0) 0.94 
Numerical rating score for Pain  
[0-10; 0=best] 
 
6.7 (1.8) 6.1 (2.1) 0.19 
VAS for Quality of life EQ-5D-3L 
[0-100; 100=best] 
 
66.6 (16.9) 59.8 (21.5) 0.11 
Quality of life EQ-5D-3L 
[-0.5 to 1.0; 1 = best] 
 
0.65 (0.21) 0.65 (0.19) 0.95 
Tampa Scale of Kinesiophobia 
[17-68; 17 = best] 
 
38.0 (6.) 40.0 (6.6) 0.17 
   
Hospital Anxiety and Depression Scale: 
Anxiety component 
[0-21; 0=best]  
 
7.4 (4.0) 8.8 (3.1) 0.11 




4.9 (3.4) 5.7 (3.3) 0.28 
Patient Specific Functional Scale 
[0-10; 10 = best] 
 
4.3 (1.7) 4.8 (2.0) 0.27 




Table 5.6 Roland Morris Disability Questionnaire score at each assessment   
Outcome measure Assessment point 
Intervention 
Flat sole shoe          
(n=43) 





[0-24; 0 = best] 
Baseline 9.2 (7.8-10.6) 7.1 (5.6-8.5) 
6 weeks 6.1 (4.9-7.2)* 4.9 (3.4-6.3)* 
6 months 5.3 (3.8-6.7)* 4.8 (3.3-6.2)* 
12 months 4.8 (3.4-6.1)* 4.0 (2.5-5.6)* 
Summary measures are Means (95% Confidence Intervals).* represents a significant 









Although not significantly different, baseline mean disability was lower in the rocker sole 
shoe group than the flat sole shoe group by 1.4 points (and by 2.1 points when the mean is 
calculated using only data from the complete data sets utilised when calculating an 
ANOVA). Therefore, data was further analysed using an ANCOVA with baseline Roland 
Morris Disability Questionnaire score as a covariate. When taking into account the effect of 
baseline score, differences between groups for changes in Roland Morris Disability 
Questionnaire score between groups at reassessment remained non-significant (F(1.76, 
140.55) = 0.51, p = 0.58, Ƞ2 = 0.006). 
There were no differences in disability between groups at reassessment following missing 
number imputation (using ‘expectation maximisation’) (F(2.39,270.20) = 1.98, p = 0.13, Ƞ2 = 
0.02) (Table 5.7). 
Table 5.7 Roland Morris Disability Questionnaire scores imputing missing values 
using expectation maximisation 
Outcome measure Assessment point 
Intervention 
Flat sole shoe         
(n=58)   
Rocker sole shoe 
(n=57) 
Roland Morris Disability 
Questionnaire 
(0-24; 0 = best) 
Baseline 9.2 (8.0-10.5) 7.8 (6.6-9.1) 
6 weeks 6.3 (5.1-7.4) 5.7 (4.5-6.9) 
6 months 5.4 (4.2-6.6) 5.4 (4.2-6.6) 
12 months 4.9 (3.6-6.1) 4.8 (3.5-6.0) 
Summary measures are Means (95% Confidence Intervals) 
 
Although not significant, there was a trend for reductions in disability at one year to be 
greater for the flat sole shoe group (-4.4 points, 95% confidence interval -5.8 to -3.1) than 




Figure 5.9 Change in disability from baseline (negative value represents 
improvement in disability) 
 
5.4.5.2 Participants achieving clinically important change in disability 
At six weeks, 16/50 (32%) of the participants in the rocker sole group and 18/50 (36%) of 
the participants in the flat sole shoe group showed a clinically important improvement in 
perceived disability (a four point or greater reduction in the Roland Morris Disability 
Questionnaire) and 2/50 (4%) and 1/50 (2%) respectively reported a minimal clinically 
important deterioration (a four point or greater increase in the Roland Morris Disability 
Questionnaire score). These differences were not significantly different between the two 
footwear groups (χ2 (1) = 0.18, p = 0.67 for clinically important improvement, and χ2 (1) = 
0.34, p = 0.56 for clinically important deterioration). 
At six months, 13/45 (31%) of the rocker sole shoe group and 25/47 (53%) of the flat sole 
shoe group reported a minimal clinically important improvement  (χ2 (1) = 4.60, p = 0.03), 
indicating a greater proportion of participants allocated to wear flat sole shoes improved at 
six months when compared to those allocated to the rocker sole shoe group. At six months, 
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2/45 (4%) of those in the rocker sole shoe group and 2/47 (4%) in the flat sole shoe group 
reported a minimal clinically important deterioration in disability (χ2 (1) < 0.01, p = 0.97).  
At 12 months, 18/44 (41%) of the rocker sole shoe group and 26/49 (53%) of the flat sole 
shoe group demonstrated a minimal clinically important improvement, and 3/44 (7%) and 
0/49 (0%) respectively reported a minimal clinically important deterioration regarding 
disability. These differences were not significant (χ2 (1) = 1.37, p = 0.24 for clinically 
important improvement, and χ2 (1) = 3.45, p = 0.06 for clinically important deterioration). 
5.4.5.3 Comparison of disability scores for participants reporting pain 
aggravated by standing or walking  
Baseline variables for the sub-group of participants reporting pain on standing or walking at 
baseline are presented in Table 5.8. There were no significant differences between shoe 
groups. 
Table 5.8 Baseline data for those reporting pain on standing and walking 
  














Age [years] 44.2 (11.9) 43.8 (12.4) 0.88 
Body Mass Index [kgm-2] 26.9 (5.4) 26.17 (5.3) 0.62 
Time since first episode 
of LBP [years] 
7.4 (7.1) 9.2 (9.5) 0.41 
Outcome 
measures 
Roland Morris Disability 
questionnaire 
8.7 (4.8) 8.8 (5.8) 0.95 
Numerical rating score 
for pain 
6.6 (1.9) 6.6 (1.9) 0.94 





There were no between group differences in change in disability at reassessment within the 
sub-group of participants reporting pain on standing or walking (using the 43 complete data 
sets) (Table 5.9)(F (2.32, 95.22) = 2.35, p = 0.09, Ƞ2 =0.05 ), however, there was a tendency 
for the flat sole shoe sub-group to demonstrate greater reductions in disability.  The flat 
sole shoe sub-group demonstrated significant within group reductions in disability at all 
time points when compared to baseline (F(1.97,43.34)=13.37, p <0.01, Ƞ2 = 0.38) (Table 
5.9). 






Flat sole shoe 
group (n=23) 






[0-24; 0 = best] 
Baseline 8.2 (6.3–10.2) 7.3 (5.2-9.4) 
6 weeks 4.9 (3.2-6.6)* 6.4 (4.5-8.2) 
6 months 4.6 (2.7-6.5)* 5.6 (3.6-7.6) 
12 months 3.9 (1.8-6.0)* 5.6 (3.3-7.8) 
Summary measures are Means (95% Confidence Intervals).* represents a significant 
(p<0.01) within group score change when compared to baseline. 
Sensitivity analysis 
Following missing value imputation, there was a significant difference in reduction in 
disability between the two shoe sub-groups at reassessment points (F(2.24, 127.64) = 2.97, 
p = 0.046, Ƞ2 = 0.05). Participants in the flat sole shoe group showed a greater improvement 
in disability than participants in the rocker sole shoe group at six weeks (p = 0.02) and at 
twelve months (p = 0.04) when compared to baseline disability. At twelve months, 
participants in the flat sole shoe group demonstrated a reduction in Roland Morris 
Disability Questionnaire score of -4.4 (-6.0 to -2.8) and those in the rocker sole shoe group a 




Table 5.10 Disability for sub-group of participants reporting baseline pain on 
standing or walking (with missing number imputation) 





Flat sole shoe 
group (n=30) 






[0-24; 0 = best] 
Baseline 8.7 (6.8-10.7) 8.8 (6.9-10.8) 
6 weeks 5.5 (3.8-7.3) 7.6 (5.8-9.4) 
6 months 4.9 (3.2-6.7) 6.8 (5.1-8.6) 
12 months 4.3 (2.4-6.3) 6.8 (4.8-8.8) 
Summary measures are Means (95% Confidence Intervals). 
 
Figure 5.10 demonstrates disability at each assessment point for the sub-group of 
participants in each shoe group reporting baseline pain on standing or walking (with 
missing number imputation).  
Figure 5.10 Disability for sub-group of participants reporting baseline pain when 
standing or walking (with missing number imputation) 
 
        (Reduction in score represents reduction in disability) 
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5.4.6 Secondary outcome measures 
5.4.6.1 Pain intensity 
Both shoe groups demonstrated reductions in pain at each time point when compared to 
baseline (flat sole shoe group: F(3,126) = 23.72, p >0.01, Ƞ2 = 0.36; rocker sole shoe group 
F(3, 117) = 13.43, p > 0.01, Ƞ2 = 0.26) (Table 5.11 and Figure 5.11). There were no between 
group differences in pain reduction over the four time points (F(3, 243) = 0.17, p = 0.92, Ƞ2 < 
0.01) indicating that the reduction in pain was unaffected by the type of shoe worn. 
 
Table 5.11 Pain intensity: Numerical rating score 
Outcome measure Assessment point 
Intervention 
Flat sole shoe   
(n=43) 
Rocker sole shoe 
(n=40) 
Numerical rating 
score for pain                          
[0-10; 0 = best] 
 
Baseline       6.9 (6.3-7.5)        6.4 (6.0-6.9) 
6 weeks 4.9 (4.3-5.5)* 4.6 (3.9-5.4)* 
6 months 4.3 (3.5-5.0)* 4.0 (3.2-4.8)* 
12 months 4.2 (3.4-5.0)* 4.2 (3.2-5.1)* 
Summary measures are means (95% Confidence Intervals). * represents a significant 






(Reduction in sore represents reduction in pain) 
5.4.6.2 Patient Specific Functional Score 
Both groups demonstrated improvements in function at each time point when compared to 
baseline (flat sole shoe group: F(2.12, 84.75) = 33.68, p <0.01, Ƞ2 = 0.46; rocker sole shoe 
group: F(2.37, 90.00) = 23.96, p < 0.01, Ƞ2 = 0.39) (Table 5.12, Figure 5.12).  
There were no between group differences in change in functional improvement over the 
four time points (F(2.35, 183.29) = 0.46, p = 0.67, Ƞ2 <0.01) indicating that functional 
improvement was unaffected by the type of shoe worn. 
  





Table 5.12 Patient Specific Functional Score 
Outcome measure Assessment point 
Intervention 
Flat sole shoe      
(n=43) 




[0-10; 10 = best] 
 
Baseline 4.3 (3.8-4.8) 4.4 (3.8-5.0) 
6 weeks 6.1 (5.6-6.7)* 5.8 (5.2-6.5)* 
6 months 6.7 (6.1-7.3)* 6.4 (5.8-7.1)* 
12 months 7.1 (6.4-7.7)* 6.7 (6.1-7.4)* 
Summary measures are means (95% Confidence Intervals). * represents a significant 
(p<0.05) within group score change when compared to baseline. 
 
Figure 5.12 Patient Specific Functional Score 
 




5.4.6.3 Health related quality of life (EQ-5D-3L) 
There was no change in health related quality of life in the rocker sole shoe group over the 
four time points (F(2.38,83.26)=2.80, p=0.06, Ƞ2=0.07). The flat sole shoe group 
demonstrated an improvement in quality of life over the four time points (F(2,23,88.99)= 
3.47, p =0.03, Ƞ2=0.08); post hoc tests demonstrated an improvement in health related 
quality of life at 12 months compared to baseline (p = 0.02) (Table 5.13).  
 
There were no between group differences for change in health related quality of life over 
the four time points (F(3, 225) = 1.10 p = 0.35, Ƞ2 = 0.01) indicating that health related 
quality of life was unaffected by the type of shoe worn in this study. 
Table 5.13 Health related quality of life 
Outcome measure Assessment point 
Intervention 
Flat sole shoe           
(n=43) 
Rocker sole shoe 
(n=40) 
Quality of life 
 EQ -5D 
[-0.5-1; 1 = best] 
 
Baseline 0.68 (0.64-0.72) 0.62 (0.55-0.68) 
6 weeks 0.74 (0.69-0.78) 0.63 (0.55-0.72) 
6 months 0.71 (0.66-0.76) 0.66 (0.66-0.73) 
12 months 0.76 (0.73-0.80)* 0.70 (0.62-0.79) 
Summary measures are Means (95% Confidence Intervals). * represents a significant 
(p<0.05) within group score change when compared to baseline. 
5.4.6.4 Health related quality of life (EQ-5D-3L) visual analogue score 
Neither shoe group demonstrated change in health related quality of life over the four time 
points (F(3,105)=1.79, p =0.15, Ƞ2= 0.05, and F(3,130)=1,37, p =0.25, Ƞ2= 0.03 respectively) 
(Table 5.14).  
 
There were no between group differences for change in visual analogue score for health 
related quality of life over the four time points (F(3, 225) = 0.18 p = 0.91, Ƞ2 <0.01), 
indicating that the visual analogue score for health related quality of life was unaffected by 




Table 5.14 Visual analogue score for health related quality of life 
Outcome measure Assessment point 
Intervention 
Flat sole shoe            
(n=43) 
Rocker sole shoe 
(n=40) 
Visual analogue 
score for health 
related quality of 
Life (EQ-5D-3L) 
[0-100; 100 = best] 
Baseline 70.0 (65.6-74.5) 64.4 (58.2-70.5) 
6 weeks 72.1 (67.1-77.0) 69.1 (62.5-75.8) 
6 months 72.0 (66.4-77.6) 66.9 (60.7-73.1) 
12 months 75.6 (71.0-80.3) 70.5 (63.3-77.6) 
Summary measures are Means (95% Confidence Intervals). 
5.4.6.5 Tampa Scale of Kinesiophobia 
There was no change in self-reported fear of movement for the rocker sole shoe group over 
the four time points (F(2.40, 83.85) = 1.69, p = 0.19, Ƞ2= 0.05). The flat sole shoe group 
demonstrated improvement between the four time points (F(2.47,98.95) = 3.36, p  = 0.03, 
Ƞ2 = 0.08), however, post hoc tests did not show a difference between individual 
assessment points (p > 0.05) (Table 5.15).  
 
There were no between group differences for change in self-reported fear of movement 
over the four time points (F(2.57, 192.76) = 0.75 p = 0.51, Ƞ2= 0.01, indicating that self-
reported fear of movement was unaffected by the type of shoe worn. 
Table 5.15 Tampa Scale of Kinesiophobia 
Outcome measure Assessment point 
Intervention 
Flat sole shoe   
(n=43) 
Rocker sole shoe    
(n=40) 
Tampa Scale of 
Kinesiophobia 
[17-68; 68 = best] 
 
Baseline 37.9 (36.0-39.8) 36.2 (34.4-37.9) 
6 weeks 36.8 (34.9-38.6) 34.7 (32.5-36.9) 
6 months 37.1 (34.8-39.4) 34.7 (32.1-37.3) 
12 months 34.7 (32.0-37.4) 34.3 (31.8-36.7) 
Summary measures are Means (95% Confidence Intervals). 
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5.4.6.6 Hospital Anxiety and Depression Scale: anxiety component 
There was no difference in anxiety between time points in the rocker sole shoe group 
(F(1.82,63.70) = 1.32, p = 0.27, Ƞ2 = 0.04). Anxiety scores in the flat sole shoe group differed 
between the four time points (F(3, 120) = 3.73, p = 0.01, Ƞ2 = 0.09) with a reduction in 
anxiety at 6 weeks compared to baseline (p = 0.02) (Table 5.16). 
There were no between group differences in change in anxiety over the four time points 
(F(2.31, 173.36)=1.84, p=0.16, Ƞ2=0.02) indicating that self-reported anxiety was unaffected 
by the type of shoe worn. 
Table 5.16 Hospital Anxiety and Depression Scale: anxiety component 
Outcome measure Assessment point 
Intervention 
Flat sole shoe   
(n=43) 
Rocker sole shoe 
(n=40) 
Hospital Anxiety and 
Depression Scale : 
Anxiety component 
[0-21; 21 = best] 
Baseline 7.3 (6.2-8.4) 6.9 (5.4-8.4) 
6 weeks 6.1 (5.1-7.1)* 7.4 (5.7-9.0) 
6 months 6.9 (5.8-7.9) 7.2 (5.4-9.0) 
12 months 6.0 (4.9-7.1) 6.3 (4.7-8.0) 
Summary measures are Means (95% Confidence Intervals).* represents a significant 
(p<0.05) within group score change when compared to baseline. 
5.4.6.7 Hospital Anxiety and Depression scale: depression component 
There was no change in self-reported depression in the rocker sole shoe group over the 
four time points (F(3,105) = 0.08, p = 0.95, = Ƞ2 <0.01). Depression in the flat sole shoe 
group differed between the four time points (F(2.40, 95.92) = 3.87, p = 0.02, Ƞ2 = 0.09) with 
a reduction in depression at six weeks compared to baseline (p = 0.03) (Table 5.17). 
There were no between group differences for change in depression over the four time 
points (F(2.60, 194.88) = 1.60, p = 0.20, Ƞ2 = 0.02) indicating that self-reported depression 




Table 5.17 Hospital Anxiety and Depression Scale: depression component 
Outcome measure Assessment  point Intervention 
Flat sole shoe 
(n=43) 
Rocker sole shoe 
(n=40) 
Hospital Anxiety and 
Depression Scale : 
Depression component 
(0-21; 21 = best) 
Baseline 4.7 (3.8-5.7) 4.3 (3.0-5.7) 
6 weeks  3.2 (2.3-4.2)* 4.1 (2.6-5.7) 
6 months 4.0 (3.1-5.0) 4.2 (2.4-6.0) 
12 months 3.5 (2.7-4.4) 4.3 (2.7-5.9) 
Summary measures are Means (95% Confidence Intervals).* represents a significant 
(p<0.05) within group score change when compared to baseline. 
5.4.6.8 Spinal impairment measures 
Although a small number of within group changes in spinal impairment measures were 
demonstrated (flat sole shoe group: increase in spinal extension at six months, increase in 
left and right straight leg raise at six months and twelve months compared to baseline; 
rocker sole shoe group: increase in right spinal side flexion at twelve months and increase 
in right straight leg raise at six months) (Table 5.18), there were no between group 
differences over the four time points for change in range of: 
 Spinal flexion (F(2.67, 189.75) = 0.46, p = 0.69, Ƞ2 <0.01 ) 
 Spinal extension (F(1.62, 115.33) = 0.10, p = 0.86, Ƞ2 <0.01) 
 Spinal left or right side flexions (F(2.32, 164.53) = 0.11, p = 0.92, Ƞ2 <0.01, 
and F(3, 213) = 1.68, p = 0.17, Ƞ2 =0.02  respectively) 
 Left or right straight leg raise (F(3, 213) = 1.70, p = 0.17, Ƞ2 = 0.02, and 
F(2.43, 172.53) = 0.77, p = 0.49, Ƞ2 =0.01  respectively) 
 Thoracic spine kyphosis angle (F(3, 213) = 1.34, p = 0.26, Ƞ2 =0.02) 




Table 5.18 Spinal impairment measures 




Flat sole shoe      
(n=43) 




Baseline 20.9 (15.8-25.9) 19.1 (13.5-24.8) 
6 weeks 20.7 (15.2-26.1) 19.0 (13.8-24.2) 
6 months 17.8 (12.9-22.8) 18.5 (13.7-23.2) 
12 months 17.8 (13.0-22.6) 17.1 (11.9-22.3) 
Spinal extension 
[cm] 
Baseline 62.9 (61.5-64.2) 62.2 (60.6-63.8) 
6 weeks 61.9 (60.5-63.3) 61.2 (59.7-62.7) 
6 months   61.3 (59.8-62.8)* 60.3 (56.6-64.0) 
12 months 61.8 (60.1-63.5) 61.5 (59.8-63.2) 
Spinal left side flexion 
[cm] 
Baseline 48.4 (46.6-50.2) 48.2 (46.4-50.1) 
6 weeks 48.3 (46.7-49.9) 48.3 (46.0-50.6) 
6 months 47.2 (45.7-48.7) 47.3 (45.5-49.1) 
12 months 46.7 (45.0-48.5) 47.1 (45.3-49.0) 
Spinal right side flexion 
[cm] 
Baseline 46.9 (44.8-49.0) 48.4 (46.8-50.1) 
6 weeks 47.1 (45.4-48.7) 47.1 (45.5-48.7) 
6 months 46.3 (44.7-47.8) 47.4 (45.7-49.1) 
12 months  46.8 (45.2-48.5)   46.9 (45.3-48.5)* 
Left straight leg raise 
[degrees] 
Baseline 71.9 (66.8-77.0) 78.8 (73.2-84.5) 
6 weeks 78.1 (73.2-82.9) 82.4 (75.6-89.1) 
6 months  80.8 (76.0-85.6)* 81.4 (75.1-87.6) 
12 months  78.4 (74.3-82.4)* 82.1 (76.1-88.0) 
Right straight leg raise 
[degrees] 
Baseline 68.6 (62.3-74.9) 75.6 (68.8-82.4) 
6 weeks 75.5 (70.8-80.2) 78.8 (72.9-84.7) 
6 months  78.3 (73.3-83.2)*   81.4 (76.0-86.9)* 
12 months   76.9 (72.3-81.6)* 80.4 (74.8-86.0) 
Thoracic kyphosis 
angle [degrees] 
Baseline 40.7 (37.8-43.6) 42.3 (38.8-45.9) 
6 weeks 39.2 (36.1-42.3) 40.5 (37.5-43.6) 
6 months 40.3 (37.6-43.1) 40.0 (36.6-43.4) 
12 months 42.8 (40.3-45.3) 41.3 (38.4-44.3) 
Summary measures are Means (95% Confidence Intervals).* represents a significant 




5.4.6.9 Time off work 
For those in paid employment, there was no difference in the average number of days off 
work, resulting from low back pain, between the footwear groups from baseline to six 
months (U = 479.0, z = -0.77, p = 0.44) or from six months to twelve months (U= 505.5, z = -
0.12, p = 0.91) (Table 5.19). 




Flat sole shoe   Rocker sole shoe 
Baseline to  
6 months 
Participants taking 
time off work  
5/32 (15.6%)* 3/32 (9.4%)* 
Average days off 
work/participant 
1.7 (6.5) 0.5 (1.6) 
6 months  
to 12 months 
Participants taking 
time off work 
3/34 (8.8%)* 3/30 (10.0%)* 
Average days off 
work/participant 
1.5 (6.2) 0.7 (2.8) 
Summary measures represent means (SD) or *numbers (percentages) 
5.4.6.10 Adherence to shoe use protocol. 
There were no differences between groups in reported adherence to the shoe use protocol 
(to wear study shoes for two hours or greater each day) at the three reassessment points. 
At six weeks, there was a 52.4 % reported adherence to the shoe use protocol for the flat 
sole shoe group and a 60.0 % reported adherence for the rocker sole shoe group (χ2 (1) = 
0.48, p = 0.49). At six months, there was a 34.8 % reported adherence to the shoe use 
protocol for the flat sole shoe participants and a 52.3 % reported adherence for the rocker 
sole shoe group (χ2 (1) = 2,80, p = 0.09). At twelve months, there was a 41.7 % reported 
adherence to the shoe use protocol for the flat sole participants and a 32.6 % reported 
adherence for the rocker sole group (χ2 (1) = 0.80, (p = 0.37). 
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5.4.6.11 Hours of reported shoe use at each reassessment point. 
The average hours that study shoes were worn per week did not differ within either group 
over the three reassessment points (Flat sole shoe group: F(2,72) = 0.61, p = 0.54, Ƞ2 = 0.02; 
rocker sole shoe: F(2,62) = 2.30, p = 0.11, Ƞ2 = 0.07) (Table 5.20). There was no between 
group difference for change in the average number of hours study shoes were worn per 
week over the three reassessment points (F(2, 134) = 0.46, p = 0.63, Ƞ2 < 0.01).  
Table 5.20 Reported average hours per week that study shoes were worn 
Outcome measure Assessment point 
Intervention 
Flat sole shoe   Rocker sole shoe 
Average hours 
study shoes worn 
per week 
6 weeks 17.0 (13.3-20.6) 18.0 (14.8-21.2) 
6 months 15.0 (10.6-19.4) 14.0 (9.9-18.0) 
12 months 14.4 (10.3-18.6) 11.9 (7.5-16.4) 
Summary measures represent means (95% Confidence Intervals). 
5.4.6.12 Participants’ satisfaction with allocated footwear 
At both six months (χ2 (1) = 5.18, p = 0.02) and 12 months (χ2 (1) = 6.40, p = 0.01), 
participants in the flat sole shoe group were more satisfied with the shoe they received 
than participants in the rocker sole shoe group.  
The majority of participants in the flat sole shoe group were ‘very’ or ‘extremely’ satisfied 
with their shoe allocation at six months (26/42, 62%). At twelve months the number of 
participants ‘very’ or ‘extremely’ satisfied increased in the flat sole shoe group (33/45, 
73%). In the rocker sole shoe group 16/43 (37%) of participants reported to be ‘very’ or 
‘extremely’ satisfied with their footwear at six months (Table 5.21 and Table 5.22). At 
twelve months, this percentage increased to 46%, however, due to a concurrent reduction 
in group size, the number of participants reporting to be ‘very’ or ‘extremely’ satisfied at 




Table 5.21 Participant’s satisfaction with footwear allocation 
  Satisfaction with 
footwear at 6 
months 
Satisfaction with 
footwear at 12 
months 
Flat sole  
shoe group 
Extremely unsatisfied 0/42 (0.0%) 3/45 (6.7%) 
Very unsatisfied 1/42 (2.4%) 1/45 (2.2%) 
Somewhat unsatisfied 4/42 (9.5%) 2/45 (4.4%) 
Mixed 4/42 (9.5%) 3/45 (6.7%) 
Somewhat satisfied 7/42 (16.7%) 3/45 (6.7%) 
Very satisfied 10/42 (23.8%) 13/45 (28.9%) 
Extremely satisfied 16/42 (38.1%) 20/45 (44.4%) 
Rocker sole  
shoe group 
Extremely unsatisfied 1/43 (2.3%) 1/37 (2.7%) 
Very unsatisfied 0/42 (0.0%) 1/37 (2.7%) 
Somewhat unsatisfied 4/43 (9.3%) 6/37 (16.2%) 
Mixed 5/43 (11.6%) 6/37 (16.2%) 
Somewhat satisfied 17/43 (39.5%) 6/37 (16.2%) 
Very satisfied 8/43 (18.6%) 8/37 (21.6%) 
Extremely satisfied 8/43 (18.6%) 9/37 (24.3%) 
Summary measures are numbers of participants (percentages). Denominator varies 
according to number of valid responses.  
Table 5.22 Participants ‘very satisfied’ or ‘extremely satisfied’ with allocated 
footwear 
 
Flat sole shoe   
group 
Rocker sole shoe 
group 
P - value 
Very/extremely 
satisfied at 6 months 
26/42 (61.9%) 16/43 (37.2%) 0.02 
Very/extremely 
satisfied at 12 months 
33/45 (73.3%) 17/37 (45.9%) 0.01 
Summary measures are numbers of participants (percentages). Denominator varies 
according to number of valid responses. 
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5.4.6.13 Consistency of exercise class at each site 
Observation of the back exercise group at all sites after the last participant consenting into 
the study competed the group, confirmed that all groups continued to run as described in 
5.3.7.2, (p75). 
5.4.6.14 Adverse events 
No serious adverse events were reported. Two subjects withdrew from the rocker sole shoe 
group for shoe related reasons. One participant (with diabetes and poor skin condition on 
their feet) withdrew after wearing the shoes on one occasion, due to fear of foot blisters. 
The second participant who withdrew reported a blister on their heel and voiced concerns 
that further use of the shoes may result in further blisters. The Participant Information 
Sheet stated that no major adverse effects were expected, however ‘as with any new 
footwear, participants may develop blisters as a result of wearing either shoe type.’ 
5.5 Discussion 
This study demonstrated that in a CLBP population, people who attended a four week 
exercise programme and wore flat sole or rocker sole shoes reported improvements in 
disability (reductions in Roland Morris Disability Questionnaire score) at one year when 
compared to baseline. Improvement in disability was similar for both shoe groups - the flat 
sole shoe group reported an overall reduction in Roland Morris of 4.4 points and the rocker 
sole shoe group a reduction of 3.1 points.  In addition, this study suggests that for people 
reporting pain on standing and walking, improvement in disability score, following missing 
data imputation, at six weeks and twelve months was significantly greater for participants 
in the flat sole shoe group compared to participants in the rocker sole shoe group. For 
people reporting pain on standing or walking, there were within-group reductions of 
disability in the flat sole shoe group at all reassessment points; there were no within-group 
changes in disability in the rocker sole shoe group. A significantly greater proportion of 
participants in the flat sole shoe group reported a minimal clinically important 
improvement in disability at six months when compared to participants wearing the rocker 
sole shoe. At both six months and 12 months, participants in the flat sole shoe group were 
more satisfied than participants in the rocker sole shoe group with the shoe they received. 
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5.5.1 Baseline demographic data 
Participants referred for physiotherapy in this study were in their early middle age, and 66% 
were female - typical of a CLBP population seeking treatment within the United Kingdom 
(Critchley et al., 2007; Croft et al., 1998). Baseline Roland Morris Disability Questionnaire 
scores of 7.82 - 9.21 were similar to recent UK physiotherapy trials (Cairns et al., 2006; UK 
BEAM Trial Team, 2004) suggesting the sample in this study was representative of the 
general UK CLBP population. Although the average body mass index of participants  in the 
current study (25.9) falls into the ‘overweight’ classification, this score is usual for a UK 
population of this age (National Audit Office, 2001). These similarities to a general low back 
pain population strengthen the ability to generalise findings from this study to the larger 
back pain population. 
Participants were recruited from five sites in south west London including both inner city 
and suburban localities. This resulted in a diverse study population likely to be more 
representative of a general city population than if recruitment had occurred from one 
referring site. 
5.5.2 Participation and attrition 
Retaining 80.9% (93/115) of participants at one year compares well with other UK based 
physiotherapy trials in secondary care: 57% (UK BEAM Trial Team, 2004) and 73% (Critchley 
et al., 2007) retention have been achieved from previous studies at one year follow-up 
conducted in similar south London CLBP populations. The 93 participants assessed at 
primary follow-up point (twelve months) was one less than indicated by the sample size 
calculation. Although there is a small discrepancy between actual (n=93) and planned 
number of participants (n=94) reassessed at twelve months, with the knowledge that the 
results obtained between groups were similar between interventions, it seems unlikely that 
a type two error (‘false negative’ due to under powering) would have occurred in the 
primary clinical outcome due to this small discrepancy. 
 
Baseline primary outcome data obtained in the study was used to recalculate the 
appropriate sample size based on the actual study population. For a power of 0.9 and an 
alpha of 0.01 based on a standard deviation of 4.86 (baseline Roland Morris Disability 
Questionnaire standard deviation data) and an ability to detect a four point change in the 
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mean Roland Morris Disability Questionnaire scores between baseline and reassessment 
(Maughan and Lewis, 2010), the number of participants needed for each of the groups 
equalled 44. In this study, 49 participants in the flat sole shoe group and 44 participants in 
the rocker sole shoe group were assessed at the primary follow up point indicating that the 
study had a high probability of detecting a statistically significant result if one did occur.  
 
Although not significant, a larger proportion of participants not completing the study had 
been allocated to the rocker sole shoe group. Allocation to the rocker sole group may in 
some way be accountable for this increased drop-out rate. Two subjects allocated to the 
rocker sole shoe group withdrew within the first week due to the presence of shoe related 
foot blisters or the fear of getting a foot blister. Other possible explanations for the slightly 
greater numbers lost to follow-up in the rocker sole shoe include; difficulties adapting to 
walking with a rocker sole; impracticalities of wearing a rocker sole style of shoe; and 
difficulties adjusting to the additional weight of the rocker sole shoes (which were twice the 
mass of the flat sole shoes). Baseline outcome measures were very similar between 
participants who completed and participants who did not complete the study suggesting 
differential attrition did not affect clinical outcomes. 
5.5.3 Reasons for clinical outcomes 
Regression to the mean refers to the phenomenon that a variable that is extreme on its first 
measurement will tend to be closer to the centre of the population distribution on a later 
measurement (Davis, 2007). People with conditions such as back pain generally seek 
medical interventions at the peak of their symptoms (Dunn et al., 2006), and that natural 
improvement is likely to follow. In this study the greatest change in reduction in disability 
occurred at the six week assessment. During this time participants started wearing the 
allocated shoes, and completed the low back exercise programme. Both groups also 
showed improvement in reported disability at twelve months when compared to baseline. 
Due to the lack of a non-treatment group it is not possible to determine how much of the 
changes reported at six weeks and twelve months were predominantly attributable to 
regression to the mean, the immediate or long term effects of attending the exercise class, 
or the immediate or long term influence of the footwear received. 
 
A randomised controlled trial (Costa et al., 2009) endeavoured to clarify whether positive 
intervention results, such as the within group reductions in disability demonstrated in the 
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current study, may in fact be due to participants’ regression to the mean. Costa et al. (2009) 
conducted a research trial (n=154) with an exercise intervention arm and a placebo-
controlled arm. There was no difference between groups in reduction of Roland Morris 
Disability Questionnaire score at the twelve month assessment. These findings support the 
suggestion that the within group reduction in disability in the current study may have 
resulted from regression to the mean, and not from the effect of the interventions. 
 
A ‘placebo effect’ has been defined as “a genuine psychological or physiological effect, in a 
human or another animal, which is attributable to receiving a substance or undergoing a 
procedure, but is not due to the inherent powers of that substance or procedure” (Stewart-
Williams and Podd, 2004). In this study, a pragmatic control group, allocated flat sole shoes, 
was used as a comparison to the rocker sole shoe group. The allocation of a shoe to the 
‘control’ group aimed to reduce the possibility that study findings, if demonstrating 
significance in the rocker sole shoe, were related to a placebo effect of receiving ‘a’ pair of 
shoes as opposed to potential benefits resulting from the structure of the shoe.  
 
Although both groups received footwear, hence introducing the potential for a placebo 
effect in both groups, due to media and marketing surrounding the rocker sole shoe during 
the trial it is likely that any placebo effect would have favoured people in the rocker sole 
shoe group (Shiv et al., 2005). However, due to the lack of difference observed in this study 
between the two groups, if a positive placebo effect did occur in the rocker sole shoe group 
it may have been too small to result in differences between the groups or may have been 
negated by an effect associated with the footwear, such as a biomechanical effect 
disadvantageous to those with CLBP. 
 
Timing of follow-up assessments may have been a contributing factor to the results 
obtained. The initial follow-up assessment occurred at six weeks. During this time 
participants also attended up to four low back exercise groups. It is well documented that 
improvement in disability is likely to occur following such a six week exercise intervention 
period (Cairns et al., 2006; Critchley et al., 2007; Lewis et al., 2005; UK BEAM Trial Team, 
2004). Improvement in disability associated with attendance to the exercise group may 
have overshadowed any change in disability directly associated with footwear use. 
However, a general exercise approach is a current best practice intervention for those with 




It is possible that clinical differences did occur between groups, but were not detected by 
the outcome measures assessed. Although the primary outcome assessed disability, a range 
of measures, sensitive to clinical change and in accordance with the recommendations of 
Deyo et al (1998) and Bombardier (2000) were additionally completed. These aimed to 
detect change in pain, functional activity (specific to each participant), anxiety and 
depression, fear of movement, general health status, time off work, and lumbar 
impairment measures. There were no between group differences for any of the measures 
assessed over the four time points. This adds strong support to the study conclusions that 
clinical difference between the groups did not occur.  
 
A further explanation for similar clinical outcomes between groups is that treatment effects 
resulted from changes in psychological and social factors. The low back exercise group 
educated both groups on pain, managing a flare-up, and the benefits of exercise and 
relaxation. In addition, both groups were encouraged to walk for two hours a day, possibly 
increasing their daily activity level when compared to pre-study activity levels. 
Furthermore, participants in the study had regular reassessment over the duration of the 
study with the C.I., who offered encouragement to maintain their exercise programme. 
Increasing activity level (NICE, 2009), improving coping strategies (Linton, 2000), and higher 
levels of therapist supervision (Hayden et al., 2005c) have all been demonstrated to 
improve clinical outcome in those with CLBP. 
A pre-planned sub-group analysis demonstrated that in participants reporting baseline low 
back pain on standing or walking, disability improved less for those allocated to the rocker 
sole shoe group than for those allocated to the flat sole shoe group. Although this sub- 
group analysis did not undergo an a-priori power calculation to determine appropriate 
sample size, standard deviation data of the primary outcome measure from the sub-group 
sample  was  used to determine  the sample size that would be needed in order to ensure 
conclusions were statistically viable: for a power of 0.8 and an alpha of 0.05 based on a 
standard deviation of 5.26 (standard deviation data collected from the sub-group of 
participants reporting baseline low back pain on standing or walking) and an ability to 
detect a 4 point change in the mean Roland Morris Disability Questionnaire scores between 
baseline and reassessment, the number of participants needed for each of the groups 
equalled 28. The flat sole shoe sub-group for those reporting pain on standing and walking 
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totalled 30 participants and the rocker sole shoe sub-group totalled 29 participants. 
Therefore, this sub-group analysis had appropriate power.  
If enough hypotheses are tested, on different sub-sets of the data, the likelihood that some 
will appear to be ‘falsely’ statistically significant may increase (Lord et al., 2004). This may 
account for the significant finding in the sub-group reporting pain on standing or walking. 
However, in this study, the knowledge that only one sub-group analysis was conducted, 
that it was pre-planned (i.e. the findings did not arise from exploratory data analysis) and 
that the sample size of the subgroup had appropriate power, improve confidence that the 
findings are true. 
5.5.4 Comparison of findings with other studies investigating the 
effect of rocker sole shoes in people with chronic low back pain 
The only identified randomised controlled trial investigating rocker sole footwear in LBP 
(Nigg et al., 2009) reported a non-clinically important reduction in pain in male golfers at six 
weeks compared to normal footwear. This finding concurs with the absence of clinical 
improvement in pain in the current study in either footwear group at six weeks. Disability 
scores were not assessed by Nigg et al. (2009), nor were other relevant outcome measures, 
recommended when assessing those with CLBP (Bombardier, 2000; Deyo et al., 1998), such 
as health status, satisfaction and time off work, hence further between study comparison 
cannot be made. 
5.5.5 Can certain footwear be detrimental to chronic low back pain? 
Researchers have observed an increase in centre of pressure sway in people with CLBP 
compared to asymptomatic individuals in numerous studies (Brumagne et al., 2008; Della 
Volpe et al., 2006; Mok et al., 2004) and have hypothesised that  proprioceptive 
rehabilitation may be beneficial as a treatment option to reduce this dysfunction with the 
view to reducing symptoms of  LBP.  The current study suggests that for people with CLBP 
the use of a rocker sole shoe, adding instability to the lower limb whilst standing and 
walking offers no greater improvement in their symptoms than if a flat sole shoe is worn. 
Furthermore, for those reporting difficulties with standing or walking due to their low back 
pain, wearing a rocker sole shoe may be detrimental to the level of improvement reported. 
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The concurrent biomechanical study conducted in this thesis investigates the effect of shoe 
type on centre of pressure displacement over time (Chapter 7, p148).  
 
It may be that although proprioceptive rehabilitation is recommended for people with 
CLBP, the use of a rocker shoe (which in asymptomatic individuals may increase medio-
lateral centre of pressure displacement by approximately 100% and antero-posterior 
displacement by approximately 50% (Nigg et al., 2006b)) may present too great a challenge 
for those individuals reporting pain on standing or walking. It has been suggested that due 
to the presence of pain, those with low back pain may co-contract muscles around the 
lumbo-pelvic region (Radebold et al., 2000). Furthermore, the presence of pain has been 
associated with inhibition and delayed contraction (Hodges and Richardson, 1998; Hodges 
and Richardson, 1999) of spinal postural stabilising muscles. These observations have been 
proposed to detrimentally affect the initiation of appropriate balance strategies (Mok et al., 
2004). For the sub-group of participants reporting pain on standing or walking, and hence, 
the sub-group more likely to be in pain whilst wearing their footwear, the added instability 
offered by the shoes, accompanied by potential pain induced spinal muscle inhibition and 
co-contraction, may have contributed to the reduced improvement in disability when 
compared to improvement in those not reporting pain on standing or walking. 
 
High levels of anxiety have been suggested as dominant psychological risk factors 
contributing to the presence of CLBP (Linton, 2000). Further exploration of data 
demonstrated that the rocker sole shoe sub-group, reporting pain on standing or walking, 
had an above average mean (standard deviation) anxiety score at baseline when compared 
to the study population (8.97 (3.89) compared to 7.63 (3.89) respectively), whereas the flat 
sole shoe sub-group reported lower anxiety (6.97 (3.70)). Although the role of anxiety as a 
predictor for outcome in low back pain remains unclear (Frymoyer and Cat-Baril (1987) 
reported that baseline psychological variables did not predict long term disability outcome, 
whereas opposing findings were reported by van Doorn (1995)), it may be that baseline 





5.5.6 Implications for clinicians 
This is a novel study investigating effects of rocker sole shoes on a CLBP population and 
provides clinicians with evidence from a relatively large clinical trial. Based on the findings 
of this study, clinicians should feel confident to advise patients with CLBP that if the patient 
does not report pain when standing or walking a rocker sole shoe may offer a similar 
outcome when compared to a flat sole shoe. If a patient reports pain with standing or 
walking it may be more beneficial to wear a flat sole shoe than a rocker sole shoe. The 
findings in this study do not warrant a change in practice in the management of CLBP from 
current best-practice proposed in the NICE guidelines (2009). 
5.5.7 Strengths and limitations 
5.5.7.1 Unmasking of group allocation 
Face-to-face assessment by the C.I. may have inadvertently resulted in unmasking of group 
allocation due to comments made by the participants regarding their footwear. For 
example, inadvertently describing the colour of the shoe (different between the two shoe 
groups) or using descriptors such as feeling ‘wobbly’ whilst in the shoes. The failure of the 
process to blind the assessor to the patient group on some occasions may have introduced 
a degree of bias to the results; however, no results were analysed until data from all 
participants had been collected in an attempt to minimise bias. 
5.5.7.2 Hours of shoe wear 
Results obtained from completion of the study diary sheets relied on accurate self-
reporting of shoe use from participants. It is acknowledged that this method of reporting 
may not be accurate (Moseley, 2006) with a tendency to overestimate adherence by 
approximately 10 % (Moseley, 2006). However, there does not appear to be a reason why 
those in the rocker sole shoe group would be more prone to inaccurate recall of such data 





Although participants were asked to report ‘hours of shoe wear per day’ whilst standing 
and walking, not sitting, it was not deemed feasible to expect participants to report with 
this degree of precision. However, it is unlikely that the ratio of time spent standing and 
walking, to sitting would vary between groups, hence unlikely to bias the results. 
5.5.8 Further research 
It is not possible to determine whether the use of either footwear type resulted in an 
increased improvement in disability, a reduced improvement in disability or offered similar 
outcomes in disability to patients not in the research study but who also attended the 
exercise class. Conducting a similar trial comparing a flat or rocker sole shoe group with a 
patient’s normal footwear would answer this query. However, as flat sole sports shoes are 
likely to be a very common ‘normal’ shoe choice, findings from such a study are unlikely to 
differ from those in the current study. 
 
Many studies investigating the effects of exercise interventions on LBP have reached similar 
conclusions - the greatest improvement in pain or disability or both tends to occur at the 
first reassessment point following the study intervention, followed by a general but more 
gradual reduction in the primary outcome measure over time (Cairns et al., 2006; Critchley 
et al., 2007; Lewis et al., 2005; UK BEAM Trial Team, 2004; van Tulder et al., 2006). It is not 
clear how much of this improvement may be due to the intervention and how much may be 
due to regression to the mean, or the natural history of the condition. Although exercise, as 
proposed in national (NICE, 2009) and international guidelines (Airaksinen et al., 2006; Koes 
et al., 2001), is deemed a current best practice for CLBP and appears to offer improvement 
in most randomised controlled trials  (Cairns et al., 2006; Critchley et al., 2007; Lewis et al., 
2005; UK BEAM Trial Team, 2004) it may be that mechanistic pathways that are 
uninfluenced or less influenced by exercise are also contributing to the presence of such a 
long standing recurrent condition. More recently, it has been suggested that central brain 
changes (reductions in volume in the dorso-lateral pre-frontal cortex and changes in 
biochemical composition (Grachev et al., 2000; May, 2008; Rodriguez-Raecke et al., 2009)) 
in regions thought to be associated with the transmission of pain, and sensory-motor 
feedback may be contributing to some of the symptoms of LBP. This will be discussed 
further in Chapter 10 (p210). Further research into such potential underpinning 
mechanisms of CLBP is needed. Results from such research may direct novel management 
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approaches which in addition to exercise may result in greater improvement for people 
with CLBP than exercise alone. 
5.6 Conclusions 
This study is the first randomised, controlled trial with long term follow-up to assess the 
effects of rocker sole shoes in chronic low back pain. Results of this study can offer 
clinicians robust evidence to guide patients towards the appropriate choice of footwear for 
those with chronic low back pain. 
 Change in self-reported pain and disability scores were similar between groups over 
all follow-up points. 
 A greater proportion of participants who wore the flat soles shoes reported a 
clinically important change in self-reported disability at six months. 
 For those reporting pain on standing or walking, a greater reduction in disability 
was observed in those wearing flat sole shoes than those wearing rocker sole shoes 
at six weeks and twelve months.  
 At both six months and twelve months, participants in the flat sole shoe group were 
more satisfied than the participants in the rocker sole shoe group with the shoe 
they received. 
 It is not clear from this study if either shoe offers additional benefits to the 
reduction of disability obtained from attendance to an exercise class alone (a 
current best practice).  
 Based on the findings of this study those with chronic low back pain can be 
informed that use of either shoe type is likely to result in a similar clinical outcome 
at one year. However, if a person’s chronic low back pain is predominately 
aggravated by standing or walking it may be more beneficial to wear a flat sole 




6 Methods used in the biomechanical studies 
6.1 Chapter summary 
This chapter presents the development of methodologies common to the three 
biomechanical studies in Chapter 7 (p148), Chapter 8 (p170) and Chapter 9 (p189). 
6.2 Introduction 
The biomechanical section of this thesis includes three studies: 1) the short and long term 
influence of rocker sole and flat sole shoes on postural control whilst standing in people 
with CLBP (Chapter 7, p148); 2) the short and long term influence of rocker sole and flat 
sole shoes on gait in people with CLBP (Chapter 8, p170); and 3) a cross sectional study to 
compare gait and postural control in standing in people with CLBP to age- and gender-
matched asymptomatic individuals (Chapter 9, p189). This chapter outlines the 
development of methods common to all three biomechanical studies namely, the  
recruitment of participants with CLBP, choice of outcome measures, protocol for motion 
analysis marker placement, protocol for obtaining anthropometric measurements, protocol 
for assessment of standing and walking trials, and the extraction of clinically relevant 
parameters from gait laboratory data. 
6.3 Choice of motion analysis system 
Several systems are available for the measurement of human kinematics (the study of 
movement of body segments). The electro-goniometer, an electronic version of the 
goniometer, is a basic system, commonly used in clinical practice to assess joint angles. Two 
brackets are attached to the segments either side of the joint under assessment. Although 
an easily accessible assessment tool, providing immediate results, the accuracy of the data 
obtained depends on the correct placement of the brackets to correctly assess the axis of 
rotation at the joint of interest (Kirtley, 2006). In addition, the straps attaching the brackets 
to the body segments may move during gait, reducing measurement accuracy (Chao, 1980). 
Furthermore, these devise are mainly used to obtain two not three dimensional data. 
Flexible goniometers reduce the errors associated with joint centre alignment, however, 
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can be restrictive to a participants gait due to associated cabling. Furthermore, although 
able to measure motion between two adjacent segments, they do not have the ability to 
inform on absolute motion of body segments in space (Kirtley, 2006). 
To assess such absolute motion, measurements must be taken with respect to a fixed global 
reference system. This can be done through: optical tracking, whereby skin marker 
locations are digitized from images recorded by a video camera; electromagnetic motion 
analysis systems; ultrasonic motion analysis systems, which utilise the delay in sound 
transmission through air to triangulate the position of ultrasound emitting markers; or 
inertial systems, which utilise a combination of miniature micro-electro-mechanical system 
sensors (Kirtley, 2006). Three dimensional optical methods are currently the favoured 
approach for clinical gait analysis (Kirtley, 2006), hence, the method of choice to assess 
postural control and gait in the current studies.  
Although a favoured approach, limitations and measurement errors are reported with this 
assessment technique. Firstly, some error will occur in the accuracy of body marker 
placement. Secondly, further error may occur when digitising the position of the body 
markers. Such inaccuracies in the coordinates recorded result in what is known as 
digitization noise. Much of this noise can however be filtered by an appropriately chosen 
cut-of frequency to separate the wanted signal from the unwanted noise, improving 
accuracy of the data obtained.  Digitisation errors for marker location are dependent on 
specific systems, however, for modern hi-resolution systems such as the system used in this 
study, these are very small (less than one millimetre) (Chester et al., 2005). Errors are more 
likely to arise from the anthropometric model used to calculate joint centres and axes of 
rotation of the major joints, such as the hip, knee and ankle (Della Croce, 2005; Leardini, 
2005) though in near normal walking in adults these are quite small  (Stagni et al, 2004). 
Greater errors occur when investigating spinal motion or motion in the foot for three main 
reasons: i) the segments are small; ii) joint motions may not conform to a simplistic model, 
such as a hinge of ball and socket joint); c) relative skin to segment motion may be larger 




6.4 Choice of marker set 
The Modified Helen Hayes marker set, the conventional biomechanical model for 
calculation of joint centres and subsequently of joint kinematics during movement, was 
implemented in the current study (Davis et al., 1991). The model is based on the placement 
of 13 retro-reflective markers on the following anatomical locations: left and right ASIS, 
spinous process of the second sacral vertebra, left and right lateral thigh, left and right 
lateral femoral condyle, left and right lateral shank, left and right lateral malleoli, and the 
left and right second metatarsal head. In the current study, additional markers were placed 
on the spinous process of the cervico-thoracic  junction, left and right acromion, left and 
right Iliac crests, and left and right posterior calcanei.  
6.5  Choice of software to derive kinematics and kinetics 
In clinical gait laboratories, the Vicon system accompanied by the Modified Helen Hayes 
model as implemented in the Vicon Clinical Manager software is commonly used. Vicon 
Nexus and Polygon (Vicon Motion Systems, Oxford, UK) were utilized in the biomechanical 
studies to derive the biomechanical parameters of interest.  This system has shown good 
within and between session repeatability in the assessment of lower limb biomechanics 
(Yavuzer et al, 2008; Wilkin et al., 2012). The Plug-in-Gait model for deriving joint 
kinematics is based on the Davis model (Davis, 1991) and is often used in clinical research 
and applications. Although the model tends to produce systemic errors in the location of 




6.6 Choice of biomechanical outcome measures 
The biomechanical studies did not aim to investigate the full biomechanics of standing and 
gait, but instead aimed to investigate specific measures that: 
i)may be influenced from wearing rocker sole shoes compared to flat sole shoes – 
such measures were selected from the analysis of results of previous studies that 
had investigated difference in lower limb biomechanics when standing and walking 
in rocker sole shoes compared to flat sole shoes, and: 
ii) have been demonstrated by research to differ significantly between people with 
and without CLBP hence proposed as causative factors in the presence of CLBP.  
For example, antero-posterior displacement of the centre of pressure (6.11, p142) was 
analysed, but medio-lateral displacement was not - when standing in rocker sole shoes the 
greatest displacement of the centre of pressure (CoP) occurs in the antero-posterior 
direction (Nigg et al., 2006b), hence, it was anticipated that movement in this direction 
would demonstrate the greatest changes between the rocker sole shoe and barefoot or flat 
sole shoe comparisons.  Furthermore, the hip and ankle strategy predominantly displace 
the CoP in the antero-posterior direction, hence this outcome parameter was deemed of 
greatest relevance to assess. Similarly, due to the expected greater displacement of the CoP 
in the antero-posterior direction, due to the convex nature of the sole in the antero-
posterior direction, sagittal plane kinetics and kinematic parameters were analysed, 
whereas frontal and transverse plane parameters were not. The biomechanical parameters 




6.7 Recruitment of participants with chronic low back pain 
Commencing with the 60th participant in the main clinical investigation (REC 09/H0706/4) 
participants were requested to consider participating in the biomechanical studies. At this 
stage they were unaware of their shoe allocation (5.3.2, p63). Potential participants were 
provided with the Patient Information Sheet by a physiotherapist at one of the five 
referring research sites for the main clinical study (09/H0706/4). They were also provided 
with a Patient Information Sheet for the biomechanical studies (11.26, p297). A total of 
twenty participants who had consented into the main clinical study also expressed an 
interest to additionally participate in the biomechanical study. These twenty participants 
were recruited from the following four sites:  
 Balance Performance Physiotherapy, Clapham, London SW4 
 Chelsea and Westminster Hospital, Chelsea, London SW10 
 Kingston Hospital, Kingston, Surrey, KT2 
 St. George’s Hospital, Tooting, London SW18 
On entering the biomechanical studies participants were already randomised into either 
the rocker sole or the flat sole group, in accordance with the randomisation for the main 
clinical study. Inclusion and exclusion criteria (Table 6.1) were similar to those in the main 
clinical study (Table 5.1, p64), with the addition of the following inclusion criteria: 
 Participants consented to participant in the main clinical study  (09/H0706/4) 




Table 6.1 Inclusion and exclusion criteria 
Inclusion criteria Exclusion criteria 
 
 Aged 18 to 65 years 
 More than 3 months of continual or 
recurrent episodes of LBP 
 Lumbosacral pain with or without 
referral (of a non-radicular nature) 
 Pain of a mechanical nature (pain 
aggravated by activity) 
 Willing to comply with the 
randomisation process 
 Able to fully communicate in 
English 
 Able to participate in an exercise 
group and perform exercises at 
home 
 Participants must have consented 
into study REC: 09/H0706/4 
 Participants must be able to travel 
to Guy’s Hospital, London, SE1 
 
 Constant pain 
 Non mechanical pain (pain that is not 
aggravated or eased by activity or 
posture) 
 Nerve root entrapment accompanied by 
neurological deficit 
 Neoplasms 
 Severe structural deformity or 
osteoporosis 
 Known spondylolysthesis or spinal 
stenosis 
 Fracture of the spine within the past 
year 
 Inflammatory disease of the spine 
 Spinal infection 
 Severe cardiovascular/ metabolic 
disease 
 Pregnancy 
 Previous spinal surgery 
 Known Morton’s Neuroma 
 Skin ulceration over the foot 
 Peripheral neuropathy with loss of 
sensation 
 History of falls 
 Surgery to the lower limb in the past 8 
weeks 
 Participants with history of deep vein 
thrombosis (DVT) yet to be stabilised 
/yet to be advised to return to exercise 
by their medical practitioner. 
 Participants undergoing prolonged 
unresolved legal issues regarding their 
back pain 
 Participants who have previously used 




6.8 Gait laboratory equipment 
6.8.1 Motion analysis system 
The motion analysis system consisted of seven T10 cameras (Vicon Motion Systems, 
Oxford, UK). The system depends on the accurate attachment of retro-reflective markers 
(Vicon Motion Systems, Oxford) (Figure 6.1) to specific bony landmarks.  These were 
captured in three-dimensional space at a rate of 120 Hertz (Hz). The three-dimensional 
position of the marker can be calculated once it is visible to two cameras at the same time 
point (Figure 6.2). 





Figure 6.2 Visualisation of retro-reflective markers (white dots) by the motion 
analysis camera system 
 
6.8.2 Force plates 
Ground reaction forces (GRFs) across three planes were captured using three ground 
mounted force plates (FP5000, AMTI Inc., Massachusetts, USA), placed in line. The force 
data were integrated with the Vicon software, allowing for the calculation of joint moments 
(rotation joint forces) from the kinematic and GRF data by inverse dynamics (Kirtley, 2006). 
Force plate data were captured at a rate of 1080Hz, synchronised to the camera 
frequencies (precisely nine force plate samples per camera frame). Figure 6.3 shows a 
participant striking the second and third force plate during a gait trial, with real time 
capture of a ground reaction force (vertical red arrow), used to calculate joint moments, by 





Figure 6.3 Participant striking the force plate during a gait trial (ground reaction 
force shown by the vertical red arrow) 
 
Two force plates were used to calculate joint moments within each limb, whilst standing, 
using an inverse dynamics approach (Kirtley, 2006). Inverse dynamics involves the 
modelling of the human body as a series of linked segments each with certain inertial 
properties (for example, mass and radius of gyration) (Kirtley, 2006). The forces acting on 
the body are both inertial (acceleration of the body segments) and external forces (for 
example, the ground reaction force) (Winter, 2009). The method of calculation proceeds by 
resolving distal forces and moments using the ground reaction force, then uses the resolved 
values, to resolve moments and forces at more proximal joints (Kirtley, 2006).  A free body 
diagram is drawn for each segment (for example, the foot, the shank, and the thigh), with 




6.9 Methodological considerations in three-dimensional 
motion analysis 
6.9.1 Calibration of the gait laboratory 
Prior to each participant’s assessment the force plates and motion analysis cameras were 
calibrated as described in the One Small Step gait laboratory calibration protocol (11.27, 
p302). This aimed to improve accuracy of the gait laboratory equipment in the data 
collection process. 
6.9.2 Anthropometric measurements 
Anthropometric data informs the mechanical model formulated for each participant in 
Nexus (Vicon’s capture software [Vicon Motions systems, Oxford, UK]) (6.10.3, p134). The 
anthropometric measurements assessed are presented in Table 6.2 and in Figures 6.4 to 
6.7. The calibration of anthropometric measuring equipment is presented in 11.28 (p305). 
The seated weighing scales (Weightcare chair scale, Marsden Weighing Machine Group, 
Henley-on-Thames, UK) were calibrated every six months to ensure accuracy of 








device  [units] 
Pelvic width Distance between the inferior aspect of the left and 
right anterior superior iliac spine 
Large calliper 
[mm] 
Leg length In supine, distance from the inferior aspect of the 
anterior superior iliac spine to the inferior aspect of 
medial malleolus (left and right) 
Tape measure 
[mm] 
Knee width In supine, knees in extension, distance between the 
lateral femoral epicondyle at the lateral aspect of the 
knee joint line and the midpoint of the medial collateral 




Ankle width In supine, knees in extension, distance between the 
most medial point of the medial malleolus and the most 
lateral point on the lateral malleolus (left and right) 
Small calliper 
[mm] 
Height The head was measured in the Frankfurt plane, a 
standard plane established by an imaginary line passing 
through the right tragion and the lowest point of the 
right eye. The vertical distance from the floor to the 
vertex of the head, its highest point in the mid-sagittal 
plane, was measured with the participant standing 
barefoot 
Stadiometer   
[mm] 
Weight Seated in weighing scales wearing shorts and short 
sleeved shirt. 
Seated scales    
[kg] 
Legend: mm: millimetres; kg: kilogramme 
125 
 
Figure 6.4 Measurement of pelvic width  
 
 






Figure 6.6 Measurement of knee joint width  
 
 





6.9.3 Marker placement 
Twenty infra-red reflective markers (14mm diameter) were positioned on each participant 
by the same researcher (Dr Adam Shortland [AS]) at each testing session. This researcher 
was highly experienced in the use of the motion analysis system and positioning of the 
motion markers (Gough et al., 2004; Gough and Shortland, 2008; McNee et al., 2009). 
Identification of joint centres depends heavily on accurate marker placement (Kratzenstein 
et al., Epub ahead of print). Particular attention must therefore be given to minimising 
errors associated with marker placement. A standard protocol for marker placement was 
used to maximize consistency and repeatability of the data collection process (11.29, p307, 
Table 6.3). Table 6.3 describes the location and anatomical landmarks used in the 







Table 6.3 Description of marker placement 
Marker label Description 
Sacrum A marker was placed over the sacrum between the posterior 
superior iliac spines as palpated by the examiner. 
Anterior superior 
iliac spine (ASIS) 
A marker was placed over the left and right ASIS 
Posterior pelvic 
markers 
A marker was placed at the midpoint of an imaginary line between 
the sacrum marker and the left ASIS marker and the sacrum marker 
and the right ASIS marker  
Knee A marker was attached over the lateral aspect of the left and right 
knee joint line   
Thigh A marker was placed over the lateral aspect of the left and right 
thigh in the plane defined from an estimate of the hip joint centre 
and knee flexion axis.  
Ankle Ankle markers were placed over the most lateral aspect of left and 
right lateral malleoli. 
Shank A marker was placed in the plane defined by the knee joint centre 
and the ankle flexion axis.  
Forefoot A marker was placed between the second and third rays proximal to 
the equinus break.  
Heel A marker was placed on the posterior aspect of the left and right 
calcanei, at the same height as the forefoot marker 















6.9.3.1 Placement of retro-reflective markers on study footwear 
Assessment of participants in their study shoes required foot markers to be removed and 
replaced onto the footwear. The co-researcher (AS) removed the 2nd metatarsal head 
marker, and the calcaneum marker from each foot in order for participants to put on their 
study shoes. The outer material design of both shoes consisted of retro-reflective strips. 
Due to the motion analysis system perceiving these reflective strips as markers, the co-
researcher covered all reflective strips with non-transparent sticky tape (Figure 6.9 and 
Figure 6.10).  Study shoes were then put on, and the removed markers were replaced onto 
the shoe overlying the relevant anatomical sites of the head of the 2nd metatarsal and the 
posterior calcaneum (Figure 6.9 and Figure 6.10). The toe marker was placed on the shoe 
proximal to the equinus break. Toe and heel markers were placed on the shoes at an equal 
height from the ground. 






Figure 6.10 Rocker sole shoe with retro-reflective regions covered, and footwear 
marker placement  
 
6.10 Gait laboratory assessment 
Participants in the biomechanical investigation attended for assessment at the Guy’s 
Hospital gait laboratory on three occasions at: 
 baseline 
 six weeks 
 six months 
In comparison to individuals participating in the main clinical study, participants in the 
biomechanical study attended three additional assessments when compared to those 
participating only in the main clinical study. Participants in the biomechanical study did not 
receive additional treatment to those participating only in the main clinical study 
(09/H0706/4). Following initial assessment at their referring site for consent into the main 
study, participants were instructed not to wear their allocated study shoes until the 
assessment in the ‘One Small Step’ Gait laboratory, Guy's Hospital. They were asked to 
bring their study shoes with them to each gait laboratory assessment, and to keep them 
hidden in a bag to ensure that the chief investigator (C.I.), blinded to group allocation, did 
not see the shoes. The initial gait laboratory assessment took place within a week of a 
participant’s baseline assessment for the main clinical study.  
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6.10.1 Development of standing trial assessments 
6.10.1.1 Trial conditions 
During more challenging standing conditions, people with LBP have been shown to present 
with differing postural control to people without (Byl and Sinnott, 1991; Della Volpe et al., 
2006; Luoto et al., 1996; Mientjes and Frank, 1999; Mok et al., 2004; Moseley and Hodges, 
2005; Takala et al., 1997b). Therefore, in the current study, and in concurrence with other 
research studies investigating the effect of CLBP on postural control during standing 
(Brumagne et al., 2008; Della Volpe et al., 2006; Mientjes and Frank, 1999; Mok et al., 2004; 
Salavati et al., 2009b), participants were assessed during four different standing conditions. 
These involved the manipulation of visual input (eyes open or eyes closed) and support 
surface (firm or compliant). The following standing conditions were assessed: 
(1) firm ground with eyes open 
(2) firm ground with eyes closed  
(3) compliant ground with eyes open 
(4) compliant ground with eyes closed 
Compliant surfaces represent a more challenging standing surface. This was achieved by 
placing an AirexTM cushion (48.5 x 40.0 x 6.4 cm, 0.7kg), made of high density (50kg/m3), 
closed-cell foam, (l-group, St. Louis, MO) over each force plate (Figure 6.11).  
The removal of visual input was used to provide an additional challenge to the postural 
control system (Mann et al., 2010) and aid in the detection of potential postural control 
differences between groups. Furthermore, data obtained with visual occlusion has been 
shown to have higher reliability than data obtained with eyes open, although both 
conditions have demonstrated acceptable reliability (Ruhe et al., 2010). 
6.10.1.2 Number of trial repetitions 
Although it has been suggested that three to five trials is most appropriate for obtaining 
reliable centre of pressure (CoP) parameters (Ruhe et al., 2010), due to the presence of 
CLBP in study participants and the number of trial conditions also under investigation it was 
decided to conducted three trial repetitions for each standing condition. The averaging of 
three trials has been shown to produce acceptable reliability for the majority of CoP 
parameters when assessing musculoskeletal disorders (Salavati et al., 2009a). 
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6.10.1.3 Trial duration 
Reliable CoP measurements have been reported from trials of 30 second durations (Pinsault 
and Vuillerme, 2009; Salavati et al., 2009a). In the current study, 40 seconds of trial data 
were recorded with data from only the middle 30 seconds of each trial analysed. This aimed 
at avoiding any initial sway errors occurring whilst attaining the standing starting position, 
and removing the possible effects of either fatigue at the end of each test, or participant’s 
anticipation of a trial reaching its end. A systematic review investigating acceptable 
reliability for CoP parameters in asymptomatic individuals, published subsequently to the 
start of the current study, recommended a minimum trial duration of 90 seconds (Ruhe et 
al., 2010). However, in the current study sample, prolonged standing may have aggravated 
symptoms, and negatively influenced attrition rates. 
6.10.1.4 Standardised visual focus point  
During trials with eyes open participants were requested to keep their eyes focused on a 
red sticker placed on a tripod three metres in front of them at eye height (Figure 6.11).  
Deviations in eye focus have been shown to influence postural control (Ivanenko et al., 
1999), hence, standardisation of gaze orientation aimed to increase data reliability. 




6.10.2 Development of gait trial assessments 
6.10.2.1 Clear force plate strikes 
The assessment of gait required each participant to attain three clear force plate strikes for 
both the left and the right foot. A clear force plate strike required a heel strike and toe off 
to occur with the foot making contact with one plate only, and without contacting the force 
plate with the contralateral foot (Figure 6.12). If, after several attempts, the required clear 
force plate heel strikes were not obtained, participants were asked to alter their starting 
position by taking half a step backwards, and the collection of further trials continued.  
 
Figure 6.12 Clear force plate strike with right leg 
 
Borders of the force plate outlined by the dashed line 
added to figure for clarification 
6.10.3 Data collection and processing of standing and gait trials 
Video and analogue data captured by the motion capture system were processed using 
proprietary software in Nexus v1.7, (Vicon Motion Systems, Oxford,UK) using the Plug-in-
Gait (PiG) model to generate the spatio-temporal, kinematic and kinetic data of interest. 




6.10.3.1 Association of instrumented data with the anthropometric data 
collected from the participant. 
Participants’ anthropometric data (6.9.2, p123) were inputted into Nexus (Figure 6.13) by 
the C.I. in order to determine lower limb joint centres (6.10.3.2, p136). 
 





6.10.3.2 Static calibration trial  
A static data capture was performed with all markers in situ, under barefoot and shod 
conditions. The participant was instructed to stand with feet on neighbouring force plates 
for the static capture, with arms folded. The markers in the static calibration trial were 
labelled (Figure 6.14) and Vicon’s ‘static plug in gait’ model procedure was applied. This 
procedure determined lower limb joint centres from the anthropometric data and marker 
locations (Figure 6.15). Static trials were used to calculate particular offsets for the 
computation of ankle angles that were used in the modelling of trials collected 
subsequently. For barefoot trials, ankle offsets were calculated with the assumption that 
feet were plantar-grade. For shod trials, plantarflexion offsets were determined from the 
relative heights of the heel and toe markers. This calibration formed the basis of the Plug-
in-Gait (PiG) routine that calculated kinematics and kinetics for the remaining trials in that 
session. 
Figure 6.14 Labelling of retro-reflective markers in Nexus  
 
Blue dots represent the five pelvic markers, red dots represent left lower limb markers, 
green dots represent right lower limb markers, white dots represent markers awaiting 





Figure 6.15 Application of Vicon’s ‘static plug in gait’ model procedure 
 
Blue dots represent the five pelvic markers, red dots represent left lower limb markers, 
green dots represent right lower limb markers. Vertical blue lines with short perpendicular 
red and green lines represent orthogonal reference frames for the underlying body 
segments. 
6.10.3.3 Labelling of standing and gait trials 
Following processing of the static trial, individual standing and gait trials were processed in 
Nexus. Three-dimension trajectories were reconstructed from the raw video trials shown in 
Figure 6.2 and labelled as shown in Figure 6.14. Gaps in the trajectories were inspected and 
filled using inbuilt commands in Nexus either by interpolation for small gaps or by copying 
the pattern of an adjacent trajectory if the gaps were large. If trials could not be filled 
without including obvious errors in the marker trajectory the trial was abandoned. 
6.10.3.4 Filtering marker trajectories 
The motion of the skin during gait can result in trajectory noise when markers are captured 
in three dimensional space. This artefact is normally minimised by the use of a digital low 
pass filter such as the Woltring cross-validatory quitic spline routine (Woltring, 1986). The 
Woltring filter is incorporated into the Vicon system. A Woltring system with mean 
standard error 10mm2 was selected. 
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6.10.3.5 Processing standing and gait trials 
Calculation of motion at the centres of each underlying joint was carried out via the PiG 
software model provided in the Vicon Nexus application that enables data to be processed; 
GRFs captured in three planes by a line of three AMTI force plates were integrated with 
kinematic data to calculate joint moments and powers using inverse dynamics. Kinetic 
parameters were normalised to body height to enable comparison between participants. 
6.10.3.6 Gait cycle events 
Gait cycle events of heel strike and toe off were defined in Nexus to facilitate the 
calculation of spatio-temporal parameters. These events were derived from force plate 
data when the participant had achieved a complete stride of the foot on the force plate 
without contacting the force plate with the contralateral foot (6.10.2.1, p134). Figure 6.16 
shows the labelling of heel strike and toe off events. A threshold of 10 Newtons was used to 
determine the points of heel strike and toe off. Trials without force plate data, or where 
force plate data were contaminated were defined by observation of the patterns of the 
heel and forefoot trajectories to determine gait cycle events (Figure 6.16). An error analysis 
of the two different methods employed to define the phases of gait demonstrated that this 




Figure 6.16 Inspection of heel and forefoot trajectories to determine gait cycle 
events in the absence of force plate data  
 
Blue curves represent left heel and toe movements through gait cycle. Participant 
captured walking from right to left side of screen. Red dots and red linking lines 
represent the left leg, green dots and green linking lines represent the right leg. 
Plug-in-gait model visible as shown in Figure 6.15. Bar directly below model 
indicates heel strike (diamond) and toe-off (upward arrow) for left (top row) and 
right (middle row) lower limbs. 
6.10.3.7 Extraction of spatio-temporal, kinetic and kinematic gait data 
Data was inspected using Polygon (Version 3.1) (Vicon Motion Systems, Oxford, UK) to 
identify artefacts in the computed kinematic and kinetic data. For example, it was used to 
identify and correct knee varus artefacts during swing – a common artefact observed in the 
data that may be caused by the misalignment of the thigh markers. The spatio-temporal, 
kinematic and kinetic data for each trial were then exported to Microsoft Excel (Microsoft, 
Reading, UK) using a macro routine in Polygon. An average was obtained for each 
participant for each limb for spatio-temporal parameters, and kinetic and kinematic data. 
Figure 6.17 demonstrates the visualisation of trials in Polygon. Table 6.4 lists the spatio-
temporal, kinematic and kinetic key points exported from Polygon over the gait cycle. 
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Figure 6.17 Visualisation of joint motion in the software application Vicon Polygon 
Legend for graphs: 
Top row (left to right): Pelvic 
obliquity; Pelvic tilt; Pelvic 
rotation 












Green joint motion lines on 
graphs represent right lower 
limb 
Red joint motion lines on 
graphs represent left lower 
limb 
Y-axis represents joint angle. 
X-axis represents percent of 
gait cycle starting with heel 
strike X/Y interface  
Vertical green/red lines on 
graph represent point of 
‘foot-off’ during gait cycle. 
Legend for graphs: 
Top row (left to right): Pelvic 
obliquity; Pelvic tilt; Pelvic 
rotation 












Green joint motion lines on 
graphs represent right lower 
limb 
Red joint motion lines on 
graphs represent left lower 
limb 
Y-axis repr sents joint angle. 
X-axis represents percent of 
gait cycle starting with heel 
strike X/Y interface  
Vertical gr en/red lines on 
graph represent point of 
‘foot-off’ during gait cycle. 
Legend for graphs: 
Top row (left to right): Pelvic 
obliquity; Pelvic tilt; Pelvic 
rotation 












Green joint motion lines on 
graphs represent right lower 
limb 
Red joint motion lines on 
graphs represent left lower 
limb 
Y-axis represents joint angle. 
X-axis represents percent of 
gait cycle starting with heel 
strike X/Y interface  
Vertical green/red lines on 
graph represent point of 
‘foot-off’ during gait cycle. 
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Table 6.4 Parameters extracted from Polygon by Excel macro 
Parameter Description Units of 
measurement 
Spatio-temporal   
Cadence Number of steps taken in one minute Steps/minute 
Gait velocity Distance covered over time Metres/second 
Stride length Distance covered from heel strike of one limb 
to heel strike of the same limb 
Metres 
Kinematic   
Hip Peak hip flexion 
Degrees 
 Peak hip extension 
 Range of hip movement in the sagittal plane 
Knee Peak knee flexion during first half of stance 
Kinetic   
Moments Peak hip flexor moment 
Nmm/kg 
 Peak hip extensor moment 
Legend: kg = kilograms, Nm = Newton millimetres 
6.10.3.8 Extraction of centre of pressure parameters from standing trials 
Centre of pressure parameter data for each trial were exported to Microsoft Excel using a 
macro routine written in Visual Basic for Applications. This programme read force plate 
data from each trial (contained within a c3d file – industry standard format) using 
c3dServer (Motion Lab Systems, 2012). The centre of pressure variables were calculated 
from extracted force plate moment and force data. The equations computed are presented 




Table 6.5 Description of the postural control parameters assessed 
 
Variable Description Units of 
measurement 
CoP RMSE AP The root-mean squared error of the centre of 
pressure in the antero-posterior direction where 
error refers to the distance between the centre of 
pressure and the current value of the centre of 
pressure 
Millimetres 
CoP VEL AP The total distance travelled by the centre of 
pressure in the antero-posterior direction  divided 





Root-mean squared error (RMSE), a measure of 
deviation from a signal mean, was calculated for 
the hip flexor/extensor moment and the ankle 
plantarflexor/dorsiflexor moment. The ratio of 
these two variables was used to calculate the 
index. 
- 
Increase in CoP parameters represent a decrease in postural stability, a decrease in a 
parameter represents improved postural stability. 
6.11 Outcome measures 
6.11.1 Centre of pressure parameters 
Centre of pressure excursions are typically computed to assess postural stability. A 
systematic review, investigating the reliability and assessment protocols of CoP measures 
(Ruhe et al., 2010), published subsequently to the design of the current study protocol, 
reinforced the appropriateness of the selection of outcome measures chosen.  From thirty-
two studies assessed, no single measure of CoP appeared significantly more reliable than 
any other (Ruhe et al., 2010). Mean CoP velocity, however, consistently demonstrated 
acceptable reliability values hence was considered the most reliable CoP parameter (Ruhe 
et al., 2010). It is recommended to include a distance parameter (e.g. mean displacement) 
as well as a time-distance parameter (e.g. mean velocity) to gain an alternative description 
of the CoP excursion. Therefore, in the current study the root mean squared error of the 
CoP displacement in the anterior posterior direction, and mean CoP velocity in the antero-
posterior direction were selected as appropriate outcome measures. 
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6.11.2 Centre of pressure calculations 
Centre of pressure (CoP) calculations were made from the output from two force plates 




Yellow arrow represents the x-axis; green arrow, the y-axis; 
and orange arrow, the z-axis. 
The x-coordinate of the CoP was calculated under each limb from the moments and forces 
produced by each plate with respect to the origin of the laboratory space, as follows: 
        
      
     
                 
         
      
     
                 
where                  are x- coordinates of the CoP under the left and right feet at time 
point i, and     ,     ,      ,       are directional components of the moments and forces 
acting on the body from each forceplate. These coordinates are expressed relative to the 
global coordinates of the laboratory space by a translation between the origin of the 
forceplate and the origin of the laboratory (                              . 
Figure 6.18 Force plate axes 
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The x-coordinate of the CoP of the whole body was calculated by multiplying the x-
coordinate of the CoP for each limb by the fraction of the total vertical force (Fz) acting 
through that limb, and adding the two terms together, as follows: 
 
                (
     
            
)          (
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where        is the x-coordinate of the CoP of the whole body. 
6.11.2.1 Calculation of the root mean squared error of the centre of pressure 
in the antero-posterior direction (CoPRMSE AP) 
The root mean squared error of the CoP in the antero-posterior direction (x-direction) is 
given by: 
 
            √∑







where       ̅̅ ̅̅ ̅̅ ̅̅  is the mean position of the x-coordinate of the CoP, and N is the number of 
time points in the trial.  
6.11.2.2 Calculation of centre of pressure velocity in the antero-posterior 
direction (CoP VEL AP) 
The mean velocity of the CoP in the antero-posterior direction (x-direction) is given by: 
 
          ∑
|               |
  
    
 




6.11.3 Postural strategy  
Previous research has suggested that those with CLBP present with different hip and ankle 
strategies to people without back pain during more challenging standing conditions, such as 
with eyes closed on a compliant surface (Brumagne et al., 2008; Byl and Sinnott, 1991; Mok 
et al., 2004). These conclusions, regarding postural strategy were obtained from various 
approaches to calculating both hip and ankle strategies including; displacement of CoP data 
(Brumagne et al., 2008; Mok et al., 2004); horizontal shear force (Mok et al., 2004); and 
from visual inspection of the location of the fulcrum of body sway (Byl and Sinnott, 1991). 
 
Although a variation in methods for interpreting the dominant postural control strategy in 
LBP participants exists, there is no agreement between studies as to a gold standard 
approach. It is usual to utilise a combination of hip and ankle strategies when maintaining 
posture (Horak and Nashner, 1986), however, few studies appear to consider a ratio of hip 
to ankle strategy in order to determining dominance of one strategy over another. Previous 
research (Brumagne et al., 2008) utilized a ratio approach to determine ‘relative 
proprioceptive weighting’ whereby the CoP displacement during mechanical vibration to 
the calf muscle was divided by the summation of both CoP displacement during mechanical 
vibration of the calf muscle and CoP displacement during mechanical vibration of the 
lumbar multifidus muscle. However, the validity of this approach in providing hip and ankle 
strategy data is unknown.  
 
In the current study, the magnitude of fluctuation in joint moment was calculated to inform 
the contribution of each joint to the control of standing posture in the antero-posterior 
direction. When standing, increased fluctuation (standard deviation) in a joint moment 
implies an increased contribution from that joint to maintain postural stability (Winter, 
2009). A greater moment fluctuation at the hip indicates an increase in hip strategy. 
Similarly, an increase in fluctuation values at the ankle represents an increase in ankle 




6.11.3.1 Calculation of the hip to ankle strategy ratio 
To calculate the Hip to ankle postural control index (HAPCI) it was necessary to calculate 
the root mean squared error of the hip extensor/flexor moment            and the ankle 
plantarflexor/dorsiflexor moment          over the course of the standing trial, as 
follows: 
       √∑
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Where                are the hip and ankle flexor/extensor moment at time point i, and 
     ̅̅ ̅̅ ̅̅ ̅̅     ̅̅ ̅̅ ̅̅ ̅ are the mean hip and ankle flexor/extensor moments over the trial. 
To calculate the HAPCI, the root mean squared error of the hip extensor/flexor moment  
         was divided by the root mean squared error of the ankle 
plantarflexor/dorsiflexor moment         , as follows: 
 
      
      
      
 
 
6.11.3.2 Justification for the statistical analysis chosen to analyse data in the 
biomechanical studies 
As described in 4.3.5 (p50), an independent t-test is an appropriate statistical test to 
analyse the difference in mean values between two groups, when participants in each 
group are different, and where the assumption of normality is met (the variances of 
populations are similar and scores are independent) (Field, 2009). When assumptions of 
normality are not met, and data were non-parametric, the Mann-Whitney test will be 
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chosen as the appropriate method to statistically analyse the difference in mean values 
between groups (Field, 2009).  
A paired t-test will be used to analyse the difference in mean values from two samples of 
data from the same group of participants when assumptions of normality are met, and data 
are measured at least at the interval level (Field, 2009). When data do not meet these 
criteria the Wilcoxon signed rank test will be used as the appropriate method to statistically 
analyse the difference in mean values between the two samples (Field, 2009).  
Justification for using the Chi square test and analysis of variance have been described in 
4.3.5 (p50). A multivariate analysis of variance (MANOVA) is also conducted in the 
biomechanical studies. This is a type of ANOVA used when there is more than one outcome 
variable under investigation, and takes account of any relationship between the variables 
(Field, 2009). To assess postural control, measures of CoP velocity and CoP displacement 
were analysed. The MANOVA is chosen as an appropriate method to statistically analyse 
whether groups differed across a combination of postural control parameters, as opposed 




7 The effect of footwear on balance and postural 
control in standing in chronic low back pain 
7.1 Chapter summary 
This study investigated the immediate, short term (six weeks) and long term (six month) 
effects of rocker sole and flat sole shoes on postural control and the relationship between 
the hip and ankle strategy in standing in those with chronic low back pain (CLBP). Four 
standing conditions with varying levels of postural challenge were assessed, whilst barefoot 
and whilst wearing study shoes. Although wearing rocker sole shoes introduced greater 
postural instability when standing compared to flat sole shoes, no difference between 
groups were observed in barefoot balance parameters, or the barefoot ratio of hip to ankle 
strategy at any follow-up point. This indicated that wearing both shoe types had a similar 
influence on barefoot postural control in standing in the short and long term. Neither shoe 
type appeared to offer a detectable long term training effect to the postural control system 
from the balance measures assessed. 
7.2 Introduction 
Differences in the postural control of standing have been reported between people with 
CLBP and asymptomatic individuals (Byl and Sinnott, 1991; Della Volpe et al., 2006; Luoto et 
al., 1996; Mientjes and Frank, 1999; Mok et al., 2004; Moseley and Hodges, 2005; Takala et 
al., 1997b). During more challenging standing conditions people with CLBP have 
demonstrated increased centre of pressure (CoP) displacements and velocities, thought to 
indicate a reduced ability to maintain postural stability. Furthermore, although under stable 
standing conditions people with and without CLBP both favour the ankle strategy to 
maintain postural control (Horak and Nashner, 1986), during more challenging conditions, 
people with CLBP continue to favour the ankle strategy whereas asymptomatic individuals 
favour a hip strategy (Brumagne et al., 2008; Mok et al., 2004), suggested as the more 
appropriate strategy to maintain postural control (Horak and Nashner, 1986). Although 
evidence for these conclusions is not strong, poor postural control has been proposed as an 
underpinning mechanisms in the presence and recurrent nature of CLBP (Brumagne et al., 
2008; Mok et al., 2004). 
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Rehabilitation with proprioceptive or balance training has demonstrated clinical benefits to 
other regions of the body with postural control deficits (Fitzgerald et al., 2000; Tropp and 
Askling, 1988). It has been suggested that proprioceptive or balance training may also be 
effective in the treatment of CLBP (Johanssen et al., 1995). A manufacturer of rocker sole 
shoes (Masai Barefoot Technology Limited) has suggested that the unstable sole in their 
footwear can help to improve balance through ‘sensorimotor’ training and hence, ‘benefit’ 
functional daily activities (Masai Barefoot Technology GB Ltd, 2011).  When standing in 
rocker sole shoes, greater centre of pressure (CoP) displacements have been reported 
compared to when wearing a flat sole shoe (Nigg et al., 2006b). A larger displacement of 
the (CoP) is interpreted as increased instability. If rocker sole shoes do serve as an effective 
balance training device by increasing postural instability compared to flat sole shoes they 
may offer clinical benefit to those with CLBP and impaired postural control as 
demonstrated in other lower limb dysfunctions treated with proprioceptive rehabilitation 
programmes (Fitzgerald et al., 2000; Tropp and Askling, 1988). This study therefore 
investigated the following study hypotheses: 
Null hypothesis (H0): 
H0 1 There will be no difference in postural stability when standing in rocker sole shoes 
or flat sole shoes.  
H0 2: Both shoe groups will demonstrate no change in postural stability in the antero-
posterior direction during barefoot standing at six weeks or six months compared 
to baseline. 
H0 3: There will be no change in the hip to ankle postural control index in either group 
during more challenging barefoot standing conditions at six weeks and six months 
when compared to baseline. 
Alternative hypothesis (H1): 
H1 1 Standing in rocker sole shoes will promote a greater postural instability than 
standing in flat sole shoes in the antero-posterior direction compared to barefoot 
standing.  
H1 2: Both shoe groups will demonstrate an improvement in postural stability in the 
antero-posterior direction during barefoot standing at 6 weeks and 6 months, with 
the rocker shoe group demonstrating a greater improvement. 
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H1 3: Both groups will demonstrate an increase in the hip to ankle postural control index 
(indicating an increased proportional input from the hip strategy) during more 
challenging barefoot standing conditions at six weeks and six months in both study 
groups, with the rocker shoe group demonstrating a greater increase. 
7.3 Methods 
7.3.1 Design 
This prospective randomised controlled trial with repeated measures at baseline, six weeks 
and six months recruited participants from the main clinical study (Chapter 5, p61). Cross-
sectional and longitudinal analysis of data were conducted. The chief investigator (C.I.) 
remained blind to subject group allocation. 
7.3.2 Ethical approval 
Ethical approval for the study was gained through the Outer North London Research Ethics 
Committee (REC: 10/H0724/7) (11.31, p312). 
7.3.3 Participant recruitment 
Participants were recruited into this study as described in 6.7 (p118). 
7.3.4 Interventions 
All assessments were conducted in the ‘One Small Step’ gait laboratory, Guy’s hospital. On 
arrival to the laboratory, and under supervision of the C.I., participants completed the trial 
consent form (11.32, p315), the Roland Morris Disability questionnaire (11.3, p225) and 
were asked to report a numerical rating score for their low back pain.  
Participants changed into shorts and vest top, and removed their shoes and socks. 
Anthropometric measurements (6.9.2, p123) from each participant were recorded by the 
C.I. and co-researcher, Dr Adam Shortland (PhD supervisor and Clinical Manager of the One 
Small Step Gait Laboratory). Retro-reflective markers were placed on the appropriate bony 
landmarks (6.9.3, p127) by Dr Shortland followed by a short data capture (6.10.3.2, p136). 
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7.3.4.1 Static balance test procedure - barefoot 
Each participant stood barefoot, their feet approximately pelvis width apart with their left 
and right feet on adjacent force plates. No additional instructions were given to the 
participants regarding how to place their feet on the force plates in order to allow them to 
assume their habitual standing posture. A brief familiarisation period of wearing the 
markers and standing on the force plates, prior to the data acquisition, allowed the subjects 
to become accustomed to the equipment and testing procedure. Participants were 
assessed under four standing conditions, each condition assessed over three 40 second 
trials: 
(1) firm ground with eyes open 
(2) firm ground with eyes closed  
(3) compliant ground (foam cushion) with eyes open 
(4) compliant ground (foam cushion) with eyes closed 
 
Each participant received the same instructions at the start of each trial: 
 
“When I say ‘Go’ I want you to stand and maintain your balance until you hear the 
instruction to rest. Each trial will last for 40 seconds. Focus on the red sticker on the tripod 
ahead of you. Keep your arms relaxed by your sides.” 
 
A rest period of approximately 20 seconds occurred between each 40 second trial. A test 
was invalidated if the participant: 1) moved their foot position on the force plate during the 
test; 2) changed their arm starting position or; 3) opened their eyes during an eyes-closed 
task. Sufficient trials were performed to enable three valid sets of data to be recorded.  
 
The C.I. advised subjects that if they felt particularly unstable during the trials they should 
open their eyes and/or step off the foam cushion or force plate. Between trials on the 





7.3.4.2 Static balance test procedure - shod 
In order to maintain blinding of the C.I. to participant footwear group allocation, the C.I. 
vacated the gait laboratory. The co-researcher then continued with the shod assessment. 
Foot markers were relocated to the study footwear (6.9.3.1, p130). Following a short data 
capture and whilst wearing study shoes, the study protocol described in 7.3.4.1 (p151) was 
repeated by the participants.  
7.3.5 Outcome measures 
The following outcome measures were assessed at baseline, six weeks and six months: 
 Postural stability (root mean squared error and velocity of the centre of pressure in 
the antero-posterior direction: CoP RMSE AP and CoP VEL AP respectively [6.11.2, p143]) 
 Postural strategy (Hip to ankle postural control index [6.11.3, p145]) 
 Disability (Roland Morris Disability questionnaire) 
 Pain (Numerical rating score) 
7.3.6 Sample size 
Recruitment into the biomechanical study commenced in June 2010 and ended at the same 
time as recruitment into the main clinical study (November 2010). Twenty CLBP participants 
were recruited from the remaining 55 participants consenting into the main clinical study 
(Chapter 5, p61). A sample size calculation to determine appropriate power was not 
conducted due to the lack of reporting of minimal clinically important difference data for 
the primary outcome measures (CoP parameters). 
7.3.7 Data analysis 
Baseline data are presented in order that results may be compared with other trials and to 
judge the effectiveness of randomisation. Distributions were checked to see if normal 
distributions had been met, if this was not the case, non-parametric tests were performed. 
Mixed ANOVAs were conducted with one within-subject factor (assessment time point) and 
one between group factor (footwear type) to compare the influence of footwear type over 
time, and one within groups factor (standing condition) and one between group factor 
(footwear type) to compare baseline data between groups. ANOVA utilised data from 
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participants with complete data sets (rocker sole shoe group n = 11, flat sole shoe group n = 
5 for long term follow-up; rocker sole shoe group n = 13, flat sole shoe group n = 7 for 
baseline comparisons and immediate effect of footwear). The alpha level for determining 
statistical significance was set at 0.05.The reasoning underpinning choice of statistical tests 
has been described in  6.11.3.2  (p146).  
Data were analysed using IBM SPSS 20.0.0 (IBM, New York). Results are presented as means 
(standard deviations (SD)) unless otherwise stated. 
7.4 Results 
7.4.1 Recruitment 
During the recruitment period (June 2010 - November 2010) 38 patients in the main clinical 
study (REC reference number: 09/H0706/4) showed interest in participating in the 
biomechanical study. Following telephone conversation or face-to-face meeting with the 
C.I., 18 of the potential participants reported that they were not able to take part in the 
biomechanical trial. Reasons for the non-participation of these potential participants are 
presented in Figure 7.1. Twenty participants were consented into the study. 
Figure 7.1 Reasons for non-participation of participants 
 
0 2 4 6 8 10 12
Looking after young child
Too far to travel
Not interested in taking part
Work commitments
Number of potential patricipants 
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7.4.2  Participant baseline characteristics 
Baseline study demographic data and self-reported pain and disability outcome measures 
for the 20 participants are presented in Table 7.1. Of the 20 participants recruited seven 
had been randomized to receive the flat sole shoe and 13 to receive the rocker sole shoe. 
There were no differences between groups for any of the baseline demographic data, pain 
or disability outcome measures. At baseline those in the flat sole shoe group tended to be 
heavier and report increased disability than those in the rocker sole shoe group. 
Table 7.1. Participant demographic data 
 
Flat sole shoe        
group 
(n=7) 
Rocker sole shoe 
group 
 (n=13) 
P - value 
Gender : Male 
               : Female 
3 (42.9 %)* 
4 (57.1 %)* 
6 (46.2 %)* 
7 (53.8 %)* 
0.89† 
Age (years) 37.9 (13.0) 42.6 (12.5) 0.43 
Weight (kg) 82.4 (22.0) 70.3 (11.3) 0.12 
Height (cm) 173.8 (7.3) 173.5 (9.5) 0.95 
Roland Morris Disability 
Questionnaire                                     
(0-24; 0=best) 
7.9 (1.8) 5.7 (3.3) 0.13 
Numerical rating score for pain      
(0-10; 0=best) 
6.3 (1.5) 5.7 (1.7) 0.48 
Summary measures represent means (SD) or *numbers (percentages). Data analysed with 





Baseline barefoot CoP parameters are presented in Table 7.2. No differences were 
detected in change in CoP RMSE AP or CoP VEL AP between the flat sole and rocker sole shoe 
groups for any of the four standing conditions (F(3,51) = 0.41, p = 0.75, Ƞ2= 0.02 and 
F(1.14,19.31)= 0.74, p = 0.69 Ƞ2=0.01). 
Table 7.2 Barefoot antero-posterior centre of pressure parameters at baseline  
Standing 
condition 
Group CoP RMSE AP [mm] CoP VEL AP [mm/s] 
Eyes open no 
cushion 
Flat sole shoe 4.89 (2.27) 6.93 (2.66) 
Rocker sole shoe 4.51 (1.85) 7.07 (1.97) 
Eyes closed no 
cushion 
Flat sole shoe 5.73 (2.36) 8.21 (2.17) 
Rocker sole shoe 4.23 (1.29) 8.24 (2.60) 
Eyes open 
cushion 
Flat sole shoe 10.36 (2.50) 16.31 (3.53) 
Rocker sole shoe 8.84 (2.67) 14.94 (3.28) 
Eyes closed  
cushion 
Flat sole shoe 12.01 (2.49) 27.34 (11.89) 
Rocker sole shoe 11.49 (2.67) 25.91 (9.13) 







Tables 7.3 presents baseline hip:ankle postural control indexes for the different standing 
conditions. No difference was observed in change in hip to ankle strategy between groups 
for any of the standing conditions assessed for the left or right lower limb 
(F(4.87,77.97)=0.96, p=0.44, Ƞ2=0.06 and F(4.82,77.03)=1.44, p=0.22, Ƞ2=0.08 respectively). 
Table 7.3 Baseline sagittal plane hip to ankle postural control index during standing  
 
Hip : ankle postural control index 
Left Right 
Eyes open no 
cushion 
 
Flat sole shoe 0.31 (0.11) 0.37 (0.12) 
Rocker sole shoe 0.31 (0.09) 0.35 (0.13) 
Eyes closed no 
cushion 
 
Flat sole shoe 0.31 (0.07) 0.41 (0.12) 




Flat sole shoe 0.28 (0.10) 0.32 (0.11) 
Rocker sole shoe 0.28 (0.08) 0.24 (0.07) 
Eyes closed  
cushion 
 
Flat sole shoe 0.30 (0.08) 0.33 (0.09) 
Rocker sole shoe 0.25 (0.09) 0.41 (0.27) 
Summary measures represent means (SD). 
7.4.3  Participant retention and attrition 
Sixteen (80%) participants were reassessed at six weeks and at 12 months. Two participants 
were lost to follow-up from each group. Participant retention and attrition during the study 























Participant identification codes are reported as ‘P’ = participant, followed by a number 
identifying the ‘nth’ participant entering the trial. 
  
Assessed for eligibility  
(n= 38) 
Excluded (n= 18) 
18 unable to participate 
Entered study (n=20) 
Flat sole shoe group  
Total randomised (n=7) 
Total completing baseline data collection 
(n= 7) 
 
Rocker sole shoe group 
Total randomised (n=13) 
Total completing baseline data collection 
(n=13) 
 
6 week follow up  
Total completing data collection (n=5) 
Total lost to follow-up (n=2) 
 unable to attend assessment: 
o P18 
 lost to follow-up:  
o P5 
 
6 month follow up  
Total completing data collection (n= 5) 
Total lost to follow-up (n=2) 
 lost to follow-up:  





6 week follow up  
Total completing data collection (n=11) 
Total not lost to follow-up (n=2) 
 lost to follow-up: 
o P4 




6 month follow up  
Total completing data collection (n=11) 
Total lost to follow-up (n=2) 
 lost to follow-up: 
o P4 









Total included in final analysis 
(n= 5) 
% dropout = 28.6% 
 
Total included in final analysis 
(n= 11) 
% dropout = 15.4% 
 
Figure 7.2 Flow of participants through trial 
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7.4.3.1 Comparison of centre of pressure parameters when standing 
barefoot and standing shod  
Standing in a rocker sole shoe, with eyes-open on firm ground, resulted in a mean increase 
in CoP RMSE AP of 6.62mm (146.8%, p < 0.01) when compared to standing barefoot (Table 
7.4). Standing, eyes-open on firm ground, in rocker sole shoes resulted in a mean increase 
in CoP VEL AP of 8.10mm/s (114.4%, p < 0.01) when compared to standing barefoot. There 
was no difference in CoP RMSE AP or CoP VEL AP when standing barefoot compared to standing 
in flat sole shoes (Table 7.4). 
Table 7.4 Sagittal plane centre of pressure parameters during barefoot and shod 
standing, with eyes open on firm ground 
 Flat sole shoe group (n=7) Rocker sole shoe group (n=13) 
 CoP RMSE AP    
[mm] 
CoP VEL AP 
[mm/s] 
CoP RMSE AP     
[mm] 
CoP VEL AP 
[mm/s] 
Barefoot 4.89 (2.27) 6.93 (2.66) 4.51 (1.85) 7.07 (1.97) 












Summary measures represent means (SD) or percentages where indicated (%).* Significant 
difference within groups between barefoot and shoe conditions (paired t-test, p < 0.01). 




7.4.3.2  Longitudinal comparison of clinical outcome in biomechanical study 
sample and main clinical study 
Comparison of change in disability for each shoe group between the biomechanical study 
and the main clinical study demonstrated similar reductions in disability and pain at six 
weeks and six month follow-ups (disability: rocker sole group F(2, 106) = 0.20, p = 0.82 , Ƞ2 
= 0.001; flat sole shoe, F(1.53, 73.4) = 0.24, p = 0.73, Ƞ2 = 0.01; pain: rocker sole shoe, 
F(1.70,90.10)=0.01, p=0.99, Ƞ2 <0.01, and flat sole shoe group, F(2,96) = 1.04, p = 0.36, Ƞ2 
0.02) (Table 7.5).This indicates that for each shoe group the biomechanical study sample 
was representative of the main study sample for measures of disability and pain. 
 
Table 7.5 Disability and pain outcomes for biomechanical study participants and 



















-3.2                  
(-4.4 to -1.9) 
-4.4                   
(-6.8 to -2.0) 
-2.2               
(-3.2 to -1.2) 
-1.7                    
(-3.6 to 0.2) 
Baseline to 
6 months 
-4.2                  
(-5.7 to -2.7) 
-5.2                  
(-7.2 to -3.2) 
-2.3               
(-3.4 to -1.1) 
-1.6                    






-1.9                  
(-2.7 to -1.1) 
-1.3                  
(-3.3 to 0.7) 
-2.0               
(-2.7 to -1.2) 
-1.95                  
(-3.4 to -0.5) 
Baseline to 
6 months 
-2.6                  
(-3.4 to -1.8) 
-3.6                  
(-5.9 to -1.3) 
-2.4               
(-3.2 to -1.6) 
-2.45                  
(-4.0 to -0.9) 




7.4.3.3 Influence of long term shoe wear on barefoot sagittal plane centre of 
pressure parameters 
Neither the rocker sole nor the flat sole shoe group demonstrated change in CoP RMSE AP or 
CoP VEL AP when assessed barefoot, with eyes closed on compliant ground,  at any follow-up 
point (rocker sole shoe group F(2, 20) = 2.81, p = 0.08, Ƞ2 = 0.22 and F(2, 20) = 1.96, p = 
0.17, Ƞ2 = 0.16 respectively; flat sole shoe group F(2, 6) = 2.22, p = 0.81, Ƞ2 = 0.07 and F(2, 
6) = 0.42, p = 0.67, Ƞ2 = 0.12 respectively) (Table 7.6). Furthermore, there were no 
differences between groups in CoP RMSE AP or CoP VEL AP at any follow-up point during the 
most challenging standing condition (F(2,26) = 0.51, p = 0.61, Ƞ2 = 0.04 and F(2,26)=0.96, 
p=0.40, Ƞ2 =0.07). A trend for a reduction in velocity was observed in the rocker sole shoe 
group at six weeks and six months when compared to baseline. 
 
Table 7.6 Change in barefoot centre of pressure parameters during standing, eyes 
closed on foam cushion at reassessment points 
 
Centre of pressure 
parameter 
Assessment P-value 
Baseline 6 weeks 6 months 
Flat sole shoe 
group 






























Summary measures represent means (SD). 
No difference in COP RMSE AP or CoP VEL AP were found for the three other less challenging 
standing conditions assessed (eyes open, no cushion; eyes closed, no cushion; and eyes 




7.4.3.4 Influence of long term shoe wear on postural control assessed when 
shod. 
When standing in study shoes, with eyes open on firm ground, no significant differences 
where observed in CoP RMSE AP or CoP VEL AP for either shoe group at any reassessment point 
(rocker sole shoe group: F(2, 20) = 1.29, p = 0.30, Ƞ2 = 0.11, and F(2, 20) = 2.06, p = 0.15, Ƞ2 
= 0.17 respectively; flat sole shoe group: F(2, 8) = 0.77, p = 0.50, Ƞ2 = 0.16, F(2, 8) = 1.62, p = 
0.26, Ƞ2 = 0.30). Furthermore, whilst wearing study shoes there were no differences 
between groups in change in CoP RMSE AP or CoP VEL AP at any reassessment point (F(2,28) = 
1.17, p = 0.33, Ƞ2= 0.08, and F(2,28) = 2.37, p = 0.11, Ƞ2= 0.14 respectively) (Table 7.7). 
Table 7.7 Change over time in antero-posterior centre of pressure parameters 
during shod standing, eyes open on firm ground 
 
Centre of pressure 
parameter 
Assessment P - value 
Baseline 6 weeks 6 months 
Flat sole shoe 
group 














Rocker sole shoe 
group 


















7.4.3.5  Comparison of hip and ankle strategies when barefoot and shod 
A greater increase in ankle strategy from barefoot to shod was observed in the rocker sole 
compared to the flat sole shoe group (right ankle: F(1, 18)=10.40, p=0.01, Ƞ2= 0.37; and the 
left ankle: F(1,18) = 8.51, p=0.01, Ƞ2= 0.32). Changes in hip strategy from barefoot to shod 
were not different between groups (left hip: F(1.18)=0.12, p=0.74, Ƞ2= 0.01; right hip: 
F(1,18)=1.50, p=0.24, Ƞ2 =0.08). Figure 7.3 demonstrates that hip strategy is minimally 
influenced by rocker sole shoes compared to when barefoot.  
The hip:ankle postural control index was reduced in the rocker sole shoe group, when shod 
compared to barefoot (Table 7.8). Figure 7.3 indicates that the reduced index results from 
an increase in ankle strategy. In the flat sole shoe group, barefoot and shod standing 
resulted in similar Hip: ankle postural control indexes (Table 7.8), indicating change in hip 
and ankle strategy between barefoot and shod standing was directly proportional.  
There were no differences between groups in hip to ankle postural control index from 
barefoot to shod (F(1, 18) = 2.83, p=0.10, Ƞ2 = 0.14 for the left, and F(1,18)=3.46, p=0.08, 
Ƞ2= 0.16 for the right side) (Table 7.8). 
Table 7.8 Hip to ankle postural control index when barefoot and shod 
 Flat sole shoe group Rocker sole shoe group 
Left Right Left Right 
Barefoot 0.31 (0.11) 0.37 (0.12) 0.31 (0.09) 0.35 (0.13) 
Shod 0.37 (0.23) 0.39 (0.16) 0.24 (0.07)* 0.26 (0.08)* 





Figure 7.3 Hip and ankle strategy during barefoot and shod standing (for the left 
lower limb) 
 
7.4.3.6  Influence of long term shoe wear on postural strategy in barefoot 
standing 
There were no differences, within groups or between groups, in the hip: ankle postural 
control index at baseline, six weeks and six months when assessed in standing with eyes 
open on firm ground or during more challenging trial conditions (eyes closed standing on 




Table 7.9 Ratio of hip to ankle strategy in the maintenance of an upright standing 
posture 
  
Flat sole shoe 
 group 
Rocker sole shoe 
group 
P - value 
  























































Summary measures represent means (SD). A value of 0 would represent a 100% 
contribution from the ankle strategy. Analysis: repeated measures and mixed ANOVA’s. 
7.5 Discussion 
Rocker sole shoes provided a less stable surface to stand on than flat sole shoes. 
Furthermore, the increase in ankle strategy from standing barefoot to shod was 
significantly greater in the rocker sole shoe than in the flat sole shoe. Change in hip strategy 
between barefoot and shod standing was similar between groups. This suggests that whilst 
wearing the rocker sole shoes the ankle strategy, and not the hip strategy appears to be the 
primary strategy for maintenance of postural stability in people with CLBP.  Although these 
findings suggest that rocker sole shoes may be more likely to influence postural control 
strategies there was no difference in barefoot postural strategy ratios or CoP parameters 
within or between groups during barefoot trials at 6 weeks or 6 months for stable or 
unstable standing conditions. Furthermore, there was no change from baseline in CoP 
parameters in the rocker sole shoe group when shod at six weeks and six months. These 
findings suggest that adaptation of the postural control system did not occur following long 
term wear of rocker sole shoes. The lack of change in CoP and postural strategy outcomes 
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suggests that wearing rocker sole shoes did not appear to cause a training effect capable of 
influencing postural stabilising systems in those with CLBP. 
7.5.1 Outcomes 
7.5.1.1 Antero-posterior centre of pressure parameters. 
Baseline values of antero-posterior CoP parameters were compared to available results 
from CLBP trials investigating the same outcome measures under similar study protocols. 
The current study demonstrated similar CoP parameters between shoe groups at baseline, 
however, when compared to the findings of other studies the current study demonstrated 
increased postural stability during more stable standing (Brumagne et al., 2004; Brumagne 
et al., 2008; Della Volpe et al., 2006), and reduced postural stability during more 
challenging standing (Brumagne et al., 2004; Brumagne et al., 2008; Lafond et al., 2009).  
These differences may be due to a number of methodological differences, namely: 
calculating the mean from three or more trials (as conducted in the current study) produces 
more reliable data than that obtained from one trial (Ruhe et al., 2011a) as conducted by 
Brumage et al. (2004; 2008) and Lafond et al. (2009) - only using one repetition may have 
reduced the reliability of data collected in these other studies; greater trial durations 
provide more reliable data (Ruhe et al., 2011a) – a minimal trial duration time by Della 
Volpe et al. (2006) may have reduced data reliability. Further factors have been 
demonstrated to influence outcome measure data include participant age (postural 
stability reduces with age (Doyle et al., 2004; Era and Heikkinen, 1985; Hageman et al., 
1995; Hasselkus and Shambes, 1975)), weight (Chiari et al., ; Hue et al., 2007), height 
(increased height may reduce postural stability) (Chiari et al., ; Hue et al., 2007) and gender 
(due to the fact that males are generally taller than females) (Hageman et al., 1995). 
Brumage et al (2004; 2008) recruited only young adults, two studies did not report 
participant gender (Brumagne et al., 2004; Lafond et al., 2009), and although mean height 
of participants was similar across studies, Brumage et al (2008) reported reduced mean 
weight of participants compared to the other studies. All studies, including the current 
study, have investigated small sample sizes (between 10 and 21 participants) – which may 
increase the risk of statistical error. The consistent increase in CoP parameters from stable 
to more challenging standing conditions in the current study concurred with findings of 
other trials (Brumagne et al., 2008; Mok et al., 2004). 
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Reduction in a CoP parameter is interpreted as an improvement in postural stability (Ruhe 
et al., 2011a). It was hypothesised that due to the increased proprioceptive input from 
wearing the rocker shoes (Masai Barefoot Technology GB Ltd, 2011) a greater reduction in 
barefoot and shod postural excursion may occur at reassessment in the rocker sole 
compared to the flat sole group. However, neither group demonstrated a significant change 
in CoP parameters at six weeks or six months. This lack of change suggests that the rocker 
sole footwear, reported by the manufacturing company to be a ‘sensorimotor training 
device’ which ‘can help to improve balance’ (Masai Barefoot Technology GB Ltd, 2011) 
either i.) provided an additional postural challenge, however this type of challenge does not 
affect long term improvements in sensori-motor function, ii.) did not influence balance 
sufficiently for a training effect (classified by a change in CoP parameters) to occur, or iii.) 
did influence potential proprioceptive deficits, however, improvements were not detected 
possibly due to: insensitivity of outcome measures investigated; a type two error resulting 
from an underpowered sample;  or poor data reliability due to methodological faults. These 
explanations are discussed in greater detail below. 
The first explanation, suggesting that the increased postural challenge from rocker sole 
shoes does not influence long term improvements in sensori-motor function compared to 
wearing flat sole shoes, concurs with the findings of other studies (Nigg et al., 2009; Nigg et 
al., 2006a). Nigg et al. investigated the influence of rocker sole footwear on balance in 
golfers with LBP (Nigg et al., 2009) and in people with knee osteoarthritis (Nigg et al., 
2006a). In support of the current study findings, Nigg et al. concluded that no differences in 
balance performance were detected between the intervention (rocker sole group) or 
control groups (normal shoes) at six weeks in the low back pain study and at twelve weeks 
in the knee study. The current study adds to Nigg et al’s conclusions by demonstrating that 
longer term use of rocker sole shoes has no further influence on postural stability. 
The second explanation, suggests that if a greater postural challenge had been elicited, a 
training effect (identified by a significant change in CoP parameters) may have occurred. 
When compared to standing barefoot, the rocker shoes demonstrated more than a 100% 
increase in the CoP parameters assessed. Introducing additional postural challenge in an 
attempt to increase the CoP parameters further may not only be unsafe or impractical in a 
CLBP population, but may also, in the absence of evidence to support a relationship 




The third explanation suggests that the null hypothesis was incorrectly accepted and that 
study conclusions are incorrect. Several factors may contribute to this explanation. The 
sample may be underpowered because of poor reliability of the outcome variables and 
because of an insensitivity to detect genuine changes in postural control. The reliability of 
the outcome variables would be improved by increasing the duration of the trials and by 
introducing more trials. However, of the numerous CoP parameters regularly reported in 
research assessing postural stability, the two parameters chosen in the current study have 
been reported as highly reliable (Ruhe et al., 2011a). 
Change in CoP parameters have been suggested as an appropriate outcome measure to 
detect clinical change (Ruhe et al., 2011b). In the current study, differences in mean CoP 
RMSE AP at six months during challenging standing conditions were -0.52 and 0.85 mm for the 
different shoe types and change in mean CoP VEL AP were 2.04 and -3.58 mm/s for the 
different shoe types. To the authors knowledge, measurements of the standard error of 
CoP parameters, during challenging standing conditions, are yet to be reported in the 
literature for people with CLBP, however, the figures reported above are less than the 
reported standard errors from reliability studies conducted in elderly participants (who also 
demonstrate poor postural stability) (2010). Changes in CoP parameters following an 
intervention may be too small to reliably determine whether change in postural stability 
has occurred. 
Regarding the sensitivity of the CoP parameters, the current thesis demonstrates clinically 
important significant reductions in disability and pain at follow-up, but no change in 
postural parameters. This thesis and the findings of (Kuukkanen and Malkia, 2000) suggest 
that CoP parameters may be insensitive to real changes in postural control or that there 
may be no significant changes in control. If the latter, the use of any mechanical indices as 
outcome measures would be inappropriate; if the former, alternative mechanical outcome 




7.5.1.2 Hip to ankle strategy ratio 
The control of standing balance is thought to be strongly linked to the relationship between 
hip and ankle strategies (Horak and Nashner, 1986).  Due to a paucity in the reporting of hip 
to ankle strategy ratios, as calculated in the current study (from standard deviations of joint 
moments, obtained from two force plates by an inverse dynamics method), it was not 
possible for the baseline data from this current study to be compared with other CLBP 
populations. Furthermore, lack of research reporting long term changes in postural strategy 
following an intervention does not allow comparison of the current study findings to other 
research. 
Neither footwear group demonstrated a change in barefoot hip to ankle postural control 
index at any reassessment point when compared to baseline. This suggests that the 
reductions in pain and disability observed in the current study did not influence, or result 
from a change in the hip to ankle ratio (Horak and Nashner, 1986). In people with CLBP, 
during more challenging conditions, the ankle strategy is reported to be the favoured 
strategy (Brumagne et al., 2008; Mok et al., 2004) whereas in asymptomatic individuals the 
hip strategy is favoured (Brumagne et al., 2008; Mok et al., 2004) and suggested as a more 
appropriate strategy to maintain postural control (Horak and Nashner, 1986). In the current 
study it was hypothesised that, due to the unstable surface of the rocker sole shoe, a 
‘sensorimotor’ training effect may influence or ‘normalise’ dominance of the hip over the 
ankle strategy during more challenging postural standing conditions. However, wearing the 
rocker sole shoes had a similar minimal influence on the hip strategy as the flat sole shoes, 
hence is unlikely to have a greater or lesser influence on postural strategy than a flat sole 
shoe.  
7.5.2 Clinical implications 
Long term use of rocker sole shoes or flat sole shoes in addition to attendance to a four 
week LBP exercise group do not appear to influence barefoot postural control (as 
determined by CoP parameters and the ratio of hip to ankle strategy) during standing in 
those with CLBP. 
 
Changes in CoP parameter measures are suggested to correlate with postural control 
impairment in humans (Ruhe et al., 2010). Although clinical improvement in pain and 
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disability are noted in this sample, change in CoP parameters did not occur, raising doubt to 
the theory that treatment approaches directed towards influencing or ‘normalising’ altered 
CoP parameters may result in clinical improvements in those with CLBP. Predicting 
presence and severity of CLBP using CoP parameters alone cannot currently be advised. 
7.6 Conclusions 
This is the first RCT with long term (six month) follow-up comparing the influence of rocker 
sole and flat sole shoes on CoP parameters and postural strategy ratios in a chronic pain 
population. 
 
 Standing in a rocker sole shoe reduced postural stability compared to standing 
barefoot whereas standing in a flat sole shoe did not influence postural stability. 
 At baseline, standing in a rocker sole shoe reduced the hip to ankle postural control 
index compared to barefoot. This resulted from a greater proportional increase in 
ankle strategy, not the hip strategy.  
 Neither shoe group demonstrated change from baseline in the hip to ankle postural 
control index or CoP parameters during stable or more challenging standing 
conditions when barefoot or shod when reassessed at six weeks and six months. 
This suggest that long term use of rocker sole or flat sole shoes in those with CLBP 
do not appear to influence postural stability. 
 This study questions the belief that sensorimotor rehabilitation, especially when 
delivered in standing using rocker sole shoes, will influence postural control in 
people with CLBP.  
 It remains unclear as to whether CoP parameters are appropriate measures to 
imply presence and severity of CLBP or clinical change in those with CLBP. 
 It is unclear what effect either shoe type may have on CoP parameters and postural 





8 The effect of footwear on kinetic, kinematic and 
spatio-temporal parameters during gait in people 
with chronic low back pain 
8.1 Chapter summary 
This study investigated the immediate and long term (six month) influence of rocker sole 
and flat sole shoes on kinetic, kinematic and spatio-temporal parameters during gait in 
people with chronic low back pain (CLBP). Parameters of gait were assessed whilst walking 
barefoot and shod. Although walking in both shoe types compared to barefoot gait resulted 
in mild alterations to participants gait parameters at baseline, neither shoe group 
demonstrated significant differences in barefoot gait at six months. This suggests that 
neither shoe type provided a long term training effect capable of influencing the kinetic, 
kinematic or spatio-temporal parameters assessed during barefoot gait. 
8.2 Introduction 
Differences in gait have been identified between people with and without CLBP (Al-Obaidi 
et al., 2003; Keefe and Hill, 1985; Lamoth et al., 2002; Lee et al., 2007; Vogt et al., 2003; 
Vogt et al., 2001); people with CLBP demonstrating a reduced self-selected walking speed 
(Al-Obaidi et al., 2003; Keefe and Hill, 1985; Lamoth et al., 2002; Lee et al., 2007), stride 
time (Vogt et al., 2003; Vogt et al., 2001), stride length (Al-Obaidi et al., 2003; Keefe and 
Hill, 1985), and range of hip movement (Vogt et al., 2003). Researchers have proposed that 
these gait changes may be an attempt by the individual to reduce pain by reducing ground 
reaction forces at heel strike (Voloshin and Wosk, 1982), excessive muscle activity or joint 
movement (Ahern et al., 1988). Alternatively, differences may be a result of altered 
proprioceptive feedback (Mazzocchio et al., 2001) or psychological factors associated with 
low back pain, such as anxiety, fear avoidance, hyper-vigilance and catastrophising (Leeuw 
et al., 2007). Psychological factors may lead to adaptation of normal physical activities, such 
as fast walking, due to the fear of an increase in pain. Although gait alterations may initially 
be protective, such alterations may induce mechanical problems in the longer term, for 
example, a slower walking speed has been shown to produce longer periods of loading on 
the lumbar spine during gait (Callaghan et al., 1999), which may be detrimental to spinal 
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structures in the long term, whereas more cyclic, shorter periods of loading, thought to be 
less detrimental, occur during faster walking (Callaghan et al., 1999). Variations in gait in 
people with compared to asymptomatic individuals have been proposed as an 
underpinning mechanism in the presence and recurrent nature of CLBP. For this theory to 
be accepted, change in gait parameters (for example, an increase in gait velocity or stride 
length) would be expected in the presence of reduced pain or disability.  
Different footwear types have demonstrated an ability to influence gait. Shod compared to 
barefoot walking increases stride length and velocity (Demura et al., 2012; Keenan et al., 
2011; Lythgo et al., 2009). Wearing shoes increases the mass and the distribution of mass of 
the limb. This alters the dynamics of walking in a similar way to how the dynamics of a 
Grandfather clock pendulum is altered by moving the attached mass. In the current study, 
the rocker sole shoes are twice the mass of the flat sole shoe and have the thicker sole. 
Therefore, at baseline, it was expected that the rocker sole shoes would result in a greater 
increase in stride length, lower cadence and greater walking velocity than the flat sole 
shoes when compared to barefoot walking. However, this theory challenges previous 
research reporting reduced gait velocity (Romkes et al., 2006; Taniguchi et al., 2012) and 
stride length (Romkes et al., 2006) in rocker sole compared to flat sole shoes in 
asymptomatic individuals. 
A longer stride length is likely to be related to a greater excursion at the hip since angular 
changes at the hip are more likely to have a greater influence on step length than changes 
at the more distal joints. A greater hip range of movement was therefore expected for shod 
walking, with a greater increase in range for the rocker sole compared to the flat sole 
group. However, this theory challenges previous research reporting similar (Demura and 
Demura, Epub ahead of print), or decreased (New and Pearce, 2007; Romkes et al., 2006; 
Taniguchi et al., 2012) hip range during gait in rocker sole shoes compared to flat sole 
trainers. 
Peak hip extensor moments occur immediately after initial contact of the foot with the 
ground to decrease hip flexion and trunk rotation; peak hip flexor moments occur as the 
foot leaves the ground, to swing the leg forward (Apkarian et al., 1989). Due to the 
proposed increases in stride length, walking speed and hip range of movement whilst shod, 
hip joint moments are likely to increase during shod compared to barefoot gait, and by a 
greater amount in the rocker sole shoes. If either footwear has a long term influence on the 
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musculoskeletal system, increased hip moments may be demonstrated during barefoot gait 
at long term follow up compared to baseline. 
 Transient force peaks, the sharp increases in ground reaction force detected immediately 
after heel strike, have been implicated as a potential cause and aggravator of LBP (Light et 
al., 1980; Voloshin and Wosk, 1982). Whittle et al (1999) stated that the body has two 
natural defences against potential damage from these transient force peaks : appropriate 
joint alignment during the first half of stance and the presence of viscoelastic materials in 
the heel pad and joints. A cushioning effect from footwear may further assist in reducing 
external forces reaching the spine, or may influence lower quadrant joint angles during the 
stance phase of the gait cycle, increasing shock attenuation. A greater peak flexion angle 
during the first half of stance, suggested to increase shock attenuation of ground reaction 
forces (Whittle, 1999), has been observed whilst walking in rocker sole shoes compared to 
flat sole shoes (Taniguchi et al., 2012). Furthermore, a reduced incidence of transient force 
peaks when walking in rocker sole shoes compared to flat sole shoes has been 
demonstrated in asymptomatic individuals (Vernon et al., 2004). Therefore, if increased 
forces passing through the body contribute to CLBP, the rocker sole shoe may contribute to 
improved shock attenuation. If rocker sole shoes improve shock attenuation, and if such 
forces contribute to CLBP, a concomitant reduction in pain and disability, and hence 
increases in gait speed, stride length, and hip range of movement may be expected in the 
long term. 
Due to the paucity of evidence available and hence lack of understanding of the 
biomechanical response from the body from wearing rocker sole shoes the following 




Null hypotheses (H0): 
Immediate effects  
H0 1  Shod and barefoot walking will demonstrate similar stride lengths and self-selected 
walking speed. 
H0 2  Shod and barefoot walking will demonstrate similar hip range of movement. 
H0 3 Shod and barefoot walking will demonstrate similar incidence of transient force 
peaks associated with heel strike. 
H0 4 Shod and barefoot walking will demonstrate similar peak knee flexion angle during 
the first half of stance. 
Long term effects  
 
H0 5 During barefoot walking at six months, both shoe groups will demonstrate similar 
self-selected walking speed and stride length when compared to baseline  
 
H0 6 During barefoot walking at six months, both shoe groups will demonstrate a similar 
magnitude of hip moment when compared to baseline.  
 
H0 7  During barefoot walking at six months, both shoe groups will demonstrate similar hip 





Alternative hypotheses (H1): 
Immediate effects  
H1 1  Shod walking will demonstrate an increase in stride length and self-selected 
walking speed compared to walking barefoot, with a greater increase in the rocker 
sole shoe group compared to the flat sole shoe group. 
H1 2  Shod walking will demonstrate an increase in hip range of movement during gait 
when compared to walking barefoot, with a greater increase in the rocker sole shoe 
group compared to the flat sole shoe group. 
H1 3 Shod walking will demonstrate a decreased incidence of transient force peaks 
associated with heel strike compared to walking barefoot, with a greater decrease 
in the rocker sole shoe group compared to the flat sole shoe group. 
H1 4 Shod walking will demonstrate an increase in peak knee flexion angle during the 
first half of stance compared to walking barefoot, with a greater increase in the 
rocker sole shoe group compared to the flat sole shoe group. 
Long term effects  
H1 5 During barefoot walking at six months, both groups will demonstrate an increase in 
self-selected walking speed and increase in stride length when compared to baseline. 
The rocker shoe group will demonstrate greater increases from baseline than the flat 
sole shoe group.  
 
H1 6 During barefoot walking at six months, both groups will demonstrate an increase in 
the magnitude of the hip moments when compared to baseline. The rocker shoe 
group will demonstrate greater changes from baseline than the flat sole shoe group.  
 
H1 7  During barefoot walking at six months, both groups will demonstrate an increase in 
hip range of movement when compared to baseline. The rocker shoe group will 







This prospective randomised controlled trial with repeated measures at baseline and six 
months recruited participants from the main clinical study described in Chapter 5 (p61). The 
same participants taking part in the study described in Chapter 7 (p148) also participated in 
this study. Cross-sectional and longitudinal analysis of data was conducted. The chief 
investigator (C.I.) remained blind to participant group allocation.  
8.3.2 Ethical approval 
Ethical approval for the study was gained through the Outer North London Research Ethics 
Committee (REC: 10/H0724/7) (11.31, p312). 
8.3.3 Participant recruitment 
Recruitment of participants into this study is described in 6.7 (p118). 
8.3.4 Assessment 
All assessments were conducted in the ‘One Small Step’ gait laboratory, Guy’s hospital.  This 
study occurred in conjunction with the study described in Chapter 7 (p148). Study 
documentation forms had been completed, anthropometric measurements recorded and 




8.3.4.1 Assessment of barefoot gait 
Participants were asked to walk barefoot, at a pace that felt comfortable to them, from one 
end of the laboratory to the other, in a line which passed over the three force plates. Each 
participant received the same instructions: 
 
“When I say go I want you to walk in a straight line to the marker at the other end of the 
room. Walk at a pace that feels comfortable to you.” 
 
Participants continued walking the length of the laboratory until the C.I. had observed three 
clear force plate strikes for each foot (6.10.2.1, p134).  
8.3.4.2 Assessment of shod gait 
The C.I. left the gait laboratory in order to remain blind to participant group allocation. The 
co-researcher (Dr Adam Shortland) continued with the footwear assessment. Foot markers 
were relocated to the study footwear (6.9.3.1, p130). The study protocol (8.3.4.1, p176) 
was repeated by the participants, whilst wearing their study footwear.  
 
The co-researcher then removed all markers from the participant and from their shoes. 
Participants were informed that the double sided sticky tape used to attach the markers to 
the skin may leave a red mark on the skin for approximately one hour following marker 
removal. Participants were advised that this is normal and should not be of concern. Once 
participants had removed their study shoes and changed back into their normal clothing 
the C.I. was permitted to re-enter the laboratory. 
 
At the end of the initial assessment the C.I. informed participants to start wearing their 
study shoes for a minimum of two hours per day (as instructed by the C.I. in their baseline 




8.3.5 Outcome measures 
The following outcome measures were assessed at baseline and 6 months: 
 Self-selected walking speed [metres/second] 
 Stride length [metres] 
 Cadence [steps per minute] 
 Hip range of movement [degrees] 
 Peak knee flexion during the first half of stance [degrees] 
 Hip moments [Newton millimetres/kilogram] 
8.3.6 Sample size 
Sample size is described in 7.3.6 (p152). 
8.3.7 Data analysis 
All statistical tests were performed using SPSS statistical software (version 20.0) (IBM, New 
York). Paired t-tests, were applied to spatio-temporal parameters to determine change 
between walking barefoot and walking in study shoes. Independent t-tests for parametric 
data, or Mann-Whitney U-tests for non-parametric data, were applied to determine 
differences between groups. Long-term between group effects were assessed by mixed 
analysis of variance (ANOVA). The alpha level for determining statistical significance was 
0.05. The reasoning underpinning choice of statistical test is presented in 6.11.3.2 (p146). 
8.4 Results 
8.4.1 Recruitment 




8.4.2 Participant baseline characteristics 
Demographic characteristics of participants at baseline are described in 7.4.2 (p154). 
Baseline parameters of gait are presented in Table 8.1. No differences were observed 
between groups. 






P - value  
Walking speed [metres/second] 1.28 (0.16) 1.20 (0.27) 0.36 
Cadence [steps/minute] 114.30 (9.95) 108.97 (14.90) 0.35 
Stride length [metres] 1.35 (0.13) 1.31 (0.14) 0.50 
Left hip range of movement 
[degrees] 
44.1 (4.8) 44.3 (5.1) 0.92 
Right hip range of movement 
[degrees] 
43.2 (4.5) 42.4 (4.7) 
0.71 
Summary measures represent mean (SD). P-values : Independent t-test. 
8.4.3 Participant retention and attrition 
Participant retention and attrition is presented in 7.4.3 (p156). 
8.4.4 Spatio-temporal parameters 
8.4.4.1 Immediate effects of footwear on spatio-temporal parameters 
Both groups demonstrated an increase in walking speed and stride length during shod 
compared to barefoot gait. No differences were detected between groups for either 
parameter (walking speed, F(1,18) = 2.72, p = 0.11, ƞ2 = 0.13; stride length F(1.18) = 2.74, p 
= 0.12, ƞ2 = 0.13).  Compared to walking barefoot, cadence reduced when walking in rocker 
sole shoes, but did not change when walking in flat sole shoes. There was no difference in 
cadence between groups when comparing barefoot and shod walking (F(1,18) = 2.64, p = 
0.12, ƞ2 = 0.13) (Table 8.2). 
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Table 8.2 Immediate effects of footwear on spatio-temporal parameters of gait 
compared with barefoot gait 
 
Shoe group Barefoot Shod P - value  
Walking speed 
[metres/second] 
Rocker  1.28 (0.16) 1.37 (0.10)¥ 
0.11 
Flat 1.20 (0.27) 1.37(0.19)* 
Cadence 
[steps/minute] 
Rocker  114.30 (9.95) 111.60 (9.1)¥ 
0.12 
Flat  108.97 (14.90) 109.9 (10.30) 
Stride length 
[metres] 
Rocker  1.35 (0.13) 1.48 (0.08)* 
0.12 
Flat  1.31 (0.14) 1.49 (0.12)* 
Summary measures represent mean (SD). Within group differences between barefoot and 
shod are represented by ¥ p <0.05, and * p <0.01. P - value: between group mixed ANOVA 
8.4.4.2 Long term effects of footwear on barefoot spatio-temporal 
parameters 
No differences were detected in barefoot spatio-temporal parameters at six months 
compared to baseline from long term wear of either shoe type. Furthermore, no between 
group differences were detected in spatio-temporal parameters from long term shoe wear 
(walking speed: F(1,14) = 1.83, p=0.20, ƞ2 = 0.12; cadence, F(1,14) = 2.82, p = 0.12, ƞ2 = 
0.17; stride length, F(1,14) = 0.51, p = 0.49. ƞ2 = 0.04) (Table 8.3). 
Table 8.3 Barefoot spatio-temporal parameters of gait at baseline and 6 months 
 
Shoe group Baseline 6 months P - value  
Walking speed 
[m/s] 
Rocker  1.28 (0.17) 1.32 (0.16) 
0.20 
Flat 1.20 (0.22)  1.18 (0.18) 
Cadence 
[steps/minute] 
Rocker  113.77 (10.80) 115.86 (8.84) 
0.12 
Flat  109.99 (9.57) 108.38 (5.58) 
Stride length [m] 
Rocker  1.35 (0.13) 1.37 (0.15) 
0.49 
Flat  1.30 (0.15) 1.30 (0.15) 
Summary measures represent mean (SD). P - value : between group mixed ANOVA 
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8.4.5 Kinematic parameters 
8.4.5.1 Immediate effects of footwear on kinematic parameters 
Walking in flat sole shoes increased sagittal hip range of movement compared to walking 
barefoot (left: t(6) = -3.20, p = 0.02; right: t(6) = -4.29, p = 0.01). There was a small increase 
in hip range when walking in rocker sole shoes for the right hip (right, t(12)=-2.41, p = 0.03; 
left, t(12) =-1.48, p = 0.17). The flat sole group demonstrated a greater increase in right hip 
range from barefoot to shod gait than the rocker sole group; there was no difference 
between groups for the change in left hip range (left hip: F(1,18) = 2.32, p = 0.15, ƞ2 = 0.11; 
right hip: F(1,18) = 5.64, p = 0.03, ƞ2 = 0.24) (Table 8.4). 
 
Neither shoe type significantly altered peak knee flexion angle during the first half of stance 
compared to barefoot walking (rocker sole shoe, left: t(12) = -1.17, p = 0.27; right: t(12) = -
1.76, p = 0.10, flat sole shoe, left: t(6) = -2.12, p = 0.08; right: t(6) = -0.32, p = 0.76). There 
were no between group differences in change in peak knee flexion angle, during the first 
half of stance, when mobilising shod compared to barefoot (left: F(1,18)=1.93, p = 0.18, ƞ2 = 
0.10; right: F(1,18) = 0.63, p = 0.63, ƞ2 = 0.01). 
Table 8.4 Immediate effect of footwear on kinematics of gait 
Joint angle  Shoe 
group 
Barefoot     Shod P-value  
Left hip range of 
movement 
[degrees] 
Rocker  44.1 (4.8) 45.4 (4.0) 
0.15 
Flat 44.3 (5.1) 47.8 (5.6)* 
Right hip range of 
movement 
[degrees] 
Rocker  43.2 (4.5) 44.7 (4.1)* 
0.03 
Flat  42.4 (4.7) 46.4 (4.7)* 
Peak left knee 
flexion during first 
half of stance 
Rocker  19.2 (5.3) 21.2 (5.3) 
0.18 
Flat  18.1 (6.9) 21.3 (7.5) 
Peak right knee 
flexion during first 
half of stance 
Rocker  19.7 (4.9) 21.1 (4.6) 
0.63 
Flat  18.1 (8.2) 18.7 (7.9) 
Summary measures represent mean (SD); *represents within group p <0.05 (paired t-test). 




8.4.5.2 Long term effects of footwear on barefoot kinematic parameters 
There was no change in barefoot hip range of movement at six months compared to 
baseline for either shoe group (rocker sole shoe, left: t(10) = -1.70, p = 0.12; right: t(10) = -
0.93, p = 0.37, flat sole shoe, left: t(4) = -1.19, p = 0.30; right: t(4) = -1.55, p = 0.20) 
indicating that long term use of either shoe type did not influence range of hip movement 
during barefoot gait (Table 8.5). Change in barefoot hip range of movement at six months 
compared to baseline was not significantly different between groups (left hip F(1,14) <0.01, 
p = 0.97, ƞ2 <0.01, right hip F(1,14 ) = 1.27, p = 0.28, ƞ2 = 0.08). 
Table 8.5 Long term effect of footwear use on barefoot sagittal hip range of 
movement during gait 
 Shoe group Baseline 6 months P-value  
Left hip range 
of movement 
[degrees] 
Rocker  43.7 (5.1) 45.4 (6.6) 
0.97 
Flat 43.9 (2.5) 45.7 (3.3) 
Right hip range 
of movement 
[degrees] 
Rocker  42.8 (4.6) 43.7 (5.8) 
0.28 
Flat  42.8 (2.1) 46.0 (4.2) 
Summary measures represent mean (SD); analysis within-group: paired t-test; between 
group: mixed ANOVA. 
8.4.6 Kinetic parameters 
8.4.6.1 Immediate effect of footwear on transient force peaks 
For both groups there was a reduction in the percentage of foot falls with transient force 
peaks when shod compared to barefoot (rocker sole shoe group: z = -3.19, p <0.01; flat sole 
shoe group z = -2.02, p = 0.04) (Table 8.6). There were no differences between groups in the 
percentage of foot falls with transient force peaks when barefoot (U = 33.0, z = -1.01, p = 
0.32) or shod (U = 33.5, z = -1.25, p=0.21). Figure 8.1 and Figure 8.2 demonstrate the 
transient force peaks associated with heel strike during barefoot gait and the absence of 
such peaks during shod gait for the flat sole and rocker sole shoe group respectively. 
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Table 8.6 Immediate effect of footwear on transient force peaks at heel strike 




Rocker  73.2 (29.4) 5.8 (15.0)* 
Flat 56.9 (35.3) 14.3 (19.7)*  
Summary measures represent mean percent of heel strikes with associated transient force 
peaks (SD). Within shoe group analysis: Wilcoxon signed rank, * represents p <0.05.  
 
Figure 8.1 Flat sole shoe group: transient forces peaks associated with heel strike 
during barefoot and shod gait 
 
Left hand graph: barefoot; right hand graph: flat sole shoes. Y-axis: vertical ground reaction 
force. X-axis: time. Transient force peak (highlighted by circle) visible during barefoot gait 




Figure 8.2 Rocker sole shoe group: transient forces peaks associated with heel strike 
during barefoot and shod gait 
 
Left hand graph: barefoot; right hand graph: flat sole shoes. Y-axis:  vertical ground reaction 
force. X-axis: time. Transient force peak (highlighted by circle) visible during barefoot gait 
(data from participant number ‘Gait010’). 
 
8.4.6.2 Long term effects of footwear on joint moments during barefoot gait  
No differences were observed within groups for barefoot hip moment data from baseline to 
six months. Furthermore, no differences were observed between groups for change in 
barefoot hip moment data from baseline to six months (Left hip extensor F(1,14) = 1.34, p = 
0.27, ƞ2 = 0.09; right hip extensor: F(1,14) = 0.01, p = 0.91, ƞ2 < 0.01; left hip flexor: F(1,14) = 
0.12, p = 0.74, ƞ2 = 0.01; right hip flexor: F(1,14) = 0.02, p = 0.89, ƞ2 <0.01). This indicates 
that long term use of either footwear did not influence hip flexor or extensor moments 




Table 8.7 Joint moments at baseline and six months during barefoot gait 
Peak joint 
moment  
Shoe group Baseline       
[Nmm/kg] 
6 months      
[Nmm/kg] 
%       
difference 
























































§ represents within group non-parametric Wilcoxon test for within group analysis, 





Abnormal spatio-temporal, kinetic and kinematic parameters of gait have previously been 
suggested as factors associated with the presence and recurrence of CLBP. Findings from 
the current study suggest that although immediate differences between groups were 
demonstrated in some parameters when comparing barefoot to shod gait, rocker and flat 
sole shoes had no long term influence on specific kinetic, kinematic, and spatio-temporal 
parameters of barefoot gait. The lack of long term change in these parameters suggests 
that if proposed underpinning mechanisms such as gait speed (Callaghan et al., 1999), 
stride length (Al-Obaidi et al., 2003; Keefe and Hill, 1985) or transient force peaks (Light et 
al., 1980; Voloshin and Wosk, 1982) do contribute to the presence of CLBP it is unlikely that 
rocker sole shoes would provide any greater or lesser long term influence on these 
mechanisms or CLBP, than a flat sole shoe.  
Walking in either shoe compared to walking barefoot increased gait speed and stride 
length. These increases were similar between groups. Although increased walking speeds 
have demonstrated reduced durations of spinal loading during gait (Callaghan et al., 1999) 
and are hence proposed to be beneficial to people with CLBP, the associated increased 
stride length observed in the current study has been previously suggested to increase 
antero-posterior ground reaction forces (Kirtley, 2006), and therefore the loading of the 
musculoskeletal structures. Hence, it is unclear whether the increases in velocity and stride 
length in the current study are likely to be beneficial or disadvantageous to a CLBP 
population. When barefoot gait at six months was compared to baseline no differences 
were detected within or between groups for change in spatio-temporal parameters. This 
indicates that long term use of either footwear type did not influence walking speed, stride 
length or cadence. Hence, if spatio-temporal parameters of gait are underpinning 
mechanisms of CLBP it is unlikely that a rocker sole shoe would provide any greater or 
lesser long term influence on these mechanisms than a flat sole shoe. 
Flat sole shoes induced greater increases in range of movement at the hip than rocker sole 
shoes. These findings agree with previous research demonstrating reduced hip range of 
movement whilst walking in rocker sole compared to flat sole shoes (Romkes et al., 2006; 
Taniguchi et al., 2012). However, there is also research detecting no difference in hip joint 
range between the rocker and flat sole shoes (Demura and Demura, Epub ahead of print; 
Nigg et al., 2006b). 
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The reduced hip range observed in people with CLBP has been hypothesised as a 
mechanism to alleviate pain in the low back region (Lee et al., 2007). If true, due to the 
reduced hip range observed during gait in the rocker sole shoe, compared to a flat sole 
shoe, a rocker sole shoe may assist in pain relief. However, findings from the main study 
(Chapter 5, p61) demonstrate similar changes in pain in both groups at all assessment 
points, hence, it is unlikely that this hypothesis is correct for the angular joint change 
demonstrated in the current study. This will be discussed further in Chapter 10. When 
barefoot gait at six months was compared to baseline no differences were detected within 
or between groups for hip range of movement. This indicates that long term use of either 
shoe type did not influence barefoot hip range of movement during gait. If hip range of 
movement does contribute to the symptoms of CLBP, it is unlikely that a rocker sole shoe 
would provide any greater or lesser long term influence on CLBP symptoms than a flat sole 
shoe. 
There were no changes in peak knee flexion angle during the first half of stance for 
barefoot and shod gait for either shoe group, nor were any differences between the shoe 
groups demonstrated. These findings concur with previous research investigating the effect 
of rocker sole and flat sole shoes on peak knee flexion during the first half of stance (Nigg et 
al., 2006b; Romkes et al., 2006). In contrast, Taniguchi et al. (Taniguchi et al., 2012) 
demonstrated a greater peak knee flexion during early stance when walking in rocker sole 
shoes compared to flat sole shoes. The population in their study was younger than in the 
current study, otherwise methodologies differences do not appear to account for the 
difference in findings. It may be that differences in design of the flat sole shoe between 
studies may account for the difference in findings, as peak knee flexion in rocker sole shoes 
was similar between studies. If peak knee flexion angle does influence CLBP, due to the lack 
of change in peak knee flexion angle during barefoot and shod gait within and between 
groups in the current study, it is unlikely that a rocker sole shoe would provide any greater 
or lesser long term influence on CLBP than a flat sole shoe. 
The current study demonstrated no difference in the incidence of transient force peaks 
between flat and rocker sole shoes during shod gait (14.3% and 5.8% respectively). Vernon 
et al. (2004), in an unpublished study, reported that transient force peaks occurred more 
frequently when walking in normal shoes than in rocker sole shoes (59% and 27% of trials 
respectively). These contrasting study findings may be due to the differences in shock 
attenuation properties of the ‘normal shoes’ worn by participants in the different studies 
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(in Vernon et al.’s (2004) study participants wore their own exercise shoes) or due to the 
gait speed as transient force peaks are more likely to occur at faster walking speeds, 
however, information on this parameter is omitted in Vernon et al’s study. If transient force 
peaks are detrimental to CLBP, due to the similar effect of both shoe types in reducing the 
occurrence of these peaks, it is unlikely that a rocker sole shoe would provide any greater 
or lesser influence on CLBP symptoms than the flat sole shoe investigated in the current 
study. 
No differences were detected within or between groups for peak hip flexor or extensor 
moments at six months compared to baseline. This suggests that neither shoe had a long 
term influence on joint loading around the hip. If increased hip extensor moments 
contribute to the symptoms of CLBP, it is unlikely that a rocker sole shoe would provide any 
greater or lesser long term influence on this factor than a flat sole shoe. 
8.5.1 Clinical implications 
Long term use of rocker sole shoes or flat sole shoes in addition to attendance to a four 
week exercise group does not appear to influence barefoot walking speed, stride length, 
sagittal hip moments or sagittal hip range of movements in people with CLBP. Furthermore 
both shoe types have a similar influence on reducing transient force peaks at heel strike 
compared to barefoot walking. From these findings, clinicians should feel confident to 
advise patients with CLBP that long term use of either rocker sole or flat sole shoes will not 





8.5.2 Further research 
It is possible that the parameters chosen to investigate changes in gait pattern due to the 
intervention are insensitive to genuine changes in movement. More direct measures of 
muscle function, for example EMG, may provide greater insight into underlying 
biomechanical mechanisms that may be promoting the observed improvement in pain and 
disability. 
One of the limitations is that both shoes had a force transient reducing effect. It is possible 
as indicated by Vernon et al. (2004) that normal ‘everyday’ shoes with harder heels may 
promote transients and delay improvement of pain and disability. This could be tested in a 
future study. 
8.6 Conclusions 
This is the first RCT with long term (six month) follow-up comparing the influence of rocker 
sole and flat sole shoes on spatio-temporal, kinetic and kinematic parameters of gait in a 
chronic pain population. 
 
Between groups differences at baseline were detected only for change in hip range of 
movement during barefoot and shod gait. The findings from the main study, demonstrating 
no difference in clinical outcome between groups, suggest that this biomechanical 
difference is unlikely to influence outcome in those with CLBP. 
 
There were no long term effects on spatio-temporal, kinetic or kinematic parameters of gait 
for either group when walking barefoot at six months when compared to baseline. This 
suggests that no long term training effect, capable of influencing the spatio-temporal, 
kinetic and kinematic parameters of gait, occurred from wearing either a rocker sole or a 




9 A comparison of gait and postural control in 
standing in people with and people without chronic 
low back pain.  
9.1 Chapter summary 
This study investigated differences in gait and postural control in people with and without 
chronic low back pain (CLBP). Barefoot standing postural stability and gait data from the 
CLBP participants in Chapters 7 (p148) and 8 (p170), respectively, were compared with that 
from age- and gender-matched asymptomatic participants. People with CLBP presented 
with similar postural stability for stable and more challenging standing conditions to 
asymptomatic individuals. CLBP participants increase hip and ankle strategies in similar 
proportions to the asymptomatic individuals during more challenging standing 
circumstances.  During gait, both groups presented with similar spatio-temporal 
parameters. In contrast to previous research, these findings suggest that for those with 
CLBP of mild to moderate intensity, postural control during standing, and the kinetics, 
kinematics, and spatio-temporal parameters of gait do not differ significantly from people 
without LBP.  
9.2 Introduction 
Differences in postural control (Brumagne et al., 2008; Della Volpe et al., 2006; Mientjes 
and Frank, 1999; Mok et al., 2004) and gait (Al-Obaidi et al., 2003; Keefe and Hill, 1985; 
Lamoth et al., 2002; Lee et al., 2007; Vogt et al., 2003; Vogt et al., 2001) have been 
identified between people with and without CLBP. During more challenging standing 
conditions people with CLBP have demonstrated increased centre of pressure 
displacements and velocities (Brumagne et al., 2008; Della Volpe et al., 2006; Mientjes and 
Frank, 1999; Mok et al., 2004), indicative of poorer postural stability (Ruhe et al., 2010; 
Ruhe et al., 2011a). During gait, people with CLBP have demonstrated reduced self-selected 
walking speed (Al-Obaidi et al., 2003; Keefe and Hill, 1985; Lamoth et al., 2002; Lee et al., 
2007), stride time (Vogt et al., 2003; Vogt et al., 2001), stride length (Al-Obaidi et al., 2003; 
Keefe and Hill, 1985), and range of hip movement (Vogt et al., 2003). As a result of these 
changes, hip moments are likely to be reduced in people with CLBP compared to 
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asymptomatic individuals due to the differences in spatio-temporal parameters of gait 
(reduced stride length, walking speed and hip range of movement) reported in detail in 8.2 
(p170) (Apkarian et al., 1989). These differences in postural control and gait have been 
proposed as contributing factors to the presence and recurrent nature of CLBP (Brumagne 
et al., 2008; Mok et al., 2004; Voloshin and Wosk, 1982).  
No previous study replicates the exact methodologies conducted in Chapters 7 (p148) and 8 
(p170), making direct comparison between these studies and previous studies difficult. 
Therefore, to determine whether barefoot postural control and gait data from the CLBP 
participants recruited in Chapters 7 (p148) and 8 (p170) differs from age- and gender-
matched asymptomatic participants, a further study was conducted. The recruitment of an 
age- and gender-matched asymptomatic sample, undertaking the barefoot baseline 
standing and gait protocol described in Chapters 7 (p148) and 8 (p170)  enabled direct 
comparison to be made between asymptomatic and CLBP participants, hence increasing 
the certainty of study conclusions. This study investigated the following hypotheses: 
Null hypothesis (H0): 
Standing hypotheses 
H0 1: The CLBP group and asymptomatic group will demonstrate similar postural stability 
in the antero-posterior direction during stable and challenging barefoot standing 
conditions.  
H0 2: Under more challenging standing conditions the asymptomatic and CLBP group will 





H0 3: Similar self-selected walking speed, stride time and step length will be observed in 
people with CLBP and asymptomatic individuals. 
H0 4: During gait, people with CLBP will present with a similar hip range of movement to 
asymptomatic individuals. 
H0 5:  During gait, people with CLBP will present with similar peak hip moments during 
the stance phase of gait to asymptomatic individuals. 
Alternative hypothesis (H0): 
Standing hypotheses 
H1 1: Both groups will demonstrate similar postural stability in the antero-posterior 
direction during stable standing conditions. However, the CLBP group will 
demonstrate poorer postural stability in the antero-posterior direction when 
compared to the asymptomatic group during more challenging barefoot standing 
conditions.   
H1 2: Under more challenging standing conditions the asymptomatic group will control 
their balance using a strategy which includes a greater element of control at the hip 
than the CLBP group.  
Gait hypotheses 
H1 3: Reduced self-selected walking speed, stride time and step length will be observed 
in people with CLBP compared to asymptomatic individuals. 
H1 4: During gait, people with CLBP will present with a reduced hip range of movement 
compared to asymptomatic individuals. 
H1 5: During gait, people with CLBP will present with reduced peak hip moments during 






This trial compared barefoot standing balance and gait data from CLBP participants with 
that from predominantly age- and gender-matched asymptomatic participants. 
9.3.2 Ethical approval 
Ethical approval for the recruitment of asymptomatic participants was gained through the 
King’s College London ‘Biomedical & Health Sciences, Dentistry, Medicine and Natural & 
Mathematical Sciences Research Ethics Subcommittee’ (research reference: BDM/10/11-
71) (11.33, p317). 
9.3.3 Participant recruitment 
Participants in the CLBP group were recruited as described in 6.7 (p118). Potential 
asymptomatic participants - work colleagues and friends of the C.I. (Siân MacRae) or co-
researcher (Dr Adam Shortland) - were contacted via email, which included the Participant 
Information Sheet (11.34, p318). Asymptomatic participants were classed as 
‘asymptomatic’ if they reported no history of LBP in the last year. Asymptomatic 
participants were required to meet all criteria presented in Table 6.1 (p119), with the 
exception of a three month or greater history of LBP, and match in age and gender with a 
CLBP participant (10/H0724/7). An age range of two years above or below the age of the 





Asymptomatic participants attended one assessment in the gait laboratory at Guy’s 
Hospital. Participants were asked to complete the study consent form (11.35, p321), Roland 
Morris Disability Questionnaire and to report a numerical rating score for low back pain (to 
confirm that asymptomatic participants had no current low back problems) (7.3.4, p150). 
Participants changed into shorts and vest top, and removed their shoes and socks. 
Anthropometric measurements and the placement of retro-reflective markers were 
conducted (7.3.4, p150) and a short data capture (6.10.3.2. p136) recorded with 
participants barefoot. 
 
Asymptomatic participants were assessed standing (7.3.4.1, p151) and walking barefoot 
(8.3.4.1, p176). The biomechanical assessment lasted approximately 30 minutes. Following 
completion of the walking trials the co-researcher removed all markers from the 
participant. Participants were informed that the double sided sticky tape used to attach the 
markers to the skin may leave a red mark on the skin for approximately one hour following 
marker removal. They were advised that this is normal and should not be of concern. 
Participants then changed back into their normal clothing and their involvement in the 
study ended. 
9.3.5 Outcome measures 
Outcome measures assessed during standing and gait are described in 7.3.5 (p152) and 
8.3.5 (p177), respectively. 
9.3.6 Sample size 
The study compared data obtained from CLBP participants (Chapters 6 and 7) with a 
matched sample of asymptomatic participants. Hence, recruitment of an equal sample size 




9.3.7 Data analysis 
Distributions were checked to see if normal distributions had been met, if this was not the 
case, non-parametric test were performed. Independent t-tests for parametric data, or 
Mann-Whitney U-tests for non-parametric data, were applied to determine differences 
between groups. A mixed repeated measures ANOVA with 2 within-subject factors each 
with 2 levels - vision [eyes open and eyes closed] and support surface [firm ground or foam 
cushion] determined possible significant main effects and interactions of the two groups for 
centre of pressure variables. A multivariate analysis of variance (MANOVA) assessed for 
significant effects of the dependent variables CoP RMSE AP and CoP VEL AP. 
The alpha level for determining statistical significance was set at 0.05. The reasoning 
underpinning choice of statistical tests has been described in 6.11.3.2 (p146).  
Data were analysed using IBM SPSS 20.0.0 (IBM, New York). Results are presented as means 
(standard deviations (SD)) unless otherwise stated. 
9.4 Results 
9.4.1 Recruitment 
During the recruitment period (June 2011-November 2011) sixteen asymptomatic 
participants were recruited. The recruitment of matched asymptomatic participants, over 
the age of 50 years, who had not experienced any LBP over the past twelve months proved 
difficult. This prevented recruitment of the planned sample size of 20 participants.  
Although no significant differences were detected between ages of the two groups, the 




9.4.2 Baseline characteristics of participants 
Demographic characteristics of CLBP and asymptomatic individuals are presented in Table 
9.1. No differences were observed between groups. 






Low back pain 
participants   
(n=20) 
P-value 
Gender : Male 
               : Female 
8 (50.0%)* 




Age (years) 37.3 (11.1) 41.0 (12.5) 0.36 
Weight (kg) 76.3 (13.6) 74.5 (16.3) 0.74 
Height (cm) 173.4 (9.3) 173.6 (8.6) 0.95 
Summary measures represent means (SD) or *numbers (percentages). †Chi squared test, 
otherwise independent t-test. 
9.4.3 Participant retention and attrition 
There was 100% retention. All sixteen asymptomatic and twenty symptomatic participants 
completed the data collection process. 
9.4.4 Centre of pressure parameters during barefoot standing in 
people with and without chronic low back pain 
No differences were observed between groups for change in root mean squared error and 
velocity of the centre of pressure in the antero-posterior direction (CoP RMSE AP or CoP VEL AP 
respectively) across the four standing condition (mixed repeated measures ANOVA with 2 
within-subject factors each with 2 levels - vision [eyes open and eyes closed] and support 
surface [firm ground or foam cushion]: vision and group interaction: F(1,33) = 0.93, p = 
0.34, Ƞ2 = 0.03 and F(1,33)<0.01, p = 1.00, Ƞ2<0.01 respectively; support surface and group 
interaction: F(1,33) = 1.01, p = 0.32, Ƞ2 = 0.03 and F(1,33) = 0.12, p = 0.73, Ƞ2<0.01 
respectively; vision, support surface and group interaction: F(1,33) = 2.70, p = 0.11, Ƞ2 = 
0.08 and F(1,33) = 0.02, p = 0.90, Ƞ2 <0.01 respectively) (Table 9.2). However, although not 
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significantly different, there was a tendency for people with CLBP to be less stable than 
asymptomatic individuals across all standing conditions (Figure 9.1 and 9.2). 
A MANOVA analysing the dependent variables CoP RMSE AP and CoP VEL AP demonstrated no 
difference between groups for each standing condition (eyes open no cushion: F(2,33) = 
1.16, p = 0.33, Ƞ2 = 0.07; eyes closed, no cushion: F(2,33 )= 0.91, p = 0.41, Ƞ2 = 0.05; eyes 
open, cushion: F(2,33) = 0.42, p = 0.64, Ƞ2 = 0.03; eyes closed, cushion: F(2,32) = 2.85, p = 
0.07, Ƞ2 = 0.15). 
Table 9.2 Antero-posterior centre of pressure parameters for chronic low back pain 
and asymptomatic participants during different standing conditions 
  
CoP RMSE AP                     
[mm] 


























































Summary measures represent means (95% Confidence Intervals). (RMSE: root-mean 




Figure 9.1 Root mean squared error of centre of pressure displacement in the 
antero-posterior direction for chronic low back pain and asymptomatic participants 





Figure 9.2 Antero-posterior centre of pressure velocity for chronic low back pain 
and asymptomatic participants during different standing conditions 
 
9.4.5 Postural strategy during standing in people with and without 
chronic low back pain 
No differences were observed between groups for left or right hip:ankle postural control 
index across the four standing condition when assessing interactions between: group and 
vision; group and ground surface; and vision, support surface and group (mixed design 
factorial repeated measures ANOVA with 2 within-subject factors each with 2 levels: vision 
[eyes open and eyes closed], and support surface [firm ground or foam cushion] : vision and 
group interaction: F(1,33) = 1.19, p = 0.28, Ƞ2 = 0.04 and F(1,33) = 0.86, p = 0.36, Ƞ2 = 0.03 
respectively; support surface and group interaction: F(1,33) = 1.49, p=0.23, Ƞ2 = 0.04 and 
F(1,33) = 3.22, p = 0.08, Ƞ2 = 0.09 respectively; vision, support surface and group: F(1,33) = 
0.38, p = 0.54, Ƞ2 = 0.01, and F(1,33) = 4.26, p = 0.05, Ƞ2 = 0.11) (Table 9.3).  
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Table 9.3 Hip:ankle postural control index for chronic low back pain and 
asymptomatic participants during different standing conditions  
  
Left hip:ankle postural 
control index  




Asymptomatic 0.34 (0.11) 0.35 (0.14) 
Symptomatic 0.31 (0.10) 0.36 (0.12) 
Eyes closed 
no cushion 
Asymptomatic 0.36 (0.14) 0.31 (0.07) 
Symptomatic 0.32 (0.08) 0.38 (0.13) 
Eyes open 
cushion 
Asymptomatic 0.25 (0.07) 0.27 (0.08) 
Symptomatic 0.27 (0.09) 0.26 (0.08) 
Eyes closed  
cushion 
Asymptomatic 0.29 (0.07) 0.32 (0.08) 
Symptomatic 0.27 (0.09) 0.29 (0.09) 
Summary measures represent means (SD). 
No differences were observed between groups for left or right hip or left or right ankle 
strategy across the four standing conditions when assessing interactions between: group 
and vision; group and ground surface; and vision, support surface and group (mixed design 
factorial repeated measures ANOVA with 2 within-subject factors each with 2 levels: vision 
[eyes open and eyes closed], and support surface [firm ground or foam cushion]: vision and 
group interaction:  
 Left hip  
o group and vision: F(1,33) = 0.02, p = 0.88,  Ƞ2 <0.01 
o group and ground surface: F(1,33) = 0.11, p = 0.74, Ƞ2  <0.01 
o vision, support surface and group: F(1,33) = 0.25, p = 0.63, Ƞ2 < 0.01 
 Right hip 
o group and vision: F(1,33) = 1.14, p = 0.29, Ƞ2 = 0.03 
o group and ground surface: F(1,33) = 0.23, p = 0.63, Ƞ2 <0.01 




 Left ankle  
o group and vision: F(1,33) = 0.88, p = 0.36,  Ƞ2 = 0.03 
o group and ground surface: F(1,33) = 0.02, p = 0.89, Ƞ2  <0.01 
o vision, support surface and group: F(1,33) = 3.96, p = 0.06, Ƞ2 = 0.11 
 Right ankle 
o group and vision: F(1,33) = 0.41, p = 0.53, Ƞ2 = 0.01 
o group and ground surface: F(1,33) = 1.78, p = 0.19, Ƞ2 = 0.05 
o vision, support surface and group: F(1,33) =1.92, p = 0.18, Ƞ2 <0.06 
 
Figure 9.3 demonstrates that the CLBP participants increase hip and ankle strategies in 
similar proportions to the asymptomatic individuals during more challenging standing 
conditions.  
Figure 9.3 Hip and ankle strategy during quiet standing and more challenged 





9.4.5.1 Spatio-temporal parameters of barefoot gait in chronic low back pain 
and asymptomatic individuals 
No differences were observed between groups for any of the spatio-temporal gait 
parameters assessed (Table 9.4).  
Table 9.4 Spatio-temporal parameters of gait in chronic low back pain and 
asymptomatic individuals 
 Asymptomatic Chronic low back 
pain 
P - value 
Walking speed [m/s] 1.32 (0.13) 1.25 (0.20) 0.26 
Cadence [steps per minute] 115.14 (6.59) 112.43 (11.81) 0.42 
Stride length [m] 1.38 (0.12) 1.33 (0.13) 0.33 
Summary measures represent means (SD). Analysis by independent t-test. 
9.4.5.2 Hip joint range of movement during barefoot gait 
No differences were detected between groups for maximum, minimum and total ranges of 
movement at the hip in the sagittal plane during gait (Table 9.5). 
Table 9.5 Sagittal plane hip range of movement during gait in people with chronic 
low back pain and asymptomatic individuals [degrees] 
 Asymptomatic Chronic low back 
pain 
P - value 
Left maximum hip flexion 34.35 (5.55) 33.70 (8.55)  0.78 
Right  maximum hip flexion 34.46 (4.51) 33.82 (9.17) 0.79 
Left maximum hip extension -9.71 (7.39) -10.44 (9.02) 0.80 
Right maximum hip extension -9.40 (6.67) -9.12 (8.74) 0.92 
Left hip range of movement 44.07 (3.94) 44.14 (4.79) 0.97 
Right hip range of movement 43.85 (3.71) 42.94 (4.44) 0.51 
Summary measures represent means (SD). Analysis by independent t-test. 
  
 202 
9.4.5.3 Joint moments during gait 
No differences were observed between groups for hip joint moments during gait (Table 
9.6). 
Table 9.6 Hip and ankle joint moments during gait in people with chronic low back 
pain and asymptomatic individuals 
Joint moment      
[Nmm/kg] 
Asymptomatic Chronic low back 
pain 
P - value 
Left hip extensor 1029.30 (329.38) 955.80 (429.78) 0.58 
Right hip extensor§ 960.99 (235.24) 1029.57 (460.62) 0.94 
Left hip flexor -990.76 (184.25)  -1098.07 (231.85) 0.14 
Right hip flexor -1041.87 (174.80) -977.77 (194.64) 0.31 
Summary measures represent means (SD).§ represents Mann-Whitney test for non-
parametric data, otherwise Independent t-test conducted. 
9.5 Discussion 
In contrast to much other research, the current findings suggest that postural control 
during standing, and the kinetics, kinematics, and spatio-temporal parameters of gait do 
not differ between people with CLBP of a mild to moderate intensity and asymptomatic 
individuals. There were no differences between people with and without CLBP in hip and 
ankle strategy preferences or postural stability during all standing conditions. During 
barefoot gait, both groups presented with similar hip joint moments, hip joint ranges of 
movement, and spatio-temporal parameters of gait.  
9.5.1 Comparison of demographic data for the chronic low back pain 
and asymptomatic population. 
Demographic data of participants in both groups were well matched at baseline. Although 
not significant, the CLBP group was on average 3.7 years older than the asymptomatic 
group. The difficulties in recruiting matched asymptomatic participants over the age of 50 
years, who had not experienced any LBP over the past twelve months lead to this 
difference, hence although this study aimed to provide a matched asymptomatic 
population, matching was only possible for sixteen of the CLBP participants. Being over 50 
  
 203 
years of age is a contributing factor to poorer postural stability (Choy et al., 2003). 
Therefore, the absence of these older participants in the asymptomatic group increases the 
likelihood of detecting differences in CoP parameters between the groups.  
9.5.2 Centre of pressure parameters 
There was no difference in postural stability between CLBP and asymptomatic individuals 
during stable and more challenging standing conditions. These findings differ from previous 
research (Brumagne et al., 2008; Della Volpe et al., 2006; Mientjes and Frank, 1999; Mok et 
al., 2004) possibly due to methodological variation. Della Volpe et al. (2006) assessed a 
small sample (n=12 per group) with an ‘instrumented platform system’, constructed of a 
moveable support surface and movable visual surround likely to present participants with a 
greater postural challenge than that in the current study. Such an increased challenge may 
contribute to the reduced postural stability in the CLBP group in the Della Volpe et al. study 
(2006). Brumagne et al. (2008) assessed a similar sample size to the current study (n=45), 
however, trials were only repeated once – the current study averaged three trials per 
standing condition, likely to increase the reliability of data (Ruhe et al., 2011a). Although 
Brumagne et al. (2008) reported reduced postural stability in the CLBP group during the 
more challenging standing conditions (eyes closed on foam) the between group difference 
in CoPRMSE AP was 1.8mm, and the p value, 0.046 – bordering on non-significance. In the 
current study the non-significant difference in CoPRMSE AP between the symptomatic and 
asymptomatic groups during the most challenging postural condition was 1.76mm. 
Although Brumagne et al. (2008) demonstrated statistical significance it is unlikely that such 
a minimal difference in CoPRMSE AP is responsible for the clinical differences in pain and 
disability observed between the two groups. Mientjes and Frank (1999) assessed a small 
sample (n=8 per group) and although reporting significant differences between CLBP and 
asymptomatic groups during challenged standing conditions, these differences were small 
(less than 2mm) and similar to those of both the current study and Brumagne et al. (2008). 
Furthermore, Mientjes and Frank (1999) report a mean pain score of 0.5 in the 
‘asymptomatic’ group at baseline raising concerns that the asymptomatic data may not be 
a true representation of a pain free population.  
The CoP parameters assessed in a research study may influence the reliability of results. 
CoP velocity consistently demonstrates the best overall reproducibility of all CoP 
parameters in both the short and long term (nine months) (Ruhe et al., 2010; Takala et al., 
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1997b), hence, findings from this parameter are likely to provide more reliable conclusions 
to those gained from CoPRMSE AP data or other CoP parameters. The current study 
demonstrated similar CoPVEL AP in people with and without CLBP, whereas previous research 
has demonstrated reduced (Mok et al., 2004; Salavati et al., 2009b) (n=24 and 22 per group 
respectively) and increased (Della Volpe et al., 2006; Lafond et al., 2009; Mann et al., 2010) 
(n=12, 12, and 10 per group respectively) CoP velocities. These mixed results suggest it 
likely that research demonstrating no difference between groups has been conducted, 
however, due to publication bias may not have gained acceptance for publication. 
Interestingly, the studies conducted with the greater sample size, demonstrate poorer 
postural control in the asymptomatic groups not the CLBP groups. Furthermore, research 
demonstrating between group differences in CoPVEL AP report differences of less than 4mm/s 
during more challenging standing conditions (Della Volpe et al., 2006; Lafond et al., 2009; 
Mann et al., 2010; Mok et al., 2004; Salavati et al., 2009b). It is unlikely that such minimal 
differences are responsible for the clinical differences in pain and disability between people 
with CLBP and asymptomatic individuals. Furthermore, findings from previous research 
(Salavati et al., 2009a; Salehi et al., 2010) highlight that the small differences observed 
between groups in this study may be due to random error associated with the reliability of 
the measurement technique and not clinical change.   
Difference in participant demographics (for example, age (Della Volpe et al., 2006; Salavati 
et al., 2009b), gender (Mann et al., 2010) or disability (Mok et al., 2004)), and 
methodological design (for example, trial duration and repetitions, (Lafond et al., 2009; 
Mok et al., 2004; Takala et al., 1997b)), make it difficult to directly compare study findings. 
Due to the numerous factors which may contribute to the variation in CoP outcomes 
reported, comparison of one study data with another is likely to reveal potential 
differences, however, choice of outcome measures and the number and duration of trials 
conducted in the current investigation improves the likelihood that data collected is 
reliable. 
9.5.3 Methods for calculating hip and ankle strategies 
Findings from the current study do not suggest that people with CLBP select different 
postural control strategies from asymptomatic individuals. In asymptomatic individuals it 
has been proposed that under more challenging standing conditions, the hip musculature 
would be activated to a greater extent to promote stability than during stable standing 
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(Horak and Nashner, 1986), whereas people with CLBP would continue to favour an ankle 
strategy, with little change in contribution from the hip strategy (Brumagne et al., 2008). 
The current study finding is in contrast to conclusions of other studies which, although 
employed similar methodologies (Brumagne et al., 2008; Mok et al., 2004), determined the 
magnitude of each postural strategy from very different approaches. 
Brumagne et al. (2008) applied a ratio approach to determine ‘relative proprioceptive 
weighting’ calculated from dividing the CoP displacement during mechanical vibration to 
the calf muscle by the summation of CoP displacement obtained during i.) mechanical 
vibration of the calf muscle and ii.) mechanical vibration of the lumbar multifidus muscle. In 
contrast, Mok et al. (2004) inferred a hip strategy from horizontal shear forces, and implied 
the magnitude of the ankle strategy from displacement of the CoP. However, neither of 
these calculation methods enabled hip or ankle moments to be measured directly. In the 
current study, the use of two force plates and the retro-reflective marker set enabled the 
direct measurement of joint moments. The root mean squared error (RMSE) (a measure of 
deviation from a signal mean), was calculated for the hip flexor/extensor moment and the 
ankle plantarflexor/dorsiflexor moment, and the ratio of these two variables determined 
the hip: ankle postural control index. There is little in the literature regarding the validity of 
methods assessing postural strategy. However, the ability to directly assess joint moments 
in the current study as opposed to inferring strategy activity from other measures (such as 
CoP parameters or horizontal shear forces) increases the likelihood that the method for 
calculating strategies in the current study is valid. Furthermore, this increases confidence 
that the current results are a more valid representation of postural strategy in CLBP than 
that reported in previous research (Brumagne et al., 2008; Mok et al., 2004). 
The current study demonstrated a similar hip strategy between people with CLBP and 
asymptomatic individuals during stable and more challenging standing conditions (Figure 
9.3, p200), challenging the suggestion that people with CLBP have a reduced ability to 
initiate a hip strategy during more challenging standing tasks (Brumagne et al., 2008; Mok 
et al., 2004). The proposed reduced hip strategy in people with CLBP has been suggested to 
result from co-contraction of superficial muscles at the hip (Mok et al., 2004). The current 
study suggests that, if a difference existed in muscle co-contraction around the hip between 





It was hypothesised that people with CLBP would present with a reduced walking speed, 
cadence and stride length compared to asymptomatic individuals. However, no differences 
were detected in these spatio-temporal parameters between groups. In support of the 
current study findings, Al-Obaidi et al. (2003) and Simmonds et al. (1997) demonstrated no 
difference in cadence and  self-selected walking speed respectively between people with 
and without CLBP (with a similar age and gender to those in the current study), whilst 
walking on normal ground. However, previous research investigating participants with 
similar self-reported pain and disability (mild to moderate) to the current study 
demonstrated reduced walking speed (Al-Obaidi et al., 2003; Keefe and Hill, 1985; Lamoth 
et al., 2002; Lee et al., 2007), stride time (Vogt et al., 2003; Vogt et al., 2001), and stride 
length (Al-Obaidi et al., 2003; Keefe and Hill, 1985) in people with LBP. The current study 
averaged data from three trials for each participant, aiming to improve reliability (Ruhe et 
al., 2010), whereas other studies analysed data from only one walking trial (Al-Obaidi et al., 
2003; Lee et al., 2007; Vogt et al., 2003), possibly reducing data reliability. In addition, 
where other studies investigated predominantly (Keefe and Hill, 1985) or all male (Lee et 
al., 2007; Vogt et al., 2003) participants, the current study assessed male and female 
subjects, enabling findings to be more representative of a general population. Furthermore, 
the current study assessed participants walking on normal ground, as opposed to on a 
treadmill (Lamoth et al., 2002; Vogt et al., 2003; Vogt et al., 2001), hence the current study 
findings are likely to be more representative of a natural walking pattern. These factors 
increase confidence that the current results are a more reliable and more valid 
representation of gait in CLBP than that reported in previous research (Al-Obaidi et al., 
2003; Keefe and Hill, 1985; Lamoth et al., 2002; Lee et al., 2007; Vogt et al., 2003; Vogt et 
al., 2001)  
In contrast to the current study, previous research has reported reduced hip range of 
movement in people with LBP during gait compared to asymptomatic individuals (Vogt et 
al., 2003). This may be due to co-contraction of muscles crossing the hip and pelvic region 
(Hodges and Moseley, 2003) limiting hip movement, or from participants reducing step 
length, and hence hip range, in an attempt to reduce potentially detrimental GRFs at heel 
strike (Light et al., 1980; Voloshin and Wosk, 1982). The reduced hip range demonstrated 
by Vogt et al. (2003), occurred during treadmill gait, whereas the current study assessed 
people walking on normal ground hence likely to be more representative of a natural gait 
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pattern. Furthermore, Vogt et al (2003) assessed hip range by attaching an electrical 
goniometer to the greater trochanter. This method of assessment provides less reliable 
data than the retro-reflective marker system utilised in the current study (Pomeroy et al., 
2006; Rowe et al., 2001). These methodological differences increase confidence that the 
current results are a more valid representation of gait in CLBP than that reported in 
previous research (Vogt et al., 2003). In the current study, due to the lack of difference in 
stride length between CLBP and asymptomatic individuals, the similar range of hip 
movement between the two groups was an expected finding. 
9.5.5 Strengths and Limitations 
Although the sample size of the current study is small, possibly contributing to the 
occurrence of type II errors, a larger number of participants were assessed compared to 
most previous studies investigating postural control and gait in CLBP and asymptomatic 
individuals (Brumagne et al., 2004; Della Volpe et al., 2006; Lafond et al., 2009; Mann et al., 
2010; Mientjes and Frank, 1999). This increases the likelihood that the current study 
findings are more representative of the larger CLBP population.  
Difficulties recruiting asymptomatic participants over the age of 50 who had no history of 
LBP in the past year may have increased the likelihood that differences in CoP parameters, 
between the groups, would be detected. This is due to the negative association between 
age and postural stability. Improved matching in the asymptomatic group, to include the 
four asymptomatic individuals over the age of 50, omitted from this study, is likely to 
increase not decrease CoP parameters in the asymptomatic group. This increases 
confidence in the current study’s findings that people with CLBP do not present with poorer 
postural stability than asymptomatic individuals. 
The current study recruited CLBP participants from clinical populations, who had sought 
medical opinion regarding their symptoms and hence represented a typical population 
treated within physiotherapy departments. Previous research has recruited participants 
from alternative sources such as university populations (Mok et al., 2004) which may not be 
representative of the sub-group of CLBP individuals who seek medical help and advice; 
hence caution should be taken if relating findings from such studies to a person with CLBP 
who is attending for treatment.  
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9.5.6 Further research 
The velocity of the CoP is reported as the most reliable CoP parameter, however it is 
unclear if this measure is the most appropriate to detect difference in postural stability. 
Hence, a difference in postural control between the symptomatic and asymptomatic groups 
may have been present, but not detected. Alternative balance measures could be 
investigated, such as time to fail in a single leg stand, or the forward reach test to 
determine whether more functional or challenging outcomes possess the necessary 
discriminatory value to detect differences in balance in people with and without CLBP (and 
assist in confirming whether such differences exist). 
The current research suggests that ‘dysfunctions’ in standing postural control and 
kinematic, kinetic and spatio-temporal parameters of gait are unlikely to present in a CLBP 
population with mild to moderate disability and pain. Future research investigating 
treatments aimed at ‘correcting’ postural stability, hip and ankle strategies, or gait 
dysfunctions in people with CLBP is likely to be inappropriate. 
9.5.7 Clinical implications 
The current study assessed a larger sample than the majority of previous research 
investigating similar outcome measures in people with and without LBP. Therefore, it is 
likely that this study will provide clinicians with more robust and reliable conclusions. Based 
on the findings of this study, clinicians should feel confident that standing postural stability, 
kinetic, kinematic and spatio-temporal parameters of gait in people with and without mild 
to moderate CLBP do not differ, and that treatments directed at influencing postural 
stability (for example, standing on a wobble board) or specific parameters of gait may be an 





This study suggests that people with CLBP and asymptomatic individuals present with 
similar standing postural control, and kinetic, kinematic and spatio-temporal parameters of 
gait.   
 There were no between group differences in change in postural stability over the 
four standing conditions. 
 There were no between group differences in change in hip strategy over the four 
standing conditions. 
 There were no between group differences in change in ankle strategy over the four 
standing conditions 
 There were no between group differences in change in hip: ankle postural control 
index over the four standing conditions. 
 Both groups presented with similar hip range of movement during gait. 
 During gait, people with CLBP demonstrated similar walking speeds, stride lengths 





10.1 Aim of chapter  
The importance of this thesis is briefly restated, followed by a summary of findings from the 
studies conducted within this thesis. Conclusions from the biomechanical studies are 
related to those in the main study. Explanations for differences in findings between current 
and previous research are proposed. The clinical relevance of the research is discussed and 
topics for further research are presented. 
10.2 The importance of this thesis 
Mechanisms underpinning chronic low back pain (CLBP) remain unclear. Recommended 
treatment approaches, such as exercise therapy, generally demonstrate only mild 
improvement in symptoms (Keller et al., 2007). Although many mechanisms have been 
proposed to underpin CLBP, a lack of knowledge regarding which mechanism is the most 
relevant to target through treatment may account for the minimal long term improvement 
in people with CLBP. 
Many of the proposed mechanisms underpinning CLBP relate to trunk and lower limb 
biomechanics, hence treating the spine in isolation appears inappropriate (McGregor and 
Hukins, 2009). Incorporating more distal regions of the body into rehabilitation 
programmes for CLBP may offer improved outcomes. This hypothesis is supported by 
McGregor and Hukins (2009) who propose that lower limb abnormalities, especially at the 
hip, in people with CLBP, may result from or be a contributing factor to LBP symptoms. 
Shoe manufactures have claimed that their shoes can influence lower limb and spinal 
biomechanics (Masai Barefoot Technology GB Ltd, 2011). The average UK person walks 
approximately 188 miles (303km) per year (Department of Transport, 2011), hence, if 
rocker sole shoes positively influence mechanisms underpinning CLBP, wearing such shoes 
during a daily functional activity such as walking may improve clinical outcome for people 
with CLBP, particularly if the LBP is aggravated by walking. Prior to the current thesis, there 
was a lack of research investigating the effectiveness of rocker sole shoes in CLBP to 
substantiate such claims. 
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10.3  Summary of findings 
The main clinical study (Chapter 5, p61) demonstrated that wearing rocker sole shoes or flat 
sole shoes results in similar outcomes in the short and long term management of mild to 
moderate CLBP. However, if a person’s pain is aggravated by standing or walking, wearing 
rocker sole shoes may be detrimental to clinical improvement.  
The biomechanical studies (Chapters 7, p148 and 8, p170) demonstrated no long term 
effects on barefoot postural control, kinetics, kinematics or spatio-temporal parameters of 
gait from wearing either shoe type. Although some immediate biomechanical differences 
were observed between groups when shod compared to barefoot, the lack of between 
group differences in outcomes in the main clinical study suggests it unlikely that the 
minimal differences in the parameters assessed influence clinical outcome in people with 
CLBP. 
No participants reported any adverse effects; however, two participants withdrew from the 
rocker sole group due to the occurrence of a blister and the fear of blister occurrence. 
These reasons for withdrawal, in addition to the lower participant satisfaction scores and 
greater number of participants lost to follow up in the rocker sole group suggest the rocker 
sole shoes were less acceptable. 
Comparison of biomechanical parameters of participants with CLBP and age- and gender-
matched asymptomatic individuals (Chapter 9, p189) demonstrated no significant 
difference in spatio-temporal, kinetic or kinematic parameters. This suggests that although 
the mechanism(s) underpinning back pain remain equivocal, for people with mild to 
moderate CLBP, pure biomechanical mechanisms are unlikely.  
10.4 Similarity in clinical outcome between groups 
The mild to moderate similar improvement in clinical outcome between interventions in 
the main clinical study, concurs with findings from many other studies investigating 
physiotherapy treatments and other treatments for CLBP (Cairns et al., 2006; Critchley et 
al., 2007; Frost et al., 2004; Hay et al., 2005; Hayden et al., 2005b). Explanation for this 
consistent finding include: i) a greater effect was gained from one intervention than the 
other but the effect was not detected by the outcome measures assessed; ii) the 
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interventions had no influence on CLBP – within group reductions in disability and pain 
resulted from the natural history of the condition, and not due to either interventions 
influence; iii) sub-groups within the sample may have improved, however, these findings 
were diluted by the heterogeneous nature of CLBP or;  iv) improvements in disability and 
pain resulted from effects common to both intervention groups. These four explanations 
are discussed in greater detail below. 
A range of recommended outcome measures, sensitive to clinical change were assessed in 
both the clinical study (Bombardier, 2000; Deyo et al., 1998) and the biomechanical studies 
(Ruhe et al., 2010; Ruhe et al., 2011a). The consistent finding of no difference between 
shoe groups for any of the measures assessed at any follow-up point in either the main 
clinical or biomechanical studies adds strong support to study conclusions that clinical 
difference between the groups did not occur.  
It is well documented that people with conditions such as back pain seek medical 
interventions at the peak of their symptoms (Dunn et al., 2006), and that natural 
improvement is likely to follow. It is possible that the reductions in disability and pain, 
reported in the main clinical study, may have resulted from the natural history of the 
condition and not from a participant’s involvement in the study. This has been discussed in 
Chapter 5 (p61).  However, this theory, suggesting that the intervention (shoe type) had no 
influence on participants’ improvement, does not account for the poorer outcome in the 
rocker sole shoe sub-group reporting pain at baseline aggravated by standing or walking 
activities. 
The sub-group analysis of participants reporting pain on standing or walking demonstrated 
poorer outcomes at one year in the rocker sole shoe group than the flat sole shoe group. 
This supports the hypothesis that sub-groups within the heterogeneous non-specific LBP 
population exist (Foster et al., 2011). The current research suggests that therapists should 
be mindful of a patient’s self-reported aggravating factors, such as pain during standing 
activities, when planning treatment approaches as these factors may influence outcome; 
further research to determine appropriate clinical sub-groups may influence treatment 
choice and improve outcome for those with CLBP. 
The fourth explanation suggests that reductions in disability and pain may have resulted 
from effects common to all interventions. In the current study participants in both groups 
attended a back exercise class, received a free pair of shoes, were encouraged to increase 
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daily activity through walking, and received long term follow-up from a physiotherapist. 
Increasing physical activity is recommended for people with CLBP (NICE, 2009). A Cochrane 
review of interventions that promote physical activity concluded that a mixture of 
professional guidance and on-going professional support can encourage adults to be more 
physically active (Foster et al., 2005). Walking has been suggested as a beneficial treatment 
approach for those with CLBP (McDonough et al., 2010).  Long term follow-up resulted in 
the participant meeting with the chief investigator on four occasions during the main 
clinical study and if participating in the biomechanical studies, a further three meetings. 
During these assessments, a positive influence on treatment outcome may have resulted 
from the therapist-patient relationship (Hall et al., 2010). In addition, informal advice 
received during these assessments and participants being able to talk about their back 
problems may have reduced fear avoidance behaviours and improved coping strategies 
which have been reported to correlate with improvements in CLBP (Mannion et al., 2001). 
Furthermore, receiving a free pair of shoes may have resulted in a positive placebo effect 
influencing outcome. These factors may have contributed to the similar positive outcome in 
both shoe groups.  
The gait laboratory was not local for the majority of participants. This provides a further 
explanation for the similarity between CLBP and asymptomatic groups. People with greater 
self-reported pain have demonstrated poorer postural stability (Ruhe et al., 2011b); this 
sub-group with greater postural control impairments or greater mobility problems may 
have declined to participate in the biomechanical study as a consequence of the journey to 
the laboratory, whereas those with mild to moderate symptoms were happier to travel. 
This is supported by the reduced mean self-reported pain and disability in the 
biomechanical study participants compared to the main clinical study participants (pain: 




10.5  Is treatment for chronic low back pain directed at the 
mechanisms responsible for the symptoms?  
In contrast to much previous research (Byl and Sinnott, 1991; Della Volpe et al., 2006; Keefe 
and Hill, 1985; Khodadadeh and Eisenstein, 1993; Luoto et al., 1996; Mientjes and Frank, 
1999; Mok et al., 2004; Moseley and Hodges, 2005; Takala et al., 1997a; Vogt et al., 2001), 
this thesis demonstrated similar biomechanical parameters in people with and without 
CLBP. The similarities between groups question whether proposed biomechanically based 
unpinning mechanisms of CLBP are correct. Alternatively, biomechanical mechanisms may 
underpin CLBP, but between group differences were undetected due to insensitivity of the 
measures used in this thesis. However, for reasons discussed in Chapter 9 (p189) the latter 
is unlikely. The thesis findings therefore question whether treatment directed at influencing 
biomechanical mechanisms thought to underpin back pain is a valuable use of treatment 
time. A systematic review demonstrating no relationship between clinical and physical 
outcomes following exercise interventions (Steiger et al., 2012), supports the suggestion 
that biomechanical mechanisms are unlikely.  
Small differences in biomechanical parameters were demonstrated between the rocker 
sole and flat sole groups when comparing barefoot with shod assessments with some 
changes hypothesised as beneficial and others detrimental to CLBP (for example, increased 
hip range of movement [in flat sole shoes] may be detrimental to CLBP due to a 
concomitant increase in spine movement, activity of the surrounding muscles, or spinal 
loading). However, the main clinical study demonstrated similar outcomes between shoe 
groups suggesting that the minimal biomechanical differences observed between groups 
from barefoot to shod are unlikely to result in clinical change. Furthermore, the lack of 
change in barefoot biomechanical parameters at six months follow-up, where participants 
reported clinical improvement in pain and disability, suggests that improvements in 
disability and pain were unlikely to have resulted from a biomechanical influence. Findings 
from previous research support this suggestion (Mannion et al., 2012; Steiger et al., 2012). 
Proprioceptive treatment approaches are common practice in knee (Fitzgerald et al., 2000) 
and ankle rehabilitation (Tropp and Askling, 1988), and have been recommended in the 
management of CLBP (Johanssen et al., 1995). The current research indicates that wearing 
an unstable sole, challenging postural stability, has no greater benefit to pain and disability 
in the short or long term when compared to wearing a flat sole shoe. This suggests that for 
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those with CLBP a specific proprioceptive rehabilitation programme performed whilst 
standing is no more beneficial than a general exercise programme alone, and may be 
detrimental for people with pain aggravated whilst standing or walking. The lack of change 
in barefoot postural parameters at six months compared to baseline in the rocker sole shoe 
group questions whether postural control can be ‘trained’ through such a balance 
orientated management programme in people with mild to moderate CLBP. The similarities 
in postural control between the CLBP population and the asymptomatic individuals 
(Chapter 9, p189) further questions whether treatments directed at improving postural 
control is a necessary or appropriate rehabilitation goal in CLBP management. However, if 
the CLBP group had presented with greater postural instability at baseline (possibly present 
in individuals with more severe pain (Ruhe et al., 2011b) or higher disability than 
participants in the current research) then a training effect may have been observed.  
Anxiety and depression are predictors of outcome for people with CLBP (Trief et al., 2000). 
If anxiety and depression levels reduce, a concomitant reduction in disability and pain may 
be expected. Therefore, it has been recommended that management of CLBP incorporates 
not only physical rehabilitation but a more bio-psychosocial approach. However, in the 
main clinical study, although pain and disability improved at one year follow-up compared 
to baseline, anxiety and depression did not change. This implies that factors other than 
anxiety and depression contributed to the observed clinical improvement. If higher baseline 
anxiety and disability scores had been reported, a reduction in these outcomes may have 
correlated with pain and disability improvements (Mannion et al., 2001).  
Minimal improvements are frequently observed in RCTs investigating the effects of 
conservative treatments for CLBP, with a lack of correlation between change in pain and 
change in the hypothesised underpinning mechanisms (Steiger et al., 2012). This questions 
whether current treatments are directed at influencing correct underpinning mechanisms 
but with little effect, or are designed to influence epiphenomena - secondary symptoms 
occurring alongside a disease or condition but not directly related to its cause (Stedman, 
2005) - hence may be targeting the wrong pathways. Recent research has demonstrated 
reductions in volume and a change in biochemical composition of certain regions of the 
brains’ gray matter, thought to be associated with the transmission of pain, in individuals 
with CLBP (Apkarian et al., 2004; Grachev et al., 2000; Grachev et al., 2003; Schmidt-Wilcke 
et al., 2006). Magnetic resonance imaging scanning has identified gray matter decreases in 
the dorsolateral prefrontal cortex and brainstem and magnetic resonance spectroscopy has 
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demonstrated reductions in N-acetly aspartate (a brain specific metabolite) in the 
dorsolateral prefrontal cortex, indicative of neuronal loss or dysfunction (Apkarian et al., 
2004; Grachev et al., 2000; Grachev et al., 2003; Schmidt-Wilcke et al., 2006). It is unclear 
whether these volume and biochemical changes may be the cause of, the result of, or are 
unrelated to the concomitant chronic pain state. The dorsolateral prefrontal cortex 
integrates motor and sensory information (Fink et al., 1999). It may be that atrophy or a 
reduction in volume of this region of the brain has a negative influence on sensory-motor 
feedback. This altered feedback may contribute to the presence of epiphenomena 
incorrectly assumed by researchers and clinicians to be the underpinning mechanisms of 
CLBP. The biomechanical mechanisms considered in this thesis may be examples of such 
epiphenomena. Such misbeliefs may be misleading and detrimental to researchers 
investigating appropriate and effective management programmes for people with CLBP. 
A further potential underpinning mechanism to explain the presence of CLBP, and direct 
research towards brain orientated treatments, is the observation of an alternative 
representation of the lumbar spine in the somatosensory cortex of the brain in people with 
CLBP compared to asymptomatic individuals (Flor et al., 1997). It has been suggested that 
an altered cortical representation of somatic input may result in incongruence between 
motor intention and the resultant movement (Harris, 1999). If there is incongruence 
between motor output and sensory feedback, it has been hypothesised that pain is 
produced to warn the individual of the abnormal sensory-motor processing (McCabe et al., 
2005). In the sub-group reporting pain on standing and walking the use of a rocker shoe, 
introducing additional postural instability, may have further increased sensory-motor 
incongruence, and hence increased the perception of pain. Conditions that generate 
ineffective sensory-motor processing are associated with increased activation in the right 
dorsolateral prefrontal cortex (Fink et al., 1999). The over-activation of this brain region 
may lead over time to excitotoxicity, a possible cause for the dorsolateral prefrontal cortex 
atrophy (Apkarian et al., 2004). For the sub-group analysed, the addition of an unstable 
standing surface to a potentially inefficient postural control or sensory-motor feedback 
system may be detrimental (Brumagne et al., 2008; Della Volpe et al., 2006; Mok et al., 
2004), and therefore account for the poor outcome observed in the rocker sole group. 
Further research is required to determine whether brain directed treatment can influence 
CLBP. It is currently unknown as to whether the observed chemical and volume 
abnormalities within regions of the brain are reversible when pain has been reduced 
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following conservative management. However, following surgical intervention in CLBP, 
dorsolateral prefrontal cortex abnormalities have been shown to be reversible (Seminowicz 
et al., 2011). For CLBP, mechanism-based treatments directed at influencing the dorso-
lateral prefrontal cortex may be an effective management approach for CLBP. 
10.6 Appropriateness of reassessment time points 
Reassessment of CLBP participants at one year is accepted as ‘long term’ follow-up (Hayden 
et al., 2012; van Tulder et al., 2003), hence was deemed adequate for the assessment of 
participants in the main study. This trial duration is similar to that of previous research 
investigating CLBP rehabilitation (Cairns et al., 2006; Johnson et al., 2007; UK BEAM Trial 
Team, 2004). 
The main aims of the biomechanical studies (Chapter 7, p148 and 8, p170) were to detect 
change in biomechanical parameters in the short (immediate) and long term (six months) 
following shoe use. Previous research investigating neuro-musculoskeletal and functional 
change during a one year exercise programme detected change in functional capacity at 
two months (Belardinelli et al., 1999) and in muscular activity at three months  (Pyka et al., 
1994), with changes maintained at one year follow-up. If footwear influenced the neuro-
musculoskeletal system, it was anticipated that by six months, such changes should be 
established and maintained (assuming that shoes continued to be worn) enabling detection 
by the measures assessed. 
10.7 Strengths and limitations 
The main clinical study had 90% statistical power to detect clinically important change in 
the primary outcome measure, at the 0.05 significance level. This was in keeping with the 
recommendation that studies using multiple outcome measures should have a minimum 
power of 90% to detect change in the primary measures (Borm et al., 2006). The power of 
the biomechanical studies to detect change in kinematic, kinetic, or spatio-temporal 
variables cannot be assumed, and, although the sample sizes of the current biomechanical 
studies were as large or larger than most other biomechanical studies investigating similar 
outcomes in CLBP and asymptomatic individuals, it is possible that some type two errors 
may have occurred. However, baseline demographic data and pain and disability measures 
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were similar between participants in the main study and biomechanical studies, as were 
changes in pain and disability at six weeks and six months. This suggests that those entering 
the biomechanical study were a representative sample of the main study, strengthening the 
ability to interrelate study conclusions, and to relate findings to the larger CLBP population. 
10.8 Clinical relevance of these findings 
This thesis suggests that wearing rocker sole shoes or flat sole shoes results in similar 
outcomes in the short and long term management of CLBP. However, if a person’s pain is 
aggravated by standing or walking, rocker sole shoes may be detrimental to clinical 
improvement. These findings question whether proprioceptive rehabilitation programmes 
delivered in standing offer any training effect to the postural control system or clinical 
benefit to people with CLBP. 
The current study investigated one brand of rocker sole shoe, hence caution must be taken 
when relating the current thesis findings to all brands of rocker sole shoes. However, 
considering the high proportion of similar between group findings in this thesis, it is unlikely 
that a different rocker sole brand would provide markedly different results. 
It is not possible to compare the current studies with other research investigating footwear 
and CLBP due to a paucity of published research in this field. This paucity may exist due to a 
lack of research conducted; alternatively, conducted research may have demonstrated no 
improvement in CLBP, hence publication bias may be accountable. Either way, there is no 
evidence to indicate that footwear can positively influence CLBP in the short or long term. 
This is supported by a Cochrane review investigating the use of insoles in the prevention 




10.9 Summary of further research 
Potential future projects arising from this research process are listed: 
 Research could be conducted to determine whether people reporting and not 
reporting pain during standing, walking, or other weight bearing activities respond 
differently to other physiotherapy interventions. 
 Biomechanical studies should be conducted with an appropriately powered sample 
to determine whether postural control differences are present between people 
with mild, moderate and severe CLBP and asymptomatic individuals. 
 The participants in the current biomechanical studies demonstrated, on average, 
similar postural control and stability to the asymptomatic individuals. It would be of 
interest to investigate CLBP participants with poor postural stability to determine 
whether ‘balance training’ programmes may influence postural stability in this 
population.  
 There is no gold standard for assessing the relationship between the hip and ankle 
strategy. Reliability and validity of methods for determining the hip and ankle 
strategies and their relationship to each other in the maintenance of postural 





 Wearing a rocker sole or a flat sole shoe is likely to result in a similar clinical 
outcome at one year for people with CLBP. 
 If a person’s CLBP is predominately aggravated by standing or walking it may be 
more beneficial to wear a flat sole shoe than a rocker sole shoe. 
 People with mild to moderate CLBP present with similar standing postural stability 
to people without CLBP. 
 Long term wear of rocker sole shoes has no influence on postural control and 
stability in standing. 
 Long term wear of rocker sole shoes has no influence on kinetic, kinematic and 
spatio-temporal parameters of gait. 
 Proprioceptive rehabilitation delivered in standing is unlikely to improve postural 
stability in people with mild to moderate CLBP. 
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11.3 Roland Morris disability questionnaire 
This list contains sentences that people have used to describe themselves when they have 
back pain.  When you read them, you may find that some stand out because they describe 
you today.  As you read the list, think of yourself today.  When you read a sentence that 
describes you today, put a tick against it.  If the sentence does not describe you, then leave 
the space blank and go on to the next one.  Remember, only tick the sentence if you are 
sure it describes you today. 
 
 
1. I stay at home most of the time because of my back. 
 
2. I change position frequently to try and get my back comfortable. 
 
3. I walk more slowly than usual because of my back. 
 
4. Because of my back I am not doing any of the jobs that I usually do around 
the house. 
 
5. Because of my back, I use a handrail to get upstairs. 
 
6. Because of my back, I lie down to rest more often. 
 
7. Because of my back, I have to hold on to something to get out of an easy 
chair. 
 
8. Because of my back, I try to get other people to do things for me. 
 
9. I get dressed more slowly than usual because of my back. 
 
10. I only stand for short periods of time because of my back. 
 
11. Because of my back, I try not to bend or kneel down. 
 




13. My back is painful almost all the time. 
 
14. I find it difficult to turn over in bed because of my back. 
 
15. My appetite is not very good because of my back pain. 
 
16. I have trouble putting on my socks (or stockings) because of the pain in my 
back. 
 
17. I only walk short distances because of my back. 
 
18. I sleep less well because of my back. 
 
19. Because of my back pain, I get dressed with help from someone else. 
 
20. I sit down for most of the day because of my back. 
 
21. I avoid heavy jobs around the house because of my back. 
 
22. Because of my back pain, I am more irritable and bad tempered with people 
than usual. 
 
23. Because of my back, I go upstairs more slowly than usual. 
 



























11.5 Tampa scale of kinesiophobia 
1 = strongly disagree  
2 = disagree  
3 = agree  
4 = strongly agree  
 
1. I’m afraid that I might injure myself if I exercise  
 
1  2  3  4  
2. If I were to try to overcome it, my pain would increase  
 
1  2  3  4  
3. My body is telling me I have something dangerously wrong  
 
1  2  3  4  
4. My pain would probably be relieved if I were to exercise  
 
1  2  3  4  
5. People aren’t taking my medical condition seriously enough  
 
1  2  3  4  
6. My accident has put my body at risk for the rest of my life  
 
1  2  3  4  
7. Pain always means I have injured my body  
 
1  2  3  4  
8. Just because something aggravates my pain does not mean it 
is dangerous  
1  2  3  4  
9. I am afraid that I might injure myself accidentally  
 
1  2  3  4  
10. Simply being careful that I do not make any unnecessary 
movements is the safest thing I can do to prevent my pain from 
worsening  
1  2  3  4  
11. I wouldn’t have this much pain if there weren’t something 
potentially dangerous going on in my body  
 
1  2  3  4  
12. Although my condition is painful, I would be better off if I 
were physically active  
 
1  2  3  4  
13. Pain lets me know when to stop exercising so that I don’t 
injure myself  
 
1  2  3  4  
14. It’s really not safe for a person with a condition like mine 
to be physically active  
 
1  2  3  4  
15. I can’t do all the things normal people do because it’s too 
easy for me to get injured  
 
1  2  3  4  
16. Even though something is causing me a lot of pain, I don’t 
think it’s actually dangerous  
 
1  2  3  4  
17. No one should have to exercise when he/she is in pain  
 
1  2  3  4  
  
 232 
11.6 Hospital anxiety and depression score 
I feel tense or 'wound up':   I feel as if I am slowed down:   
Most of the time   Nearly all of the time   
A lot of the time   Very often   
Time to time, occasionally   Sometimes   
Not at all   Not at all   
I still enjoy the things I used to 
enjoy:  
 I get a sort of frightened 
feeling like 'butterflies in the 
stomach':  
 
Definitely as much   Not at all   
Not quite so much   Occasionally   
Only a little   Quite often   
Not at all   Very often   
I get a sort of frightened feeling 
like something awful is about 
to happen:  
 I have lost interest in my 
appearance:  
 
Very definitely and quite badly   Definitely   
Yes, but not too badly   I don't take as much care as I 
should  
 
A little, but it doesn't worry me   I may not take quite as much 
care  
 
Not at all   I take just as much care as ever   
I can laugh and see the funny 
side of things:  
 I feel restless as if I have to 
be on the move:  
 
As much as I always could   Very much indeed   
Not quite so much now   Quite a lot   
Definitely not so much now   Not very much   
Not al all   Not at all   
Worrying thoughts go through 
my mind:  
 I look forward with enjoyment 
to things:  
 
A great deal of the time   A much as I ever did   
A lot of the time   Rather less than I used to   
From time to time but not too 
often  
 Definitely less than I used to   
Only occasionally   Hardly at all   
I feel cheerful:   I get sudden feelings of 
panic:  
 
Not at all   Very often indeed   
Not often   Quite often   
Sometimes   Not very often   
Most of the time   Not at all   
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I can sit at ease and feel 
relaxed:  
 I can enjoy a good book or 
radio or TV programme:  
 
Definitely   Often   
Usually   Sometimes   
Not often   Not often   












PARTICIPANT INFORMATION SHEET  
V 1.   04/07/2007 
 
1. Study title 
Lower back pain: Can shoe type reduce the pain and recurrence rate? 
RREC No: 07/H0706/74 
 
Evidence exists that suggests footwear type may play a role in 
activating the small muscles of the back making them stronger and in 
doing so reduce back pain and the recurrence of repeated episodes of 
back pain. 
 
2. Invitation paragraph 
 
You are being invited to take part in a research study that is aiming to 
investigate the benefit of different footwear type in the treatment of lower back 
pain. 
 
Before you decide to participate it is important for you to understand why the 
research is being conducted and what it will involve. Please take time to read 
the following information carefully and discuss it with friends, relatives and 
your GP, Consultant, or the Chief Investigator of the study, if you wish.  Please 
ask us if there is anything that is not clear or if you would like more 
information.  Please take time to decide whether or not you wish to take part. 
There will be no difference in waiting times for your treatment if you decide 
that you do not wish to participate in this research study. Please let us know if 
you are currently participating or have recently participated in another 
research project. If you have, it may not be appropriate for you to consider 
participating in this study. 
 
3. What is the purpose of the study? 
 
Research studies have clearly shown that exercise and rehabilitation is 
beneficial for the majority of patients with lower back pain. Research also 
suggests that shoe type may be influential in force reduction in the spine 
improving muscle activation around the spine, and in doing so may further 
help to facilitate an improvement in outcome for patients with low back pain. 
There is, however very little guidance as to the best type of footwear to 
achieve these effects. Recommendations have included force reduction/shock 
absorption flat sole sport shoes, and force reduction/shock absorption rocker 
sole sport shoes (these are shoes that have a slight curve on their sole). 
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Although both shoe types are designed to reduce forces through the spine, it 
is not known as to which shoe type is more effective at doing this. 
  
What we are aiming to achieve in this study is to determine if the addition of 
either a flat sole sport shoe, or a rocker sole sport shoe to traditional 
physiotherapy exercises and rehabilitation improves the outcome for patients 
with lower back pain. 
 
4. Why have I been chosen? 
 
Most probably you will be reading this document because you have lower 
back pain and will be offered a physiotherapy exercise programme for your 
pain as part of the normal treatment for your condition.  
 
We are approaching you because we would like you to consider taking part in 
a research study that is being conducted in the physiotherapy department. 
The study will involve measuring the effectiveness of treatment in 2 different 
treatment groups for patients suffering with lower back pain. Group 1: Rocker 
sole sport shoes and exercise, and Group 2: Flat sole sport shoes and 
exercise. 
 
It is up to you to decide whether or not to take part.  If you do decide to take 
part you will be given this information sheet to keep and be asked to sign a 
consent form before the study starts.  If you decide to take part you are still 
free to withdraw at any time and without giving a reason.  Refusal to 




5. What will happen to me if I take part? 
 
Research studies have demonstrated that exercise therapy is very effective for 
the treatment of lower back pain. In the physiotherapy department we have 
developed a specialized group lower back pain rehabilitation group 
programme. The lower back pain rehabilitation programme in the 
physiotherapy department is normally 8 treatments, each of approximately 1 
hour, over a 4 week period. This programme is given as a group treatment 
where you will be with up to 9 other people (10 in total) who are also suffering 
from lower back pain. This programme is run by two experienced 
physiotherapists. The group is a specialised programme and involves 
education, exercises and treatments based on current research evidence. In 
addition to attending the lower back rehabilitation class you will be requested 
to continue with the exercises at home. This is to maximize the benefit of the 
rehabilitation programme. We carefully select patients to participate in our 
group programme and certain people cannot participate. People with lower 
back pain who are ineligible to participate in the group get offered alternative 
treatment. 
 
In this study we are aiming to compare whether the addition of rocker sole 
sport shoes or flat sole sport shoes when added to the lower back 
rehabilitation programme improves the outcome of treatment. As with most 
research investigations it would not be appropriate for certain people to 
participate for example, if you are pregnant, or if you have had surgery to you 




If you are eligible for both the rehabilitation programme and for the research 
study and you choose to participate in the research study, you will be asked to 
wear either rocker sole sport shoes or flat sole sport shoes during the period 
of time that you are involved in the rehabilitation programme (i.e. 4 weeks). 
You will be requested to gradually increase the amount you wear the shoes 
from 1 hour per day, to two hours per day to three hours per day etc, up to 5 
hours per day. This is important because we are trying to determine which 
shoe type will have an increased effect on low back pain, and we need you to 
wear the shoes for this period of time. We will provide the shoes for you and 
you may keep the shoes after the study is complete.  You will be required to 
document daily, the number of steps you have taken in the shoes. You will be 
provided with a diary to record your daily number of steps. The number of 
steps will be counted by a pedometer. You will also be asked to fill in an 





The lower back exercise class time is set at the same time each week. This is 
to facilitate a regular period of time between each class and to ensure all the 
necessary equipment and teaching information is available at each class. If 
you agree to participate you will be required to attend the hospital twice a 
week for a period of 4 weeks to attend the classes. 
 
If you are eligible and choose to participate in this study you will be requested 
to complete a number of questionnaires about your lower back pain. These 
questionnaires take approximately 15 minutes to fill in and involve placing a 
tick or mark next to an answer that you feel is the most appropriate. We will 
also measure how much movement there is in your lower back. These are 
routine tests performed by all physiotherapists to assess the function of the 
lower back. 
 
As this is a research study you will not be able to choose which group you will 
be in. This is to ensure that strict research standards are adhered to. If you 
agree to participate, and after you have had your first series of tests the chief 
investigator for the study will give you a sealed envelope to take to the 
physiotherapy reception desk. The group that you will join will be written on a 
folded piece of paper in the envelope. It is only at this time you will know which 
group you will be in. It will not be possible to change the group you are 
allocated to.  You will then be fitted with either a pair of rocker sole sport 
shoes, or flat sole sport shoes. You will then be instructed how to walk 
effectively in the shoes, and hoe to use the pedometer, which will monitor the 
number of steps you take in the investigation period. 
 
As this is a research investigation and we want to learn what is the most 
effective way to treat lower back pain, we will ask your permission to measure 
your lower back movements, amount of pain and to complete questionnaires 
on a further one occasion at the end of the 4 week exercise programme. This 
is to determine how the different treatments have affected you. 
 
We will request that you allow us to measure your range of movement, pain 
levels and to complete questionnaires at the following times; 
 
(1) Before you start the lower back rehabilitation programme. 




That is two times in total (each time should take no more than 30 
minutes).These measurements will be made in a private treatment area. To 
make these measurements you will be asked to remove your shirt or top, and 
will be asked to wear a pair of shorts. Female participants will keep their bras 
on or if they choose may wear a singlet. If you wish you will be provided with a 
treatment gown. 
 
During the course of your treatment hospital transport will be provided for 
anyone requiring this service who meets the Trusts transport regulations. 
 
The following table summarises the required involvement for this study for 
those agreeing to participate and who are eligible to participate. 
 
 Consent form 














(4 weeks in total) 
Post treatment  follow-up 
Immediately following 








Group 1:  
Specialised lower 
back rehabilitation 
group and rocker 
sole sport shoes 
 
Yes 
2 lower back rehabilitation 
groups  per week of one 
hour for 4 weeks 
 
That is 2 hospital visits a 





Group 2:  
Specialised lower 
back rehabilitation 




2 lower back rehabilitation 
groups per week of one 
hour for 4 weeks. 
 
That is 2 hospital visits a 






Please note: If you already know that you will not be able to attend the 
programme twice a week for four weeks we would request that you do not 
offer to participate. The reason for this is that all scientific investigations 
require that a certain number of people are followed for the entire time of the 
study. If there are not enough people at the end of the time period then the 
results of the study may not be of any meaning.  
 
However, please remember that you are free not to participate and you are 
free to leave the study for whatever reason you choose at any stage. Your 
decision to leave the study will not affect the quality of care you receive. 
 
It is important for you to know that there will be no difference in the waiting 
times for the lower back rehabilitation group for those agreeing to participate in 
this study and those not wishing to participate. 
 
6. What do I have to do? 
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The first thing you need to do is decide if you would like to participate or not. 
This is entirely your decision and deciding not to participate will not affect the 
quality of your care. If you do decide to participate you will need to follow the 
procedure outlined in section 5.  
 
7. What is the procedure that is being tested? 
We are trying to determine if the addition of rocker sole sport shoes or flat sole 
sport shoes in addition to a specialised lower back rehabilitation exercise 
group, further helps to reduce pain and improve function. 
 
We will be investigating this in a randomised clinical trial. This means that 
people participating in this trial will be randomly allocated into one of two 
groups; Group 1 (exercise and rocker sole sport shoes), and Group 2 
(exercise and flat sole sport shoes). To ensure the scientific integrity of this 
investigation a computer programme will determine your group allocation. You 
will not be able to choose the group you are allocate to. You will have a 1 in 2 
chance of being placed in the exercise and rocker sole shoe group (Group 1), 
and a 1 in 2 chance of being placed in the exercise and flat sole shoe group 
(Group 2). 
 
8. What are the side effects of taking part?  
Some participants may find the physical test (range of movement) for the 
lumbar spine produce some pain. In most cases this will be similar to the pain 
experienced in their back. The tests are used clinically to help determine 
which structure or structures are involved in their symptoms and are an 
essential part of the assessment procedure. We also perform these tests to 
see if you are improving as a result of the treatment you have received. 
A subject walking in their new shoes may initially be aware of increased lower 
back pain. Subjects walking in these shoes may attain a slightly different 
posture than normal. This can lead to an increased activation of the lower 
back muscles. When muscles start to work harder they can be painful. This 
should normally resolve within a few days. Additionally, a burning sensation 
may be experienced by certain individuals whilst wearing new shoes. This is 
due to increased blood flow to the small muscles in the foot. This should settle 
after a few weeks. Sensations such as pins and needles, sweaty feet and 
numbness may occur initially and will subside after wearing their shoes. 
Participants in the exercise group may also lead to an initial increase in 
discomfort. This is a well recognised phenomenon in any individual 
undertaking a new exercise programme and is known as delayed onset 
muscle soreness. It normally settles after a few days.  
As with any new footwear, participants may develop blisters as a result of 
wearing either shoe type. 
You may discuss any concerns you have with the clinical investigator, Siân 
MacRae on 020 8746 8404. 
 
9. What are the possible disadvantages and risks of taking part? 
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There are no perceived disadvantages or risks for those taking part in this 
study. The examination procedures and treatment procedures are ones used 
daily in physiotherapy clinics. 
 
10. What are the possible benefits of taking part? 
 
We do not currently know the most effective treatments for lower back pain 
and we hope that this research will help us understand the best way to treat 
this problem. However, as with all research, this cannot be guaranteed.  
 
 
11. What if something goes wrong? 
 
We do not anticipate for anything to go wrong in this study as we are not trying 
any new procedure, we are simply investigating the benefit of treatments 
people with lower back pain currently receive in a scientific manner. 
However, if you are harmed by taking part in this research project, there are 
no special compensation arrangements.  If you are harmed due to someone’s 
negligence, then you may have grounds for legal action but you may have to 
pay for it. Regardless of this, if you wish to complain about any aspect of the 
way you have been approached or treated during the course of this study, the 
normal NHS complaints mechanisms may be available to you. 
 
12. Will my taking part in this study be kept confidential? 
 
All information that is collected about you during the course of the research 
will be kept strictly confidential.  Any information about you which leaves the 
hospital/surgery will have your name and address removed so that you cannot 
be recognised from it. 
If you do participate your GP (and Consultant if appropriate) will be sent a 
letter notifying them of your participation in this study (if you give your 
permission for this letter to be sent). 
 
 
13. What will happen to the results of the research study? 
 
We hope to use the information we obtain from this study to inform other 
health professionals about our results. We therefore ask your permission to 
publish the data we obtain. However, we guarantee to keep your name and 
identity confidential and this will not be made available to anyone at any stage. 
The results will probably be published about one year after the end of the 
study and if you are interested in finding out about our results, we would be 
happy to send you a one page summary of our findings.  
 
 




This research is being organised by the Department of Physiotherapy at the 
Chelsea and Westminster Health Care NHS Trust. The provision of footwear 
is funded by a research grant from MBT Physiological Footwear. 
 
15. Who has reviewed this study? 
 
This study has been reviewed by external experts. In addition it has been 
reviewed by the Hospitals Research and Development Committee and the 
Riverside Research Ethics Committees. 
 
16. Contact for further information 
 
If you would like any further information about this study, please feel free to 
contact Siân MacRae, Senior Physiotherapist, on telephone number 020 8746 
8404. 
Additionally, if you are a patient and decide to participate in this research we 
will also ask you if you would like us to send a letter to your GP or consultant, 
informing them that you are participating in this study. We will also go through 
a series of screening questions to ensure that for ethical and healthcare 
reasons it is appropriate for you to participate in this study 
 
17. After you have read this information sheet 
If you think you would like to participate in this study please take time to think 
about your involvement. You might find speaking to family and friends and 
other healthcare professionals helpful. If you do decide to participate we will 
ask you to fill in and sign a Research Consent Form, in front of someone who 
will witness the signature. 
If you agree to participate you will be given a copy of this information sheet 
and a copy of the consent form you signed. If you are a patient and do not 
wish to participate then your physiotherapist will organise a course of 
treatment for you. 
 










Research Subject Consent Form  
 
Title of Project: Lower back pain: Can shoe type reduce the pain and 
recurrence rate? 
 
Protocol Version: Version … Date ……………. 
 
Local Research Ethics Number:  R & D Registration Number: 
 






  Please initial box if 
correct 
I have been given the chance to read and understand the 
information sheet (dated …/…/…)  relating to the above study 
 
  
   
I have been given the opportunity to ask questions and 
discuss the study. 
 
  
   




   
I understand that authorised individuals may look at my 




   
I understand that I am free to withdraw from this study at any 
time without prejudice to my future care/ treatment 
  
  
   




   
I would like my GP or consultant to know that I am 
participating in this research project.  
  
  
   
I would like to receive a one page summary of the findings of 









Title of Project:  Lower back pain: Can shoe type reduce the pain and 
recurrence rate?  
 
 
Local Research Ethics Number:  
     
R & D Registration Number: 
 
Patient Hospital Number:     
 
 





Name  ……………………………………………………………… 
 
Date  ……………………………………………………………… 
 
 
Person responsible for obtaining Informed Consent: 
'To the best of my knowledge I have provided the above individual with 




Name  ……………………………………………………………… 
 









Name  ……………………………………………………………… 
 




11.9 Diary sheet 
(first two pages only) 
              Therapy Department 
Chelsea and Westminster Healthcare NHS 
Trust 
Tel: +44 20 8746 8404 Email: sian.macrae@kcl.ac.uk 
        Research ParticipantsTraining Diary   
Version ……………. 
 
Local Research Ethics Number:       Patient Hospital Number:  Patient Study Identification Number:  Patient Initials: 
 Date No.of steps per 
day in study 
shoes 
Times shoes 
worn per day 
(hrs:mins) 
Form of Exercise session undertaken 
each day 
Pain relief  
(analgesia) 
 
Low back pain 
exercise group 
(Y/N) 
Low back pain 










       
 
 
       
 
 
       
 
 






Date No.of steps per 
day in study 
shoes 
Times shoes 
worn per day 
(hrs:mins) 
Form of Exercise session undertaken 
each day 
 
Pain relief  
(analgesia) 
Low back pain 
exercise group 
(Y/N) 
Low back pain 










       
 
 
       
 
 
       
WEEK 1 
 
       
 
 
       
 
 
       
 
 
       
 
 
       
 
 






11.10  EuroQol 5D-3L 
Appendix 4.4 Euro-Qol-5D-3L 
 
By placing a tick in one box in each group below, please indicate which 
statements 





I have no problems in walking about      � 
I have some problems in walking about      � 




I have no problems with self-care      � 
I have some problems washing or dressing myself    � 
I am unable to wash or dress myself      � 
 
Usual Activities (e.g. work, study, housework, family or 
leisure activities) 
 
I have no problems with performing my usual activities   � 
I have some problems with performing my usual activities   � 




I have no pain or discomfort       � 
I have moderate pain or discomfort      � 




I am not anxious or depressed       � 
I am moderately anxious or depressed      � 





                                                           
To help people say how good or bad a health 
state is, we have drawn a scale (rather like a 
thermometer) on which the best state you can 
imagine is marked 100 and the worst state you 
can imagine is marked 0. 
 
We would like you to indicate on this scale how 
good or bad your own health is today, in your 
opinion. Please do this by drawing a line from 
the box below to whichever point on the scale 
indicates how good or bad your health state is 
today. 
 








































11.13 Reliability of measuring thoracic kyphosis angle, lumbar 







































11.14 Reliability study ethical approval letter 
Dr Matt Morrissey 
Physiotherapy Division 
School of Biomedical Sciences 
Shepherd's House 
Guy's Campus 
King's College London 
London SE1 1UL 
 
 





BDM/08/09-85 Thoracic Kyphosis Angle, Lumbar Lordosis Angle and Hamstring Length: A 
Reliability and Correlation Study 
 
Thank you for sending in the amendments requested to the above project. I am pleased to inform you 
that these meet the requirements of the BDM and therefore that full approval is now granted provided 
that the following changes are made in the information sheet and a copy of the amended information 
sheet is submitted for our records: 
1. State that anonymised data is shared with other researchers. 
2. Replace the last two sentences under the heading ‘What are the possible 
disadvantages and risks of taking part?’ with the following: We will check 
for any leg pain. When you first become aware of any such sensations, let 
us know and your leg will be returned to the start position.  
 
Please ensure that you follow all relevant guidance as laid out in the King's College London Guidelines 
on Good Practice in Academic Research 
(http://www.kcl.ac.uk/college/policyzone/attachments/good_practice_May_08_FINAL.pdf). 
 
For your information ethical approval is granted until 18/06/2010. If you need approval beyond this 
point you will need to apply for an extension to approval at least two weeks prior to this explaining why 
the extension is needed, (please note however that a full re-application will not be necessary unless 
the protocol has changed). You should also note that if your approval is for one year, you will not be 
sent a reminder when it is due to lapse. 
 
If you do not start the project within three months of this letter please contact the Research Ethics 
Office. Should you need to modify the project or request an extension to approval you will need 
approval for this and should follow the guidance relating to modifying approved applications: 
http://www.kcl.ac.uk/research/ethics/applicants/modifications.html 
 
Any unforeseen ethical problems arising during the course of the project should be reported to the 
approving committee/panel. In the event of an untoward event or an adverse reaction a full report must 
be made to the Chairman of the approving committee/review panel within one week of the incident. 
 
Please would you also note that we may, for the purposes of audit, contact you from time to time to 
ascertain the status of your research.  
 





administrator in the first instance (http://www.kcl.ac.uk/research/ethics/contacts.html). We wish you 
every success with this work. 
 






Riina Heinonen – Research Ethics Officer 
For and on behalf of 
Professor Tim Newton, Chairman 
Biomedical and Health Sciences, Dentistry, Medicine and Physical Sciences & 
Engineering Research Ethics Subcommittee 





11.15 Reliability study recruitment email 
Research Study – Thoracic Kyphosis Angle, Lumbar Lordosis Angle and Hamstring Length: 
A Reliability and Correlation Study 
 
This project contributes to the College's role in conducting research, and teaching research methods. 
You are under no obligation to reply to this email, however, if you choose to, participation in this 
research is voluntary and you may withdraw at any time. 
 
We would like to invite you to participate in a postgraduate physiotherapy research project. We are 
looking for male or female volunteers aged 18 to 65 to take part in the above study being carried out 
at King’s College London. You are not  suitable to take part if you have any indications of lower limb 
neurological compromise, limitation of hip and knee movement, systemic illness, abnormal 
hamstring tightness, history of thoracic pain, back pain, or lower limb problems over the past six 
months that required medical attention. 
 
This study aims to determine the intrarater reliability of the chief investigator in the study entitled 
'Low Back Pain: Can Footwear Influence the Pain and Recurrence Rate.' (REC No: H0706/04), 
measuring thoracic kyphosis angle using an Isomed Unilevel inclinometer (Isomed, 975 Sandy Blvd., 
Portland, OR 97214). It also aims to establish if a correlation exists between between thoracic 
kyphosis angle, lumbar lordosis angle and hamstring length which may offer explanations for 
potential findings in the low back pain clinical study. Participation will involve you attending Guy’s 
Campus, King’s College London at a mutually convenient time twice, at least one hour apart, for 
approximately 20 minutes each time. To protect your modesty, all data will be collected in a quiet 
room.  
 
On the first appointment you will be given a full explanation of the testing procedure and warned of 
any potential risk factors that may occur. You will then be asked to sign and date the consent form. 
During the data collection process, you will be expected to wear a pair of shorts. Male volunteers will 
be asked to remove their shirts, and female volunteers asked to undress down to vest tops or open-
backed bathing suits. You will be asked to stand in a comfortable position on a spot marked on the 
floor. Non-allergenic adhesive markers will then be placed on three sites along your spine. 
Measurements will then be taken from these markers using the inclinometer to record the angle of 
your middle spine and lower back.  On completion of the standing measurements, you will be asked 
to lie down on your back on a plinth. Another non-allergenic adhesive marker will be placed just 
below the knee of the test leg. Your leg will be lifted passively in a straightened position until your 
pelvis begins to move. A measurement using the inclinometer will then be taken at this point and 
hamstring length recorded.  
 
In accordance with the Data Protection Act, all data will be handled with confidentiality and there 
will be no personal or medical details recorded. If you would like more information, please contact 
either Andrew Van Blommestein or Sian MacRae on the contact details below. You will then be sent 
the information sheet for the study containing further details of the procedure. An appointment will 
also be arranged to confirm your suitability for the study and give you the opportunity to ask any 
questions prior to agreeing to take part. 
 




Andrew Van Blommestein       Sian MacRae 
Student in MSc in Advanced Neuromusculoskeletal Physiotherapy Chief Investigator, PhD 
Student, MSc graduate 
King’ s College London      sianmacrae@hotmail.com 





11.16 Reliability study participant 
information sheet 
 
REC Reference Number: BDM/08/09-85 
 
 
YOU WILL BE GIVEN A COPY OF THIS INFORMATION SHEET 
 
Thoracic Kyphosis Angle, Lumbar Lordosis Angle and Hamstring 
Length: A Reliability and Correlation Study. 
 
We would like to invite you to participate in a postgraduate research project which is being 
conducted as part of an MSc in Advanced Neuromusculoskeletal Physiotherapy.  You should 
only participate if you want to; choosing not to take part will not disadvantage you in any 
way. Before you decide whether you want to take part, it is important for you to understand 
why the research is being done and what your participation will involve.  Please take time to 
read the following information carefully and discuss it with others if you wish.  Ask us if 
there is anything that is not clear or if you would like more information. 
 
What is the purpose of the study? 
To investigate the ability of the researcher (Sian MacRae) to reliably measure the angle of 
the curve in your upper back (your thoracic spine), the curve on your lower back (lumbar 
spine)  and the length of the muscle in the back of your thigh (the hamstring muscle) using 
an inclinometer (an instrument for measuring the angle of an object).  
 
Who are we recruiting to participate in this study? 
We are recruiting healthy volunteers between 18 and 65 years of age with no recent back or 
lower limb injuries. People who fulfil any of the following criteria are unable to participate 
in this study: any indication of lower limb neurological compromise, history of thoracic pain, 
lower back pain, or lower limb problems over the past six months that required medical 
attention, limitation or movement at the hip or knee, scoliosis, chest conditions such as 
asthma, chronic bronchitis and emphysema, disease of the peripheral or central nervous 
system, pregnancy, any systemic illness, abnormal tightness of the hamstrings, or are unable 
to give consent. 
 
Do I have to take part? 
No. It is up to you to decide whether to take part or not.  If you decide to take part you are 
still free to withdraw at any time and without giving a reason. If you do decide to take part 
you will be given this information sheet to keep and asked to sign a consent form. 
 
What happens if I choose to take part? 
You will be asked to attend Guy’s Campus, King’s College London at a mutually convenient 
time twice, at least one hour apart, for approximately 20 minutes each time. To protect your 
modesty, all data will be collected in a quiet room.  
 
On the first appointment you will be given a full explanation of the testing procedure and 
warned of any potential risk factors that may occur. You will then be asked to sign and date 
the consent form.  
 
During the data collection process, you will be expected to wear a pair of shorts. Male 
volunteers will be asked to remove their shirts, and female volunteers asked to undress down 






You will be asked to stand in a comfortable position on a spot marked on the floor. Non-
allergenic adhesive markers will then be placed on three sites along your spine. Measurements 
will then be taken from these markers using the inclinometer to record the angle of your 
middle spine and lower back.   
 
On completion of the standing measurements, you will be asked to lie down on your back on 
a plinth. A pillow will be placed under the knee not being tested. Another non-allergenic 
adhesive marker will be placed on bare skin just below the knee of the test leg. Your leg will 
be lifted passively in a straightened position until your pelvis begins to move. A measurement 
using the inclinometer will then be taken at this point and hamstring length recorded.  
 
Each measurement will be recorded three times on both the initial and subsequent 
appointment (1 hour later). The test procedure will remain unchanged on both visits. The 
second test will last for approximately 20 minutes. 
 
If you do decide to take part, please let us know beforehand if you have been involved in any 
other study during the last year. 
 
What are the possible disadvantages and risks of taking part? 
There is a small risk of discomfort during the hamstring length test which may be felt as 
tightness, stretching or pulling sensations in the back of the leg. This is a normal, 
reversible consequence of performing the straight leg raise procedure. Participants will be 
informed of these potential effects and any leg pain will be monitored. We will check for any 
leg pain. When you first become aware of any such sensations, let us know and your leg will 
be returned to the start position.  
 
If this study has harmed you in any way you can contact King's College London using the 
details below for further advice and information: 
 
Dr Matt Morrissey 
Division of Applied Biomedical Research 
School of Biomedical and Health Sciences 
Room 3.18, Shepherd’s House 
King’s College London 
London 
SE1 1UL 
Tel: 0207 848 6678 
Email: matt.morrissey@kcl.ac.uk 
What will happen to the information collected?  
All information collected during the course of research will be kept strictly confidential i.e. 
in a locked filing cabinet and stored on a dedicated, password protected computer.  Any 
information we obtain from you will have your name removed and will be numerically 
coded so that you remain anonymous. Only the researchers and the research supervisor will 
have access to the anonymised data which may be shared with other researchers. The results 
of the study may be published in medical journals or presented at medical conferences. 
Copies of the results can be obtained from the study organiser (Dr Matt Morrissey) when the 
study is completed. 
 
You may withdraw from the study at any time without giving a reason. Data provided by 







What are the possible benefits of taking part? 
There will be no expected benefits to the participants in this study.  
 
Thank you for reading this information sheet. 
 
If you would like more information, please contact: 
Andrew Van Blommestein MCSP  
Chartered Physiotherapist/ MSc Student  














11.17 Reliability study consent form 
 
CONSENT FORM FOR PARTICIPANTS IN RESEARCH STUDIES 
 
Please complete this form after you have read the Information Sheet and/or listened 
to an explanation about the research. 
 
Title of Study:  Thoracic Kyphosis Angle, Lumbar Lordosis Angle and Hamstring Length: A 
  Reliability and Correlation Study. 
 
King’s College Research Ethics Committee Ref: BDM/08/09-85 
 
(i) Thank you for considering taking part in this research. The person organizing 
the research must explain the project to you before you agree to take part. 
 
(ii) If you have any questions arising from the Information Sheet or explanation 
already given to you, please ask the researcher before you decide whether to 
join in. You will be given a copy of this Consent Form to keep and refer to at 
any time. 
 
(iii) I understand that if I decide at any other time during the research that I no 
longer wish to participate in this project, I can notify the researchers involved 
and be withdrawn from it immediately. 
 
(iv) I consent to the processing of my personal information for the purposes 
explained to me.  I understand that such information will be handled in 






agree that the research project named above has been explained to me to my satisfaction 
and I agree to take part in the study. I have read both the notes written above and the 
Information Sheet about the project, and understand what the research study involves. 
 






confirm that I have carefully explained the nature, demands and any foreseeable risks 
(where applicable) of the proposed research to the volunteer. 
 
 
























11.19 Main study screening questionnaire 
Participants name:     Hospital Number:     
DOB:   
  
Statement: Most research projects recommend that certain patients don't participate 
in a specific study. This is usually for ethical or medical reasons. We will ask everyone 
participating in this study the following questions.  
 
Are you younger than 18 years of age?      Yes No 
Are you older than 65 years of age?      Yes No 
 
Are you pregnant, suspect you are pregnant, or attempting to become pregnant? 
          Yes No 
Do you have any difficulty reading, writing, or communicating in English? Yes No 
 
Have you had any treatment for your low back pain including: physiotherapy, 
osteopathy, chiropractic, injections, surgery in the past 12 months?  Yes No 
 
Is there any reason why you would not be able to attend an exercise class? Yes No 
 
Are you involved in any ongoing litigation regarding your back pain?  Yes  No 
 
Have you ever worn rocker sole trainers?     Yes No 
 
Have you been involved in a research study in the past 12 months  
involving any musculoskeletal pathology especially the lower back?  Yes No 
Have you been diagnosed with ANY of the following: 
• Constant pain?        Yes No 
• Known spondylolysthesis?      Yes No 
• Severe structural deformity?      Yes No 
• Severe osteoporosis?       Yes No 
• Fracture of the spine within the last year?    Yes  No 
• Inflammatory disease of the spine?      Yes No 
• Spinal infection?       Yes No 
• Spinal stenosis?        Yes No 
• Pins and needles, numbness or generalised weakness in your legs? Yes No 
• Severe cardiovascular disease?      Yes  No 
• Severe metabolic disease?      Yes No 
• Previous spinal surgery?      Yes  No 
• Surgery to the lower limb in the past 8 weeks?    Yes No 
• Diagnosed tumour?       Yes No 
• Peripheral neuropathy?       Yes No 
• Morton’s Neuroma?       Yes No 
• Skin ulcerations over the foot?      Yes No 
• History of unexplained falls?      Yes No 
• Recent Deep Vein Thrombosis (DVT)?     Yes No 
 






11.20 Main study participant information sheet 
 
 
1 .PARTICIPANT INFORMATION SHEET  
V 2.    Date 28.01.2009 
 
2. Study title 
Low back pain: Can shoe type reduce the pain and recurrence rate? 
RREC No: 09/H0706/4 
 
Evidence exists that suggests footwear type may play a role in activating the small 
muscles of the back making them stronger and in doing so reduce back pain and the 
recurrence of repeated episodes of back pain. 
 
3. Invitation paragraph 
 
You are being invited to take part in a research study that is aiming to investigate the 
benefit of different footwear types in the treatment of low back pain. 
 
Before you decide to participate it is important for you to understand why the research 
is being conducted and what it will involve. Please take time to read the following 
information carefully and discuss it with friends, relatives and your GP, Consultant, or 
the Chief Investigator of the study, if you wish.  Please ask us if there is anything that 
is not clear or if you would like more information.  Please take time to decide whether 
or not you wish to take part. There will be no difference in waiting times for your 
treatment if you decide that you do not wish to participate in this research study. 
Please let us know if you are currently participating or have recently participated in 
another research project. If you have, it may not be appropriate for you to consider 
participating in this study. 
 
4. What is the purpose of the study? 
 
Research studies have clearly shown that exercise and rehabilitation is beneficial for 
the majority of patients with low back pain. Research also suggests that shoe type 
may be influential in reducing the stresses that pass up through the spine, improving 
muscle activation around the spine, and in doing so may further help to facilitate an 
improvement in outcome for patients with low back pain. There is, however very little 
guidance as to the best type of footwear to achieve these effects. Recommendations 
have included flat sole sport shoes, and rocker sole sport shoes (these are shoes that 
have a slight curve on their sole). Although both shoe types are designed to reduce 
forces through the spine, it is not known as to which shoe type is more effective at 
doing this. 
  
What we are aiming to achieve in this study is to determine if the addition of wearing 
either a flat sole sport shoe or a rocker sole sport shoe to traditional physiotherapy 










5. Why have I been chosen? 
 
Most probably you will be reading this document because you have low back pain 
and will be offered a physiotherapy exercise programme for your pain as part of the 
normal treatment for your condition.  
 
We are approaching you because we would like you to consider taking part in a 
research study that is being conducted in the physiotherapy department. The study 
will involve measuring the effectiveness of treatment in 2 different treatment groups 
for patients suffering with lower back pain. Group 1: Rocker sole sport shoes and 
exercise, and Group 2: Flat sole sport shoes and exercise. 
 
It is up to you to decide whether or not to take part.  If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form 
before the study starts.  If you decide to take part you are still free to withdraw at any 
time and without giving a reason.  Refusal to participate or subsequent withdrawal will 
not affect the standard of care you receive. 
 
 
8. What will happen to me if I take part? 
 
Research studies have demonstrated that exercise therapy is very effective for the 
treatment of low back pain. In the physiotherapy department we have developed a 
specialized low back pain rehabilitation programme. The low back pain rehabilitation 
programme in the physiotherapy department is normally 4 treatments, each of 
approximately 1 hour, over a 4 week period. This programme is given as a group 
treatment where you will be with up to 9 other people (10 in total) who are also 
suffering from low back pain. The programme is run by two experienced 
physiotherapists. The group is a specialised programme and involves education and 
exercises based on current research evidence. In addition to attending the low back 
rehabilitation class you will be requested to continue with the exercises at home. This 
is to maximize the benefit of the rehabilitation programme. We carefully select 
patients to participate in our group programme and certain people cannot participate, 
for example, if you are pregnant, or if you have had surgery to your lower limbs in the 
past 12 weeks. People with low back pain who are ineligible to participate in the 
group receive alternative treatment. 
 
If you are eligible for both the rehabilitation programme and for the research study 
and you choose to participate in the research study, you will be asked to wear either 
rocker sole sport shoes or flat sole sport shoes during the period of time that you are 
involved in the rehabilitation programme (i.e. 4 weeks) and for the following year. You 
will be requested to gradually increase the amount you wear the shoes from 1 hour 
per day, to two hours per day, to three hours per day, etc. You should aim to wear the 
shoes for at least two hours each day. This is important because we are trying to 
determine which shoe type might improve your low back pain condition, and we need 
you to wear the shoes for this period of time. We also ask that for the majority of the 
time that you are wearing the shoes, you are performing upright activities e.g. walking 
or standing. We will provide the shoes for you and you may keep the shoes after the 
study is complete.  You will be required to document daily, the number of steps you 
have taken in the shoes. You will be provided with a diary to record your daily number 
of steps. The number of steps will be counted by a pedometer. You will also be asked 












The low back exercise class time is set at the same time each week. This is to 
facilitate a regular period of time between each class and to ensure all the necessary 
equipment and teaching information is available at each class. If you agree to 
participate you will be required to attend the hospital once a week for a period of 4 
weeks to attend the classes. 
 
If you are eligible and choose to participate in this study you will be requested to 
complete a number of questionnaires about your low back pain. These questionnaires 
take approximately 20 minutes to fill in and involve placing a tick or mark next to an 
answer that you feel is the most appropriate. We will also measure how much 
movement there is in your lower back. These are routine tests performed by 
physiotherapists to assess the function of the lower back. 
 
As this is a research study you will not be able to choose which group you will be in. 
This is to ensure that strict research standards are adhered to. If you agree to 
participate and after you have had your first series of tests with the chief investigator 
you will then meet with another researcher. It is only at this time you will know which 
group you will be in. The chief investigator will not be informed as to which group you 
have been allocated into. It will not be possible to change the group you are allocated 
to. You will then be fitted with either a pair of rocker sole sport shoes, or flat sole sport 
shoes. You will then be instructed how to walk effectively in the shoes, and how to 
use the pedometer, which will monitor the number of steps you take in the 
investigation period. 
 
As this is a research investigation and we want to learn what is the most effective way 
to treat low back pain, we will ask your permission to measure your low back 
movements, amount of pain and to complete questionnaires on a further 3 occasions. 
This is to determine how the different treatments have affected you over time. The 
chief investigator will conduct all 3 re-assessment sessions. It is important that you do 
not let the chief investigator know which group you have been allocated to at any of 
these reassessment sessions. 
 
We will request that you allow us to measure your range of movement, pain levels 
and to complete questionnaires at the following times: 
 
(1) Before you start the lower back rehabilitation programme. 
(2) At the end of the 4 week lower back rehabilitation programme. 
(3) 6 months after joining the study 
(4) 12 months after joining the study 
 
That is four times in total (each time should take no more than 45 minutes).The 
measurements will be made in a private treatment area.  
 
During the course of your treatment hospital transport will be provided for anyone 
requiring this service who meets the Trusts transport regulations. As we are asking 
you to return 6 months and 12 months after your treatment ceases we will reimburse 
your local travel costs if required. 
 
The following table summarises the required involvement for this study for those 






 Consent form 














(4 weeks in total) 
Post treatment  
follow-up 
Immediately 
following your last 
hospital treatment 
 
(This will not require 
an additional visit – 
just an additional 30 
minutes to complete 
forms and undergo 
assessment 











OF VISITS TO 
HOSPITAL 









1 low back 
rehabilitation 
group  per week 
of one hour for 4 
weeks 
 
That is 1 hospital 














group and  




1 lower back 
rehabilitation 
groups per week 
of one hour for 4 
weeks. 
 
That is 1 hospital 











Please note: If you already know that you will not be able to attend the programme 
once a week for four weeks, or that you may be moving abroad during the next year, 
we would request that you do not offer to participate. The reason for this is that all 
scientific investigations require that a certain number of people are followed for the 
entire time of the study. If there are not enough people at the end of the time period 
then the results of the study may not be of any meaning.  
 
However, please remember that you are free not to participate and you are free to 
leave the study for whatever reason you choose at any stage. Your decision to leave 
the study will not affect the quality of care you receive. 
 
It is important for you to know that there will be no difference in the waiting times for 
the lower back rehabilitation group for those agreeing to participate in this study and 
those not wishing to participate. 
 
9. What do I have to do? 
The first thing you need to do is decide if you would like to participate or not. This is 
entirely your decision and deciding not to participate will not affect the quality of your 
care. If you do decide to participate you will need to follow the procedure outlined in 








10. What is the procedure that is being tested? 
We are trying to determine if the addition of wearing a rocker sole sport shoes or flat 
sole sport shoes in addition to a specialised low back rehabilitation exercise group 
further helps to reduce pain and improve function. 
 
We will be investigating this in a randomised clinical trial. This means that people 
participating in this trial will be randomly allocated into one of two groups; Group 1 
(exercise and rocker sole sport shoes), and Group 2 (exercise and flat sole sport 
shoes). It is desirable that the two groups in this study should be as similar as 
possible with regards to characteristics that might influence the response to 
treatment. Randomisation is used to ensure that equal numbers of participants with a 
characteristic thought to affect the response to a particular intervention will be 
allocated to each of the two groups. To ensure the scientific integrity of this 
investigation a computer programme will determine your group allocation. You will not 
be able to choose the group you are allocated to. You will have a 1 in 2 chance of 
being placed in the exercise and rocker sole shoe group (Group 1), and a 1 in 2 
chance of being placed in the exercise and flat sole shoe group (Group 2). 
 
8. What are the side effects of taking part?  
Some participants may find the physical tests (range of movement) for the lumbar 
spine produces some pain. In most cases this will be similar to the pain experienced 
in their back. The tests are used clinically to help determine which structure or 
structures are involved in their symptoms and are an essential part of the assessment 
procedure. We also perform these tests to see if you are improving as a result of the 
treatment you have received. 
A subject walking in their new shoes may initially be aware of increased low back 
pain. Subjects walking in these shoes may attain a slightly different posture than 
normal. This can lead to an increased activation of the lower back muscles. When 
muscles start to work harder they can be painful. This should normally resolve within 
a few days. Additionally, a burning sensation may be experienced by certain 
individuals whilst wearing new shoes. This is due to increased blood flow to the small 
muscles in the foot. This should settle after a few weeks. Sensations such as pins 
and needles, sweaty feet and numbness may occur initially and will subside after 
wearing their shoes for a few days. 
Participation in the exercise classes may also lead to an initial increase in discomfort. 
This is a well recognised phenomenon in any individual undertaking a new exercise 
programme and is known as delayed onset muscle soreness. It normally settles after 
a few days. If during the study your back pain symptoms worsen and do not settle 
after a few days, or you become aware of new symptoms, you are advised to contact 
the Chief Investigator, or your GP.  
As with any new footwear, participants may develop blisters as a result of wearing 
either shoe type. 
 
You may discuss any concerns you have with the clinical investigator, Siân MacRae, 







9. What are the possible disadvantages and risks of taking part? 
There are no perceived disadvantages or risks for those taking part in this study. The 
examination procedures and treatment procedures are ones used daily in 
physiotherapy clinics. 
10. What are the possible benefits of taking part? 
 
We do not currently know the most effective treatments for low back pain and we 
hope that this research will help us understand the best way to treat this problem. 
However, as with all research, this cannot be guaranteed.  
 
All participants will be at liberty to keep their shoes at the end of the study if they wish 
to do so. A pair of the more advantageous shoes, if found, will be given to all subjects 
at the end of the study. 
 
11. What if something goes wrong? 
 
We do not anticipate that anything will go wrong in this study as we are not trying any 
new procedure, we are simply investigating, in a scientific manner, the benefit of 
treatments currently received by people with low back pain. 
However, if you are harmed by taking part in this research project, there are no 
special compensation arrangements. If you are harmed due to someone’s 
negligence, then you may have grounds for legal action but you may have to pay for 
it. Regardless of this, if you wish to complain about any aspect of the way you have 
been approached or treated during the course of this study, the normal NHS 
complaints mechanisms are available to you. 
12. Will my taking part in this study be kept confidential? 
 
All information that is collected about you during the course of the research will be 
kept strictly confidential.  Any information about you which leaves the hospital/surgery 
will have your name and address removed so that you cannot be recognised from it. 
If you do participate your GP (and Consultant, if appropriate) will be sent a letter 
notifying them of your participation in this study (if you give your permission for this 
letter to be sent). 
 
 
13. What will happen to the results of the research study? 
 
We hope to use the information we obtain from this study to inform other health 
professionals about our results. We therefore ask your permission to publish the data 
we obtain. However, we guarantee to keep your name and identity confidential and 
this will not be made available to anyone at any stage. The results will probably be 
published about one year after the end of the study and if you are interested in finding 











14. Who is organising and funding the research? 
 
This research is being organised by the Department of Physiotherapy at the Chelsea 
and Westminster Health Care NHS Foundation Trust. It has been funded by a 
research grant from MBT Physiological Footwear. 
 
 
15. Who has reviewed this study? 
 
This study has been reviewed by external experts. In addition it has been reviewed by 
the Hospitals Research and Development Committee and the Riverside Research 
Ethics Committees. 
 
16. Contact for further information 
 
If you would like any further information about this study, please feel free to contact 
Siân MacRae, Senior Physiotherapist, on telephone number 07504 294 858. 
Additionally, if you are a patient and decide to participate in this research we will also 
ask you if you would like us to send a letter to your GP or consultant, informing them 
that you are participating in this study. We will also go through a series of screening 
questions to ensure that for ethical and healthcare reasons it is appropriate for you to 
participate in this study 
 
17. After you have read this information sheet 
If you think you would like to participate in this study please take time to think about 
your involvement. You might find speaking to family and friends and other healthcare 
professionals helpful. If you do decide to participate we will ask you to fill in and sign a 
Research Consent Form, in front of someone who will witness the signature. 
If you agree to participate you will be given a copy of this information sheet and a 
copy of the consent form you signed. If you are a patient and do not wish to 
participate then your physiotherapist will organise a course of treatment for you. 
 



























































DR JEREMY LEWIS 






















11.22 Standing and walking instructions for study shoes 
ROCKER SOLE SHOE (wording as recommended by shoe manufacturer) 
Walking Technique: 
“Begin by walking naturally on a flat surface.” 
Cues: 
- (Good speed):  “Walk at a brisk pace.” 
- (Short steps):  “Shorten the stride length.” 
- (Good posture) “Walk with good posture…” 
o (Draw up crown of head):  “Lengthen your spine by drawing the crown of 
your head up.)  
o (Proper gaze):  “Look straight ahead.”  
o (Tummy in):  “Pull your lower abdominal muscles in to help activate your 
core stability.” 
o (Shoulders back):  “Bring your shoulders back and in line with your ears and 
hips.” 
- (Swing arms with proper trunk movement):  “Gently swing your arms and move 
your torso as you walk.” 
- (Roll through):  “Make sure you roll through the feet with every step.” 
o (Demonstrate proper roll through) 
o (Demonstrate where the heel sensor should hit):  “Your foot should contact 
at the heel.  As your foot rolls through from heels to toes, roll through the 
centre of the foot.  When your foot pushes off, the weight in your toes 
should be evenly distributed so that the pressure is from the middle rather 








- (Foot position):  “Stand with your feet parallel and shoulder width apart.” 
- (Rock through the feet):  “Roll forwards and backwards through the feet and 
ankles… 
- (Find the Pivot Area): “…feeling the pivot area just in front of the heels.” 
- (Heels and toes off floor): “Come to rest on the Pivot area.  You should feel that 
your heels and toes are slightly off the floor.” 
- (Posture):  “Draw up your posture, lengthening your spine, gently drawing your 
shoulders back and softening your knees.” 
Correction of Wrong Technique:  “When wearing your shoes, certain mistakes can occur.  
Be aware that you are walking properly in your shoes to gain the maximum benefit.” 
- (Watching feet):  “Do not watch your feet or the floor – look straight ahead when 
wearing your shoes.” 
- (Slouched posture):  “Walk and stand with good posture at all times.” 
- (Poor core control):  “Remember to engage your core muscles.” 
- (Stiff arms):  “Walk with a relaxed, natural gait letting your arms swing gently and 
your torso move.” 
- (Over-pronation):  “Do not let your feet roll in when you stand or walk.” 
- (Flat foot-strike):  “Roll through the foot to get the full benefit of the shoes.” 
- (Pain): “Walking should feel comfortable and natural.  If you have pain, stop and 
check your technique or consult with your physiotherapist.” 
Fitting: “Always make sure your shoes are snug on the instep, tight on the heel and 
comfortable on the toes.” 
- Should not:  “Your shoes should not slip at all, squeeze or rub the toes, press on the 





- General medical precautions:  “When you first start wearing your shoes you may 
experience certain short-term effects.  These include tingling in the feet and toes 
and general aches in the muscles.  These effects normally stop within one to two 
weeks of wearing them.” 
- Build up the amount of time you wear your shoes:  Start wearing the shoes for 15 
to 30 minutes per day building up daily over the first week to two hours.  Progress 
only as your comfort allows, to wearing a minimum of two hours per day. 
- Comfort:    If you encounter any problems with wearing your shoes, please contact 





FLAT SOLE SHOE (wording altered from rocker sole shoe instructions above to apply to 
the flat sole shoe)   
 
Walking Technique: 
“Begin by walking naturally on a flat surface.” 
Cues: 
- (Good speed):  “Walk at a normal pace.” 
- (Normal stride):  “Walk with your normal stride length.” 
- (Good posture) “Walk with good posture…” 
o (Draw up crown of head):  “Lengthen your spine by drawing the crown of 
your head up.)  
o (Proper gaze):  “Look straight ahead.”  
o (Tummy in):  “Pull your lower abdominal muscles in to help activate your 
core stability.” 
o (Shoulders back):  “Bring your shoulders back and in line with your ears and 
hips.” 
- (Swing arms with proper trunk movement):  “Gently swing your arms and move 
your torso as you walk.” 
- (Roll through):  “Make sure you roll through the feet with every step.” 
o (Demonstrate proper roll through) 
o (Demonstrate where the heel should hit):  “Your foot should contact at the 
heel.  As your foot rolls through from heels to toes, roll through the centre 









- (Foot position):  “Stand with your feet parallel and shoulder width apart.” 
-  (Heels and toes on floor): “You should feel that your weight is evenly distributed 
over both feet.” 
- (Posture):  “Draw up your posture, lengthening your spine, gently drawing your 
shoulders back and softening your knees.” 
Correction of Wrong Technique:  “When wearing your shoes, certain mistakes can occur.  
Be aware that you are walking properly in your shoes to gain the maximum benefit.” 
- (Watching feet):  “Do not watch your feet or the floor – look straight ahead when 
wearing your shoes.” 
- (Slouched posture):  “Walk and stand with good posture at all times.” 
- (Poor core control):  “Remember to engage your core muscles.” 
- (Stiff arms):  “Walk with a relaxed, natural gait letting your arms swing gently and 
your torso move.” 
- (Over pronation):  “Do not let your feet roll in when you stand or walk.” 
- (Flat foot-strike):  “Roll through the foot to get the full benefit of the shoes.” 
- (Pain): “Walking should feel comfortable and natural.  If you have pain, stop and 
check your technique or consult with your physiotherapist.” 
Fitting: “Always make sure your shoes are snug on the instep, tight on the heel and 
comfortable on the toes.” 
- Should not:  “Your shoes should not slip at all, squeeze or rub the toes, press on the 
tips of your toes, rub against the ankle bones or cause you any pain. 
- General medical precautions:  “When you first start wearing your shoes you may 





and general aches in the muscles.  These effects normally stop within one to two 
weeks of wearing them.” 
- Build up the amount of time you wear your shoes:  Start wearing the shoes for 15 
to 30 minutes per day building up daily over the first week to two hours.  Progress 
only as your comfort allows, to wearing a minimum of two hours per day. 
- Comfort:    If you encounter any problems with wearing your shoes, please contact 






11.23 Participant assessment sheet 
Assessment No: ……… SUBJECT No: …………… 
MALE/FEMALE Weight: ……………………..Kg     Height/cm: ………….. 
D.O.B:   ………………………  BMI:…………………………    
Duration of symptoms: ………………………… Constant/Intermittent: …………………. 
 
Previous conservative treatment: 
…………………………………………………………………………………………………………………………………. 
Present analgesic requirement: 
……………………………………………………………........................................................................ 
Main functional problem: …………………………………………………………    Score: ……… / 10 
 
 Reading 1 
 





     
Lumbar 
Extension /cms 
     
Lumbar 
RSF /cms 
     
Lumbar 
LSF /cms 
     
Right SLR  
/degs 
     
Left SLR 
 /degs 
     
Thoracic kyphosis 
angle/degs 
     
Waist 
circumference/cms 
     
Name of Assessor: ………………………………….   Signature of Assessor: ……………………….... 





11.24 Low back pain group exercises 




1: Beginner Lie on back with knees bent, 
feet flat on floor, and hands 
under small of back. Slowly 
raise one foot a short distance 
from the floor, bringing knee 
towards you. Then slowly lower 





2: Intermediate As beginner. 
 
Raise foot from floor bringing 
knee closer to chest, slowly 




3: Advanced As intermediate. 
 
Maintain position for 5 seconds, 
pressing opposite hand into 






1: Beginner On hands and knees. Raise one 
arm or leg at a time to the 
horizontal. Keep back still – do 







2: Intermediate As beginner. Now raise 
opposite arm and leg together, 
do not raise past horizontal.  Do 
not let back arch or dip. Hold 





3: Advanced As intermediate. Now sweep 
opposite hand and knee 
together and repeat – don’t let 









CLAM 1: Beginner Lie on your side. Keeping your 
back straight, bend knees to 90 
degrees keeping thighs in line 
with your body. Raise your top 
knee from your lower knee by 
squeezing bottom muscles 







Straighten your top knee. Raise 






3: Advanced As intermediate. 
 
Raise top leg and pulse leg up 
and down. Remember to draw 




BRIDGING 1: Beginner Lye on your back, arms by sides, 
and knees bent. Squeeze 
buttocks, raise and lower pelvis. 





2: Intermediate As beginner. Now place arms 
across your chest. Squeeze 
buttocks, raise and lower pelvis. 






3: Advanced As beginner. 
 
Straighten one leg. Squeeze 
buttocks, raise pelvis up and 















2: Intermediate On hands and knees, bend 
elbows, lowering head to the 
floor. Keep low back still. 
 
  
3: Advanced Move knees further away from 
hands, progressing to full press-
ups. Keep low back still. 
 
 














3: Advanced Raise arms above head as step 













2: Intermediate Sit to stand from low 











3: Advanced Sit to stand on one leg/or hold 








1: Beginner Stand with weight in each hand 






2: Intermediate As beginner, but sitting on gym 







3: Advanced Sit on ball and raise one leg 








1: Beginner Stand as still as possible on 
surface (2 legs), keeping all 
edges off the floor 
 
2: Intermediate Standing on one leg – keep as 
still as possible, keeping all 
edges off the floor. 
3: Advanced Stand on wobble-board, throw 
and catch ball. 
EXERCISE BIKE 1: Beginner Pedal slowly 
 
 
2: Intermediate Increase speed 







11.25 Low back pain group education sessions 
1 : EXERCISE 
 
WHY DO WE EXERCISE? 
 
1. Regain movement/function 
2. Maintain or gain general physical fitness i.e. loose weight. 
3. Maintain or improve movement/function i.e. training for specific 
reason/event. 
4. Enjoyment. 
5. Social interaction. 
6. Sense of achievement. 
 
THE NORMAL EFFECTS OF EXERCISE ARE: - 
 
1. Increased heart rate. 
2. Increased breathing rate. 
3. Increase in temperature. 
4. Sweat. 
5. Muscle Fatigue. 
 
Exercise also stimulates the body to release endorphins, which are the 
body’s natural painkillers, thereby reducing pain and increasing your 
pain thresholds (i.e. the level at which you feel the pain). 
 
WHY WARM UP? 
 
1. Prepare the body for exercise especially heart and lungs. 
2. Increase circulation to muscles. 
3. Reduce risk of injury to the muscles during the exercises by 
stretching. 
Stretching should be performed once the muscles have been 
warmed up to prevent injury. 
 
POINTS TO REMEMBER WHEN STRETCHING 
 
1. Do not bounce, but push gently into the stretch. 
2. Hold each stretch for at least 10 seconds. ( increase to 30 





3. You should feel no pain; the muscle tension should “give” the 
longer you hold the stretch. 




Pain over a period of time reduces activity levels and creates a ‘fear’ of 
exercise.  To avoid an increase in your symptoms it is important to do 
appropriate exercise, as too much of the wrong exercise can increase 
pain and reinforce the idea that movement is causing harm.  It is likely 
that you are experiencing “deconditioning” i.e. that there is reduced 






     
 
 





Appropriate exercise will help to break this cycle. 
 
1. Set an achievable number of exercises or time yourself. 
 
2. Regulate your daily exercises to balance exercise and rest to 
avoid exacerbating your pain. 
 
3. Set aside a regular time to do your exercises. 
 
4. Make achievable goals for the following week, to gradually work 
towards your final aim. Progress the number of repetitions, 

















5. Pick an exercise you enjoy and are likely to continue.  
 
 
2: DEALING WITH FLARE UPS 
  
 What is a flare up? 
 A flare up is a temporary increase in pain or return of symptoms. 
 
 How long do they last?  
 This varies but can be anything from a few hours to a couple of 
weeks. 
 
 What symptoms are normal to experience? 
The symptoms are different for everyone but can include pain, 
swelling, stiffness, spasm, weakness, tingling, burning, aching, or 
locking. 
 
 Why do I get flare ups? 
It is usually because you have done too much or too little.  Most 
people can think back to a change in activity, or a situation, where 
they did too much or something new. eg gardening for a day, or it 
may just be a combination of things that could have caused a flare 
up.  Colds, flu, stress and anxiety and lack of exercise can all lead to 
flare ups.   
  
 Have I damaged myself? 
No! If you ran a marathon without training for it, you would expect to be 
very sore for a few days afterwards. This is not damage but normal 
training pain as your body has worked outside of its normal tolerance. 
Athletes gradually building up their marathon training week by week for 
weeks/ months to help minimise  pain. This is called pacing – a gradual 
return to activity so the body can adjust and strengthen in preparation. 
Remember even though you used to be able to do certain activities you 





Suggested strategies for a flare-up plan 
 
Don’t panic! 
 Any added stress or tension will build up in the muscles; 
sore joints will feel worse if tense muscles are 
surrounding them.   
 Try the relaxation and breathing exercises you have 
learnt to allow the muscles to let go.  
 It has happened before and you have got through it! 
 
 
Challenge unhelpful thoughts 
 
 A flare up can be a worrying time and it is important not 
to let negative thoughts hinder your progress.   
 Remember, pain does not necessarily mean damage and 
hurt does not always mean harm.   
 Setbacks are a common part of the recovery process and 
will give you valuable information about your body and 
its tolerance levels.  
 Don’t be discouraged! Remember your flare up will pass. 
 
Pacing /plan your day  
 
 If possible, rearrange activities to allow you to pace more 
effectively.  This is often the hardest bit!  
 Try and keep at least one pleasure activity. 
 
 
Use heat or ice 
 
 Muscle spasm is often the main source of pain during a 
flare up; it is the body’s way of protecting itself although 
sometimes it can be an over-protective.   
 Heat is often helpful to release painful muscle spasms 





 Cold packs are considered better for initial acute pain 
and the cold will help settle any temporary inflammation 
that has occurred.   
 Long term inflammation is not helpful so it is important 




 Tight muscles are a common source of unnecessary pain.  
It’s important to gently stretch these out as soon as 
possible.   
 Gentle controlled stretching can help release any muscle 
spasm. It helps if your muscles are warm before you 
stretch them. After a bath or gentle activity is good.  
 
Gradually Restore Full Movement 
 
 To avoid movement as a result of pain is often the worst thing you 
can do.   
 Give the body the right message that movement is good by 
continuing your exercises.  
 Resist the temptation to avoid anything that may bring on the pain. 
 By all means adjust how far you move into the exercise - 
try and stick to the numbers even if you are not moving 
as far. 
 As a last resort if you are not managing – reduce the 
number of exercises to half but immediately plan a 
gradual build up back to your normal amount over the 
next 5 days. 
 
 
It takes patience and confidence to keep going, without overdoing it. It is 









Acute and Chronic Pain 
 
 Acute Pain is the pain we feel immediately after injuring 
ourselves and while the injury is healing, i.e. touching a hot 
object.  
 Chronic pain is pain that continues even though healing has 
occurred, or pain that has been present for more than 3 months. 
 
How We Feel Pain – Acute pain 
 
 We have sensors (receptors) in our skin, ligaments, muscles, 
joints and other structures in our body.   
 These all have different functions – they are activated when there 
is heat, pressure, stretch, and also strong input. 
 The information from the tissues is sent along nerves, via the 
spinal cord, to the brain which interprets the message. 
 When the nerve itself is irritated it can give symptoms such as 
pins and needles, numbness, burning or shooting sensations. 
 Acute pain is helpful – it makes us take things easy to allow 
healing to occur. 
 
How We Feel Pain – Chronic pain 
 
 With chronic pain the link between pain and damage is 
complicated. 
 It is not unusual to find no direct link between your pain and the 
original damage which may have long healed. 
 Chemical changes happen in the brain and spinal cord to re-route 
signals to pain centres in the brain.  
 Normal sensation – movement, touch, pressure, stretch, hot, cold 
can therefore all be felt as pain. 
 Sometimes the pain system can be activated without even any 
physical stimulus – by changes in the weather, by mood and 
thoughts or even no stimulus at all… 








What makes your pain worse?  
 
 If you are able to recognise all the different factors that can 
contribute to your pain experience, you can learn techniques to 
deal with them better. For example: 
  
o Physical demands on your body (over exertion) 





o Low mood 
 
Turning the pain up and down  
 
 Have you ever had an injury and not felt it at the time? 
 The nervous system is very good at filtering information. 
 In extreme situations, such as danger, your brain and spinal cord 
have to filter out what it doesn’t consider as important at the 
time - it can filter out pain signals. 
 It releases natural pain killing chemicals into the blood stream 
and these can damp down and reduce the pain signals. These 
include Endorphin, Encephalin and Serotonin. 
  The natural pain killing system doesn’t just occur in an 
emergency. In normal life, when you are not stressed and are in 
control of your pain, the brain also releases these pain killing 
chemicals into the bloodstream. 
 However the nervous system may see pain as a threat and can 
trigger a state of alertness, which is a type of stress response.  
 In this state of alertness it will look out for any pain signals and 
odd sensations throughout the body. It can choose to highlight 
this information as pain information, instead of filtering it out. 
 When this occurs the brain stops releasing the natural pain killing 
chemicals and releases other hormones, such as adrenalin, into 
the bloodstream.   
 In the long term, this stress response can make your pain worse. 
It can cause changes to muscle tension, blood pressure, breathing 





 Clinical research has clearly shown that the more you are 
unaware of why you have pain, the less confident you are to deal 
with it; the more worried you are about your pain, the more you 
will activate your brain’s pain centres and the more you will 
switch off your brain’s painkilling system.  
 Conversely, the more confident you are to deal with your pain, 
and the more you are in control of it, the more you will activate 
your brain’s painkilling system. 
 
Techniques to help manage your pain 
 
 We can produce more of our own pain killers two ways: 
exercise and relaxation 
 Clinical research has clearly shown that the ability to relax deeply 
is vital to our emotional well-being and physical health.  
 As the pace of modern life continues to accelerate, relaxation 
may be used as a simple way of reducing tension, stress and 
anxiety.  
 It can also be an extremely effective tool in the management of 
chronic pain. 
 You can get similar benefits from doing activities you enjoy: 
o Going for a walk in the fresh air 
o Exercising 
o Singing 
o Going out and seeing friends 
o Having hobbies and interests 
 
Pain and Sleep 
 
 You will often experience greater levels of stress and pain when 
you are tired so it is important to get restful sleep.  
 Bedtime is a time with fewer distractions so worrying negative 
thoughts have the opportunity to come through.  
 Here are some suggestion to aid more peaceful sleep: 
o Exercise, particularly in the afternoons, can enhance sleep.  
o Use your bed and bedroom for sleep only.  
o Before going to bed, write down any problems of the day 
or unfinished tasks and note the next action to be taken 
(unfinished business like this can disturb sleep). 





o If you wake up in the night worrying, write it down to deal 
with the next day.  
o If you are lying awake for say 20 mintues, don’t clock watch 
– get up and do something relaxing.  
o If you are not tired when you go to bed, get up earlier in 
the mornings.  
o Quality of sleep before midnight is better than that late 
into the morning.    
Pain and Posture 
 
 Postures are partly developed genetically but are also altered by 
the environment and our lifestyles. 
 Maintaining ANY position or activity for too long builds up 
stresses on our joints and soft tissues (ligaments, muscles, 
nerves) which can cause pain. 
 Your body needs to have a healthy balance of strength and 
flexibility. 
 Joints and the surrounding soft tissues need to move and stretch 
regularly to maintain strength and flexibility otherwise they get 
short and tight, or long and weak.  
 Short muscles can become overactive and long muscles don’t get 
'switched on' as easily; the surrounding area becomes less well 
supported and is vulnerable to pain. 
 Many people who maintain one position for hours at a time 
sitting at a computer for example can develop back, neck and 
shoulder pain.  








WHY DO WE NEED TO RELAX? 
 
 To decrease levels of stress/tension in the body 
 To decrease pain 
 To decrease fatigue 
 To improve sleep patterns 
 
PROLONGED TENSION  CAUSES: 
 
 Aches, discomfort, tiredness 
 Stiff movement 
 Worry, frustration, irritability and stress 
 
LEARNING TO RELAX CAN ALSO HELP: 
 
 Reduce blood pressure 
 Reduce heart rate 
 
HOW TO LEARN TO RELAX: 
 
 Allow yourself time each day to learn how to relax 
 Give yourself quiet time to relax 
 Using music or a relaxation tape may help 
 Find a comfortable position and close your eyes 
o In this position practise deep breathing. Concentrate on 
feeling your ribs rise and fall for a few breaths. 
o Then tense each part of your body in turn for a count of 10. 
Do this as you breathe in, and feel the tension. Then 
breathe out and let the muscles relax. 
 Toes  - curl toes towards the floor 
 Calves – point toes away from you 
 Buttocks – clench your buttocks 
 Stomach – squeeze stomach muscles 
 Shoulders – shrug shoulders to ears 
 Neck – press your chin in your chest 
 Face – screw up your face 








Sit back comfortably in a chair, or lie down, so that your body is well 
supported. Close your eyes to shut out distractions. Listen to the sounds 
around you and identify them. If you identify the sounds, they will not 
intrude. 
 
Now be very aware of the support for your body. Feel the contact with that 
support. Feel that it is safe enough for your body to let go. Notice your feet, 
be aware of their position, where they are pointing and where they are 
touching the ground. Scrunch up your toes, hold it briefly and let go. Feel 
your calves and back of your knees. Tighten your knee muscles then let the 
tension ease out of them. They should feel relaxed and light. Feel the contact 
between your hips and thighs to the contact surface. Now gently tighten 
those muscles and let that tension drop away. Feel the position of your back 
on the supporting surface, you can feel the curves and pressure through your 
back and feel that it is safe to let it go. 
 
Next, feel your breathing. Feel that your rib cage is relaxed and able to gently 
rise and fall. Feel each breath go into the base of your lungs and gently pass 
out through your mouth. 
 
Now, feel the position of your arms. Where are your hands? Feel each finger 
tip. What is the texture under your hands? Squeeze your fingers together and 
let go. Be aware of your elbows and tighten gently your arm muscles for a 
few seconds and let go. When the elbows feel supported, feel how your 
shoulders let go. Pull the points of your shoulders up to your ears. Feel the 
activity in the muscle and gradually let the muscle go so that your shoulders 
sink down towards your waist. 
 
Now, feel the support for your head. Let the pillow or contact surface take 
the weight of your head. Tighten your neck muscles by ‘nodding yes’ and 
then let all tension subside. Lastly, be aware of your face. Let your 
expressions drop to a neutral resting position. Scrunch up your forehead and 
scalp. Hold this briefly and let the tension fade away. Your eyes should now 
be effortlessly held shut. Scrunch up your nose and mouth – again hold the 
tension briefly then feel able to let the muscle activity level drop down to 
nothing. 
 
Notice your jaw – let it sag a little and allow your teeth to separate a bit. 
When your jaw is loose, your cheeks will be soft. Now lie there for a few 






11.26 Biomechanics study participant information sheet 
for studies in Chapter 7 and 8 
PARTICIPANT INFORMATION SHEET 
V 2.    Date 09.03.2010 
 
1.  Study title 
Low back pain: Can shoe type reduce the pain and recurrence rate? A 
biomechanical assessment. 
REC No: 10/H0724/7 
 
2. Invitation paragraph 
 
You are being invited to take part in a research study aiming to investigate the 
potential beneficial mechanisms that may be involved in the short and longer 
term use of different footwear types in the treatment of low back pain. Before 
you decide to participate it is important for you to understand why the research 
is being conducted and what it will involve. Please take time to read the 
following information carefully and discuss it with friends, relatives and your 
GP, Consultant, or the Chief Investigator of the study, if you wish.  Please ask 
us if there is anything that is not clear or if you would like more information.  
Please take time to decide whether or not you wish to take part. There will be 
no difference in waiting times for your treatment if you decide that you do not 
wish to participate in this research study. Please let us know if you are 
currently participating or have recently participated in another research 
project. If you have, it may not be appropriate for you to consider participating 
in this study. 
 
3. What is the purpose of the study? 
  
What we are aiming to achieve in this study is to determine if the addition of 
wearing either a flat sole sport shoe or a rocker sole sport shoe to traditional 
physiotherapy exercises and rehabilitation improves the outcome for patients 
with low back pain.  Research suggests that shoe type may be influential in 
reducing the stresses that pass up through the spine, improving muscle 
activation around the spine, and in doing so may further help to facilitate an 
improvement in outcome for patients with low back pain. There is, however 
very little guidance as to the best type of footwear to achieve these effects. 
This project aims to provide further evidence regarding the best practice in 
treatment of chronic low back pain. This biomechanical study will be 
conducted to explore the potential effects short term (4 weeks) and longer 
term (6 months) use of rocker sole shoes and flat sole shoes may have on 
people with low back pain over time.   
 
4. Why have I been chosen? 
 
If you are eligible to participate in the research study investigating footwear 
and low back pain (REC: 09/H0706/4) you may also be asked if you would be 
happy to take part in this additional biomechanical study. It is up to you to 
decide whether or not to take part. You may choose to be involved in this 
biomechanical study in addition to the back pain and footwear study, or to just 





you will be given this information sheet to keep and be asked to sign a 
consent form before the study starts.  If you decide to take part you are still 
free to withdraw at any time and without giving a reason.  Refusal to 




5. What will happen to me if I take part? 
 
 
The aims of the biomechanical study are to assess whether the study shoes 
have an effect on your posture, balance, and the way you move. If you chose 
to participate in this additional study you will be required to attend the gait 
laboratory at Guy’s Hospital on three occasions: 
 
(1) Before you start the lower back rehabilitation programme. 
(2) At the end of the 4 week lower back rehabilitation programme. 
(3) 6 months after joining the study 
We will ask you not to wear the study shoes you receive at your referring 
physiotherapy department until you have undergone the initial assessment in 
the gait laboratory. These two appointments will be approximately one week 
apart.  
 
The assessment in the gait analysis laboratory will consist of the following: 
 You will be asked to stand on a force plate (a measuring instrument on the 
floor that measures forces generated by you whilst standing on or moving 
across it) for three 40 second trials under different balance situations, for 
example, standing on an unstable surface such as a piece of foam, or 
standing with your eyes-closed. For the eyes-closed assessments we will ask 
you to wear a blindfold. Small markers will be placed at different points on you 
legs and trunk, which will enable us to analyse how you are moving during the 
tasks.  
 You will also be asked to walk in the laboratory, whilst still wearing the 
markers on your skin. This will enable us to assess the movements that occur 
at your joints, and the forces that occur whilst you are walking both in your 
study shoes and barefoot. 
 Certain measurements of your lower limbs (such as the width of your ankles, 
and the distance between your ankle and your knee) will be recorded by the 
chief investigator during your initial visit using a tape measure or callipers. 
These measurements will be used by the chief investigator in the analysis of 
the data recorded during your visits.  
 You will also be asked to complete a questionnaire regarding how your low 
back pain may affect your day to day activities. This should take 2-3 minutes 
to complete. 
 
The markers will be placed on your legs and pelvis trunk with double sided 
sticky tape, and removed at the end of the assessment. The assessment in 
the laboratory will take approximately 1 hour. As we are asking you to travel to 
Guy’s Hospital on 4 occasions for assessment reasonable travel expenses to 






The chief investigator, Sian MacRae, will conduct all 3 assessment sessions. 
It is important that you do not let the chief investigator know which group you 
have been allocated to at any of these reassessment sessions. 
 
The following table summarises the required involvement for this study for 





 Baseline Assessment 
 
Consent form signed, 
body measurements, 
























VISITS TO THE 
GAIT 






















Please note: If you already know that you will not be able to attend the three 
sessions or that you may be moving abroad during the next 6 months, we 
would request that you do not offer to participate. The reason for this is that all 
scientific investigations require that a certain number of people are followed 
for the entire time of the study. If there are not enough people at the end of the 
time period then the results of the study may not be of any meaning.  
 
However, please remember that you are free not to participate and you are 
free to leave the study for whatever reason you choose at any stage. Your 
decision to leave the study will not affect the quality of care you receive. 
 
 
6. What do I have to do? 
 
The first thing you need to do is decide if you would like to participate or not. 
This is entirely your decision and deciding not to participate will not affect the 
quality of your care. If you do decide to participate you will need to follow the 
procedure outlined in section 5.  
 
 
7. What is the procedure that is being tested? 
 
We are trying to determine if the addition of wearing a rocker sole sport shoes 
or flat sole sport shoes in addition to a specialised low back rehabilitation 





back pain. We aim to further investigate whether any such changes correlate 
with an alteration in pain and function. 
 
 
8. What are the side effects of taking part?  
Following the removal of the body markers at the end of the biomechanical 
assessment you may be aware of a slight redness/itchiness of the area 
directly underlying where the marker had been placed. This is normal and 
should settle in approximately one hour.  
 
9. What are the possible disadvantages and risks of taking part? 
There are no perceived disadvantages or risks for those taking part in this 
study. The examination procedures are ones used daily in gait laboratories. 
 
10. What are the possible benefits of taking part? 
 
We do not currently know the most effective treatments for low back pain and 
we hope that this research, investigating the potential biomechanical changes 
in people with low back pain wearing different designs of footwear, will help us 
understand the best way to treat this problem. However, as with all research, 
this cannot be guaranteed.  
 
 
11. What if something goes wrong? 
 
We do not anticipate that anything will go wrong in this study as we are not 
trying any new procedure, we are simply investigating, in a scientific manner, 
the potential effects footwear may have on the biomechanics of people with 
low back pain. 
However, if you are harmed by taking part in this research project, there are 
no special compensation arrangements. If you are harmed due to someone’s 
negligence, then you may have grounds for legal action but you may have to 
pay for it. Regardless of this, if you wish to complain about any aspect of the 
way you have been approached or treated during the course of this study, the 
normal NHS complaints mechanisms are available to you. 
 
12. Will my taking part in this study be kept confidential? 
 
All information that is collected about you during the course of the research 
will be kept strictly confidential.  Any information about you which leaves the 
hospital/surgery will have your name and address removed so that you cannot 
be recognised from it. 
If you do participate your GP (and Consultant, if appropriate) will be sent a 
letter notifying them of your participation in this study (if you give your 







13. What will happen to the results of the research study? 
 
We hope to use the information we obtain from this study to inform other 
health professionals about our results. We therefore ask your permission to 
publish the data we obtain. However, we guarantee to keep your name and 
identity confidential and this will not be made available to anyone at any stage. 
The results will probably be published about one year after the end of the 
study and if you are interested in finding out about our results, we would be 
happy to send you a one page summary of our findings.  
 
 
14. Who is organising and funding the research? 
 
This research is being organised by the Division of Applied Biomedical 
Research, Kings College London. 
 
 
15. Who has reviewed this study? 
 
This study has been reviewed by external experts. In addition it has been 
reviewed by the Hospitals Research and Development Committee and the 
Outer North London Research Ethics Committee. 
 
16. Contact for further information 
 
If you would like any further information about this study, please feel free to 
contact Siân MacRae, Senior Physiotherapist/Doctoral student, on telephone 
number 07504 294 858. 
 
17. After you have read this information sheet 
If you think you would like to participate in this study please take time to think 
about your involvement. You might find speaking to family and friends and 
other healthcare professionals helpful. If you do decide to participate we will 
ask you to fill in and sign a Research Consent Form, in front of someone who 
will witness the signature. 
If you agree to participate you will be given a copy of this information sheet 
and a copy of the consent form you signed.  






11.27 Gait laboratory calibration protocols 
C1 Protocol for the Routine Calibration of Forceplates & Analysis 
Space 
Modified:  Tanya Sale, Laura Wherity; Date:  06 August 2009 
Approved: Adam Shortland. Date: 20/11/2009 
Modified: Adam Shortland Date: 28-10-2010 
 
To be performed at the beginning of each day containing a gait analysis.  The power to the 
forceplates should be on permanently.  If not, turn on power to forceplates 2 hours prior to 
calibration. 
Force plate calibration 
1. Use a shim to check for and remove any material that has got into the gaps around 
the forceplates. 
2. With a trimmer of an appropriate size, adjust pots for each channel on each 
forceplate amplifier (AMTI) until the channel is balanced (green lights go out). 
3. Check switches on Forceplate amplifiers – ensure that the filters are set to 1050 Hz 
and the gain is set to 2000. 
 
Calibration of analysis space 
1. Turn on laboratory PC. 
2. Switch on the giganet box and open Nexus 1.4.116. 
3. In the subjects section on the left hand side ensure that no subjects are checked.  
Make sure that the system setting is on Guy’s Hospital 2. In the resources section 
on the left hand side highlight the MX cameras under Local vicon system, then in 
the properties section below, change the grayscale mode to all.   Select camera 
view in the middle window, so that the view from all cameras can be seen in Live 
mode.  Place the MX calibration wand on forceplate 2. 
4. Zoom in to check that all the markers can be seen on the calibration wand correctly 
(grey and white pixels slightly overlapping the circle representing the marker) for 
each camera 
5. Change the grayscale mode back to auto.  Remove the calibration wand from the 
analysis space. 
6. In the tools section on the right hand side click the “system preparation” button.  
Ensure “5 marker wand and L-frame” is selected in the wand and L-frame drop 





7. Create MX camera masks by pressing the start button, waiting two seconds and 
pressing the stop button. 
8. Under calibrate MX cameras click “show parameters” and check that the settings 
are: Full Calibration; MX cameras; 200; 1600 and the autostop is selected. Press 
“start” and wave the wand through the analysis space, letting each camera see the 
wand from different perspectives, until blue light on every camera stops flashing. 
9. Under MX Camera Calibration feedback check that the wand count and image error 
boxes are green for all cameras and record the image error on the data collection 
sheet to 3 signficant figures.  If the wand count and image error boxes are not 
green repeat step 7. 
10. Place the calibration wand on forceplate 2 (central forceplate) with the handle 
pointing towards camera 7 (and the penguins).  Locate the calibration wand at the 
corner of the forceplate, and adjust the screws on the wand until the spirit levels 
indicate level. 
11. Change the middle window to 3D perspective.   Under set volume origin click 
“start”, followed by “set origin”.  The calibration wand should now be visible in the 
correct position on forceplate 2.   If it is not repeat the calibration process. 
12. Put the calibration wand away in the store room. 
 
Static Daily Weight Test  Protocol: 
1. Make sure the force plate amplifier potentiometers (pots) have been zeroed (all green 
lights are off) 
2. Reduce force threshold to zero (In Nexus live, in the System tab, select Force Plates and 
click to show the Advanced Properties in the Properties window below. Expand the Force 
Threshold field and move the main slider so all three devices are zero) 
3. Start recording a trial named Weight Test with nothing on the FPs, then after c.1 second 
wheel the trolley with 30kg onto FP1, move to FP2, move to FP3, end trial 
4. Run the ResetFPs pipeline function 
5. View the Fz forces for each forceplate (In Nexus non-live, in the System tab, select Force 
Plates and expand to highlight all three Force/Fz fields (hold down control to select more 
than one field at once). Also ensure the tabs at the top of the main window are changed 
from 3D Perspective to Graph,and Trajectory Count to Components. 
6. Move the time bar to locate a static portion of Fz for each force-plate and record the Fz 
value on the patient data-sheet for the trial and then in the three grey columns on the left. 
If outside the set tolerance the cells will turn green, if not, then red. 
 
Note: The trolley is 6.1 kg + 30kg = 31.6kg = 354.14N. The tolerance is set on the right with 
the upper and lower limits automatically calculated. 
 
Daily Dynamic Pole Test 
 
1. Dynamic data for each force plate is to be collected in a single trial. 
2. Start collecting dynamic data by placing the stick at the centre of each force plate in 
turn. At the corners, the stick should be positioned approximately 5 - 6cm from the 





as possible (greater than 50N). Then, whilst pushing down on the stick, move the stick 
around the point of contact.  
3. Be careful not to apply off-axis forces to the pole. 
4. Apply reset forceplate offsets in software. 
5. Inspect data in the workspace window to assess agreement between direction and 
origin of the force vector and the direction and position defined by the pole. 
6. Record pass/fail on patient sheet. 
 
 
Signed.................................................  Date:................................ 
 
 
C2 Protocol for the routine static calibration check of the forceplates 
Author: Tanya Sale, Adam Shortland 
Date: 12th February 2010 
- To be performed at 6 monthly intervals.. 
- Requires 2 people 
 
1) Zero the forceplates on the forceplate pots. 
2) Open ‘ViconNexusLocal’. ‘GraphView’. In the ‘System’ tab, ‘Resources’ window 
select ‘Forceplates’, ‘Forceplate 1’, ‘force’, ‘Fz’. 
3) Open the ‘data management’ window of Nexus and select ‘tests’, ‘forceplate 
stability’. 
4) Make a new session called FP(no of forceplate)-date eg. FP112-Feb-10. 
5) Import the session to Nexus using the middle button in the ‘resources’ window, 
accept ‘forceplate stability’ as the patient name, and select ‘GuysPlugInGait’ 
6) To begin data collection click ‘start’ in the data collection window. 
7) The other member of staff puts weights of 10, 20, 40, 60, 80, 100kg onto forceplate 
one leaving a few seconds in between each addition.   
8) After 100kg has been added to forceplate 1, press stop. 
9) Save the trial as ‘LaboratoryForcePlateRoutineStaticCalibration..plus the date’ eg.  
LaboratoryForcePlateRoutineStaticCalibration25-oct-2010. 
10) Repeat stages 6-9 on forceplate 2 and 3. 
11) To process the results of the trials open the trial in NexusLocal.  In the ‘Resource’ 
window go to ‘Forceplates’, ‘Force’, ‘Fz’ and select ‘GraphView’ in the middle 
window.  Use the slider bar to view the forces recorded for each weight, and record 
this dat on the ForceplateStability’ template. 






11.28 Calibration of anthropometric measuring 
equipment 
C6 Protocol for simple measurements tool check 
 
Author: Tanya Sale and Adam Shortland 10/03/2010 
Approved: Adam Shortland 10/03/2010 
 
Perform the following checks annually: 
Tape measure 
The white and purple tape measure is routinely used for clinical examination 
measurements. 
Check 3  15 cm sections of the measuring tape. These should be between 10 
and 25 cm, 40 and 55 cm, and 80 and 95 cm as indicated on the tape. Use 
the  Vernier callipers (the Gold standard) to define a 15 cm length. If any 
discrepancy is larger than 0.2 cm discard the tape measure, get a new one 
and repeat checks. 
Stadiometer 
Check 3  15 cm sections of the metal carpet measuring tape. These should 
be between 10 and 25 cm, 100 and 115 cm, and 150 and 165 cm as 
indicated on the tape. Use the  Vernier callipers (the Gold standard) to define 
a 15 cm length. If any discrepancy is larger than 0.2 cm discard the tape 
measure, get a new one and repeat checks. 
Large Calipers 
Check 15 cm inter-calliper distance using Vernier calliper. If any discrepancy 
larger than 0.3 cm modify ratchet mechanism. 
Small Calipers 
Check 15 cm inter-calliper distance using Vernier calliper. If any discrepancy 
larger than 0.3 cm replace callipers. 
Goniometer 
Place goniometer over laminated template with the centre of the goniometer 
over the central dot. Place one arm of the goniometer on the reference line. 
Then place the moveable arm at each of the following indicated graduations 
(0, 30, 60, 90, 120, 150, 180 ,210, 240, 270, 300, 330 degrees). If any of the 
measurements disagree by any more than three degrees, replace 
goniometer and repeat. 
 






C3_Protocol for calibration of gait lab weighing scales 
 
Author: Tanya Sale, Adam Shortland 
Date: 12th February 2010 
Last Reviewed:  05/03/10 (APS) 
Modified: 28-oct-2010 (APS) 
-to be performed at six monthly intervals. 
1) Open ‘GaitLabDocs’, 
‘MedicalDeviceCalibrationChecksWeighingScalesStability’, 
‘LabWeighingScalesRoutineCalibrationCheck’ 
2) Turn on the weighing scales. 
3) Note the value the scales are reading with no weight applied in the 
excel spreadsheet ‘LabWeighingScalesRoutineCalibrationCheck’ as 
described in note (1). 
4) Put a 10kg weight on the scales and note the value the scales are 
recording in the excel spreadsheet. 
5) Repeat for weights of 20, 40, 60, 80 and 100kg and record in the excel 
spreadsheet. 
6) Save the completed form as an excel 97-2003 workbook with the 
same name and the date on the end eg: 
LabWeighingScalesRoutineCalibrationCheck12-Feb-10. 











11.29  Protocol for marker placement  
 
Date: 10/10/08 
Author: Adam Shortland/Tanya Sale 
Modified: 05/03/10 (TS/APS) 
Reviewed: 05/03/10 (APS) 
Modified: 04-05-12 Tanya Forster.  (SENIAM guidelines reference added) 
Approved: 04-05-12 Adam Shortland 
 
Scope:  For placement of lower limb markers for routine clinical gait analysis in the One 
Small Step Gait Laboratory 
 
With the patient sitting with legs off the side of the plinth place markers in the following 
order: 
 
Ankle marker bilaterally:  Mark most prominent point of lateral malleolus.  Stick marker to 
the lateral malleolus with the centre of the circular base of the marker over the marked 
point. 
 
Forefoot marker bilaterally:  Mark position on dorsum of foot between 2nd and 3rd rays just 
proximal to the equinus break between forefoot and midfoot.  Stick down marker with the 
centre of the circular base of the marker over the marked point. 
 
Heel marker bilaterally:  It should be placed on the back of the heel so that the line joining 
it to the forefoot markers reflects the long axis of the foot. If the subject is able to stand 
with foot flat height of the heel marker is unimportant provided foot flat check box in the 
trial form is set before processing. Mark point on hindfoot that is approximately at the 
same height from the sole of the foot as the forefoot marker. Stick down marker with the 
centre of the circular base of the marker over the marked point. 
 
Shank marker bilaterally:  placed on the lower third of the shank on a line between the 
estimated flexion axis of the knee and the lateral malleolus marker.  Alignment of the shank 
marker is carried out at the end of marker placement. 
 
Knee Marker Bilaterally:  Place a marker halfway between the most prominent point of the 
lateral epicondyle and the knee joint line.  
 
Thigh Marker Placement:  Placed over the lower third of the lateral thigh.   
 
ASIS:  ASIS markers on left and right Palpate ASIS bilaterally and place marker directly over 
these points. If the patient is obese or the markers cannot be placed directly over the ASIS’ 
bilaterally, move the markers laterally by equal distance and enter the ASIS distance 
measured in the static exam.  
 
Sacrum Marker Bilaterally: Palpate posterior superior iliac spines bilaterally. Place a marker 
on the skin midway between both posterior superior iliac spines. 
 








Have patient stand sideways on to mirror. Align patient so that the knee axis is 
perpendicular to the plane of the mirror. By looking in the mirror place the thigh marker so 
that it is aligned with the greater trochanter and knee marker. Align the child so that the 
ankle axis is perpendicular to the mirror (this may involve turning the child slightly). Place 















11.30 Error analysis to demonstrate robustness of 
determining heel strike and foot offs from a participant’s 
kinematic compared to force plate data.  
Introduction 
To determine spatio-temporal parameters in the biomechanical studies it was necessary to 
define heel strike and foot off phases of gait within Vicon Nexus (movement analysis 
software supplied by Vicon Motion Systems, Oxford, UK). Using force plate data to identify 
these phases of the gait cycle is the method of choice. However, in trials without force plate 
data, or where force plate data were contaminated, gait cycle events were determined 
through observation of the patterns of the heel and forefoot trajectories. The latter method 
may have resulted in an imprecision in the labelling of gait cycle events, potentially 
resulting in an error in the spatio-temporal data obtained. In order to determine the size of 
the potential error, an error analysis was conducted. 
 
Methods 
Ten barefoot gait trials were selected (by Dr Adam Shortland [AS]) from participants’ 
barefoot baseline assessment gait data (Chapter 7). These trials all had force plate data 
from which the events of foot strike and foot off could be marked. All heel strike and toe off 
event locators, inserted previously by Sian MacRae for analyses of trial data, were removed 
by AS. Duplicate copies of each trial were made, one copy enabling SM to visualise the force 
plate ground reaction vectors, whilst on the duplicate copy the option to visualise ground 
reaction vectors was removed. The twenty trials (10 with ground reaction vectors visible 
and 10 without) were randomly ordered by AS. SM then reviewed all trials, inserting heel 
strike and toe off phases of gait, for one gait cycle (a total of seven events), occurring across 
the three force plates. When force plate data was present, SM located gait events from 
observation of the ground reaction vectors. For trials absent of ground reaction vector data 
SM located heel strike and toe-off phases of gait through visual inspection of patterns of 
the heel and forefoot trajectories. 
 
Following the labelling of all events, SM documented the frame number of each labelled 
heel strike and toe off event for each trial. SM was then unblinded to which trials were the 
matching pairs. SM inspected the frame numbers recorded for each event, and 





force plate data). AS developed a computer programme (developed in Visual Basic for 
Applications, Microsoft, Berkshire, UK) which randomly generated errors in the gait events 
of all trials analysed in the baseline barefoot assessment of the twenty CLBP participants 
assessed in Chapter 7, according to the documented distribution of errors from the blinded 
analysis. Means and standard deviations were obtained for each participant for the 
cadence, stride length and walking speed, and compared to the results for the baseline data 
presented in Chapter 7. 
 
Results 
Table 1 shows the distribution of errors (difference between paired duplicate trials from 
which visualisation of force plate data has been removed). There were no errors greater 
than two frames (1/60th of a second). There was a wider distribution of errors for toe-off 
than for heel strike. 
Table 1. Percentage of gait events labelled through visual inspection of kinematic data that 
were identical and different to those labelled from observation of force plate data.  
Phase of 
gait cycle 
Difference in frame numbers identified as gait cycle events between 
trials with and without force plate data (%) 
-2 frames -1 frame No 
difference 
+1 frame +2 frames 
Toe-off 10 20 45 15 10 
Heel strike 5 15 50 25 5 
 
Table 2 demonstrates the mean data obtained in Chapter 7 for baseline barefoot gait, and 
the mean data and standard error of the mean obtained following the error analysis 
calculations. The simulated analysis incorporating the error distribution produced very 
similar results to the original analysis with 1 % error in estimated walking speed, stride 






Table 2. Baseline barefoot mean spatio-temporal data obtained in Chapter 7 and following 








Chapter 7 mean 
(SD) 













This error analysis investigated the concern that differences in the marking of temporal 
events due the presence or absence of force plate data may have affected the results for 
the temporal parameters (walking speed, stride length, cadence) in the study. From the 
analysis it seems that there are no systematic deviations between events marked with the 
aid of force plates and those marked without (Table 1), and that the random error is so 
small (maximum of two frames) that its impact on the results from the biomechanical 
studies would be minimal (Table 2). 
 
Limitations 
The error analysis was performed on only barefoot gait. It is possible that the errors 
between force plate-assisted and non-assisted event labelling may be greater in shod trials. 
 
Implications 
The error analysis study suggests that the approach used to determine phases of gait in the 






11.31 Biomechanical study ethical approval letter 
 
Outer North London REC 
Northwick Park Hospital 






 Telephone: 020 8869 3020  
Facsimile: 020 8869 5222 
15 March 2010 
 
Miss Sian MacRae 
Doctoral Student 
King's College London 
School of Biomedical & Health Science 
PhD Office, Room SH 3.11 




Dear Miss MacRae 
 
Study Title: Low back pain: Can shoe type reduce the pain and 
recurrence rate? A biomechanical assessment. 
REC reference number: 10/H0724/7 
Protocol number: 1 
 
Thank you for your letter of 09 March 2010, responding to the Committee’s request 
for further information on the above research and submitting revised documentation. 
 
The further information has been considered on behalf of the Committee by me 
(Committee Chair). 
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion 
for the above research on the basis described in the application form, protocol and 
supporting documentation as revised, subject to the conditions specified below. 
 
Ethical review of research sites 
 
The favourable opinion applies to all NHS sites taking part in the study, subject to 
management permission being obtained from the NHS/HSC R&D office prior to the 
start of the study (see “Conditions of the favourable opinion” below). 
 
The Committee has not yet been notified of the outcome of any site-specific 
assessment (SSA) for the non-NHS research site(s) taking part in this study. The 
favourable opinion does not therefore apply to any non-NHS site at present. I will 
write to you again as soon as one Research Ethics Committee has notified the 







Conditions of the favourable opinion 
 
The favourable opinion is subject to the following conditions being met prior to the 
start of the study. 
 
Management permission or approval must be obtained from each host organisation 
prior to the start of the study at the site concerned. 
 
For NHS research sites only, management permission for research (“R&D 
approval”) should be obtained from the relevant care organisation(s) in accordance 
with NHS research governance arrangements.  Guidance on applying for NHS 
permission for research is available in the Integrated Research Application System 
or at http://www.rdforum.nhs.uk.  Where the only involvement of the NHS 
organisation is as a Participant Identification Centre, management permission for 
research is not required but the R&D office should be notified of the study. Guidance 
should be sought from the R&D office where necessary. 
 
Sponsors are not required to notify the Committee of approvals from host 
organisations. 
 
It is the responsibility of the sponsor to ensure that all the conditions are 





The final list of documents reviewed and approved by the Committee is as follows: 
  
Document    Version    Date      
Covering Letter    01 February 2010    
REC application  1  29 January 2010    
Protocol  1  29 January 2010    
Investigator CV    29 January 2010    
Participant Consent Form  1  29 January 2010    
GP/Consultant Information Sheets  1  29 January 2010    
Evidence of insurance or indemnity         
Advertisement  1  28 November 2008    
Supervisor's CV    29 January 2010    
Roland Morris Disability Questionnaire         
Evidence of insurance or indemnity         
Participant Information Sheet  2  09 March 2010    
Response to Request for Further Information  email  09 March 2010    
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard 
Operating Procedures for Research Ethics Committees in the UK. 
 






Now that you have completed the application process please visit the National 
Research Ethics Service website > After Review 
 
You are invited to give your view of the service that you have received from the 
National Research Ethics Service and the application procedure.  If you wish to 
make your views known please use the feedback form available on the website. 
 
The attached document “After ethical review – guidance for researchers” gives 
detailed guidance on reporting requirements for studies with a favourable opinion, 
including: 
 
 Notifying substantial amendments 
 Adding new sites and investigators 
 Progress and safety reports 
 Notifying the end of the study 
 
The NRES website also provides guidance on these topics, which is updated in the 
light of changes in reporting requirements or procedures. 
 
We would also like to inform you that we consult regularly with stakeholders to 
improve our service. If you would like to join our Reference Group please email 
referencegroup@nres.npsa.nhs.uk.  
 












Enclosures: “After ethical review – guidance for researchers”  
 
Copy to: Mr Keith Brennan 
King’s College London 





Ms Karen Ignation 
Guy’s and St. Thomas’ NHS Foundation Trust 
16th Floor, Guy’s Tower Wing 
Guy’s Hospital 






11.32 Biomechanical study consent form 
Guy's Hospital 
St Thomas Street 
London SE1 9RT 
Tel: 020 7188 7188 
Research Subject Consent Form  
 
Title of Project: Low back pain: Can shoe type reduce the pain and 
recurrence rate? A biomechanical assessment. 
 
Protocol Version: Version 1 Date 29.01.10 
 
Local Research Ethics Number: 10/H0724/7  R & D Registration Number: 
 






    Please initial 
 box if correct 
I have been given the chance to read and understand the 
information sheet (dated 29.01.10)  relating to the above study 
 
  
   




   




   
I understand that authorised individuals may look at my 




   
I understand that I am free to withdraw from this study at any 
time without prejudice to my future care/ treatment 
  
  
   




   
I would like my GP or consultant to know that I am participating 
in this research project.  
  
  
   
I would like to receive a one page summary of the findings of 







Title of Project:  Low back pain: Can shoe type reduce the pain and 




Local Research Ethics Number:  10/H0724/7  
     
R & D Registration Number: 
 
Patient Hospital Number:     
 
 





Name  ……………………………………………………………… 
 
Date  ……………………………………………………………… 
 
 
Person responsible for obtaining Informed Consent: 
'To the best of my knowledge I have provided the above individual with 




Name  ……………………………………………………………… 
 









Name  ……………………………………………………………… 
 






11.33 King’s College London Ethics approval for 
biomechanical study investigating asymptomatic 
individuals 
13 June 2011 
 
Dear Sian,   
 
BDM/10/11-71 Biomechanical assessment of asymptomatic individuals whilst standing and 
walking 
 
Thank you for sending in the amendments requested to the above project. I am pleased to inform you 
that these meet the requirements of the BDM RESC and therefore that full approval is now granted 
with the following proviso:  
1. Section 5.3: Given that you intend to recruit friends and colleagues, it is strongly 
recommended that you consult the Research Ethics office guidelines, Research in the 
Workplace.  These are accessible at the link below: 
http://www.kcl.ac.uk/research/ethics/training/workplace.html 
Please ensure that you follow all relevant guidance as laid out in the King's College London Guidelines 
on Good Practice in Academic Research (http://www.kcl.ac.uk/college/policyzone/index.php?id=247). 
 
For your information ethical approval is granted until 13 June 2012. If you need approval beyond this 
point you will need to apply for an extension to approval at least two weeks prior to this explaining why 
the extension is needed, (please note however that a full re-application will not be necessary unless 
the protocol has changed). You should also note that if your approval is for one year, you will not be 
sent a reminder when it is due to lapse. 
 
If you do not start the project within three months of this letter please contact the Research Ethics 
Office. Should you need to modify the project or request an extension to approval you will need 
approval for this and should follow the guidance relating to modifying approved applications: 
http://www.kcl.ac.uk/research/ethics/applicants/modifications.html 
 
Any unforeseen ethical problems arising during the course of the project should be reported to the 
approving committee/panel. In the event of an untoward event or an adverse reaction a full report must 
be made to the Chairman of the approving committee/review panel within one week of the incident. 
 
Please would you also note that we may, for the purposes of audit, contact you from time to time to 
ascertain the status of your research.  
If you have any query about any aspect of this ethical approval, please contact your panel/committee 
administrator in the first instance (http://www.kcl.ac.uk/research/ethics/contacts.html). We wish you 
every success with this work. 
 
With best wishes 
 
Yours sincerely 
James Patterson – Senior Research Ethics Officer 





11.34 Asymptomatic study participant 
information sheet 
INFORMATION SHEET FOR PARTICIPANTS 
 
REC Reference Number: BDM/10/11-71 
 
YOU WILL BE GIVEN A COPY OF THIS INFORMATION SHEET 
 
Biomechanical assessment of asymptomatic individuals whilst standing and walking. 
 
We would like to invite you to participate in this postgraduate research project.  You should 
only participate if you want to; choosing not to take part will not disadvantage you in any way. 
Before you decide whether you want to take part, it is important for you to understand why the 
research is being conducted and what your participation will involve.  Please take time to read 
the following information carefully and discuss it with others if you wish.  Ask us if there is 
anything that is not clear or if you would like more information. 
 
Aims of the research and possible benefits. 
 
In this study we are aiming to determine if there is a difference in how people with and without 
lower back pain stand and walk. We will assess this in a gait laboratory. We will compare the 
data from this study with data collected from a similar sample of people who have lower back 
pain. The data from people with lower back pain has been collected in a preceding research 
trial. 
 
Who are we recruiting? 
 
If you are aged between 18 and 65 years and have had no history of lower back pain in the 
past year you may be eligible to participate in this research study. However, if any of the 
following points are true for you, you will not be able to participate: known structural spinal 
deformity; previous spinal surgery; fracture of the spine within the past year; inflammatory 
disease of the spine; spinal infection; severe cardiovascular or metabolic disease; pregnancy; 
known Mortons Neuroma; skin ulcerations over the foot; peripheral neuropathy with loss of 
sensation; history of falls; surgery to the lower limb less than 8 weeks ago; recent deep vein 
thrombosis yet to be stabilised by anti-coagulation therapy; those who have previously used 
rocker-bottom shoes e.g. MBT’s or FitFlops. 
 
What will happen to me if I take part? 
 
The aims of the biomechanical study are to assess your posture, balance and the way you 
move. If you chose to participate in this study you will be required to attend the One Small Step 
Gait Laboratory at Guy’s hospital on one occasion. You will be asked to wear shorts and a T-
shirt/vest top for the assessment. 
The assessment in the gait laboratory will consist of the following: 
 You will also be asked to complete a consent form and questionnaire relating to your day to 
day activities. This should take 2-3 minutes to complete. 
 You will be asked to bring with you a pair of shorts and a t-shirt or vest top to change into for 





lower limbs will be recorded by the co-researcher (Dr Adam Shortland) during your visit using a 
tape measure or callipers. These will include the width of your ankles, knees and pelvis, and 
the length of your legs. These measurements will be used by the primary investigator (Sian 
MacRae) in the analysis of the data recorded during your visit. We will also record your height 
and weight. 
 Small reflective markers (21 in total) will be placed at different points on your legs, on your 
lower abdomen, and on your lower back region, which will enable us to analyse how you are 
moving during the tasks. The markers will be placed on your legs, pelvis and trunk with double 
sided sticky tape, and removed at the end of the assessment. 
 You will be asked to stand with each leg on a separate force plate (a force plate is a measuring 
instrument on the floor, with the appearance of a normal floor tile, that measures forces 
generated by you whilst standing on or moving across it) for three 40 second trials under the 
following balance situations: 
o Standing barefoot with your eyes open 
o Standing barefoot with your eyes closed 
o Standing with each foot on a separate foam cushion with your eyes open 
o Standing with each foot on a separate foam cushion with your eyes closed 
For the eyes-closed assessments we will ask you to wear a blindfold.  
You will also be asked to walk in the laboratory, whilst still wearing the markers. We will ask 
you to walk for approximately 10 meters and repeat this approximately 5 times. This will enable 
us to assess the movements that occur at your joints, and the forces that occur whilst you are 
walking barefoot. 
The assessment in the laboratory will take approximately 1 hour. Please remember that you 
are free not to participate and you are free to leave the study for whatever reason you choose 
at any stage.  
 
What are the side effects of taking part?  
 
Following the removal of the body markers at the end of the biomechanical assessment you 
may be aware of a slight redness/itchiness of the area directly underlying where the marker 
had been placed. This is normal and should settle in approximately one hour.  
What are the possible advantages of taking part? 
We hope to use the information we obtain from this study to inform other health professionals 
about our results by means of journal publications and conference presentations. The results 
will probably be published about one year after the end of the study and if you are interested in 
finding out about our results, we would be happy to send you a one page summary of our 
findings.  
What are the possible disadvantages and risks of taking part? 
There are no perceived disadvantages or risks for those taking part in this study. The 







Will my taking part in this study be kept confidential? 
All information that is collected about you during the course of the research will be kept strictly 
confidential.  Any information about you which leaves the gait laboratory will have your name 
removed so that you cannot be recognised from it. 
 
Who is organising and funding the research? 
 
This research is being organised by the Division of Health and Social Care, Kings College 
London. 
 
It is up to you to decide whether to take part or not. If you do decide to take part you will be 
given this information sheet to keep and be asked to sign a consent form. If you decide to take 
part and then decide at any time during the research that you no longer wish to participate in 
this project, you can notify the researchers involved and withdraw from it immediately without 
giving any reason. If you have any general queries regarding the study you may contact the 




Primary Investigator: Sian MacRae  Email:  sian.macrae@kcl.ac.uk 
Division of Health and Social Care 
School of Medicine 
King’s College London 
Shepherd's House 3.11 
Guy's Campus 
London SE1 1UL 
      Tel:  020 7848 6679 
 
 
If this study has harmed you in any way you can contact King's College London using the 
details below for further advice and information:  
 
 
Dr Duncan Critchley (PhD Primary Supervisor) Email: duncan.critchley@kcl.ac.uk 
Academic Department of 
Physiotherapy / Division of Health 
and Social Care 
School of Medicine 
King’s College London 
Shepherd's House 3.18 
Guy's Campus 
London SE1 1UL 








11.35 Asymptomatic study consent form 
CONSENT FORM FOR PARTICIPANTS IN RESEARCH STUDIES 
 
Please complete this form after you have read the Information Sheet and/or listened to an 
explanation about the research. 
Title of Study: Biomechanical assessment of asymptomatic individuals whilst 
standing and walking. 
 
King’s College Research Ethics Committee Ref: BDM/10/11-71 
Thank you for considering taking part in this research. The person organising the research must 
explain the project to you before you agree to take part.  If you have any questions arising from 
the Information Sheet or explanation already given to you, please ask the researcher before you 




I understand that if I decide at any time during the research that I no longer wish to 
participate in this project, I can notify the researchers involved and withdraw from it 
immediately without giving any reason. Furthermore, I understand that I will be able to 
withdraw my data up to the point of publication. 
 
I consent to the processing of my personal information for the purposes explained to me.  
I understand that such information will be handled in accordance with the terms of the 
Data Protection Act 1998. 
 
I understand that I must not take part if I have: known structural spinal deformity; 
previous spinal surgery; fracture of the spine within the past year; inflammatory disease 
of the spine; spinal infection ; severe cardiovascular or metabolic disease; pregnancy; 
known Mortons Neuroma; skin ulcerations over the foot; peripheral neuropathy with loss 
of sensation; history of falls; surgery to the lower limb less than 8 weeks ago; recent 
deep vein thrombosis yet to be stabilised by anti-coagulation therapy; previously used 






agree that the research project named above has been explained to me to my satisfaction and I 
agree to take part in the study. I have read both the notes written above and the Information Sheet 
about the project, and understand what the research study involves. 
 




Confirm that I have carefully explained the nature, demands and any foreseeable risks (where 
applicable) of the proposed research to the participant. 
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